U.S. patent application number 12/994408 was filed with the patent office on 2011-06-09 for systems and methods for expression-based discrimination of distinct clinical disease states in prostate cancer.
This patent application is currently assigned to GENOMEDX BIOSCIENCES, INC.. Invention is credited to Elai Davicioni.
Application Number | 20110136683 12/994408 |
Document ID | / |
Family ID | 41376502 |
Filed Date | 2011-06-09 |
United States Patent
Application |
20110136683 |
Kind Code |
A1 |
Davicioni; Elai |
June 9, 2011 |
Systems and Methods for Expression-Based Discrimination of Distinct
Clinical Disease States in Prostate Cancer
Abstract
A system for expression-based discrimination of distinct
clinical disease states in prostate cancer is provided that is
based on the identification of sets of gene transcripts, which are
characterized in that changes in expression of each gene transcript
within a set of gene transcripts can be correlated with recurrent
or non-recurrent prostate cancer. The Prostate Cancer Prognostic
system provides for sets of "prostate cancer prognostic" target
sequences and further provides for combinations of polynucleotide
probes and primers derived there from. These combinations of
polynucleotide probes can be provided in solution or as an array.
The combination of probes and the arrays can be used for diagnosis.
The invention further provides further methods of classifying
prostate cancer tissue.
Inventors: |
Davicioni; Elai; (Vancouver,
CA) |
Assignee: |
GENOMEDX BIOSCIENCES, INC.
Vancouver
BC
|
Family ID: |
41376502 |
Appl. No.: |
12/994408 |
Filed: |
May 28, 2009 |
PCT Filed: |
May 28, 2009 |
PCT NO: |
PCT/CA2009/000694 |
371 Date: |
February 17, 2011 |
Related U.S. Patent Documents
|
|
|
|
|
|
Application
Number |
Filing Date |
Patent Number |
|
|
61056827 |
May 28, 2008 |
|
|
|
Current U.S.
Class: |
506/7 ; 506/16;
506/39 |
Current CPC
Class: |
C12Q 1/6886 20130101;
C12Q 2600/112 20130101; C12Q 2600/158 20130101; C12Q 2600/118
20130101 |
Class at
Publication: |
506/7 ; 506/16;
506/39 |
International
Class: |
C40B 30/04 20060101
C40B030/04; C40B 40/06 20060101 C40B040/06; C40B 60/12 20060101
C40B060/12 |
Claims
1. A system for expression-based assessment of prostate cancer
recurrence risk, said system comprising one or more
polynucleotides, each of said polynucleotides capable of
specifically hybridizing to a RNA transcript of a gene selected
from the group of genes set forth in Table 3 and/or Table 6.
2. The system of claim 1, wherein said one or more polynucleotides
comprise one or more polynucleotide probes for the detection of the
respective transcript.
3. The system of claim 1, wherein said one or more polynucleotides
comprise one or more primer pairs, each of said primer pairs
capable of amplifying a portion of a sequence corresponding to the
respective transcript.
4. The system of any one of claims 1, 2 and 3, wherein said
transcript comprises a sequence corresponding to one or more of the
sequences set forth in SEQ ID NOs: 1-2114.
5. The system of any one of claims 1, 2 and 3, wherein said
transcript comprises a sequence corresponding to one or more of the
sequences set forth in a SEQ ID NOs: 914-2114.
6. The system according to any one of claims 1 to 5, wherein said
system comprises at least 5 polynucleotides.
7. The system according to any one of claims 1 to 5, wherein said
system comprises at least 10 polynucleotides.
8. The system according to any one of claims 1 to 5, wherein said
system comprises at least 100 polynucleotides.
9. The system of claim 1, wherein each of said one or more
polynucleotides comprises a sequence corresponding to, or
complementary to, one or more of the sequences set forth in Table 4
or a fragment thereof.
10. The system of claim 1, wherein each of said one or more
polynucleotides comprises a sequence corresponding to one or more
nucleic acid molecules selected from the group consisting of: (a) a
nucleic acid depicted in any one of SEQ ID NOs: 1-2114; (b) an RNA
form of any one of the nucleic acids depicted in SEQ ID NOs:
1-2114; (c) a peptide nucleic acid form of any one of the nucleic
acids depicted in SEQ ID NOs: 1-2114; (d) a nucleic acid comprising
at least 20 consecutive bases of any of (a-c); (e) a nucleic acid
comprising at least 25 consecutive bases having at least 90%
sequence identity to any of (a-c); and (f) a complement to any of
(a-e).
11. The system of claim 1, wherein said transcript comprises one or
more of the sequences as set forth in SEQ ID NOs: 1, 4, 6, 9,
14-16, 18-21 915-917, 920, 922, 928, 929, 931, 935 and 936.
12. The system of claim 1, wherein said transcript comprises one or
more of the sequences as set forth in SEQ ID NOs: 3, 36, 60, 63,
926, 971, 978, 999, 1014 and 1022.
13. The system of claim 1, wherein said transcript comprises one or
more of the sequences as set forth in SEQ ID NOs 1-3, 32, 33, 36,
46, 60, 63, 66, 69, 88, 100, 241, 265, 334, 437, 920, 925, 934,
945, 947, 954, 971, 978, 999, 1004, 1014, 1022, 1023, 1032, 1080,
1093, 1101, 1164, 1248, 1304, 1311, 1330, 1402, 1425.
14. Use of the system according to any one of claims 1, 2 and 4 to
11 for the preparation of a nucleic acid array
15. A nucleic acid array for expression-based assessment of
prostate cancer recurrence risk, said array comprising at least ten
probes immobilized on a solid support, each of said probes being
between about 15 and about 500 nucleotides in length, each of said
probes being derived from a sequence corresponding to, or
complementary to, a transcript of a gene selected from the group of
genes set forth in Table 3, or a portion of said transcript.
16. The nucleic acid array according to claim 15, wherein each of
said probes comprises a sequence as set forth in any one of SEQ ID
NOs: 1-2114 or complement thereof.
17. A method for expression-based assessment of prostate cancer
recurrence risk, said method comprising: (a) determining the
expression level of one or more transcripts of one or more genes in
a test sample obtained from said subject to provide an expression
pattern profile, said one or more genes selected from the group of
genes set forth in Table 3, and (c) comparing said expression
pattern profile with a reference expression pattern profile.
18. The method of claim 17, wherein an increased relative level of
expression of one or more transcripts, a decreased relative level
of expression of one or more transcripts, or a combination thereof
is used to classify a prostate cancer as recurrent.
19. The method of claim 17, wherein an increased relative level of
expression of one or more transcripts, a decreased relative level
of expression of one or more transcripts, or a combination thereof
is used to classify a prostate cancer as non-recurrent.
20. The method of claim 17; wherein said transcripts comprise a
sequence as set forth in any one of SEQ ID NOs: 1-2114 or
complement thereof.
21. The method of claim 17, wherein said one or more transcripts
comprise one or more sequences as set forth in any one of SEQ ID
NOs: 1, 4, 6, 9, 14-16, 18-21 915-917, 920, 922, 928, 929, 931, 935
and 936.
22. The method of claim 17, wherein said transcript comprises one
or more of the sequences as set forth in SEQ ID NOs: 3, 36, 60, 63,
926, 971, 978, 999, 1014 and 1022.
23. The method of claim 17, wherein said transcript comprises one
or more of the sequences as set forth in SEQ ID NOs 1-3, 32, 33,
36, 46, 60, 63, 66, 69, 88, 100, 241, 265, 334, 437, 920, 925, 934,
945, 947, 954, 971, 978, 999, 1004, 1014, 1022, 1023, 1032, 1080,
1093, 1101, 1164, 1248, 1304, 1311, 1330, 1402, 1425.
24. The method of claim 17, wherein the expression level of the one
or more target sequences is determined by a method selected from
the group consisting of RT-PCR, Northern blotting, ligase chain
reaction, array hybridization, and a combination thereof.
25. The method of any one of claims 17 to 24, further comprising
measuring the expression level of at least one control nucleic acid
in the sample.
26. The method of any one of claims 17 to 25, wherein the sample is
a fine needle aspirate biopsy [FNAB], cytology smear, cytology
pellet, or a bulk tissue preparation.
27. The method of any one of claims 17 to 26, wherein the sample is
fresh-frozen or fixed.
28. The method of any one of claims 17 to 27, wherein measuring the
expression level utilizes a pattern recognition method.
29. The method of claim 28, wherein the pattern recognition method
comprises a linear combination of expression levels of the target
sequences.
30. The method of claim 28 or 29, wherein the pattern recognition
method comprises a nonlinear combination of expression levels of
the target sequences.
31. A kit for characterizing the expression of one or more nucleic
acid sequences depicted in SEQ ID NOs: 1-2114 comprising one or
more nucleic acids selected from: (a) a nucleic acid depicted in
any of SEQ ID NOs: 1-2114; (b) an RNA form of any of the nucleic
acids depicted in SEQ ID NOs: 1-2114; (c) a peptide nucleic acid
form of any of the nucleic acids depicted in SEQ ID NOs: 1-2114;
(d) a nucleic acid comprising at least 20 consecutive bases of any
of (a-c); (e) a nucleic acid comprising at least 25 consecutive
bases having at least 90% sequence identity to any of (a-c); or (f)
a complement to any of (a-e); and optionally instructions for
correlating the expression level of said one or more nucleic acid
sequences with the disease state of prostate cancer tissue.
32. The kit of claim 31, wherein said one or more nucleic acids
comprises one or more sequences as set forth in any one of SEQ ID
NOs: 1, 4, 6, 9, 14-16, 18-21 915-917, 920, 922, 928, 929, 931, 935
and 936.
33. The kit of claim 31, wherein said one or more nucleic acids
comprises one or more of the sequences as set forth in SEQ ID NOs:
3, 36, 60, 63, 926, 971, 978, 999, 1014 and 1022.
34. The kit of claim 31, wherein said one or more nucleic acids
comprises one or more of the sequences as set forth in SEQ ID NOs
1-3, 32, 33, 36, 46, 60, 63, 66, 69, 88, 100, 241, 265, 334, 437,
920, 925, 934, 945, 947, 954, 971, 978, 999, 1004, 1014, 1022,
1023, 1032, 1080, 1093, 1101, 1164, 1248, 1304, 1311, 1330, 1402,
1425.
35. The kit of any one of claims 31 to 34, wherein said one or more
nucleic acids comprises labeled nucleic acids.
36. The kit of any one of claims 31 to 35, wherein the kit
comprises one or more primers or primer pairs that specifically
amplify at least a portion of said nucleic acids.
37. The kit of any of claims 31 to 36, wherein the kit further
comprises one or more control samples comprising expressed RNA, an
amplification product produced therefrom or a surrogate therefore,
said control one or more control samples selected from: a sample
from non-recurrent prostate cancer; and a sample from recurrent
prostate cancer.
38. An array of probe nucleic acids certified for use in
expression-based assessment of prostate cancer recurrence risk,
wherein said array comprises at least two different probe nucleic
acids that specifically hybridize to corresponding different target
nucleic acids depicted in one of SEQ ID NOs: 1-2114, an RNA form
thereof, or a complement to either thereof.
39. The array of claim 38, further comprising one or more probe
nucleic acids that specifically hybridize to house keeping
genes.
40. A device for classifying a biological sample from a prostate
cancer as recurrent or non-recurrent, the device comprising: means
for measuring the expression level of one or more transcripts of
one or more genes selected from the group of genes set forth in
Table 3 and/or 6; means for correlating the expression level with a
classification of prostate cancer status; and means for outputting
the prostate cancer status.
41. The device of claim 40, wherein the machine utilizes an
algorithm to characterize said expression level.
42. A computer-readable medium comprising one or more
digitally-encoded expression pattern profiles representative of the
level of expression of one or more transcripts of one or more genes
selected from the group of genes set forth in Table 3 and/or 6,
each of said one or more expression pattern profiles being
associated with a value wherein each of said values is correlated
with the presence of recurrent or non-recurrent prostate cancer.
Description
CROSS-REFERENCE TO RELATED APPLICATIONS
[0001] This application is a continuation of Application No.
PCT/CA2009/000694 filed May 28, 2009, now pending, which claims
priority benefit of U.S. Provisional Application No. 61/056,827,
filed May 28, 2008, the entire contents both of which are
incorporated herein by reference.
FIELD OF THE INVENTION
[0002] This invention relates to the field of diagnostics and in
particular to systems and methods for classifying prostate cancer
into distinct clinical disease states.
BACKGROUND
[0003] Prostate cancer is the most common malignancy affecting U.S.
men, with approximately 240,000 new cases diagnosed each year. The
incidence of prostate cancer is increasing, in part due to
increased surveillance efforts from the application of routine
molecular testing such as prostate-specific antigen (PSA). For most
men, prostate cancer is a slow-growing, organ-confined or localized
malignancy that poses little risk of death. The most common
treatments for prostate cancer in the U.S. are surgical procedures
such as radical prostatectomy, where the entire prostate is removed
from the patient. This procedure on its own is highly curative for
most but not all men.
[0004] The vast majority of deaths from prostate cancer occur in
patients with metastasis, believed to be present already at the
time of diagnosis in the form of clinically undetectable
micro-metastases. In these patients, it is clear that prostatectomy
alone is not curative and additional therapies such as
anti-androgen or radiation therapy are required to control the
spread of disease and extend the life of the patient.
[0005] Most prostatectomy patients however face uncertainty with
respect to their prognosis after surgery: whether or not the
initial surgery will be curative several years from the initial
treatment because the current methods for assessment of the
clinical risk such as the various pathological (e.g., tumor stage),
histological (e.g., Gleason's), clinical (e.g., Kattan nomogram)
and molecular biomarkers (e.g., PSA) are not reliable predictors of
prognosis, specifically disease progression. Routine PSA testing
has certainly increased surveillance and early-detection rates of
prostate cancer and this has resulted in an increased number of
patients being treated but not significantly decreased the
mortality rate.
[0006] Despite the controversies surrounding PSA testing as a
screening tool, most physicians confidently rely on PSA testing to
assess pre-treatment prognosis and to monitor disease progression
after initial therapy. Successive increases in PSA levels above a
defined threshold value or variations thereof (i.e. `Rising-PSA`),
also known as biochemical recurrence has been shown to be
correlated to disease progression after first-line therapy (e.g.,
prostatectomy, radiation and brachytherapy). However, less than a
1/3 of patients with `rising-PSA` will eventually be diagnosed with
systemic or metastatic disease and several studies have shown that
after long-term follow up, the majority will never show any
symptoms of disease progression aside from increases in PSA
measurement. The limitations of using the PSA biomarker and the
absence of additional biomarkers for predicting disease recurrence
have led to the development of statistical models combining several
clinical and pathological features including PSA results. Several
of these `nomograms` have been shown to improve the predictive
power for disease recurrence in individual patients over any single
independent variable. These models (see Citation #14) are used
routinely in the clinic and are currently the best available tools
for prediction of outcomes, although they do not provide high
levels of accuracy for groups of patients with highly similar
histological/pathological features or those at `intermediate` risk
of disease recurrence after prostatectomy.
[0007] The use of quantitative molecular analyses has the potential
to increase the sensitivity, specificity and/or overall accuracy of
disease prognosis and provide a more objective basis for
determination of risk stratification as compared to conventional
clinical-pathological risk models (see Citation #13). The PSA test
demonstrates the deficiencies of relying on the measurement of any
single biomarker in clinically heterogeneous and complex prostate
cancer genomes. Therefore, genomic-based approaches measuring
combinations of biomarkers or a signature of disease recurrence are
currently being investigated as better surrogates for predicting
disease outcome (see Citations # 1-13). For prostate cancer
patients these efforts are aimed at reducing the number of
unnecessary surgeries for patients without progressive disease and
avoid inadvertent under-treatment for higher risk patients. To
date, genomic profiling efforts to identify DNA-based (e.g.,
copy-number alterations, methylation changes), RNA-based (e.g.,
gene or non-coding RNA expression) or protein-based (e.g., protein
expression or modification) signatures, useful for disease
prognosis have not however resulted in widespread clinical use.
[0008] There are several key reasons explaining why prior genomic
profiling methods for prostate cancer have not yet been
incorporated in the clinic. These include the small sample sizes
typical of individual studies, coupled with variations due to
differences in study protocols, clinical heterogeneity of patients
and lack of external validation data, which combined have made
identifying a robust and reproducible disease signature elusive.
Specifically for gene or RNA expression based prognostic models;
the mitigating technological limitations include the quality and
quantity of RNA that can be isolated from routine clinical samples.
Routine clinical samples of prostate cancer include needle-biopsies
and surgical resections that have been fixed in formalin and
embedded in paraffin wax (FFPE). FFPE-derived RNA is typically
degraded and fragmented to between 100-300 bp in size and without
poly-A tails making it of little use for traditional 3'-biased gene
expression profiling, which requires larger microgram quantities of
RNA with intact poly-A tails to prime cDNA synthesis.
[0009] Furthermore, as <2% of the genome encodes for protein,
traditional gene expression profiling in fact captures only a small
fraction of the transcriptome and variation in expression as most
RNA molecules that are transcribed are not translated into protein
but serve other functional roles and non-coding RNAs are the most
abundant transcript species in the genome.
[0010] This background information is provided for the purpose of
making known information believed by the applicant to be of
possible relevance to the present invention. No admission is
necessarily intended, nor should be construed, that any of the
preceding information constitutes prior art against the present
invention.
SUMMARY OF THE INVENTION
[0011] An object of the present invention is to provide systems and
methods for expression-based discrimination of distinct clinical
disease states in prostate cancer. In accordance with one aspect of
the present invention, there is provided a system for
expression-based assessment of risk of prostate cancer recurrence
after prostatectomy, said system comprising one or more
polynucleotides, each of said polynucleotides capable of
specifically hybridizing to a RNA transcript of a gene selected
from the group of genes set forth in Table 3 and/or 6.
[0012] In accordance with another aspect of the present invention,
there is provided a nucleic acid array for expression-based
assessment of prostate cancer recurrence risk, said array
comprising at least ten probes immobilized on a solid support, each
of said probes being between about 15 and about 500 nucleotides in
length, each of said probes being derived from a sequence
corresponding to, or complementary to, a transcript of a gene
selected from the group of genes set forth in Table 3 and/or 6, or
a portion of said transcript.
[0013] In accordance with another aspect of the present invention,
there is provided a method for expression-based assessment of
prostate cancer recurrence, said method comprising: (a) determining
the expression level of one or more transcripts of one or more
genes in a test sample obtained from said subject to provide an
expression pattern profile, said one or more genes selected from
the group of genes set forth in Table 3 and/or 6, and (c) comparing
said expression pattern profile with a reference expression pattern
profile.
[0014] In accordance with another aspect of the present invention,
there is provided a kit for characterizing the expression of one or
more nucleic acid sequences depicted in SEQ ID NOs: 1-2114
comprising one or more nucleic acids selected from (a) a nucleic
acid depicted in any of SEQ ID NOs: 1-2114; (b) an RNA form of any
of the nucleic acids depicted in SEQ ID NOs: 1-2114; (c) a peptide
nucleic acid form of any of the nucleic acids depicted in SEQ ID
NOs: 1-2114; (d) a nucleic acid comprising at least 20 consecutive
bases of any of (a-c); (e) a nucleic acid comprising at least 25
consecutive bases having at least 90% sequence identity to any of
(a-c); or (f) a complement to any of (a-e); and optionally
instructions for correlating the expression level of said one or
more nucleic acid sequences with the disease state of prostate
cancer tissue.
[0015] In accordance with another aspect of the present invention,
there is provided an array of probe nucleic acids certified for use
in expression-based assessment of prostate cancer recurrence risk,
wherein said array comprises at least two different probe nucleic
acids that specifically hybridize to corresponding different target
nucleic acids depicted in one of SEQ ID NOs: 1-2114, an RNA form
thereof, or a complement to either thereof.
[0016] In accordance with another aspect of the present invention,
there is provided a device for classifying a biological sample from
a prostate cancer as recurrent or non-recurrent, the device
comprising means for measuring the expression level of one or more
transcripts of one or more genes selected from the group of genes
set forth in Table 3 and/or 6; means for correlating the expression
level with a classification of prostate cancer status; and means
for outputting the prostate cancer status.
[0017] In accordance with another aspect of the present invention,
there is provided a computer-readable medium comprising one or more
digitally-encoded expression pattern profiles representative of the
level of expression of one or more transcripts of one or more genes
selected from the group of genes set forth in Table 3 and/or 6,
each of said one or more expression pattern profiles being
associated with a value wherein each of said values is correlated
with the presence of recurrent or non-recurrent prostate
cancer.
BRIEF DESCRIPTION OF THE DRAWINGS
[0018] These and other features of the invention will become more
apparent in the following detailed description in which reference
is made to the appended drawings.
[0019] FIG. 1. A) Principle components analysis (PCA) of 2,114 RNAs
identified to be differentially expressed between tumors from
patients with differing clinical outcome (see Table 2 for
comparisons evaluated), PCA plot of 22 prostate cancer tumors shows
tight clustering of samples by clinical outcome of patients
(circles, NED; diamonds, PSA; squares, SYS). B) Two-way
hierarchical clustering dendrogram and expression matrix of 526
target sequences (Table 4) RNAs filtered using linear regression
(p<0.01) to identify RNAs that followed either SYS>PSA>NED
or NED>PSA>SYS trend in differential expression. C) Two-way
hierarchical clustering dendrogram and expression matrix of 148
target sequences (Table 5), a subset of the most differentially
expressed transcripts between patients with clinically significant
`recurrent` (i.e., `SYS`) and `non-recurrent` (i.e., `PSA` and
`NED`) disease as filtered using a t-test (p<0.001). For B) and
C), sample and RNAs were optimally ordered using Pearson's
correlation distance metric with complete-linkage cluster distances
and the expression of each RNA in each sample was normalized in the
heatmap by the number of standard deviations above (blacker) and
below (whiter) the median expression value (grey) across all
samples.
[0020] FIG. 2. Histograms showing distribution patient's tumor
expression levels of a `metagene` generated from a linear
combination of the 526 RNAs for each clinical group. The histograms
bin samples with similar metagene expression values and
significantly separate three modes of patient metagene scores
(ANOVA, p<0.000001) corresponding to the three clinical status
groups evaluated.
[0021] FIG. 3. Scatter plots summarizing the mean (.+-.standard
deviation) of metagene expression values for tumor samples from
patients in the three clinical status groups (NED; PSA; SYS).
Metagenes were generated from a linear combinations of 6
(.tangle-solidup.), 18 (.diamond-solid.) or 20 (.box-solid.) RNAs
and demonstrate highly significant differential expression between
clinical groups (ANOVA, p<0.000001).
[0022] FIG. 4. Box plots showing interquartile range and
distribution of `POP` scores for each clinical group using an
18-target sequence metagene (Table 7) to derive patient outcome
predictor scores scaled and normalized on a data range of 0-100
points. T-tests were used to evaluate the statistical significance
of differences in POP scores between NED and PSA (*) as well as
between PSA and SYS (**) clinical groups (p<7.times.10.sup.-7
and p<1.times.10.sup.-6, respectively).
[0023] FIG. 5. Box plots showing interquartile range and
distribution of `POP` scores for each clinical group using a
10-target sequence metagene (Table 9) to derive patient outcome
predictor scores scaled and normalized on a data range of 0-100
points. T-tests were used to evaluate the statistical significance
of differences in POP scores between `recurrent` (i.e., `SYS`) and
non-recurrent (i.e., `PSA` and `NED`) patient groups (**,
p<4.times.10.sup.-10).
[0024] FIG. 6. Box plots showing interquartile range and
distribution of `POP` scores for each clinical group using a
41-target sequence metagene (Table 10) to derive patient outcome
predictor scores scaled and normalized on a data range of 0-100
points. T-tests were used to evaluate the statistical significance
of differences in POP scores between `recurrent` (i.e., `SYS`) and
non-recurrent (i.e., `PSA` and `NED`) patient groups (**,
p<2.times.10.sup.-11).
[0025] FIG. 7. Box plots showing interquartile range and
distribution of `POP` scores for each clinical group using a
148-target sequence metagene to derive patient outcome predictor
scores scaled and normalized on a data range of 0-100 points.
T-tests were used to evaluate the statistical significance of
differences in POP scores between `recurrent` (i.e., `SYS`) and
non-recurrent (i.e., `PSA` and `NED`) patient groups (**,
p<9.times.10.sup.-12).
DETAILED DESCRIPTION OF THE INVENTION
[0026] The present invention provides a system and method for
assessing prostate cancer recurrence risk by distinguishing
clinically distinct disease states in men with prostate cancer at
the time of initial diagnosis or surgery. The system and methods
are based on the identification of gene transcripts following a
retrospective analysis of tumor samples that are differentially
expressed in prostate cancer in a manner dependent on prostate
cancer aggressiveness as indicated by long-term post-prostatectomy
clinical outcome. These gene transcripts can be considered as a
library which can be used as a resource for the identification of
sets of specific target sequences ("prostate cancer prognostic
sets"), which may represent the entire library of gene transcripts
or a subset of the library and the detection of which is indicative
of prostate cancer recurrence risk. The invention further provides
for probes capable of detecting these target sequences and primers
that are capable of amplifying the target sequences.
[0027] In accordance with one embodiment of the invention, the
system and method for assessing prostate cancer recurrence risk are
prognostic for a post surgery clinical outcome selected from no
evidence of disease (`NED`), biochemical relapse (two successive
increases in prostate-specific antigen levels; (`PSA`) and systemic
prostate cancer systemic metastases (`SYS`).
[0028] In accordance with one embodiment of the invention, the
target sequences comprised by the prostate cancer prognostic set
are sequences based on or derived from the gene transcripts from
the library, or a subset thereof. Such sequences are occasionally
referred to herein as "probe selection regions" or "PSRs." In
another embodiment of the invention, the target sequences comprised
by the prostate classification set are sequences based on the gene
transcripts from the library, or a subset thereof, and include both
coding and non-coding sequences.
[0029] In one embodiment, the systems and methods provide for the
molecular analysis of the expression levels of one or more of the
target sequences as set forth in SEQ ID NOs: 1-2114 (Table 4).
Increased relative expression of one or more target sequences in a
`NED` Group corresponding to the sequences as set forth in SEQ ID
NOs: 1-913 is indicative of or predictive of a non-recurrent form
of prostate cancer and can be correlated with an increased
likelihood of a long-term NED prognosis or low risk of prostate
cancer recurrence. Increased relative expression of one or more
target sequences in a `SYS` Group corresponding to the sequences as
set forth in SEQ ID NOs: 914-2114 is indicative of or predictive of
an aggressive form of prostate cancer and can be correlated with an
increased likelihood of a long-term SYS prognosis or high risk of
prostate cancer recurrence. Optionally, intermediate relative
levels of one or more target sequences in a `PSA` Group
corresponding to target sequences set forth in Table 7 is
indicative of or predictive of biochemical recurrence. Subsets and
combinations of these target sequences or probes complementary
thereto may be used as described herein.
[0030] Before the present invention is described in further detail,
it is to be understood that this invention is not limited to the
particular methodology, compositions, articles or machines
described, as such methods, compositions, articles or machines can,
of course, vary. It is also to be understood that the terminology
used herein is for the purpose of describing particular embodiments
only, and is not intended to limit the scope of the present
invention.
DEFINITIONS
[0031] Unless defined otherwise or the context clearly dictates
otherwise, all technical and scientific terms used herein have the
same meaning as commonly understood by one of ordinary skill in the
art to which this invention belongs. In describing the present
invention, the following terms will be employed, and are intended
to be defined as indicated below.
[0032] The term "polynucleotide" as used herein refers to a polymer
of greater than one nucleotide in length of ribonucleic acid (RNA),
deoxyribonucleic acid (DNA), hybrid RNA/DNA, modified RNA or DNA,
or RNA or DNA mimetics, including peptide nucleic acids (PNAs). The
polynucleotides may be single- or double-stranded. The term
includes polynucleotides composed of naturally-occurring
nucleobases, sugars and covalent internucleoside (backbone)
linkages as well as polynucleotides having non-naturally-occurring
portions which function similarly. Such modified or substituted
polynucleotides are well-known in the art and for the purposes of
the present invention, are referred to as "analogues."
[0033] "Complementary" or "substantially complementary" refers to
the ability to hybridize or base pair between nucleotides or
nucleic acids, such as, for instance, between a sensor peptide
nucleic acid or polynucleotide and a target polynucleotide.
Complementary nucleotides are, generally, A and T (or A and U), or
C and G. Two single-stranded polynucleotides or PNAs are said to be
substantially complementary when the bases of one strand, optimally
aligned and compared and with appropriate insertions or deletions,
pair with at least about 80% of the bases of the other strand,
usually at least about 90% to 95%, and more preferably from about
98 to 100%.
[0034] Alternatively, substantial complementarity exists when a
polynucleotide will hybridize under selective hybridization
conditions to its complement. Typically, selective hybridization
will occur when there is at least about 65% complementarity over a
stretch of at least 14 to 25 bases, for example at least about 75%,
or at least about 90% complementarity. See, M. Kanehisa Nucleic
Acids Res. 12:203 (1984).
[0035] "Preferential binding" or "preferential hybridization"
refers to the increased propensity of one polynucleotide to bind to
its complement in a sample as compared to a noncomplementary
polymer in the sample.
[0036] Hybridization conditions will typically include salt
concentrations of less than about 1M, more usually less than about
500 mM, for example less than about 200 mM. In the case of
hybridization between a peptide nucleic acid and a polynucleotide,
the hybridization can be done in solutions containing little or no
salt. Hybridization temperatures can be as low as 5.degree. C., but
are typically greater than 22.degree. C., and more typically
greater than about 30.degree. C., for example in excess of about
37.degree. C. Longer fragments may require higher hybridization
temperatures for specific hybridization as is known in the art.
Other factors may affect the stringency of hybridization, including
base composition and length of the complementary strands, presence
of organic solvents and extent of base mismatching, and the
combination of parameters used is more important than the absolute
measure of any one alone. Other hybridization conditions which may
be controlled include buffer type and concentration, solution pH,
presence and concentration of blocking reagents to decrease
background binding such as repeat sequences or blocking protein
solutions, detergent type(s) and concentrations, molecules such as
polymers which increase the relative concentration of the
polynucleotides, metal ion(s) and their concentration(s),
chelator(s) and their concentrations, and other conditions known in
the art.
[0037] "Multiplexing" herein refers to an assay or other analytical
method in which multiple analytes can be assayed
simultaneously.
[0038] A "target sequence" as used herein (also occasionally
referred to as a "PSR" or "probe selection region") refers to a
region of the genome against which one or more probes can be
designed. As used herein, a probe is any polynucleotide capable of
selectively hybridizing to a target sequence or its complement, or
to an RNA version of either. A probe may comprise ribonucleotides,
deoxyribonucleotides, peptide nucleic acids, and combinations
thereof. A probe may optionally comprise one or more labels. In
some embodiments, a probe may be used to amplify one or both
strands of a target sequence or an RNA form thereof, acting as a
sole primer in an amplification reaction or as a member of a set of
primers.
[0039] "Having" is an open ended phrase like "comprising" and
"including," and includes circumstances where additional elements
are included and circumstances where they are not.
[0040] "Optional" or "optionally" means that the subsequently
described event or circumstance may or may not occur, and that the
description includes instances where the event or circumstance
occurs and instances in which it does not.
[0041] As used herein `NED` describes a clinically distinct disease
state in which patients show no evidence of disease (`NED`) at
least 5 years after surgery, `PSA` describes a clinically distinct
disease state in which patients show biochemical relapse only (two
successive increases in prostate-specific antigen levels but no
other symptoms of disease with at least 5 years follow up after
surgery; `PSA`) and `SYS` describes a clinically distinct disease
state in which patients develop biochemical relapse and present
with systemic prostate cancer disease or metastases (`SYS`) within
five years after the initial treatment with radical
prostatectomy.
[0042] As used herein, the term "about" refers to approximately a
+/-10% variation from a given value. It is to be understood that
such a variation is always included in any given value provided
herein, whether or not it is specifically referred to.
[0043] Use of the singular forms "a," "an," and "the" include
plural references unless the context clearly dictates otherwise.
Thus, for example, reference to "a polynucleotide" includes a
plurality of polynucleotides, reference to "a target" includes a
plurality of such targets, reference to "a normalization method"
includes a plurality of such methods, and the like. Additionally,
use of specific plural references, such as "two," "three," etc.,
read on larger numbers of the same subject, unless the context
clearly dictates otherwise.
[0044] Terms such as "connected," "attached," "linked" and
"conjugated" are used interchangeably herein and encompass direct
as well as indirect connection, attachment, linkage or conjugation
unless the context clearly dictates otherwise.
[0045] Where a range of values is recited, it is to be understood
that each intervening integer value, and each fraction thereof,
between the recited upper and lower limits of that range is also
specifically disclosed, along with each subrange between such
values. The upper and lower limits of any range can independently
be included in or excluded from the range, and each range where
either, neither or both limits are included is also encompassed
within the invention. Where a value being discussed has inherent
limits, for example where a component can be present at a
concentration of from 0 to 100%, or where the pH of an aqueous
solution can range from 1 to 14, those inherent limits are
specifically disclosed. Where a value is explicitly recited, it is
to be understood that values which are about the same quantity or
amount as the recited value are also within the scope of the
invention, as are ranges based thereon. Where a combination is
disclosed, each subcombination of the elements of that combination
is also specifically disclosed and is within the scope of the
invention. Conversely, where different elements or groups of
elements are disclosed, combinations thereof are also disclosed.
Where any element of an invention is disclosed as having a
plurality of alternatives, examples of that invention in which each
alternative is excluded singly or in any combination with the other
alternatives are also hereby disclosed; more than one element of an
invention can have such exclusions, and all combinations of
elements having such exclusions are hereby disclosed.
Prostate Cancer Prognostic System
[0046] The system of the present invention is based on the
identification of a library of gene and RNA transcripts that are
differentially expressed in prostate cancer in a manner dependent
on prostate cancer aggressiveness as indicated by the
post-prostatectomy clinical outcome of the patient. For example,
relative over expression of one or more of the gene transcripts in
a prostate cancer sample compared to a reference sample or
expression profile or signature there from may be prognostic of a
clinically distinct disease outcome post-prostatectomy selected
from no evidence of disease (`NED`), biochemical relapse (`PSA`)
and prostate cancer disease systemic recurrence or metastases
(`SYS`). The reference sample can be, for example, from prostate
cancer sample(s) of one or more references subject(s) with a known
post-prostatectomy clinical outcomes. The reference expression
profile or signature may optionally be normalized to one or more
appropriate reference gene transcripts. Alternatively or in
addition to, expression of one or more of the gene transcripts in a
prostate cancer sample may be compared to an expression profile or
signature from normal prostate tissue.
[0047] Expression profiles or signatures from prostate cancer
samples may be normalized to one or more house keeping gene
transcripts such that normalized over and/or under expression of
one or more of the gene transcripts in a sample may be indicative
of a clinically distinct disease state or prognosis.
Prostate Prognostic Library
[0048] The Prostate Prognostic Library in accordance with the
present invention comprises one or more gene or RNA transcripts
whose relative and/or normalized expression is indicative of
prostate cancer recurrence and which may be prognostic for
post-prostatectomy clinical outcome of a patient. Exemplary RNA
transcripts that showed differential expression in prostate cancer
samples from patients with clinically distinct disease outcomes
after initial treatment with radical prostatectomy are shown in
Table 3. In one embodiment of the invention, the library comprises
one or more of the gene transcripts of the genes listed in Table
3.
[0049] In one embodiment, the library comprises at least one
transcript from at least one gene selected from those listed in
Table 3. In one embodiment, the library comprises at least one
transcript from each of at least 5 genes selected from those listed
in Table 3. In another embodiment, the library comprises at least
one transcript from each of at least 10 genes selected from those
listed in Table 3. In a further embodiment, the library comprises
at least one transcript from each of at least 15 genes selected
from those listed in Table 1. In other embodiments, the library
comprises at least one transcript from each of at least 20, at
least 25, at least 30, at least 35, at least 40, at least 45, at
least 50, at least 55, at least 60 and at least 65 genes selected
from those listed in Table 3. In a further embodiment, the library
comprises at least one transcript from all of the genes listed in
Table 3. In a further embodiment, the library comprises at all
transcripts from all of the genes listed in Table 3.
[0050] In one embodiment, the library comprises at least one
transcript from at least one gene selected from the group
consisting of [NM.sub.--001004722]; [NM.sub.--001005522];
[NM.sub.--001013671]; [NM.sub.--001033517]; [NM.sub.--183049];
[NM.sub.--212559]; 5'-3' exoribonuclease 1; A kinase (PRKA) anchor
protein (yotiao) 9; AarF domain containing kinase 4; Abhydrolase
domain containing 3; Aconitase 1, soluble; Actinin, alpha 1; ADAM
metallopeptidase domain 19 (meltrin beta); Adaptor-related protein
complex 1, gamma 2 subunit; Adenosine deaminase, RNA-specific, B2
(RED2 homolog rat); Adenylate cyclase 3; ADP-ribosylation factor
GTPase activating protein 3; ADP-ribosylation factor guanine
nucleotide-exchange factor 2 (brefeldin A-inhibited);
ADP-ribosylation factor-like 4D; Adrenergic, beta, receptor kinase
2; AF4/FMR2 family, member 3; Amyloid beta (A4) precursor
protein-binding, family B, member 1 (Fe65); Anaphase promoting
complex subunit 1; Ankyrin 3, node of Ranvier (ankyrin G); Ankyrin
repeat domain 15; Ankyrin repeat domain 28; Annexin A1; Annexin A2;
Anterior pharynx defective 1 homolog B (C. elegans); Anthrax toxin
receptor 1; Antizyme inhibitor 1; Arachidonate 12-lipoxygenase, 12R
type; Arginine vasopressin receptor 1A; Arginine-glutamic acid
dipeptide (RE) repeats; ARP3 actin-related protein 3 homolog
(yeast); Arrestin 3, retinal (X-arrestin); Arrestin domain
containing 1; Aryl hydrocarbon receptor interacting protein-like 1;
Aryl hydrocarbon receptor nuclear translocator; Ataxin 1;
ATM/ATR-Substrate Chk2-Interacting Zn2+-finger protein; ATPase,
Class I, type 8B, member 1; ATPase, Na+/K+ transporting, alpha 1
polypeptide; ATP-binding cassette, sub-family F (GCN20), member 1;
Autism susceptibility candidate 2; Baculoviral IAP
repeat-containing 6 (apollon); Basonuclin 2; Brain-specific
angiogenesis inhibitor 3; Bromodomain containing 7; Bromodomain
containing 8; Bromodomain PHD finger transcription factor; BTB
(POZ) domain containing 16; BTB (POZ) domain containing 7; Calcium
activated nucleotidase 1; Calcium binding protein P22; Calcium
channel, voltage-dependent, beta 4 subunit; Calcium channel,
voltage-dependent, L type, alpha 1C subunit; Calcium channel,
voltage-dependent, L type, alpha 1D subunit; Calcyclin binding
protein; Calmodulin 1 (phosphorylase kinase, delta); Calsyntenin 1;
Carbonyl reductase 3; Cardiolipin synthase 1; Carnitine
palmitoyltransferase 1A (liver); Casein kinase 1, delta; Casein
kinase 1, gamma 1; Casein kinase 1, gamma 3; Caspase 1,
apoptosis-related cysteine peptidase (interleukin 1, beta,
convertase); CD109 molecule; CD99 molecule-like 2; CDK5 regulatory
subunit associated protein 2; CDP-diacylglycerol synthase
(phosphatidate cytidylyltransferase) 2; Cell adhesion molecule 1;
Cell division cycle and apoptosis regulator 1; Centrosomal protein
70 kDa; Chloride channel 3; Chromodomain helicase DNA binding
protein 2; Chromodomain helicase DNA binding protein 6;
Chromodomain protein, Y-like 2; Chromosome 1 ORF 116; Chromosome 1
ORF 52; Chromosome 10 ORF 118; Chromosome 12 ORF 30; Chromosome 13
ORF 23; Chromosome 16 ORF 45; Chromosome 18 ORF 1; Chromosome 18
ORF 1; Chromosome 18 ORF 1; Chromosome 18 ORF 1; Chromosome 18 ORF
17; Chromosome 2 ORF 3; Chromosome 20 ORF 133; Chromosome 21 ORF
25; Chromosome 21 ORF 34; Chromosome 22 ORF 13; Chromosome 3 ORF
26; Chromosome 5 ORF 3; Chromosome 5 ORF 33; Chromosome 5 ORF 35;
Chromosome 5 ORF 39; Chromosome 7 ORF 13; Chromosome 7 ORF 42;
Chromosome 9 ORF 3; Chromosome 9 ORF 94; Chromosome Y ORF 15B;
Chymase 1, mast cell; Citrate lyase beta like; Class II, major
histocompatibility complex, transactivator; C-Maf-inducing protein;
Coatomer protein complex, subunit alpha; Cofilin 2 (muscle);
Coiled-coil domain containing 50; Coiled-coil domain containing 7;
Coiled-coil-helix-coiled-coil-helix domain containing 4; Cold shock
domain containing E1, RNA-binding; Collagen, type XII, alpha 1;
Complement component 1, r subcomponent-like; Core-binding factor,
runt domain, alpha subunit 2; translocated to, 2; CREB binding
protein (Rubinstein-Taybi syndrome); CTD (carboxy-terminal domain,
RNA polymerase II, polypeptide A) small phosphatase 2; CTD
(carboxy-terminal domain, RNA polymerase II, polypeptide A) small
phosphatase-like; CUG triplet repeat, RNA binding protein 2; Cullin
3; Cut-like 2; Cyclin F; Cyclin Y; Cysteine-rich with EGF-like
domains 1; Cytochrome P450, family 4, subfamily F, polypeptide 11;
Cytoplasmic FMR1 interacting protein 2; DAZ interacting protein
1-like; DCP2 decapping enzyme homolog (S. cerevisiae); DEAD box
polypeptide 47; DEAD box polypeptide 5; DEAD box polypeptide 52;
DEAD box polypeptide 56; Death inducer-obliterator 1; Dedicator of
cytokinesis 2; DEP domain containing 1B; DEP domain containing 2;
DEP domain containing 6; Development and differentiation enhancing
factor 1; Diacylglycerol lipase, alpha; Diaphanous homolog 2
(Drosophila); Dickkopf homolog 3; Dihydropyrimidine dehydrogenase;
Dipeptidyl-peptidase 10; Discs, large homolog 2, chapsyn-110;
Dishevelled, dsh homolog 2; DnaJ (Hsp40) homolog, subfamily C,
member 6; Dpy-19-like 3; Dual specificity phosphatase 5;
Ectodysplasin A receptor; Ectonucleoside triphosphate
diphosphohydrolase 7; EGFR-coamplified and overexpressed protein;
ELL associated factor 1; Emopamil binding protein (sterol
isomerase); Enabled homolog; Ephrin-A5; ER lipid raft associated 1;
Erythroblast membrane-associated protein (Scianna blood group);
Erythrocyte membrane protein band 4.1 like 4A; Etoposide induced
2.4 mRNA; Eukaryotic translation initiation factor 4E family member
3; FAD1 flavin adenine dinucleotide synthetase homolog; Family with
sequence similarity 110, member A; Family with sequence similarity
114, member A1; Family with sequence similarity 135, member A;
Family with sequence similarity 40, member A; Family with sequence
similarity 80, member B; F-box and leucine-rich repeat protein 11;
F-box and leucine-rich repeat protein 7; F-box protein 2; Ferritin,
heavy polypeptide 1; Fibronectin type III domain containing 3A;
Fibronectin type III domain containing 3B; Fibulin 1; FLJ25476
protein; FLJ41603 protein; Forkhead box J3; Forkhead box J3;
Forkhead box K1; Forkhead box P1; Frizzled homolog 3; Frizzled
homolog 5; G protein-coupled receptor kinase interactor 2; GABA A
receptor, delta; GATA binding protein 2; GDNF family receptor alpha
2; Gelsolin (amyloidosis, Finnish type); Genethonin 1; Glucose
phosphate isomerase; Glucose-fructose oxidoreductase domain
containing 1; Glucosidase, beta (bile acid) 2; Glutamate
dehydrogenase 1; Glutaminase; Glutamyl aminopeptidase
(aminopeptidase A); Glutathione reductase
Glycogen synthase kinase 3 beta; Grainyhead-like 2; Gremlin 1,
cysteine knot superfamily, homolog; GTPase activating protein (SH3
domain) binding protein 1; Hairy/enhancer-of-split related with
YRPW motif 2; Heparan sulfate 6-O-sulfotransferase 3;
Hermansky-Pudlak syndrome 5; Heterogeneous nuclear
ribonucleoprotein C(C1/C2) Hippocalcin-like 1; Histocompatibility
(minor) 13; Histone cluster 1, H3d; Histone deacetylase 6; Homeobox
A1; Homeobox and leucine zipper encoding; Host cell factor C1
(VP16-accessory protein); Hyaluronan binding protein 4;
Hyperpolarization activated cyclic nucleotide-gated potassium
channel 3; Hypothetical gene supported by AK128346; Hypothetical
LOC51149; Hypothetical protein FLJ12949; Hypothetical protein
FLJ20035; Hypothetical protein FLJ20309; Hypothetical protein
FLJ38482; Hypothetical protein HSPC148; Hypothetical protein
LOC130576; Hypothetical protein LOC285908; Hypothetical protein
LOC643155; Iduronidase, alpha-L-IKAROS family zinc finger 1
(Ikaros); IlvB (bacterial acetolactate synthase)-like; Inhibitor of
kappa light polypeptide gene enhancer in B-cells, kinase beta;
Inositol polyphosphate-4-phosphatase, type II; Integrin, alpha 4
(antigen CD49D, alpha 4 subunit of VLA-4 receptor); Integrin, alpha
6; Integrin, alpha 9; Integrin, alpha V (vitronectin receptor,
alpha polypeptide, antigen CD51); Integrin, beta-like 1 (with
EGF-like repeat domains); Inter-alpha (globulin) inhibitor H3;
Interleukin enhancer binding factor 3, 90 kDa; Intestine-specific
homeobox Intraflagellar transport 172 homolog; Janus kinase 1;
Jumonji domain containing 1B; Jumonji domain containing 2B; Jumonji
domain containing 2C; Kalirin, RhoGEF kinase; Kallikrein-related
peptidase 2; Karyopherin alpha 3 (importin alpha 4); Keratinocyte
associated protein 2; KIAA0152; KIAA0241; KIAA0319-like; KIAA0495;
KIAA0562; KIAA0564 protein; KIAA1217; KIAA1244; KIAA1244; La
ribonucleoprotein domain family, member 1; Lamin A/C; LATS, large
tumor suppressor, homolog 2; Leiomodin 3 (fetal); Leptin receptor
overlapping transcript-like 1; Leucine rich repeat containing 16;
Leucine-rich repeat kinase 1; Leucine-rich repeat-containing G
protein-coupled receptor 4; LIM domain 7; Major histocompatibility
complex, class II, DR beta 1; Malignant fibrous histiocytoma
amplified sequence 1; Maltase-glucoamylase (alpha-glucosidase);
Mannosidase, alpha, class 2A, member 1; Mannosyl
(alpha-1,6-)-glycoprotein
beta-1,6-N-acetyl-glucosaminyltransferase; MBD2-interacting zinc
finger; Melanin-concentrating hormone receptor 1; Methionyl-tRNA
synthetase; Methyl CpG binding protein 2; Methyl-CpG binding domain
protein 5; Microcephaly, primary autosomal recessive 1;
Microseminoprotein, beta-; Microtubule-associated protein 1B;
Microtubule-associated protein 2; Minichromosome maintenance
complex component 3 associated protein; Mitochondrial ribosomal
protein S15; Mohawk homeobox; Monooxygenase, DBH-like 1; MORN
repeat containing 1; Muscle RAS oncogene homolog; Muscleblind-like;
Myelin protein zero-like 1; Myeloid/lymphoid or mixed-lineage
leukemia (trithorax homolog, Drosophila); translocated to, 4;
Myocyte enhancer factor 2B; Myosin IF; Myosin, heavy chain 3,
skeletal muscle, embryonic; N-acetylgalactosaminidase, alpha-;
N-acetylglucosamine-1-phosphate transferase, alpha and beta
subunits; Nascent polypeptide-associated complex alpha subunit;
NECAP endocytosis associated 2; Necdin homolog; Neural precursor
cell expressed, developmentally down-regulated 9; Neuregulin 1;
Neuron navigator 1; Nibrin; Nicotinamide N-methyltransferase; NIMA
(never in mitosis gene a)-related kinase 6; NLR family, CARD domain
containing 5; NOL1/NOP2/Sun domain family, member 3; NOL1/NOP2/Sun
domain family, member 3; NOL1/NOP2/Sun domain family, member 6;
Nuclear receptor coactivator 2; Nuclear receptor coactivator 6;
Nuclear receptor subfamily 2, group F, member 2; Nuclear receptor
subfamily 3, group C, member 2; Nuclear receptor subfamily 4, group
A, member 2; Nuclear transcription factor, X-box binding-like 1;
Nucleolar and coiled-body phosphoprotein 1; Overexpressed in colon
carcinoma-1; PAN3 polyA specific ribonuclease subunit homolog; PAP
associated domain containing 1; Paraoxonase 2; Paraspeckle
component 1; PCTAIRE protein kinase 2; Peptidase D; Pericentrin
(kendrin); Peroxisomal biogenesis factor 19; PHD finger protein 8;
Phosphatidic acid phosphatase type 2 domain containing 3;
Phosphatidylinositol 4-kinase, catalytic, alpha polypeptide;
Phosphatidylinositol glycan anchor biosynthesis, class O;
Phosphatidylinositol transfer protein, beta; Phosphodiesterase 4D,
cAMP-specific; Phosphoglucomutase 5; Phosphoglycerate mutase family
member 5; Phosphoinositide-3-kinase, class 2, beta polypeptide;
Phospholipase A2, group IVB (cytosolic); Phospholipase C, beta 1
(phosphoinositide-specific); Phospholipase C, gamma 2
(phosphatidylinositol-specific); Phosphorylase kinase, beta;
Plasminogen activator, tissue; Platelet-activating factor
acetylhydrolase, isoform Ib, alpha subunit 45 kDa; Pleckstrin
homology domain containing, family A (phosphoinositide binding
specific) member 3; Pleckstrin homology domain containing, family A
member 7; Pleckstrin homology domain containing, family G (with
RhoGef domain) member 3; Pleckstrin homology domain containing,
family H (with MyTH4 domain) member 1; Poly (ADP-ribose) polymerase
family, member 16; Poly (ADP-ribose) polymerase family, member 2;
Poly(A) polymerase alpha; Poly(A)-specific ribonuclease
(deadenylation nuclease); Polymerase (DNA directed) nu; Polymerase
(DNA directed), gamma 2, accessory subunit; Polymerase (RNA) II
(DNA directed) polypeptide L; Polymerase (RNA) III (DNA directed)
polypeptide E; Polymerase I and transcript release factor;
Potassium channel tetramerisation domain containing 1; Potassium
channel tetramerisation domain containing 2; Potassium channel
tetramerisation domain containing 7; Potassium channel, subfamily
K, member 1; Presenilin 1; PRKR interacting protein 1;
Procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2; ProSAPiP1
protein; Prostaglandin E synthase 3 (cytosolic); Protease, serine,
2 (trypsin 2); Protein kinase, Y-linked; Protein phosphatase 1,
regulatory (inhibitor) subunit 9A; Protein phosphatase 3 (formerly
2B), catalytic subunit, alpha isoform; Protein phosphatase 4,
regulatory subunit 1-like; Protein tyrosine phosphatase,
non-receptor type 18 (brain-derived); Protein tyrosine phosphatase,
non-receptor type 3; Protein tyrosine phosphatase, receptor type,
D; Protein-O-mannosyltransferase 1; Proteolipid protein 2 (colonic
epithelium-enriched); Protocadherin 7; Protocadherin gamma
subfamily A, 1; PRP6 pre-mRNA processing factor 6 homolog; Putative
homeodomain transcription factor 1; RAB GTPase activating protein
1-like; RAB10; RAB30; Rabaptin, RAB GTPase binding effector protein
1; RAD51-like 1; RALBP1 associated Eps domain containing 2; Rap
guanine nucleotide exchange factor (GEF) 1; Rapamycin-insensitive
companion of mTOR; Ras and Rab interactor 2; Receptor accessory
protein 3; Reelin; Replication factor C (activator 1) 3;
Replication protein A3; Rho GTPase activating protein 18; Rho
guanine nucleotide exchange factor (GEF) 10-like; Rhophilin, Rho
GTPase binding protein 1; Ribonuclease H2, subunit B; Ribonuclease
P 14 kDa subunit; Ring finger protein 10; Ring finger protein 144;
Ring finger protein 44; RNA binding motif protein 16; Roundabout,
axon guidance receptor, homolog 1; Roundabout, axon guidance
receptor, homolog 2; RUN domain containing 2A; Scinderin; SEC23
interacting protein; Sec61 alpha 2 subunit; Septin 11;
Serine/threonine kinase 32A; Serine/threonine kinase 32C; SGT1,
suppressor of G2 allele of SKP1; SH3 and PX domains 2A; Signal
peptide peptidase 3; Signal transducer and activator of
transcription 1, 91 kDa; Single-stranded DNA binding protein 2;
Small nuclear ribonucleoprotein polypeptide N; SNF8, ESCRT-II
complex subunit, homolog; Sodium channel, voltage-gated, type III,
alpha subunit; Solute carrier family 1 (neutral amino acid
transporter), member 5; Solute carrier family 16, member 7
(monocarboxylic acid transporter 2); Solute carrier family 2
(facilitated glucose transporter), member 11; Solute carrier family
2 (facilitated glucose transporter), member 11; Solute carrier
family 24 (sodium/potassium/calcium exchanger), member 3; Solute
carrier family 3 (activators of dibasic and neutral amino acid
transport), member 2; Solute carrier family 30 (zinc transporter),
member 6; Solute carrier family 39 (zinc transporter), member 10;
Solute carrier family 43, member 1; Solute carrier family 9
(sodium/hydrogen exchanger), member 3 regulator 2; SON DNA binding
protein; Sortilin-related VPS10 domain containing receptor 3;
Sparc/osteonectin, cwcv and kazal-like domains proteoglycan
(testican) 2; Spectrin repeat containing, nuclear envelope 1; Sperm
associated antigen 9; Splicing factor 3a, subunit 2, 66 kDa;
Splicing factor 3b, subunit 1, 155 kDa; Staphylococcal nuclease and
tudor domain containing 1; Staufen, RNA binding protein, homolog 1;
Suppression of tumorigenicity 7; Suppressor of variegation 4-20
homolog 1; Synapsin III; Syntaxin 3; Syntaxin 5; Tachykinin
receptor 1; TAO kinase 3; TBC1 domain family, member 16; TBC1
domain family, member 19; Testis specific, 10; Tetraspanin 6;
Tetratricopeptide repeat domain 23; Thioredoxin-like 2; THUMP
domain containing 3; TIMELESS interacting protein; TOX high
mobility group box family member 4; Trafficking protein, kinesin
binding 1; Transcription factor 7-like 1 (T-cell specific,
HMG-box); Transcription factor 7-like 2 (T-cell specific, HMG-box);
Translocase of inner mitochondrial membrane 13 homolog;
Translocated promoter region (to activated MET oncogene);
Translocation associated membrane protein 2; Transmembrane 9
superfamily member 2; Transmembrane emp24 protein transport domain
containing 8; Transmembrane emp24-like trafficking protein 10;
Transmembrane protein 134; Transmembrane protein 18; Transmembrane
protein 18; Transmembrane protein 29; Triadin; Tribbles homolog 1;
Trinucleotide repeat containing 6C; Tripartite motif-containing 36;
Tripartite motif-containing 61; TRNA methyltransferase 11 homolog;
TruB pseudouridine (psi) synthase homolog 2; Tubby like protein 4;
Tuftelin 1; Tumor necrosis factor receptor superfamily, member 11b
(osteoprotegerin); Tumor necrosis factor receptor superfamily,
member 25; Tumor necrosis factor, alpha-induced protein 8; Tyrosine
kinase 2; Ubiquinol-cytochrome c reductase core protein I;
Ubiquitin specific peptidase 47; Ubiquitin specific peptidase 5
(isopeptidase T); Ubiquitin specific peptidase 8; Ubiquitin-like 7
(bone marrow stromal cell-derived); UBX domain containing 6;
UDP-glucose ceramide glucosyltransferase-like 2;
UDP-N-acetyl-alpha-D-galactosamine:polypeptide
N-acetylgalactosaminyltransferase 2 (GalNAc-T2); Unc-93 homolog B1;
UTP6, small subunit (SSU) processome component, homolog; Vacuolar
protein sorting 8 homolog; V-akt murine thymoma viral oncogene
homolog 1; V-ets erythroblastosis virus E26 oncogene homolog; Viral
DNA polymerase-transactivated protein 6; WD repeat domain 33; WD
repeat domain 90; Wingless-type MMTV integration site family,
member 2B; WW and C2 domain containing 1; Yip1 domain family,
member 3; YTH domain family, member 3; Zinc finger and BTB domain
containing 10; Zinc finger and BTB domain containing 20; Zinc
finger and SCAN domain containing 18; Zinc finger homeodomain 4;
Zinc finger protein 14 homolog; Zinc finger protein 335; Zinc
finger protein 394; Zinc finger protein 407; Zinc finger protein
608; Zinc finger protein 667; Zinc finger protein 692; Zinc finger
protein 718; Zinc finger protein 721; Zinc finger, CCHC domain
containing 9; Zinc finger, matrin type 1; Zinc finger, MYND domain
containing 11; Zinc finger, ZZ-type containing 3; Zinc fingers and
homeoboxes 2; and Zwilch, kinetochore associated, homolog.
[0051] In one embodiment, the library comprises at least one
transcript from at least one gene selected from the group
consisting of Replication factor C (activator 1) 3; Tripartite
motif-containing 61; Citrate lyase beta like; Ankyrin repeat domain
15; UDP-glucose ceramide glucosyltransferase-like 2; Hypothetical
protein FLJ12949; Chromosome 22 open reading frame 13;
Phosphatidylinositol glycan anchor biosynthesis, class O; Solute
carrier family 43, member 1; Rabaptin, RAB GTPase binding effector
protein 1; Zinc finger protein 14 homolog; Hypothetical gene
supported by AK128346; Adenylate cyclase 3; Phosphatidylinositol
transfer protein, beta; Zinc finger protein 667; Gremlin 1,
cysteine knot superfamily, homolog; Ankyrin 3, node of Ranvier
(ankyrin G) and Maltase-glucoamylase (alpha-glucosidase).
[0052] In one embodiment, the library comprises at least one
transcript from at least one gene selected from the group
consisting of Replication factor C (activator 1) 3; Ankyrin repeat
domain 15; Hypothetical protein FLJ12949; Solute carrier family 43,
member 1; Thioredoxin-like 2; Polymerase (RNA) II (DNA directed)
polypeptide L; Syntaxin 5; Leucine rich repeat containing 16;
Calcium channel, voltage-dependent, beta 4 subunit;
[NM.sub.--001005522]; G protein-coupled receptor kinase interactor
2; Ankyrin 3, node of Ranvier (ankyrin G); Gremlin 1, cysteine knot
superfamily, homolog; Zinc finger protein 667; Hypothetical gene
supported by AK128346; Transmembrane 9 superfamily member 2;
Potassium channel, subfamily K, member 1; Chromodomain helicase DNA
binding protein 2; Microcephaly, primary autosomal recessive 1;
Chromosome 21 open reading frame 34 and Dual specificity
phosphatase 5.
[0053] In one embodiment, the library comprises at least one
transcript from at least one gene selected from the group
consisting of Replication factor C (activator 1) 3; Tripartite
motif-containing 61; Citrate lyase beta like; Ankyrin repeat domain
15; Ankyrin 3, node of Ranvier (ankyrin G) and Maltase-glucoamylase
(alpha-glucosidase).
[0054] In one embodiment, the library comprises at least one
transcript from at least one gene selected from the group
consisting of Replication factor C (activator 1) 3; Ankyrin repeat
domain 15; Hypothetical protein FLJ12949; Solute carrier family 43,
member 1; Thioredoxin-like 2; Polymerase (RNA) II (DNA directed)
polypeptide L; Syntaxin 5; Leucine rich repeat containing 16;
Calcium channel, voltage-dependent, beta 4 subunit;
[NM.sub.--001005522]; G protein-coupled receptor kinase interactor
2; Ankyrin 3, node of Ranvier (ankyrin G); Gremlin 1, cysteine knot
superfamily, homolog; Zinc finger protein 667; Hypothetical gene
supported by AK128346; Transmembrane 9 superfamily member 2;
Potassium channel, subfamily K, member 1; Chromodomain helicase DNA
binding protein 2; Chromosome 9 open reading frame 94; Chromosome
21 open reading frame 34; and Dual specificity phosphatase 5.
[0055] In one embodiment, the library comprises at least one
transcript from at least one gene selected from the group
consisting of Citrate lyase beta like; Phosphodiesterase 4D,
cAMP-specific; Ectodysplasin A receptor; DEP domain containing 6;
Basonuclin 2; Chromosome 2 open reading frame 3; FLJ25476 protein;
Staphylococcal nuclease and tudor domain containing 1;
Hermansky-Pudlak syndrome 5 and Chromosome 12 open reading frame
30.
[0056] In one embodiment, the library comprises at least one
transcript from at least one gene selected from the group
consisting of Replication factor C (activator 1) 3; Tripartite
motif-containing 61; Citrate lyase beta like; Adaptor-related
protein complex 1, gamma 2 subunit; Kallikrein-related peptidase 2;
Phosphodiesterase 4D, cAMP-specific; Cytochrome P450, family 4,
subfamily F, polypeptide 11; Ectodysplasin A receptor
Phospholipase C, beta 1; KIAA1244; Paraoxonase 2; Arachidonate
12-lipoxygenase, 12R type; Cut-like 2; Chemokine (C-X-C motif)
ligand 12; Rho guanine nucleotide exchange factor (GEF) 5;
Olfactory receptor, family 2, subfamily A, member 4; Chromosome 19
open reading frame 42; Hypothetical gene supported by AK128346;
Phosphoglucomutase 5; Hyaluronan binding protein 4; NECAP
endocytosis associated 2 Myeloid/lymphoid or mixed-lineage
leukemia; translocated to, 4; Signal transducer and activator of
transcription 1; Chromosome 2 open reading frame 3; FLJ25476
protein; Staphylococcal nuclease and tudor domain containing 1;
Transmembrane protein 18; Hermansky-Pudlak syndrome 5; Chromosome
12 open reading frame 30; Splicing factor 3b, subunit 1; Cofilin 2;
Heparan sulfate 6-O-sulfotransferase 3; Enabled homolog; Mannosyl
(alpha-1,6-)-glycoprotein
beta-1,6-N-acetyl-glucosaminyltransferase; Solute carrier family 24
(sodium/potassium/calcium exchanger), member 3; Inositol
1,4,5-triphosphate receptor, type 1; CAP-GLY domain containing
linker protein; Transglutaminase 4; MOCO sulphurase C-terminal
domain containing 2; 4-hydroxyphenylpyruvate dioxygenase-like; and
R3H domain containing 1.
[0057] The invention also contemplates that alternative libraries
may be designed that include transcripts of one or more of the
genes in Table 3, together with additional gene transcripts that
have previously been shown to be associated with prostate cancer
systemic progression. As is known in the art, the publication and
sequence databases can be mined using a variety of search
strategies to identify appropriate additional candidates for
inclusion in the library. For example, currently available
scientific and medical publication databases such as Medline,
Current Contents, OMIM (online Mendelian inheritance in man),
various Biological and Chemical Abstracts, Journal indexes, and the
like can be searched using term or key-word searches, or by author,
title, or other relevant search parameters. Many such databases are
publicly available, and strategies and procedures for identifying
publications and their contents, for example, genes, other
nucleotide sequences, descriptions, indications, expression
pattern, etc, are well known to those skilled in the art. Numerous
databases are available through the internet for free or by
subscription, see, for example, the National Center Biotechnology
Information (NCBI), Infotrieve, Thomson ISI, and Science Magazine
(published by the AAAS) websites. Additional or alternative
publication or citation databases are also available that provide
identical or similar types of information, any of which can be
employed in the context of the invention. These databases can be
searched for publications describing altered gene expression
between recurrent and non-recurrent prostate cancer. Additional
potential candidate genes may be identified by searching the above
described databases for differentially expressed proteins and by
identifying the nucleotide sequence encoding the differentially
expressed proteins. A list of genes whose altered expression is
between patients with recurrent disease and non-recurrent prostate
cancer is presented in Table 6.
Prostate Cancer Prognostic Sets
[0058] A Prostate Prognostic Set comprises one or more target
sequences identified within the gene transcripts in the prostate
prognostic library, or a subset of these gene transcripts. The
target sequences may be within the coding and/or non-coding regions
of the gene transcripts. The set can comprise one or a plurality of
target sequences from each gene transcript in the library, or
subset thereof. The relative and/or normalized level of these
target sequences in a sample is indicative of the level of
expression of the particular gene transcript and thus of prostate
cancer recurrence risk. For example, the relative and/or normalized
expression level of one or more of the target sequences may be
indicative of an recurrent form of prostate cancer and therefore
prognostic for prostate cancer systemic progression while the
relative and/or normalized expression level of one or more other
target sequences may be indicative of a non-recurrent form of
prostate cancer and therefore prognostic for a NED clinical
outcome.
[0059] Accordingly, one embodiment of the present invention
provides for a library or catalog of candidate target sequences
derived from the transcripts (both coding and non-coding regions)
of at least one gene suitable for classifying prostate cancer
recurrence risk. In a further embodiment, the present invention
provides for a library or catalog of candidate target sequences
derived from the non-coding regions of transcripts of at least one
gene suitable for classifying prostate cancer recurrence risk. In
still a further embodiment, the library or catalog of candidate
target sequences comprises target sequences derived from the
transcripts of one or more of the genes set forth in Table 3 and/or
Table 6. The library or catalog in affect provides a resource list
of transcripts from which target sequences appropriate for
inclusion in a Prostate Cancer Prognostic set can be derived. In
one embodiment, an individual Prostate Cancer Prognostic set may
comprise target sequences derived from the transcripts of one or
more genes exhibiting a positive correlation with recurrent
prostate cancer. In one embodiment, an individual Prostate Cancer
Prognostic Set may comprise target sequences derived from the
transcripts of one or more genes exhibiting a negative correlation
with recurrent prostate cancer. In one embodiment, an individual
Prostate Cancer Prognostic Set may comprise target sequences
derived from the transcripts of two or more genes, wherein at least
one gene has a transcript that exhibits a positive correlation with
recurrent prostate cancer and at least one gene has a transcript
that exhibits negative correlation with recurrent prostate
cancer.
[0060] In one embodiment, the Prostate Cancer Prognostic Set
comprises target sequences derived from the transcripts of at least
one gene. In one embodiment, the Prostate Cancer Prognostic Set
comprises target sequences derived from the transcripts of at least
5 genes. In another embodiment, the Prostate Cancer Prognostic set
comprises target sequences derived from the transcripts of at least
10 genes. In a further embodiment, the Prostate Cancer Prognostic
set comprises target sequences derived from the transcripts of at
least 15 genes. In other embodiments, the Prostate Cancer
Prognostic set comprises target sequences derived from the
transcripts of at least 20, at least 25, at least 30, at least 35,
at least 40, at least 45, at least 50, at least 55, at least 60 and
at least 65 genes.
[0061] Following the identification of candidate gene transcripts,
appropriate target sequences can be identified by screening for
target sequences that have been annotated to be associated with
each specific gene locus from a number of annotation sources
including GenBank, RefSeq, Ensembl, dbEST, GENSCAN, TWINSCAN,
Exoniphy, Vega, microRNAs registry and others (see Affymetrix Exon
Array design note).
[0062] As part of the target sequence selection process, target
sequences can be further evaluated for potential
cross-hybridization against other putative transcribed sequences in
the design (but not the entire genome) to identify only those
target sequences that are predicted to uniquely hybridize to a
single target.
[0063] Optionally, the set of target sequences that are predicted
to uniquely hybridize to a single target can be further filtered
using a variety of criteria including, for example, sequence
length, for their mean expression levels across a wide selection of
human tissues, as being representive of transcripts expressed
either as novel alternative (i.e., non-consensus) exons,
alternative retained introns, novel exons 5' or 3' of the gene's
transcriptional start site or representing transcripts expressed in
a manner antisense to the gene, amongst others.
[0064] In one embodiment, the Prostate Classification Set comprises
target sequences derived from 382,253 base pair 3' of Replication
factor C (activator 1) 3, 38 kDa; 58,123 base pair 3' of Tripartite
motif-containing 61; in intron #3 of Citrate lyase beta like; in
intron #2 of Ankyrin repeat domain 15; in exon #1 of UDP-glucose
ceramide glucosyltransferase-like 2; in exon of #19 of Hypothetical
protein FLJ12949; in intron #4 of Chromosome 22 open reading frame
13; in exon #2 of phatidylinositol glycan anchor biosynthesis,
class O; in exon #15 of Solute carrier family 43, member 1; in exon
#1 of Rabaptin, RAB GTPase binding effector protein 1; in intron
#38 of Maltase-glucoamylase (alpha-glucosidase); in intron #23 of
Ankyrin 3, node of Ranvier (ankyrin G); 71,333 base pair 3' of
Gremlin 1, cysteine knot superfamily, homolog; 1,561 base pair of
3' Zinc finger protein 667; in exon #4 of Phosphatidylinositol
transfer protein, beta; in intron #18 of Adenylate cyclase 3; and
in exon #2 of Hypothetical gene supported by AK128346.
[0065] In one embodiment, the Prostate Classification Set comprises
target sequences derived from 382,253 base pair 3' of Replication
factor C (activator 1) 3; in intron #2 of Ankyrin repeat domain 15;
in exon #19 of Hypothetical protein FLJ12949; in exon #15 of Solute
carrier family 43, member 1; 313,721 base pair 3' of
Thioredoxin-like 2; in exon #2 of Polymerase (RNA) II (DNA
directed) polypeptide L, 7.6 kDa; in intron #10 of Syntaxin 5;
141,389 base pair 5' of Leucine rich repeat containing 16; in
intron #2 of Calcium channel, voltage-dependent, beta 4 subunit;
5,474 base pair 5' of [NM.sub.--001005522]; in intron #14 of G
protein-coupled receptor kinase interactor 2; in intron #23 of
Ankyrin 3, node of Ranvier (ankyrin G); 71,333 base pair 3' of
Gremlin 1, cysteine knot superfamily, homolog; 1,561 base pair of
3' of Zinc finger protein 667; in exon #2 of Hypothetical gene
supported by AK128346; in intron #11 of Transmembrane 9 superfamily
member 2; in intron #1 of Potassium channel, subfamily K, member 1;
in intron #2 of Chromodomain helicase DNA binding protein 2; 22,184
base pair 5' of Microcephaly, primary autosomal recessive 1; in
intron #4 of Chromosome 21 open reading frame 34; and in intron #2
of Dual specificity phosphatase 5.
[0066] In one embodiment, the Prostate Classification Set comprises
target sequences derived from 382,253 base pair 3' of Replication
factor C (activator 1) 3, 38 kDa; 58,123 base pair 3' of Tripartite
motif-containing 61; in intron #3 of Citrate lyase beta like; in
intron #2 of Ankyrin repeat domain 15; in intron #38 of
Maltase-glucoamylase (alpha-glucosidase); and in intron #23 of
Ankyrin 3, node of Ranvier (ankyrin G).
[0067] In one embodiment, the Prostate Classification Set comprises
target sequences derived from 382,253 base pair 3' of Replication
factor C (activator 1) 3, 38 kDa; in intron #2 of Ankyrin repeat
domain 15; in exon #19 of Hypothetical protein FLJ12949; in exon
#15 of Solute carrier family 43, member 1; 313,721 base pair 3' of
Thioredoxin-like 2; in exon #2 of Polymerase (RNA) II (DNA
directed) polypeptide L, 7.6 kDa; in intron #10 of Syntaxin 5;
141,389 base pair 5' of Leucine rich repeat containing 16; in
intron #2 of Calcium channel, voltage-dependent, beta 4 subunit;
5,474 base pair 5' of [NM.sub.--001005522]; in intron #14 of G
protein-coupled receptor kinase interactor 2; in intron #2 of
Ankyrin 3, node of Ranvier (ankyrin G); 71,333 base pair of 3'
Gremlin 1, cysteine knot superfamily; 1,561 base pair 3' of Zinc
finger protein 667; in exon #2 of Hypothetical gene supported by
AK128346; in intron #11 of Transmembrane 9 superfamily member 2; in
intron #1 of Potassium channel, subfamily K, member 1; in intron #2
of Chromodomain helicase DNA binding protein 2; in exon #8 of
Chromosome 9 open reading frame 94; in intron #4 of Chromosome 21
open reading frame 34; and
in intron #2 of Dual specificity phosphatase 5.
[0068] In one embodiment, the Prostate Classification Set comprises
target sequences derived from in intron #3 of Citrate lyase beta
like; 210,560 base pair 5' of Phosphodiesterase 4D; 189,722 base
pair 5' of Ectodysplasin A receptor; 3,510 base pair 3' of DEP
domain containing 6; in exon #6 of Basonuclin 2; in intron #1 of
Chromosome 2 open reading frame 3; in intron #1 of FLJ25476
protein; in intron #10 of Staphylococcal nuclease and tudor domain
containing 1; in exon #22 of Hermansky-Pudlak syndrome 5; and in
exon #24 of Chromosome 12 open reading frame 30.
[0069] In one embodiment, the Prostate Classification Set comprises
target sequences derived from 382,253 base pair 3' of Replication
factor C (activator 1) 3, 38 kDa; 58,123 base pair 3' of Tripartite
motif-containing 61; in intron #3 of Citrate lyase beta like; in
intron #1 of Adaptor-related protein complex 1, gamma 2 subunit; in
intron #2 of Kallikrein-related peptidase 2; 210,560 base pair 5'
of Phosphodiesterase 4D; 3,508 base pair 3' of Cytochrome P450,
family 4, subfamily F, polypeptide 11; 189,722 base pair 5' of
Ectodysplasin A receptor; in intron #2 of Phospholipase C, beta 1;
in intron #10 of KIAA1244; in intron #2 of Paraoxonase 2; 11,235
base pair 3' of Arachidonate 12-lipoxygenase, 12R type; in exon #22
of Cut-like 2; 143,098 base pair 5' of Chemokine (C-X-C motif)
ligand 12; in intron #6 of Rho guanine nucleotide exchange factor
(GEF) 5; 15,057 base pair 5' of Olfactory receptor, family 2,
subfamily A, member 4; 6,025 base pair 3' of Chromosome 19 open
reading frame 42; in exon #2 of Hypothetical gene supported by
AK128346; in exon #11 of Phosphoglucomutase 5; in exon #9 of
Hyaluronan binding protein 4; in exon #8 of NECAP endocytosis
associated 2; in intron #20 of Myeloid/lymphoid or mixed-lineage
leukemia; 1,558 base pair 3' of Signal transducer and activator of
transcription; in intron #1 of Chromosome 2 open reading frame 3;
in intron #1 of FLJ25476 protein; in intron #10 of Staphylococcal
nuclease and tudor domain containing 1; 84,468 base pair 3' of
Transmembrane protein 18; in exon #22 of Hermansky-Pudlak syndrome
5; in exon #24 of Chromosome 12 open reading frame 30; 95,745 base
pair of 3' Splicing factor 3b, subunit 1; in exon #4 of Cofilin 2;
in intron #1 of Heparan sulfate 6-O-sulfotransferase 3; in intron
#1 of Enabled homolog; in intron #2 of Mannosyl
(alpha-1,6-)-glycoprotein
beta-1,6-N-acetyl-glucosaminyltransferase; in intron #8 of Solute
carrier family 24, member 3; 32,382 base pair 3' of Inositol
1,4,5-triphosphate receptor, type 1; in intron #9 of CAP-GLY domain
containing linker protein 1; in exon #14 of Transglutaminase 4; in
intron #4 of MOCO sulphurase C-terminal domain containing 2; 21,555
base pair 5' of 4 hydroxyphenylpyruvate dioxygenase-like; and in
exon #26 of R3H domain containing 1.
[0070] In one embodiment, the potential set of target sequences can
be filtered for their expression levels using the multi-tissue
expression data made publicly available by Affymetrix at
(http://www.affymetrix.com/stipport/technical/sample_data/exon_array_data-
.affx) such that probes with, for example, elevated expression
across numerous tissues (non-specific) or no expression in prostate
tissue can be excluded.
Validation of Target Sequences
[0071] Following in silico selection of target sequences, each
target sequence suitable for use in the Prostate Cancer Prognostic
Set may be validated to confirm differential relative or normalized
expression in recurrent prostate cancer or non-recurrent prostate
cancer. Validation methods are known in the art and include
hybridization techniques such as microarray analysis or Northern
blotting using appropriate controls, and may include one or more
additional steps, such as reverse transcription, transcription,
PCR, RT-PCR and the like. The validation of the target sequences
using these methods is well within the abilities of a worker
skilled in the art.
Minimal Expression Signature
[0072] In one embodiment, individual Prostate Cancer Prognostic
Sets provide for at least a determination of a minimal expression
signature, capable of distinguishing recurrent from non-recurrent
forms of prostate cancer. Means for determining the appropriate
number of target sequences necessary to obtain a minimal expression
signature are known in the art and include the Nearest Shrunken
Centroids (NSC) method.
[0073] In this method (see US 20070031873), a standardized centroid
is computed for each class. This is the average gene expression for
each gene in each class divided by the within-class standard
deviation for that gene. Nearest centroid classification takes the
gene expression profile of a new sample, and compares it to each of
these class centroids. The class whose centroid that it is closest
to, in squared distance, is the predicted class for that new
sample. Nearest shrunken centroid classification "shrinks" each of
the class centroids toward the overall centroid for all classes by
an amount called the threshold. This shrinkage consists of moving
the centroid towards zero by threshold, setting it equal to zero if
it hits zero. For example if threshold was 2.0, a centroid of 3.2
would be shrunk to 1.2, a centroid of -3.4 would be shrunk to -1.4,
and a centroid of 1.2 would be shrunk to zero. After shrinking the
centroids, the new sample is classified by the usual nearest
centroid rule, but using the shrunken class centroids. This
shrinkage can make the classifier more accurate by reducing the
effect of noisy genes and provides an automatic gene selection. In
particular, if a gene is shrunk to zero for all classes, then it is
eliminated from the prediction rule. Alternatively, it may be set
to zero for all classes except one, and it can be learned that the
high or low expression for that gene characterizes that class. The
user decides on the value to use for threshold. Typically one
examines a number of different choices. To guide in this choice,
PAM does K-fold cross-validation for a range of threshold values.
The samples are divided up at random into K roughly equally sized
parts. For each part in turn, the classifier is built on the other
K-1 parts then tested on the remaining part. This is done for a
range of threshold values, and the cross-validated
misclassification error rate is reported for each threshold value.
Typically, the user would choose the threshold value giving the
minimum cross-validated misclassification error rate.
[0074] Alternatively, minimal expression signatures can be
established through the use of optimization algorithms such as the
mean variance algorithm widely used in establishing stock
portfolios. This method is described in detail in US patent
publication number 20030194734. Essentially, the method calls for
the establishment of a set of inputs (stocks in financial
applications, expression as measured by intensity here) that will
optimize the return (e.g., signal that is generated) one receives
for using it while minimizing the variability of the return. In
other words, the method calls for the establishment of a set of
inputs (e.g., expression as measured by intensity) that will
optimize the signal while minimizing variability. Many commercial
software programs are available to conduct such operations. "Wagner
Associates Mean-Variance Optimization Application," referred to as
"Wagner Software" throughout this specification, is preferred. This
software uses functions from the "Wagner Associates Mean-Variance
Optimization Library" to determine an efficient frontier and
optimal portfolios in the Markowitz sense is preferred. Use of this
type of software requires that microarray data be transformed so
that it can be treated as an input in the way stock return and risk
measurements are used when the software is used for its intended
financial analysis purposes.
[0075] The process of selecting a minimal expression signature can
also include the application of heuristic rules. Preferably, such
rules are formulated based on biology and an understanding of the
technology used to produce clinical results. More preferably, they
are applied to output from the optimization method. For example,
the mean variance method of portfolio selection can be applied to
microarray data for a number of genes differentially expressed in
subjects with cancer. Output from the method would be an optimized
set of genes that could include some genes that are expressed in
peripheral blood as well as in diseased tissue.
[0076] Other heuristic rules can be applied that are not
necessarily related to the biology in question. For example, one
can apply a rule that only a prescribed percentage of the portfolio
can be represented by a particular gene or group of genes.
Commercially available software such as the Wagner Software readily
accommodates these types of heuristics. This can be useful, for
example, when factors other than accuracy and precision (e.g.,
anticipated licensing fees) have an impact on the desirability of
including one or more genes.
[0077] In one embodiment, the Prostate Cancer Prognostic Set for
obtaining a minimal expression signature comprises at least one,
two, three, four, five, six, eight, 10, 15, 20, 25 or more of
target sequences shown to have a positive correlation with
non-recurrent prostate disease, for example those depicted in SEQ
ID NOs:1-913 or a subset thereof. In another embodiment, the
Prostate Cancer Prognostic Set for obtaining a minimal expression
signature comprises at least one, two, three, four, five, six,
eight, 10, 15, 20, 25 or more of those target sequences shown to
have a positive correlation with recurrent prostate cancer, for
example those depicted in of SEQ ID NOs: 914-2114, or a subset
thereof. In yet another embodiment, the Prostate Cancer Prognostic
Set for obtaining a minimal expression signature comprises at least
one, two, three, four, five, six, eight, 10, 15, 20, 25 or more of
target sequences shown to have a correlation with non-recurrent or
recurrent prostate cancer, for example those depicted in SEQ ID
NOs:1-2114 or a subset thereof.
[0078] In some embodiments, the Prostate Cancer Prognostic Set
comprises target sequences for detecting expression products of SEQ
IDs:1-2114. In some embodiments, the Prostate Cancer Prognostic Set
comprises probes for detecting expression levels of sequences
exhibiting positive and negative correlation with a disease status
of interest are employed. For example, a combination target
sequences useful in these methods were found to include those
encoding RNAs corresponding to SEQ ID NOs: 1-913 (found at
increased expression in prostate cancer samples from NED patients)
and/or corresponding to SEQ ID NOs: 914-2114 (found at increased
expression levels in prostate cancer samples from SYS patients),
where intermediate levels of certain target sequences (Table 7) are
observed in prostate cancer samples from PSA patients with
biochemical recurrence, where the RNA expression levels are
indicative of a disease state or outcome. Subgroups of these target
sequences, as well as individual target sequences, have been found
useful in such methods.
[0079] In some embodiments, an RNA signature corresponding to SEQ
ID NOs: 1, 4, 6, 9, 14-16, 18-21 915-917, 920, 922, 928, 929, 931,
935 and 936 (the 21-RNA' signature) and/or SEQ ID NOs: 1-11,
914-920 (the `18-RNA` signature) and/or SEQ ID NOs: 1-4, 914,915)
(the `6-RNA` signature) and/or SEQ ID NOs: 1, 4, 6, 9, 14-16,
18-21, 915-917, 920, 922, 928, 929, 931, 935 and 936 (the `20-RNA`
signature) and/or SEQ ID NOs 3, 36, 60, 63, 926, 971, 978, 999,
1014 and 1022 (the `10-RNA` signature) and/or SEQ ID NOs 1-3, 32,
33, 36, 46, 60, 63, 66, 69, 88, 100, 241, 265, 334, 437, 920, 925,
934, 945, 947, 954, 971, 978, 999, 1004, 1014, 1022, 1023, 1032,
1080, 1093, 1101, 1164, 1248, 1304, 1311, 1330, 1402 and 1425 (the
`41-RNA` signature) are formulated into a linear combination of
their respective expression values for each patient generating a
patient outcome predictor (`POP`) score and indicative of the
disease status of the patient after prostatectomy.
[0080] Exemplary subsets and combinations of interest also include
at least five, six, 10, 15, 18, 20, 23, 25, 27, 30, 35, 40, 45, 50,
55, 60, 70, 80, 90, 100, 125, 150, 175, 200, 225, 250, 275, 300,
350, 400, 450, 500, 750, 1000, 1200, 1400, 1600, 1800, 2000, or all
2114 target sequences in Table 4; at least five, six, 10, 15, 18,
20, 23, 25, 27, 30, 35, 40, 45, 50, 55, 60, 70, 80, 90, 100, 125,
150, 175, 200, 225, 250, 275, 300, 350, 400, 450, 500, or all 526
target sequences in Table 7; SEQ ID NOs:1, 4, 915, 6, 916, 9, 917,
920, 922, 14, 15, 16, 928, 929, 18, 19, 931, 20, 21, 935, 936, or
combinations thereof; SEQ ID NOs:1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11,
914, 915, 916, 917, 918, 919, 920, or combinations thereof; SEQ ID
NOs: 1, 4, 6, 9, 14-16, 18-21, 915-917, 920, 922, 928, 929, 931,
935, 936 or combinations thereof; SEQ ID NOs 3, 36, 60, 63, 926,
971, 978, 999, 1014, 1022 or combinations thereof; SEQ ID NOs 1-3,
32, 33, 36, 46, 60, 63, 66, 69, 88, 100, 241, 265, 334, 437, 920,
925, 934, 945, 947, 954, 971, 978, 999, 1004, 1014, 1022, 1023,
1032, 1080, 1093, 1101, 1164, 1248, 1304, 1311, 1330, 1402, 1425 or
combinations thereof; at least one, two, three, four, five or six
of SEQ ID NOs:1, 4, 6, 9, 14, 15, 16, 18, 19, 20, and 21 and at
least one, two, three, four, five or six of SEQ ID NOs:915, 916,
917, 920, 922, 928, 929, 931, 935, and 936; and at least one, two,
three, four, five or six of SEQ ID NOs:1, 2, 3, 4, 5, 6, 7, 8, 9,
10, and 11 at least one, two, three, four, five or six of at least
one, two, three, four, five or six of SEQ ID NOs:914, 915, 916,
917, 918, 919, and 920 and at least one, two, three, four, five or
six of SEQ ID NOs: 1, 4, 6, 9, 14-16, 18-21, 915-917, 920, 922,
928, 929, 931, 935, 936; and at least one, two, three, four, five
or six of SEQ ID NOs 3, 36, 60, 63, 926, 971, 978, 999, 1014, 1022;
and at least one, two, three, four, five or six of SEQ ID NOs 1-3,
32, 33, 36, 46, 60, 63, 66, 69, 88, 100, 241, 265, 334, 437, 920,
925, 934, 945, 947, 954, 971, 978, 999, 1004, 1014, 1022, 1023,
1032, 1080, 1093, 1101, 1164, 1248, 1304, 1311, 1330, 1402,
1425.
[0081] Exemplary subsets of interest include those described
herein, including in the examples. Exemplary combinations of
interest include those utilizing one or more of the sequences
listed in Tables 5, 7, 8, 9 or 10. Of particular interest are those
combinations utilizing at least one sequence exhibiting positive
correlation with the trait of interest, as well as those
combinations utilizing at least one sequence exhibiting negative
correlation with the trait of interest. Also of interest are those
combinations utilizing at least two, at least three, at least four,
at least five or at least six of those sequences exhibiting such a
positive correlation, in combination with at least two, at least
three, at least four, at least five, or at least six of those
sequences exhibiting such a negative correlation. Exemplary
combinations include those utilizing at least one, two, three,
four, five or six of the target sequences depicted in Tables 5 and
6.
[0082] In some embodiments, increased relative expression of one or
more of SEQ IDs:1-913, decreased relative expression of one or more
of SEQ ID NOs:914-2114 or a combination of any thereof is
indicative/predictive of the patient exhibiting no evidence of
disease for at least seven years or more after surgery. In some
embodiments, increased relative expression of SEQ IDs:914-2114,
decreased relative expression of one or more of SEQ ID NOs:1-913 or
a combination of any thereof is indicative/predictive of the
patient exhibiting systemic prostate cancer. Increased or decreased
expression of target sequences represented in these sequence
listings, or of the target sequences described in the examples, may
be utilized in the methods of the invention.
[0083] The Prostate Cancer Prognostic Set can optionally include
one or more target sequences specifically derived from the
transcripts of one or more housekeeping genes and/or one or more
internal control target sequences and/or one or more negative
control target sequences. In one embodiment, these target sequences
can, for example, be used to normalize expression data.
Housekeeping genes from which target sequences for inclusion in a
Prostate Cancer Prognostic Set can be derived from are known in the
art and include those genes in which are expressed at a constant
level in normal and prostate cancer tissue.
[0084] The target sequences described herein may be used alone or
in combination with each other or with other known or later
identified disease markers.
Prostate Cancer Prognostic Probes/Primers
[0085] The system of the present invention provides for
combinations of polynucleotide probes that are capable of detecting
the target sequences of the Prostate Cancer Prognostic Sets.
Individual polynucleotide probes comprise a nucleotide sequence
derived from the nucleotide sequence of the target sequences or
complementary sequences thereof. The nucleotide sequence of the
polynucleotide probe is designed such that it corresponds to, or is
complementary to the target sequences. The polynucleotide probe can
specifically hybridize under either stringent or lowered stringency
hybridization conditions to a region of the target sequences, to
the complement thereof, or to a nucleic acid sequence (such as a
cDNA) derived therefrom.
[0086] The selection of the polynucleotide probe sequences and
determination of their uniqueness may be carried out in silico
using techniques known in the art, for example, based on a BLASTN
search of the polynucleotide sequence in question against gene
sequence databases, such as the Human Genome Sequence, UniGene,
dbEST or the non-redundant database at NCBI. In one embodiment of
the invention, the polynucleotide probe is complementary to a
region of a target mRNA derived from a target sequence in the
Prostate Cancer Prognostic Set. Computer programs can also be
employed to select probe sequences that will not cross hybridize or
will not hybridize non-specifically.
[0087] One skilled in the art will understand that the nucleotide
sequence of the polynucleotide probe need not be identical to its
target sequence in order to specifically hybridize thereto. The
polynucleotide probes of the present invention, therefore, comprise
a nucleotide sequence that is at least about 75% identical to a
region of the target gene or mRNA. In another embodiment, the
nucleotide sequence of the polynucleotide probe is at least about
90% identical a region of the target gene or mRNA. In a further
embodiment, the nucleotide sequence of the polynucleotide probe is
at least about 95% identical to a region of the target gene or
mRNA. Methods of determining sequence identity are known in the art
and can be determined, for example, by using the BLASTN program of
the University of Wisconsin Computer Group (GCG) software or
provided on the NCBI website. The nucleotide sequence of the
polynucleotide probes of the present invention may exhibit
variability by differing (e.g. by nucleotide substitution,
including transition or transversion) at one, two, three, four or
more nucleotides from the sequence of the target gene.
[0088] Other criteria known in the art may be employed in the
design of the polynucleotide probes of the present invention. For
example, the probes can be designed to have <50% G content
and/or between about 25% and about 70% G+C content. Strategies to
optimize probe hybridization to the target nucleic acid sequence
can also be included in the process of probe selection.
Hybridization under particular pH, salt, and temperature conditions
can be optimized by taking into account melting temperatures and by
using empirical rules that correlate with desired hybridization
behaviours. Computer models may be used for predicting the
intensity and concentration-dependence of probe hybridization.
[0089] As is known in the art, in order to represent a unique
sequence in the human genome, a probe should be at least 15
nucleotides in length. Accordingly, the polynucleotide probes of
the present invention range in length from about 15 nucleotides to
the full length of the target sequence or target mRNA. In one
embodiment of the invention, the polynucleotide probes are at least
about 15 nucleotides in length. In another embodiment, the
polynucleotide probes are at least about 20 nucleotides in length.
In a further embodiment, the polynucleotide probes are at least
about 25 nucleotides in length. In another embodiment, the
polynucleotide probes are between about 15 nucleotides and about
500 nucleotides in length. In other embodiments, the polynucleotide
probes are between about 15 nucleotides and about 450 nucleotides,
about 15 nucleotides and about 400 nucleotides, about 15
nucleotides and about 350 nucleotides, about 15 nucleotides and
about 300 nucleotides in length.
[0090] The polynucleotide probes of a Prostate Cancer Prognostic
Set can comprise RNA, DNA, RNA or DNA mimetics, or combinations
thereof, and can be single-stranded or double-stranded. Thus the
polynucleotide probes can be composed of naturally-occurring
nucleobases, sugars and covalent internucleoside (backbone)
linkages as well as polynucleotide probes having
non-naturally-occurring portions which function similarly. Such
modified or substituted polynucleotide probes may provide desirable
properties such as, for example, enhanced affinity for a target
gene and increased stability.
[0091] The system of the present invention further provides for
primers and primer pairs capable of amplifying target sequences
defined by the Prostate Cancer Prognostic Set, or fragments or
subsequences or complements thereof. The nucleotide sequences of
the Prostate Cancer Prognostic set may be provided in
computer-readable media for in silico applications and as a basis
for the design of appropriate primers for amplification of one or
more target sequences of the Prostate Cancer Prognostic Set.
[0092] Primers based on the nucleotide sequences of target
sequences can be designed for use in amplification of the target
sequences. For use in amplification reactions such as PCR, a pair
of primers will be used. The exact composition of the primer
sequences is not critical to the invention, but for most
applications the primers will hybridize to specific sequences of
the Prostate Cancer Prognostic Set under stringent conditions,
particularly under conditions of high stringency, as known in the
art. The pairs of primers are usually chosen so as to generate an
amplification product of at least about 50 nucleotides, more
usually at least about 100 nucleotides. Algorithms for the
selection of primer sequences are generally known, and are
available in commercial software packages. These primers may be
used in standard quantitative or qualitative PCR-based assays to
assess transcript expression levels of RNAs defined by the Prostate
Cancer Prognostic Set. Alternatively, these primers may be used in
combination with probes, such as molecular beacons in
amplifications using real-time PCR.
[0093] In one embodiment, the primers or primer pairs, when used in
an amplification reaction, specifically amplify at least a portion
of a nucleic acid depicted in one of SEQ ID NOs: 1-2114 (or
subgroups thereof as set forth herein), an RNA form thereof, or a
complement to either thereof.
[0094] As is known in the art, a nucleoside is a base-sugar
combination and a nucleotide is a nucleoside that further includes
a phosphate group covalently linked to the sugar portion of the
nucleoside. In forming oligonucleotides, the phosphate groups
covalently link adjacent nucleosides to one another to form a
linear polymeric compound, with the normal linkage or backbone of
RNA and DNA being a 3' to 5' phosphodiester linkage. Specific
examples of polynucleotide probes or primers useful in this
invention include oligonucleotides containing modified backbones or
non-natural internucleoside linkages. As defined in this
specification, oligonucleotides having modified backbones include
both those that retain a phosphorus atom in the backbone and those
that lack a phosphorus atom in the backbone. For the purposes of
the present invention, and as sometimes referenced in the art,
modified oligonucleotides that do not have a phosphorus atom in
their internucleoside backbone can also be considered to be
oligonucleotides.
[0095] Exemplary polynucleotide probes or primers having modified
oligonucleotide backbones include, for example, those with one or
more modified internucleotide linkages that are phosphorothioates,
chiral phosphorothioates, phosphorodithioates, phosphotriesters,
aminoalkylphosphotriesters, methyl and other alkyl phosphonates
including 3'-alkylene phosphonates and chiral phosphonates,
phosphinates, phosphoramidates including 3' amino phosphoramidate
and aminoalkylphosphoramidates, thionophosphoramidates,
thionoalkyl-phosphonates, thionoalkylphosphotriesters, and
boranophosphates having normal 3'-5' linkages, 2'-5' linked analogs
of these, and those having inverted polarity wherein the adjacent
pairs of nucleoside units are linked 3'-5' to 5'-3' or 2'-5' to
5'-2'. Various salts, mixed salts and free acid forms are also
included.
[0096] Exemplary modified oligonucleotide backbones that do not
include a phosphorus atom are formed by short chain alkyl or
cycloalkyl internucleoside linkages, mixed heteroatom and alkyl or
cycloalkyl internucleoside linkages, or one or more short chain
heteroatomic or heterocyclic internucleoside linkages. Such
backbones include morpholino linkages (formed in part from the
sugar portion of a nucleoside); siloxane backbones; sulfide,
sulfoxide and sulphone backbones; formacetyl and thioformacetyl
backbones; methylene formacetyl and thioformacetyl backbones;
alkene containing backbones; sulphamate backbones; methyleneimino
and methylenehydrazino backbones; sulphonate and sulfonamide
backbones; amide backbones; and others having mixed N, O, S and
CH.sub.2 component parts.
[0097] The present invention also contemplates oligonucleotide
mimetics in which both the sugar and the internucleoside linkage of
the nucleotide units are replaced with novel groups. The base units
are maintained for hybridization with an appropriate nucleic acid
target compound. An example of such an oligonucleotide mimetic,
which has been shown to have excellent hybridization properties, is
a peptide nucleic acid (PNA) [Nielsen et al., Science,
254:1497-1500 (1991)]. In PNA compounds, the sugar-backbone of an
oligonucleotide is replaced with an amide containing backbone, in
particular an aminoethylglycine backbone. The nucleobases are
retained and are bound directly or indirectly to aza-nitrogen atoms
of the amide portion of the backbone. The present invention also
contemplates polynucleotide probes or primers comprising "locked
nucleic acids" (LNAs), which are novel conformationally restricted
oligonucleotide analogues containing a methylene bridge that
connects the 2'-O of ribose with the 4'-C (see, Singh et al., Chem.
Commun., 1998, 4:455-456). LNA and LNA analogues display very high
duplex thermal stabilities with complementary DNA and RNA,
stability towards 3'-exonuclease degradation, and good solubility
properties. Synthesis of the LNA analogues of adenine, cytosine,
guanine, 5-methylcytosine, thymine and uracil, their
oligomerization, and nucleic acid recognition properties have been
described (see Koshkin et al., Tetrahedron, 1998, 54:3607-3630).
Studies of mis-matched sequences show that LNA obey the
Watson-Crick base pairing rules with generally improved selectivity
compared to the corresponding unmodified reference strands.
[0098] LNAs form duplexes with complementary DNA or RNA or with
complementary LNA, with high thermal affinities. The universality
of LNA-mediated hybridization has been emphasized by the formation
of exceedingly stable LNA:LNA duplexes (Koshkin et al., J. Am.
Chem. Soc., 1998, 120:13252-13253). LNA:LNA hybridization was shown
to be the most thermally stable nucleic acid type duplex system,
and the RNA-mimicking character of LNA was established at the
duplex level. Introduction of three LNA monomers (T or A) resulted
in significantly increased melting points toward DNA
complements.
[0099] Synthesis of 2'-amino-LNA (Singh et al., J. Org. Chem.,
1998, 63, 10035-10039) and 2'-methylamino-LNA has been described
and thermal stability of their duplexes with complementary RNA and
DNA strands reported. Preparation of phosphorothioate-LNA and
2'-thio-LNA have also been described (Kumar et al., Bioorg. Med.
Chem. Lett., 1998, 8:2219-2222).
[0100] Modified polynucleotide probes or primers may also contain
one or more substituted sugar moieties. For example,
oligonucleotides may comprise sugars with one of the following
substituents at the 2' position: OH; F; O--, S--, or N-alkyl; O--,
S--, or N-alkenyl; O--, S-- or N-alkynyl; or O-alkyl-O-alkyl,
wherein the alkyl, alkenyl and alkynyl may be substituted or
unsubstituted C.sub.1 to C.sub.10 alkyl or C.sub.2 to C.sub.10
alkenyl and alkynyl. Examples of such groups are:
O[(CH.sub.2).sub.n O].sub.m CH.sub.3, O(CH.sub.2).sub.n OCH.sub.3,
O(CH.sub.2).sub.n NH.sub.2, O(CH.sub.2).sub.n CH.sub.3,
O(CH.sub.2).sub.n ONH.sub.2, and O(CH.sub.2).sub.n
ON[(CH.sub.2).sub.n CH.sub.3)].sub.2, where n and m are from 1 to
about 10. Alternatively, the oligonucleotides may comprise one of
the following substituents at the 2' position: C.sub.1 to C.sub.10
lower alkyl, substituted lower alkyl, alkaryl, aralkyl, O-alkaryl
or O-aralkyl, SH, SCH.sub.3, OCN, Cl, Br, CN, CF.sub.3, OCF.sub.3,
SOCH.sub.3, SO.sub.2 CH.sub.3, ONO.sub.2, NO.sub.2, N.sub.3,
NH.sub.2, heterocycloalkyl, heterocycloalkaryl, aminoalkylamino,
polyalkylamino, substituted silyl, an RNA cleaving group, a
reporter group, an intercalator, a group for improving the
pharmacokinetic properties of an oligonucleotide, or a group for
improving the pharmacodynamic properties of an oligonucleotide, and
other substituents having similar properties. Specific examples
include 2'-methoxyethoxy (2'-O--CH.sub.2 CH.sub.2 OCH.sub.3, also
known as 2'-O-(2-methoxyethyl) or 2'-MOE) [Martin et al., Helv.
Chim. Acta, 78:486-504 (1995)], 2'-dimethylaminooxyethoxy
(O(CH.sub.2).sub.2 ON(CH.sub.3).sub.2 group, also known as
2'-DMAOE), 2'-methoxy (2'-O--CH.sub.3), 2'-aminopropoxy
(2'-OCH.sub.2 CH.sub.2 CH.sub.2 NH.sub.2) and 2'-fluoro (2'-F).
[0101] Similar modifications may also be made at other positions on
the polynucleotide probes or primers, particularly the 3' position
of the sugar on the 3' terminal nucleotide or in 2'-5' linked
oligonucleotides and the 5' position of 5' terminal nucleotide.
Polynucleotide probes or primers may also have sugar mimetics such
as cyclobutyl moieties in place of the pentofuranosyl sugar.
[0102] Polynucleotide probes or primers may also include
modifications or substitutions to the nucleobase. As used herein,
"unmodified" or "natural" nucleobases include the purine bases
adenine (A) and guanine (G), and the pyrimidine bases thymine (T),
cytosine (C) and uracil (U). Modified nucleobases include other
synthetic and natural nucleobases such as 5-methylcytosine
(5-me-C), 5-hydroxymethyl cytosine, xanthine, hypoxanthine,
2-aminoadenine, 6-methyl and other alkyl derivatives of adenine and
guanine, 2-propyl and other alkyl derivatives of adenine and
guanine, 2-thiouracil, 2-thiothymine and 2-thiocytosine,
5-halouracil and cytosine, 5-propynyl uracil and cytosine, 6-azo
uracil, cytosine and thymine, 5-uracil (pseudouracil),
4-thiouracil, 8-halo, 8-amino, 8-thiol, 8-thioalkyl, 8-hydroxyl and
other 8-substituted adenines and guanines, 5-halo particularly
5-bromo, 5-trifluoromethyl and other 5-substituted uracils and
cytosines, 7-methylguanine and 7-methyladenine, 8-azaguanine and
8-azaadenine, 7-deazaguanine and 7-deazaadenine and 3-deazaguanine
and 3-deazaadenine. Further nucleobases include those disclosed in
U.S. Pat. No. 3,687,808; The Concise Encyclopedia Of Polymer
Science And Engineering, (1990) pp 858-859, Kroschwitz, J. I., ed.
John Wiley & Sons; Englisch et al., Angewandte Chemie, Int.
Ed., 30:613 (1991); and Sanghvi, Y. S., (1993) Antisense Research
and Applications, pp 289-302, Crooke, S. T. and Lebleu, B., ed.,
CRC Press. Certain of these nucleobases are particularly useful for
increasing the binding affinity of the polynucleotide probes of the
invention. These include 5-substituted pyrimidines,
6-azapyrimidines and N-2, N-6 and O-6 substituted purines,
including 2-aminopropyladenine, 5-propynyluracil and
5-propynylcytosine. 5-methylcytosine substitutions have been shown
to increase nucleic acid duplex stability by 0.6-1.2.degree. C.
[Sanghvi, Y. S., (1993) Antisense Research and Applications, pp
276-278, Crooke, S. T. and Lebleu, B., ed., CRC Press, Boca
Raton].
[0103] One skilled in the art will recognize that it is not
necessary for all positions in a given polynucleotide probe or
primer to be uniformly modified. The present invention, therefore,
contemplates the incorporation of more than one of the
aforementioned modifications into a single polynucleotide probe or
even at a single nucleoside within the probe or primer.
[0104] One skilled in the art will also appreciate that the
nucleotide sequence of the entire length of the polynucleotide
probe or primer does not need to be derived from the target
sequence. Thus, for example, the polynucleotide probe may comprise
nucleotide sequences at the 5' and/or 3' termini that are not
derived from the target sequences. Nucleotide sequences which are
not derived from the nucleotide sequence of the target sequence may
provide additional functionality to the polynucleotide probe. For
example, they may provide a restriction enzyme recognition sequence
or a "tag" that facilitates detection, isolation, purification or
immobilisation onto a solid support. Alternatively, the additional
nucleotides may provide a self-complementary sequence that allows
the primer/probe to adopt a hairpin configuration. Such
configurations are necessary for certain probes, for example,
molecular beacon and Scorpion probes, which can be used in solution
hybridization techniques.
[0105] The polynucleotide probes or primers can incorporate
moieties useful in detection, isolation, purification, or
immobilisation, if desired. Such moieties are well-known in the art
(see, for example, Ausubel et al., (1997 & updates) Current
Protocols in Molecular Biology, Wiley & Sons, New York) and are
chosen such that the ability of the probe to hybridize with its
target sequence is not affected.
[0106] Examples of suitable moieties are detectable labels, such as
radioisotopes, fluorophores, chemiluminophores, enzymes, colloidal
particles, and fluorescent microparticles, as well as antigens,
antibodies, haptens, avidin/streptavidin, biotin, haptens, enzyme
cofactors/substrates, enzymes, and the like.
[0107] A label can optionally be attached to or incorporated into a
probe or primer polynucleotide to allow detection and/or
quantitation of a target polynucleotide representing the target
sequence of interest. The target polynucleotide may be the
expressed target sequence RNA itself, a cDNA copy thereof, or an
amplification product derived therefrom, and may be the positive or
negative strand, so long as it can be specifically detected in the
assay being used. Similarly, an antibody may be labeled.
[0108] In certain multiplex formats, labels used for detecting
different targets may be distinguishable. The label can be attached
directly (e.g., via covalent linkage) or indirectly, e.g., via a
bridging molecule or series of molecules (e.g., a molecule or
complex that can bind to an assay component, or via members of a
binding pair that can be incorporated into assay components, e.g.
biotin-avidin or streptavidin). Many labels are commercially
available in activated forms which can readily be used for such
conjugation (for example through amine acylation), or labels may be
attached through known or determinable conjugation schemes, many of
which are known in the art.
[0109] Labels useful in the invention described herein include any
substance which can be detected when bound to or incorporated into
the biomolecule of interest. Any effective detection method can be
used, including optical, spectroscopic, electrical,
piezoelectrical, magnetic, Raman scattering, surface plasmon
resonance, colorimetric, calorimetric, etc. A label is typically
selected from a chromophore, a lumiphore, a fluorophore, one member
of a quenching system, a chromogen, a hapten, an antigen, a
magnetic particle, a material exhibiting nonlinear optics, a
semiconductor nanocrystal, a metal nanoparticle, an enzyme, an
antibody or binding portion or equivalent thereof, an aptamer, and
one member of a binding pair, and combinations thereof. Quenching
schemes may be used, wherein a quencher and a fluorophore as
members of a quenching pair may be used on a probe, such that a
change in optical parameters occurs upon binding to the target
introduce or quench the signal from the fluorophore. One example of
such a system is a molecular beacon. Suitable quencher/fluorophore
systems are known in the art. The label may be bound through a
variety of intermediate linkages. For example, a polynucleotide may
comprise a biotin-binding species, and an optically detectable
label may be conjugated to biotin and then bound to the labeled
polynucleotide. Similarly, a polynucleotide sensor may comprise an
immunological species such as an antibody or fragment, and a
secondary antibody containing an optically detectable label may be
added.
[0110] Chromophores useful in the methods described herein include
any substance which can absorb energy and emit light. For
multiplexed assays, a plurality of different signaling chromophores
can be used with detectably different emission spectra. The
chromophore can be a lumophore or a fluorophore. Typical
fluorophores include fluorescent dyes, semiconductor nanocrystals,
lanthanide chelates, polynucleotide-specific dyes and green
fluorescent protein.
[0111] Coding schemes may optionally be used, comprising encoded
particles and/or encoded tags associated with different
polynucleotides of the invention. A variety of different coding
schemes are known in the art, including fluorophores, including
SCNCs, deposited metals, and RF tags.
[0112] Polynucleotides from the described target sequences may be
employed as probes for detecting target sequences expression, for
ligation amplification schemes, or may be used as primers for
amplification schemes of all or a portion of a target sequences.
When amplified, either strand produced by amplification may be
provided in purified and/or isolated form.
[0113] In one embodiment, polynucleotides of the invention include
a nucleic acid depicted in (a) any one of SEQ ID NOs: 1-2114, or a
subgroup thereof as set forth herein; (b) an RNA form of any one of
the nucleic acids depicted in SEQ ID NOs: 1-2114, or a subgroup
thereof as set forth herein; (c) a peptide nucleic acid form of any
of the nucleic acids depicted in SEQ ID NOs: 1-2114, or a subgroup
thereof as set forth herein; (d) a nucleic acid comprising at least
20 consecutive bases of any of (a-c); (e) a nucleic acid comprising
at least 25 bases having at least 90% sequenced identity to any of
(a-c); and (f) a complement to any of (a-e).
[0114] Complements may take any polymeric form capable of base
pairing to the species recited in (a)-(e), including nucleic acid
such as RNA or DNA, or may be a neutral polymer such as a peptide
nucleic acid. Polynucleotides of the invention can be selected from
the subsets of the recited nucleic acids described herein, as well
as their complements.
[0115] In some embodiments, polynucleotides of the invention
comprise at least 20 consecutive bases as depicted in SEQ ID
NOs:1-2114, or a complement thereto. The polynucleotides may
comprise at least 21, 22, 23, 24, 25, 27, 30, 32, 35 or more
consecutive bases as depicted in SEQ ID NOs:1-2114, as
applicable.
[0116] In some embodiments, the nucleic acid in (a) can be selected
from those in Table 3, and from SEQ ID NOs:1, 4, 915, 6, 916, 9,
917, 920, 922, 14, 15, 16, 928, 929, 18, 19, 931, 20, 21, 935, and
936; or from SEQ ID NOs:1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 914,
915, 916, 917, 918, 919, and 920; or from SEQ ID NOs: 1, 4, 6, 9,
14-16, 18-21, 915-917, 920, 922, 928, 929, 931, 935 and 936; or
from SEQ ID NOs 3, 36, 60, 63, 926, 971, 978, 999, 1014 and 1022;
or from SEQ ID NOs 1-3, 32, 33, 36, 46, 60, 63, 66, 69, 88, 100,
241, 265, 334, 437, 920, 925, 934, 945, 947, 954, 971, 978, 999,
1004, 1014, 1022, 1023, 1032, 1080, 1093, 1101, 1164, 1248, 1304,
1311, 1330, 1402 and 1425.
[0117] The polynucleotides may be provided in a variety of formats,
including as solids, in solution, or in an array. The
polynucleotides may optionally comprise one or more labels, which
may be chemically and/or enzymatically incorporated into the
polynucleotide.
[0118] In one embodiment, solutions comprising polynucleotide and a
solvent are also provided. In some embodiments, the solvent may be
water or may be predominantly aqueous. In some embodiments, the
solution may comprise at least two, three, four, five, six, seven,
eight, nine, ten, twelve, fifteen, seventeen, twenty or more
different polynucleotides, including primers and primer pairs, of
the invention. Additional substances may be included in the
solution, alone or in combination, including one or more labels,
additional solvents, buffers, biomolecules, polynucleotides, and
one or more enzymes useful for performing methods described herein,
including polymerases and ligases. The solution may further
comprise a primer or primer pair capable of amplifying a
polynucleotide of the invention present in the solution.
[0119] In some embodiments, one or more polynucleotides provided
herein can be provided on a substrate. The substrate can comprise a
wide range of material, either biological, nonbiological, organic,
inorganic, or a combination of any of these. For example, the
substrate may be a polymerized Langmuir Blodgett film,
functionalized glass, Si, Ge, GaAs, GaP, SiO.sub.2, SiN.sub.4,
modified silicon, or any one of a wide variety of gels or polymers
such as (poly)tetrafluoroethylene, (poly)vinylidenedifluoride,
polystyrene, cross-linked polystyrene, polyacrylic, polylactic
acid, polyglycolic acid, poly(lactide coglycolide), polyanhydrides,
poly(methyl methacrylate), poly(ethylene-co-vinyl acetate),
polysiloxanes, polymeric silica, latexes, dextran polymers,
epoxies, polycarbonates, or combinations thereof. Conducting
polymers and photoconductive materials can be used.
[0120] Substrates can be planar crystalline substrates such as
silica based substrates (e.g. glass, quartz, or the like), or
crystalline substrates used in, e.g., the semiconductor and
microprocessor industries, such as silicon, gallium arsenide,
indium doped GaN and the like, and includes semiconductor
nanocrystals.
[0121] The substrate can take the form of an array, a photodiode,
an optoelectronic sensor such as an optoelectronic semiconductor
chip or optoelectronic thin-film semiconductor, or a biochip. The
location(s) of probe(s) on the substrate can be addressable; this
can be done in highly dense formats, and the location(s) can be
microaddressable or nanoaddressable.
[0122] Silica aerogels can also be used as substrates, and can be
prepared by methods known in the art. Aerogel substrates may be
used as free standing substrates or as a surface coating for
another substrate material.
[0123] The substrate can take any form and typically is a plate,
slide, bead, pellet, disk, particle, microparticle, nanoparticle,
strand, precipitate, optionally porous gel, sheets, tube, sphere,
container, capillary, pad, slice, film, chip, multiwell plate or
dish, optical fiber, etc. The substrate can be any form that is
rigid or semi-rigid. The substrate may contain raised or depressed
regions on which an assay component is located. The surface of the
substrate can be etched using known techniques to provide for
desired surface features, for example trenches, v-grooves, mesa
structures, or the like.
[0124] Surfaces on the substrate can be composed of the same
material as the substrate or can be made from a different material,
and can be coupled to the substrate by chemical or physical means.
Such coupled surfaces may be composed of any of a wide variety of
materials, for example, polymers, plastics, resins,
polysaccharides, silica or silica-based materials, carbon, metals,
inorganic glasses, membranes, or any of the above-listed substrate
materials. The surface can be optically transparent and can have
surface Si--OH functionalities, such as those found on silica
surfaces.
[0125] The substrate and/or its optional surface can be chosen to
provide appropriate characteristics for the synthetic and/or
detection methods used. The substrate and/or surface can be
transparent to allow the exposure of the substrate by light applied
from multiple directions. The substrate and/or surface may be
provided with reflective "mirror" structures to increase the
recovery of light.
[0126] The substrate and/or its surface is generally resistant to,
or is treated to resist, the conditions to which it is to be
exposed in use, and can be optionally treated to remove any
resistant material after exposure to such conditions.
[0127] The substrate or a region thereof may be encoded so that the
identity of the sensor located in the substrate or region being
queried may be determined Any suitable coding scheme can be used,
for example optical codes, RFID tags, magnetic codes, physical
codes, fluorescent codes, and combinations of codes.
Preparation of Probes and Primers
[0128] The polynucleotide probes or primers of the present
invention can be prepared by conventional techniques well-known to
those skilled in the art. For example, the polynucleotide probes
can be prepared using solid-phase synthesis using commercially
available equipment. As is well-known in the art, modified
oligonucleotides can also be readily prepared by similar methods.
The polynucleotide probes can also be synthesized directly on a
solid support according to methods standard in the art. This method
of synthesizing polynucleotides is particularly useful when the
polynucleotide probes are part of a nucleic acid array.
[0129] Polynucleotide probes or primers can be fabricated on or
attached to the substrate by any suitable method, for example the
methods described in U.S. Pat. No. 5,143,854, PCT Publ. No. WO
92/10092, U.S. patent application Ser. No. 07/624,120, filed Dec.
6, 1990 (now abandoned), Fodor et al., Science, 251: 767-777
(1991), and PCT Publ. No. WO 90/15070). Techniques for the
synthesis of these arrays using mechanical synthesis strategies are
described in, e.g., PCT Publication No. WO 93/09668 and U.S. Pat.
No. 5,384,261. Still further techniques include bead based
techniques such as those described in PCT Appl. No. PCT/US93/04145
and pin based methods such as those described in U.S. Pat. No.
5,288,514. Additional flow channel or spotting methods applicable
to attachment of sensor polynucleotides to a substrate are
described in U.S. patent application Ser. No. 07/980,523, filed
Nov. 20, 1992, and U.S. Pat. No. 5,384,261.
[0130] Alternatively, the polynucleotide probes of the present
invention can be prepared by enzymatic digestion of the naturally
occurring target gene, or mRNA or cDNA derived therefrom, by
methods known in the art.
Prostate Cancer Prognostic Methods
[0131] The present invention further provides methods for
characterizing prostate cancer sample for recurrence risk. The
methods use the Prostate Cancer Prognostic Sets, probes and primers
described herein to provide expression signatures or profiles from
a test sample derived from a subject having or suspected of having
prostate cancer. In some embodiments, such methods involve
contacting a test sample with Prostate Cancer Prognostic probes
(either in solution or immobilized) under conditions that permit
hybridization of the probe(s) to any target nucleic acid(s) present
in the test sample and then detecting any probe:target duplexes
formed as an indication of the presence of the target nucleic acid
in the sample. Expression patterns thus determined are then
compared to one or more reference profiles or signatures.
Optionally, the expression pattern can be normalized. The methods
use the Prostate Cancer Prognostic Sets, probes and primers
described herein to provide expression signatures or profiles from
a test sample derived from a subject to classify the prostate
cancer as recurrent or non-recurrent.
[0132] In some embodiments, such methods involve the specific
amplification of target sequences nucleic acid(s) present in the
test sample using methods known in the art to generate an
expression profile or signature which is then compared to a
reference profile or signature.
[0133] In some embodiments, the invention further provides for
prognosing patient outcome, predicting likelihood of recurrence
after prostatectomy and/or for designating treatment
modalities.
[0134] In one embodiment, the methods generate expression profiles
or signatures detailing the expression of the 2114 target sequences
having altered relative expression with different prostate cancer
outcomes. In one embodiment, the methods generate expression
profiles or signatures detailing the expression of the subsets of
these target sequences having 526 or 18 target sequences as
described in the examples.
[0135] In some embodiments, increased relative expression of one or
more of SEQ IDs:1-913, decreased relative expression of one or more
of SEQ ID NOs:914-2114 or a combination of any thereof is
indicative of a non-recurrent form of prostate cancer and may be
predictive a NED clinical outcome after surgery. In some
embodiments, increased relative expression of SEQ IDs:914-2114,
decreased relative expression of one or more of SEQ ID NOs:1-913 or
a combination of any thereof is indicative of a recurrent form of
prostate cancer and may be predictive of a SYS clinical outcome
after surgery. Increased or decreased expression of target
sequences represented in these sequence listings, or of the target
sequences described in the examples, may be utilized in the methods
of the invention.
[0136] In one embodiment, intermediate levels of expression of one
or more target sequences depicted in Table 7 indicate a probability
of future biochemical recurrence.
[0137] In some embodiments, the methods detect combinations of
expression levels of sequences exhibiting positive and negative
correlation with a disease status. In one embodiment, the methods
detect a minimal expression signature.
[0138] Any method of detecting and/or quantitating the expression
of the encoded target sequences can in principle be used in the
invention. Such methods can include Northern blotting, array or
microarray hybridization, by enzymatic cleavage of specific
structures (e.g., an Invader.RTM. assay, Third Wave Technologies,
e.g. as described in U.S. Pat. Nos. 5,846,717, 6,090,543;
6,001,567; 5,985,557; and 5,994,069) and amplification methods,
e.g. RT-PCR, including in a TaqMan.RTM. assay (PE Biosystems,
Foster City, Calif., e.g. as described in U.S. Pat. Nos. 5,962,233
and 5,538,848), and may be quantitative or semi-quantitative, and
may vary depending on the origin, amount and condition of the
available biological sample. Combinations of these methods may also
be used. For example, nucleic acids may be amplified, labeled and
subjected to microarray analysis. Single-molecule sequencing (e.g.,
Illumina, Helicos, PacBio, ABI SOLID), in situ hybridization,
bead-array technologies (e.g., Luminex xMAP, Illumina BeadChips),
branched DNA technology (e.g., Panomics, Genisphere).
[0139] The expressed target sequences can be directly detected
and/or quantitated, or may be copied and/or amplified to allow
detection of amplified copies of the expressed target sequences or
its complement. In some embodiments, degraded and/or fragmented RNA
can be usefully analyzed for expression levels of target sequences,
for example RNA having an RNA integrity number of less than 8.
[0140] In some embodiments, quantitative RT-PCR assays are used to
measure the expression level of target sequences depicted in SEQ
IDs: 1-2114. In other embodiments, a GeneChip or microarray can be
used to measure the expression of one or more of the target
sequences.
[0141] Molecular assays measure the relative expression levels of
the target sequences, which can be normalized to the expression
levels of one or more control sequences, for example array control
sequences and/or one or more housekeeping genes, for example GAPDH.
Increased (or decreased) relative expression of the target
sequences as described herein, including any of SEQ ID NOs:1-2114,
may thus be used alone or in any combination with each other in the
methods described herein. In addition, negative control probes may
be included.
Diagnostic Samples
[0142] Diagnostic samples for use with the systems and in the
methods of the present invention comprise nucleic acids suitable
for providing RNAs expression information. In principle, the
biological sample from which the expressed RNA is obtained and
analyzed for target sequence expression can be any material
suspected of comprising prostate cancer tissue or cells. The
diagnostic sample can be a biological sample used directly in a
method of the invention. Alternatively, the diagnostic sample can
be a sample prepared from a biological sample.
[0143] In one embodiments, the sample or portion of the sample
comprising or suspected of comprising prostate cancer tissue or
cells can be any source of biological material, including cells,
tissue or fluid, including bodily fluids. Non-limiting examples of
the source of the sample include an aspirate, a needle biopsy, a
cytology pellet, a bulk tissue preparation or a section thereof
obtained for example by surgery or autopsy, lymph fluid, blood,
plasma, serum, tumors, and organs.
[0144] The samples may be archival samples, having a known and
documented medical outcome, or may be samples from current patients
whose ultimate medical outcome is not yet known.
[0145] In some embodiments, the sample may be dissected prior to
molecular analysis. The sample may be prepared via macrodissection
of a bulk tumor specimen or portion thereof, or may be treated via
microdissection, for example via Laser Capture Microdissection
(LCM).
[0146] The sample may initially be provided in a variety of states,
as fresh tissue, fresh frozen tissue, fine needle aspirates, and
may be fixed or unfixed. Frequently, medical laboratories routinely
prepare medical samples in a fixed state, which facilitates tissue
storage. A variety of fixatives can be used to fix tissue to
stabilize the morphology of cells, and may be used alone or in
combination with other agents. Exemplary fixatives include
crosslinking agents, alcohols, acetone, Bouin's solution, Zenker
solution, Hely solution, osmic acid solution and Carnoy
solution.
[0147] Crosslinking fixatives can comprise any agent suitable for
forming two or more covalent bonds, for example an aldehyde.
Sources of aldehydes typically used for fixation include
formaldehyde, paraformaldehyde, glutaraldehyde or formalin.
Preferably, the crosslinking agent comprises formaldehyde, which
may be included in its native form or in the form of
paraformaldehyde or formalin. One of skill in the art would
appreciate that for samples in which crosslinking fixatives have
been used special preparatory steps may be necessary including for
example heating steps and proteinase-k digestion; see methods
[0148] One or more alcohols may be used to fix tissue, alone or in
combination with other fixatives. Exemplary alcohols used for
fixation include methanol, ethanol and isopropanol.
[0149] Formalin fixation is frequently used in medical
laboratories. Formalin comprises both an alcohol, typically
methanol, and formaldehyde, both of which can act to fix a
biological sample.
[0150] Whether fixed or unfixed, the biological sample may
optionally be embedded in an embedding medium. Exemplary embedding
media used in histology including paraffin, Tissue-Tek.RTM.
V.I.P..TM., Paramat, Paramat Extra, Paraplast, Paraplast X-tra,
Paraplast Plus, Peel Away Paraffin Embedding Wax, Polyester Wax,
Carbowax Polyethylene Glycol, Polyfin.TM., Tissue Freezing Medium
TFM.TM., Cryo-Gel.TM., and OCT Compound (Electron Microscopy
Sciences, Hatfield, Pa.). Prior to molecular analysis, the
embedding material may be removed via any suitable techniques, as
known in the art. For example, where the sample is embedded in wax,
the embedding material may be removed by extraction with organic
solvent(s), for example xylenes. Kits are commercially available
for removing embedding media from tissues. Samples or sections
thereof may be subjected to further processing steps as needed, for
example serial hydration or dehydration steps.
[0151] In some embodiments, the sample is a fixed, wax-embedded
biological sample. Frequently, samples from medical laboratories
are provided as fixed, wax-embedded samples, most commonly as
formalin-fixed, paraffin embedded (FFPE) tissues.
[0152] Whatever the source of the biological sample, the target
polynucleotide that is ultimately assayed can be prepared
synthetically (in the case of control sequences), but typically is
purified from the biological source and subjected to one or more
preparative steps. The RNA may be purified to remove or diminish
one or more undesired components from the biological sample or to
concentrate it. Conversely, where the RNA is too concentrated for
the particular assay, it may be diluted.
RNA Extraction
[0153] RNA can be extracted and purified from biological samples
using any suitable technique. A number of techniques are known in
the art, and several are commercially available (e.g.,
FormaPure.TM. nucleic acid extraction kit, Agencourt Biosciences,
Beverly Mass., High Pure FFPE RNA Micro Kit.TM., Roche Applied
Science, Indianapolis, Ind.). RNA can be extracted from frozen
tissue sections using TRIzol (Invitrogen, Carlsbad, Calif.) and
purified using RNeasy Protect kit (Qiagen, Valencia, Calif.). RNA
can be further purified using DNAse I treatment (Ambion, Austin,
Tex.) to eliminate any contaminating DNA. RNA concentrations can be
made using a Nanodrop ND-1000 spectrophotometer (Nanodrop
Technologies, Rockland, Del.). RNA integrity can be evaluated by
running electropherograms, and RNA integrity number (RIN, a
correlative measure that indicates intactness of mRNA) can be
determined using the RNA 6000 PicoAssay for the Bioanalyzer 2100
(Agilent Technologies, Santa Clara, Calif.).
Reverse Transcription for QRT-PCR Analysis
[0154] Reverse transcription can be performed using the Omniscript
kit (Qiagen, Valencia, Calif.), Superscript III kit (Invitrogen,
Carlsbad, Calif.), for RT-PCR. Target-specific priming can be
performed in order to increase the sensitivity of detection of
target sequences and generate target-specific cDNA.
[0155] TaqMan.RTM. Gene Expression Analysis
[0156] TaqMan.RTM. RT-PCR can be performed using Applied Biosystems
Prism (ABI) 7900 HT instruments in a 5 .mu.l volume with target
sequence-specific cDNA equivalent to 1 ng total RNA. Primers and
probes concentrations for TaqMan analysis are added to amplify
fluorescent amplicons using PCR cycling conditions such as
95.degree. C. for 10 minutes for one cycle, 95.degree. C. for 20
seconds, and 60.degree. C. for 45 seconds for 40 cycles. A
reference sample can be assayed to ensure reagent and process
stability. Negative controls (i.e., no template) should be assayed
to monitor any exogenous nucleic acid contamination.
Amplification and Hybridization
[0157] Following sample collection and nucleic acid extraction, the
nucleic acid portion of the sample comprising RNA that is or can be
used to prepare the target polynucleotide(s) of interest can be
subjected to one or more preparative reactions. These preparative
reactions can include in vitro transcription (IVT), labeling,
fragmentation, amplification and other reactions. mRNA can first be
treated with reverse transcriptase and a primer to create cDNA
prior to detection, quantitation and/or amplification; this can be
done in vitro with purified mRNA or in situ, e.g., in cells or
tissues affixed to a slide.
[0158] By "amplification" is meant any process of producing at
least one copy of a nucleic acid, in this case an expressed RNA,
and in many cases produces multiple copies. An amplification
product can be RNA or DNA, and may include a complementary strand
to the expressed target sequence. DNA amplification products can be
produced initially through reverse translation and then optionally
from further amplification reactions. The amplification product may
include all or a portion of a target sequence, and may optionally
be labeled. A variety of amplification methods are suitable for
use, including polymerase-based methods and ligation-based methods.
Exemplary amplification techniques include the polymerase chain
reaction method (PCR), the ligase chain reaction (LCR),
ribozyme-based methods, self sustained sequence replication (3SR),
nucleic acid sequence-based amplification (NASBA), the use of Q
Beta replicase, reverse transcription, nick translation, and the
like.
[0159] Asymmetric amplification reactions may be used to
preferentially amplify one strand representing the target sequence
that is used for detection as the target polynucleotide. In some
cases, the presence and/or amount of the amplification product
itself may be used to determine the expression level of a given
target sequence. In other instances, the amplification product may
be used to hybridize to an array or other substrate comprising
sensor polynucleotides which are used to detect and/or quantitate
target sequence expression.
[0160] The first cycle of amplification in polymerase-based methods
typically forms a primer extension product complementary to the
template strand. If the template is single-stranded RNA, a
polymerase with reverse transcriptase activity is used in the first
amplification to reverse transcribe the RNA to DNA, and additional
amplification cycles can be performed to copy the primer extension
products. The primers for a PCR must, of course, be designed to
hybridize to regions in their corresponding template that will
produce an amplifiable segment; thus, each primer must hybridize so
that its 3' nucleotide is paired to a nucleotide in its
complementary template strand that is located 3' from the 3'
nucleotide of the primer used to replicate that complementary
template strand in the PCR.
[0161] The target polynucleotide can be amplified by contacting one
or more strands of the target polynucleotide with a primer and a
polymerase having suitable activity to extend the primer and copy
the target polynucleotide to produce a full-length complementary
polynucleotide or a smaller portion thereof. Any enzyme having a
polymerase activity that can copy the target polynucleotide can be
used, including DNA polymerases, RNA polymerases, reverse
transcriptases, enzymes having more than one type of polymerase or
enzyme activity. The enzyme can be thermolabile or thermostable.
Mixtures of enzymes can also be used. Exemplary enzymes include:
DNA polymerases such as DNA Polymerase I ("Pol I"), the Klenow
fragment of Pol I, T4, T7, Sequenase.RTM. T7, Sequenase.RTM.
Version 2.0 T7, Tub, Taq, Tth, Pfx, Pfu, Tsp, Tfl, Tli and
Pyrococcus sp GB-D DNA polymerases; RNA polymerases such as E.
coli, SP6, T3 and T7 RNA polymerases; and reverse transcriptases
such as AMV, M-MuLV, MMLV, RNAse H.sup.- MMLV (SuperScript.RTM.),
SuperScript.RTM. II, ThermoScript.RTM., HIV-1, and RAV2 reverse
transcriptases. All of these enzymes are commercially available.
Exemplary polymerases with multiple specificities include RAV2 and
Tli (exo-) polymerases. Exemplary thermostable polymerases include
Tub, Taq, Tth, Pfx, Pfu, Tsp, Tfl, Tli and Pyrococcus sp. GB-D DNA
polymerases.
[0162] Suitable reaction conditions are chosen to permit
amplification of the target polynucleotide, including pH, buffer,
ionic strength, presence and concentration of one or more salts,
presence and concentration of reactants and cofactors such as
nucleotides and magnesium and/or other metal ions (e.g.,
manganese), optional cosolvents, temperature, thermal cycling
profile for amplification schemes comprising a polymerase chain
reaction, and may depend in part on the polymerase being used as
well as the nature of the sample. Cosolvents include formamide
(typically at from about 2 to about 10%), glycerol (typically at
from about 5 to about 10%), and DMSO (typically at from about 0.9
to about 10%). Techniques may be used in the amplification scheme
in order to minimize the production of false positives or artifacts
produced during amplification. These include "touchdown" PCR,
hot-start techniques, use of nested primers, or designing PCR
primers so that they form stem-loop structures in the event of
primer-dimer formation and thus are not amplified. Techniques to
accelerate PCR can be used, for example centrifugal PCR, which
allows for greater convection within the sample, and comprising
infrared heating steps for rapid heating and cooling of the sample.
One or more cycles of amplification can be performed. An excess of
one primer can be used to produce an excess of one primer extension
product during PCR; preferably, the primer extension product
produced in excess is the amplification product to be detected. A
plurality of different primers may be used to amplify different
target polynucleotides or different regions of a particular target
polynucleotide within the sample.
[0163] An amplification reaction can be performed under conditions
which allow an optionally labeled sensor polynucleotide to
hybridize to the amplification product during at least part of an
amplification cycle. When the assay is performed in this manner,
real-time detection of this hybridization event can take place by
monitoring for light emission or fluorescence during amplification,
as known in the art.
[0164] Where the amplification product is to be used for
hybridization to an array or microarray, a number of suitable
commercially available amplification products are available. These
include amplification kits available from NuGEN, Inc. (San Carlos,
Calif.), including the WT-Ovation.TM. System, WT-Ovation.TM. System
v2, WT-Ovation.TM. Pico System, WT-Ovation.TM. FFPE Exon Module,
WT-Ovation.TM. FFPE Exon Module RiboAmp and RiboAmp.sup.Plus RNA
Amplification Kits (MDS Analytical Technologies (formerly Arcturus)
(Mountain View, Calif.), Genisphere, Inc. (Hatfield, Pa.),
including the RampUp Plus.TM. and SenseAmp.TM. RNA Amplification
kits, alone or in combination. Amplified nucleic acids may be
subjected to one or more purification reactions after amplification
and labeling, for example using magnetic beads (e.g., RNAClean
magnetic beads, Agencourt Biosciences).
[0165] Multiple RNA biomarkers can be analyzed using real-time
quantitative multiplex RT-PCR platforms and other multiplexing
technologies such as GenomeLab GeXP Genetic Analysis System
(Beckman Coulter, Foster City, Calif.), SmartCycler.RTM. 9600 or
GeneXpert(R) Systems (Cepheid, Sunnyvale, Calif.), ABI 7900 HT Fast
Real Time PCR system (Applied Biosystems, Foster City, Calif.),
LightCycler.RTM. 480 System (Roche Molecular Systems, Pleasanton,
Calif.), xMAP 100 System (Luminex, Austin, Tex.) Solexa Genome
Analysis System (Illumina, Hayward, Calif.), OpenArray Real Time
qPCR (BioTrove, Woburn, Mass.) and BeadXpress System (Illumina,
Hayward, Calif.).
Prostate Classification Arrays
[0166] The present invention contemplates that a Prostate Cancer
Prognostic Set or probes derived therefrom may be provided in an
array format. In the context of the present invention, an "array"
is a spatially or logically organized collection of polynucleotide
probes. Any array comprising sensor probes specific for two or more
of SEQ ID NOs: 1-2114 or a product derived therefrom can be used.
Desirably, an array will be specific for 5, 10, 15, 20, 25, 30, 50,
75, 100, 150, 200, 250, 300, 350, 400, 450, 500, 600, 700, 1000,
1200, 1400, 1600, 1800, 2000 or more of SEQ ID NOs: 1-2114.
Expression of these sequences may be detected alone or in
combination with other transcripts. In some embodiments, an array
is used which comprises a wide range of sensor probes for
prostate-specific expression products, along with appropriate
control sequences. An array of interest is the Human Exon 1.0 ST
Array (HuEx 1.0 ST, Affymetrix, Inc., Santa Clara, Calif.).
[0167] Typically the polynucleotide probes are attached to a solid
substrate and are ordered so that the location (on the substrate)
and the identity of each are known. The polynucleotide probes can
be attached to one of a variety of solid substrates capable of
withstanding the reagents and conditions necessary for use of the
array. Examples include, but are not limited to, polymers, such as
(poly)tetrafluoroethylene, (poly)vinylidenedifluoride, polystyrene,
polycarbonate, polypropylene and polystyrene; ceramic; silicon;
silicon dioxide; modified silicon; (fused) silica, quartz or glass;
functionalized glass; paper, such as filter paper; diazotized
cellulose; nitrocellulose filter; nylon membrane; and
polyacrylamide gel pad. Substrates that are transparent to light
are useful for arrays that will be used in an assay that involves
optical detection.
[0168] Examples of array formats include membrane or filter arrays
(for example, nitrocellulose, nylon arrays), plate arrays (for
example, multiwell, such as a 24-, 96-, 256-, 384-, 864- or
1536-well, microtitre plate arrays), pin arrays, and bead arrays
(for example, in a liquid "slurry"). Arrays on substrates such as
glass or ceramic slides are often referred to as chip arrays or
"chips." Such arrays are well known in the art. In one embodiment
of the present invention, the Prostate Cancer Prognosticarray is a
chip.
Data Analysis
[0169] Array data can be managed and analyzed using techniques
known in the art. The Genetrix suite of tools can be used for
microarray analysis (Epicenter Software, Pasadena, Calif.). Probe
set modeling and data pre-processing can be derived using the
Robust Multi-Array (RMA) algorithm or variant GC-RMA, Probe
Logarithmic Intensity Error (PLIER) algorithm or variant iterPLIER.
Variance or intensity filters can be applied to pre-process data
using the RMA algorithm, for example by removing target sequences
with a standard deviation of <10 or a mean intensity of <100
intensity units of a normalized data range, respectively.
[0170] In some embodiments, one or more pattern recognition methods
can be used in analyzing the expression level of target sequences.
The pattern recognition method can comprise a linear combination of
expression levels, or a nonlinear combination of expression levels.
In some embodiments, expression measurements for RNA transcripts or
combinations of RNA transcript levels are formulated into linear or
non-linear models or algorithms (i.e., an `expression signature`)
and converted into a likelihood score. This likelihood score
indicates the probability that a biological sample is from a
patient who will exhibit no evidence of disease, who will exhibit
systemic cancer, or who will exhibit biochemical recurrence. The
likelihood score can be used to distinguish these disease states.
The models and/or algorithms can be provided in machine readable
format, and may be used to correlate expression levels or an
expression profile with a disease state, and/or to designate a
treatment modality for a patient or class of patients.
[0171] Thus, results of the expression level analysis can be used
to correlate increased expression of RNAs corresponding to SEQ ID
NOs: 1-2114, or subgroups thereof as described herein, with
prostate cancer outcome, and to designate a treatment modality.
[0172] Factors known in the art for diagnosing and/or suggesting,
selecting, designating, recommending or otherwise determining a
course of treatment for a patient or class of patients suspected of
having prostate cancer can be employed in combination with
measurements of the target sequence expression. These techniques
include cytology, histology, ultrasound analysis, MRI results, CT
scan results, and measurements of PSA levels.
[0173] Certified tests for classifying prostate disease status
and/or designating treatment modalities are also provided. A
certified test comprises a means for characterizing the expression
levels of one or more of the target sequences of interest, and a
certification from a government regulatory agency endorsing use of
the test for classifying the prostate disease status of a
biological sample.
[0174] In some embodiments, the certified test may comprise
reagents for amplification reactions used to detect and/or
quantitate expression of the target sequences to be characterized
in the test. An array of probe nucleic acids can be used, with or
without prior target amplification, for use in measuring target
sequence expression.
[0175] The test is submitted to an agency having authority to
certify the test for use in distinguishing prostate disease status
and/or outcome. Results of detection of expression levels of the
target sequences used in the test and correlation with disease
status and/or outcome are submitted to the agency. A certification
authorizing the diagnostic and/or prognostic use of the test is
obtained.
[0176] Also provided are portfolios of expression levels comprising
a plurality of normalized expression levels of the target sequences
described herein, including SEQ ID NOs:1-2114. Such portfolios may
be provided by performing the methods described herein to obtain
expression levels from an individual patient or from a group of
patients. The expression levels can be normalized by any method
known in the art; exemplary normalization methods that can be used
in various embodiments include Robust Multichip Average (RMA),
probe logarithmic intensity error estimation (PLIER), non-linear
fit (NLFIT) quantile-based and nonlinear normalization, and
combinations thereof. Background correction can also be performed
on the expression data; exemplary techniques useful for background
correction include mode of intensities, normalized using median
polish probe modeling and sketch-normalization.
[0177] In some embodiments, portfolios are established such that
the combination of genes in the portfolio exhibit improved
sensitivity and specificity relative to known methods. In
considering a group of genes for inclusion in a portfolio, a small
standard deviation in expression measurements correlates with
greater specificity. Other measurements of variation such as
correlation coefficients can also be used in this capacity. The
invention also encompasses the above methods where the specificity
is at least about 50% or at least about 60%. The invention also
encompasses the above methods where the sensitivity is at least
about 90%.
[0178] The gene expression profiles of each of the target sequences
comprising the portfolio can fixed in a medium such as a computer
readable medium. This can take a number of forms. For example, a
table can be established into which the range of signals (e.g.,
intensity measurements) indicative of disease or outcome is input.
Actual patient data can then be compared to the values in the table
to determine the patient samples diagnosis or prognosis. In a more
sophisticated embodiment, patterns of the expression signals (e.g.,
fluorescent intensity) are recorded digitally or graphically.
[0179] The expression profiles of the samples can be compared to a
control portfolio. If the sample expression patterns are consistent
with the expression pattern for a known disease or disease outcome,
the expression patterns can be used to designate one or more
treatment modalities. For patients with test scores consistent with
systemic disease outcome after prostatectomy, additional treatment
modalities such as adjuvant chemotherapy (e.g., docetaxel,
mitoxantrone and prednisone), systemic radiation therapy (e.g.,
samarium or strontium) and/or anti-androgen therapy (e.g., surgical
castration, finasteride, dutasteride) can be designated. Such
patients would likely be treated immediately with anti-androgen
therapy alone or in combination with radiation therapy in order to
eliminate presumed micro-metastatic disease, which cannot be
detected clinically but can be revealed by the target sequence
expression signature. Such patients can also be more closely
monitored for signs of disease progression. For patients with test
scores consistent with PSA or NED, adjuvant therapy would not
likely be recommended by their physicians in order to avoid
treatment-related side effects such as metabolic syndrome (e.g.,
hypertension, diabetes and/or weight gain) or osteoporosis.
Patients with samples consistent with NED could be designated for
watchful waiting, or for no treatment. Patients with test scores
that do not correlate with systemic disease but who have successive
PSA increases could be designated for watchful waiting, increased
monitoring, or lower dose or shorter duration anti-androgen
therapy.
[0180] Target sequences can be grouped so that information obtained
about the set of target sequences in the group can be used to make
or assist in making a clinically relevant judgment such as a
diagnosis, prognosis, or treatment choice.
[0181] A patient report is also provided comprising a
representation of measured expression levels of a plurality of
target sequences in a biological sample from the patient, wherein
the representation comprises expression levels of target sequences
corresponding to any one, two, three, four, five, six, eight, ten,
twenty, thirty, fifty or more of the target sequences depicted in
SEQ ID NOs: 1-2114, or of the subsets described herein, or of a
combination thereof. In some embodiments, the representation of the
measured expression level(s) may take the form of a linear or
nonlinear combination of expression levels of the target sequences
of interest. The patient report may be provided in a machine (e.g.,
a computer) readable format and/or in a hard (paper) copy. The
report can also include standard measurements of expression levels
of said plurality of target sequences from one or more sets of
patients with known disease status and/or outcome. The report can
be used to inform the patient and/or treating physician of the
expression levels of the expressed target sequences, the likely
medical diagnosis and/or implications, and optionally may recommend
a treatment modality for the patient.
[0182] Also provided are representations of the gene expression
profiles useful for treating, diagnosing, prognosticating, and
otherwise assessing disease. In some embodiments, these profile
representations are reduced to a medium that can be automatically
read by a machine such as computer readable media (magnetic,
optical, and the like). The articles can also include instructions
for assessing the gene expression profiles in such media. For
example, the articles may comprise a readable storage form having
computer instructions for comparing gene expression profiles of the
portfolios of genes described above. The articles may also have
gene expression profiles digitally recorded therein so that they
may be compared with gene expression data from patient samples.
Alternatively, the profiles can be recorded in different
representational format. A graphical recordation is one such
format. Clustering algorithms can assist in the visualization of
such data.
Kits
[0183] Kits for performing the desired method(s) are also provided,
and comprise a container or housing for holding the components of
the kit, one or more vessels containing one or more nucleic
acid(s), and optionally one or more vessels containing one or more
reagents. The reagents include those described in the composition
of matter section above, and those reagents useful for performing
the methods described, including amplification reagents, and may
include one or more probes, primers or primer pairs, enzymes
(including polymerases and ligases), intercalating dyes, labeled
probes, and labels that can be incorporated into amplification
products.
[0184] In some embodiments, the kit comprises primers or primer
pairs specific for those subsets and combinations of target
sequences described herein. At least two, three, four or five
primers or pairs of primers suitable for selectively amplifying the
same number of target sequence-specific polynucleotides can be
provided in kit form. In some embodiments, the kit comprises from
five to fifty primers or pairs of primers suitable for amplifying
the same number of target sequence-representative polynucleotides
of interest.
[0185] The primers or primer pairs of the kit, when used in an
amplification reaction, specifically amplify at least a portion of
a nucleic acid depicted in one of SEQ ID NOs: 1-2114 (or subgroups
thereof as set forth herein), an RNA form thereof, or a complement
to either thereof. The kit may include a plurality of such primers
or primer pairs which can specifically amplify a corresponding
plurality of different nucleic acids depicted in one of SEQ ID NOs:
1-2114 (or subgroups thereof as set forth herein), RNA forms
thereof, or complements thereto. At least two, three, four or five
primers or pairs of primers suitable for selectively amplifying the
same number of target sequence-specific polynucleotides can be
provided in kit form. In some embodiments, the kit comprises from
five to fifty primers or pairs of primers suitable for amplifying
the same number of target sequence-representative polynucleotides
of interest.
[0186] The reagents may independently be in liquid or solid form.
The reagents may be provided in mixtures. Control samples and/or
nucleic acids may optionally be provided in the kit. Control
samples may include tissue and/or nucleic acids obtained from or
representative of prostate tumor samples from patients showing no
evidence of disease, as well as tissue and/or nucleic acids
obtained from or representative of prostate tumor samples from
patients that develop systemic prostate cancer.
[0187] The nucleic acids may be provided in an array format, and
thus an array or microarray may be included in the kit. The kit
optionally may be certified by a government agency for use in
prognosing the disease outcome of prostate cancer patients and/or
for designating a treatment modality.
[0188] Instructions for using the kit to perform one or more
methods of the invention can be provided with the container, and
can be provided in any fixed medium. The instructions may be
located inside or outside the container or housing, and/or may be
printed on the interior or exterior of any surface thereof. A kit
may be in multiplex form for concurrently detecting and/or
quantitating one or more different target polynucleotides
representing the expressed target sequences.
Devices
[0189] Devices useful for performing methods of the invention are
also provided. The devices can comprise means for characterizing
the expression level of a target sequence of the invention, for
example components for performing one or more methods of nucleic
acid extraction, amplification, and/or detection. Such components
may include one or more of an amplification chamber (for example a
thermal cycler), a plate reader, a spectrophotometer, capillary
electrophoresis apparatus, a chip reader, and or robotic sample
handling components. These components ultimately can obtain data
that reflects the expression level of the target sequences used in
the assay being employed.
[0190] The devices may include an excitation and/or a detection
means. Any instrument that provides a wavelength that can excite a
species of interest and is shorter than the emission wavelength(s)
to be detected can be used for excitation. Commercially available
devices can provide suitable excitation wavelengths as well as
suitable detection components.
[0191] Exemplary excitation sources include a broadband UV light
source such as a deuterium lamp with an appropriate filter, the
output of a white light source such as a xenon lamp or a deuterium
lamp after passing through a monochromator to extract out the
desired wavelength(s), a continuous wave (cw) gas laser, a solid
state diode laser, or any of the pulsed lasers. Emitted light can
be detected through any suitable device or technique; many suitable
approaches are known in the art. For example, a fluorimeter or
spectrophotometer may be used to detect whether the test sample
emits light of a wavelength characteristic of a label used in an
assay.
[0192] The devices typically comprise a means for identifying a
given sample, and of linking the results obtained to that sample.
Such means can include manual labels, barcodes, and other
indicators which can be linked to a sample vessel, and/or may
optionally be included in the sample itself, for example where an
encoded particle is added to the sample. The results may be linked
to the sample, for example in a computer memory that contains a
sample designation and a record of expression levels obtained from
the sample. Linkage of the results to the sample can also include a
linkage to a particular sample receptacle in the device, which is
also linked to the sample identity.
[0193] The devices also comprise a means for correlating the
expression levels of the target sequences being studied with a
prognosis of disease outcome. Such means may comprise one or more
of a variety of correlative techniques, including lookup tables,
algorithms, multivariate models, and linear or nonlinear
combinations of expression models or algorithms. The expression
levels may be converted to one or more likelihood scores,
reflecting a likelihood that the patient providing the sample will
exhibit a particular disease outcome. The models and/or algorithms
can be provided in machine readable format, and can optionally
further designate a treatment modality for a patient or class of
patients.
[0194] The device also comprises output means for outputting the
disease status, prognosis and/or a treatment modality. Such output
means can take any form which transmits the results to a patient
and/or a healthcare provider, and may include a monitor, a printed
format, or both. The device may use a computer system for
performing one or more of the steps provided.
CITATIONS
Patents and Published Applications
[0195] 1. US 2003/0224399 A1 patent application Methods for
determining the prognosis for patients with a prostate neoplastic
condition 2003 Dec. 4 [0196] 2. US 2007/0048738 A1 patent
application Methods and compositions for diagnosis, staging and
prognosis of prostate cancer 2007 Mar. 1 [0197] 3. US 2007/0099197
A1 patent application Methods of prognosis of prostate cancer 2007
May 3 [0198] 4. US 2007/0259352 A1 patent application Prostate
cancer-related nucleic acids 2007 Nov. 8 [0199] 5. US 2008/0009001
A1 patent application Method for Identification of Neoplastic
Transformation with Particular Reference to Prostate Cancer 2008
Jan. 10
Publications
[0199] [0200] 1: Cooper C S, Campbell C, Jhavar S. Mechanisms of
Disease: biomarkers and molecular targets from microarray gene
expression studies in prostate cancer. Nat Clin Pract Urol. 2007
December; 4(12):677-87. Review. [0201] 2: Reddy G K, Balk S P.
Clinical utility of microarray-derived genetic signatures in
predicting outcomes in prostate cancer. Clin Genitourin Cancer.
2006 December; 5(3):187-9. Review. [0202] 3: Nelson P S. Predicting
prostate cancer behavior using transcript profiles. J Urol. 2004
November; 172(5 Pt 2):S28-32; discussion S33. Review. [0203] 4:
Bibikova M, Chudin E, Arsanjani A, Zhou L, Garcia E W, Modder J,
Kostelec M, Barker D, Downs T, Fan J B, Wang-Rodriguez J.
Expression signatures that correlated with Gleason score and
relapse in prostate cancer. Genomics. 2007 June; 89(6):666-72. Epub
2007 Apr. 24. [0204] 5: Schlomm T, Erbersdobler A, Mirlacher M,
Sauter G. Molecular staging of prostate cancer in the year 2007.
World J Urol. 2007 March; 25(1):19-30. Epub 2007 Mar. 2. Review.
[0205] 6: Mendiratta P, Febbo P G. Genomic signatures associated
with the development, progression, and outcome of prostate cancer.
Mol Diagn Ther. 2007; 11(6):345-54. [0206] 7: Reddy G K, Balk S P.
Clinical utility of microarray-derived genetic signatures in
predicting outcomes in prostate cancer. Clin Genitourin Cancer.
2006 December; 5(3):187-9. Review. [0207] 8: True L, Coleman I,
Hawley S, Huang C Y, Gifford D, Coleman R, Beer T M, Gelmann E,
Datta M, Mostaghel E, Knudsen B, Lange P, Vessella R, Lin D, Hood
L, Nelson P S. A molecular correlate to the Gleason grading system
for prostate adenocarcinoma. Proc Natl Acad Sci USA. 2006 Jul. 18;
103(29):10991-6. Epub 2006 Jul. 7. [0208] 9: Stephenson A J, Smith
A, Kattan M W, Satagopan J, Reuter V E, Scardino P T, Gerald W L.
Integration of gene expression profiling and clinical variables to
predict prostate carcinoma recurrence after radical prostatectomy.
Cancer. 2005 Jul. 15; 104(2):290-8. [0209] 10: Bueno R, Loughlin K
R, Powell M H, Gordon G J. A diagnostic test for prostate cancer
from gene expression profiling data. J Urol. 2004 February; 171(2
Pt 1):903-6. [0210] 11: Yu Y P, Landsittel D, Jing L, Nelson J, Ren
B, Liu L, McDonald C, Thomas R, Dhir R, Finkelstein S,
Michalopoulos G, Becich M, Luo J H. Gene expression alterations in
prostate cancer predicting tumor aggression and preceding
development of malignancy. J Clin Oncol. 2004 Jul. 15;
22(14):2790-9. [0211] 12: Feroze-Merzoug F, Schober M S, Chen Y Q.
Molecular profiling in prostate cancer. Cancer Metastasis Rev.
2001; 20(3-4):165-71. Review. [0212] 13: Nakagawa T, Kollmeyer T M,
Morlan B W, Anderson S K, Bergstralh E J, Davis B J, Asmann Y W,
Klee G G, Ballman K V, Jenkins R B. A tissue biomarker panel
predicting systemic progression after PSA recurrence
post-definitive prostate cancer therapy. PLoS ONE. 2008;
3(5):e2318. [0213] 14: Shariat S F, Karakiewicz P I, Roehrborn C G,
Kattan M W. An updated catalog of prostate cancer predictive tools.
Cancer 2008; 113(11): 3062-6.
EXAMPLES
[0214] To gain a better understanding of the invention described
herein, the following examples are set forth. It will be understood
that these examples are intended to describe illustrative
embodiments of the invention and are not intended to limit the
scope of the invention in any way. Efforts have been made to ensure
accuracy with respect to numbers used (e.g., amounts, temperature,
etc.) but some experimental error and deviation should be accounted
for. Unless otherwise indicated, parts are parts by weight,
temperature is degree centigrade and pressure is at or near
atmospheric, and all materials are commercially available.
Example 1
Identification of Target Sequences Differentially Expressed in
Prostate Disease States
[0215] Tissue Samples. Formalin-fixed paraffin embedded (FFPE)
samples of human prostate adenocarcinoma prostatectomies were
collected from patients at the Mayo Clinic Comprehensive Cancer
Center according to an institutional review board-approved protocol
and stored in the Department of Pathology for up to 20 years. For
each patient sample four 4 micron sections were cut from
formalin-fixed paraffin embedded blocks. Pathological review of
FFPE tissue sections was used to guide macrodissection of tumor and
surrounding normal tissue. Patients were classified into one of
three clinical disease states; no evidence of disease (NED, n=10)
for those patients with no biochemical or other clinical signs of
disease progression (at least 10 years follow-up);
prostate-specific antigen biochemical recurrence (PSA, n=10) for
those patients with two successive increases in PSA measurements
above an established cut-point of >4 ng/mL (`rising PSA`); and
systemic disease (SYS, n=10) for those patients that had `rising
PSA` and developed metastases or clinically detectable disease
progression within five years after initial prostatectomy. Clinical
disease was confirmed using bone or CT scans for prostate cancer
metastases.
[0216] RNA Extraction. RNA was extracted and purified from FFPE
tissue sections using a modified protocol for the commercially
available High Pure FFPE RNA Micro nucleic acid extraction kit
(Roche Applied Sciences, Indianapolis, Ind.). RNA concentrations
were calculated using a Nanodrop ND-1000 spectrophotometer
(Nanodrop Technologies, Rockland, Del.).
[0217] RNA Amplification and GeneChip Hybridization. Purified RNA
was subjected to whole-transcriptome amplification using the
WT-Ovation FFPE system including the WT-Ovation Exon and FL-Ovation
Biotin V2 labeling modules, with the following modifications. Fifty
(50) nanograms of RNA extracted from FFPE sections was used to
generate amplified Ribo-SPIA product. For the WT-Ovation Exon
sense-target strand conversion kit 4 ug of Ribo-SPIA product were
used. All clean-up steps were performed with RNAClean magnetic
beads (Agencourt Biosciences). Between 2.5 and 5 micrograms of
WT-Ovation Exon product were used to fragment and label using the
FL-Ovation Biotin V2 labeling module and labeled product was
hybridized to Affymetrix Human Exon 1.0 ST GeneChips following
manufacturer's recommendations (Affymetrix, Santa Clara, Calif.).
Of the 30 samples processed, 22 had sufficient amplified material
(i.e., >2.5 ug of WT-Ovation Exon product) for GeneChip
hybridization.
[0218] Microarray Analysis. All data management and analysis was
conducted using the Genetrix suite of tools for microarray analysis
(Epicenter Software, Pasadena, Calif.). Probe set modeling and data
pre-processing were derived using the Robust Multi-Array (RMA)
algorithm. The mode of intensity values was used for background
correction and RMA-sketch was used for normalization and probe
modeling used a median polish routine. A variance filter was
applied to data pre-processed using the RMA algorithm, by removing
target sequences with a mean intensity of <10 intensity units of
a normalized data range. Target sequences typically comprise four
individual probes that interrogate the expression of RNA
transcripts or portions thereof. Target sequence annotations and
the sequences (RNAs) that they interrogate were downloaded from the
Affymetrix website (www.netaffx.com). Supervised analysis of
differentially expressed RNA transcripts was determined based on
the fold change in the average expression (at least 2 fold change)
and the associated t-test, with a p-value cut-off of p<0.001
between different prostate cancer patient disease states. Linear
regression was also used to screen differentially expressed
transcripts that displayed an expression pattern of
NED>PSA>SYS or SYS>PSA>NED and genes were selected with
a p-value cut-off of p<0.01 for two-way hierarchical clustering
using Pearson's correlation distance metric with complete-linkage
cluster distances.
[0219] Archived FFPE blocks of tumors were selected from 30
patients that had undergone a prostatectomy at the Mayo Clinic
Comprehensive Cancer Center between the years 1987-1997, providing
for at least 10 years follow-up on each patient. Twenty-two patient
samples had RNA of sufficient quantity and quality for RNA
amplification and subsequent GeneChip hybridization. Three clinical
categories of patients were evaluated; patients alive with no
evidence of disease (`NED`, n=6), patients with rising PSA or
biochemical recurrence (defined as two successive increases in PSA
measurements) (`PSA`, n=7) and patients with rising PSA and
clinical evidence of systemic or recurrent disease (e.g.,
determined by bone scan, CT) (`SYS`, n=9) after prostatectomy. No
statistically significant differences between these three clinical
groups were apparent when considering pathological factors such as
Gleason score or tumor stage (Table 1). As samples from older
archived FFPE blocks are typically more degraded and fragmented
than younger blocks, the distribution of block ages was similar in
the three clinical groups so as not to skew or bias the results due
to a block age effect. Fifty nanograms of RNA extracted from FFPE
sections was amplified and hybridized to whole-transcriptome
microarrays, interrogating >1.4 million probe target sequences
measuring RNA levels for RefSeq, dbEST and predicted transcripts
(collectively, `RNAs`).
[0220] Table 3 displays the number of target sequences identified
in two-way comparisons between different clinical states using the
appropriate t-tests and a p-value cut-off of p<0.001. At total
of 2,114 target sequences (Table 3) were identified as
differentially expressed in these comparisons and a principle
components analysis demonstrates that these target sequences
discriminate the distinct clinical states into three clusters (FIG.
1A).
[0221] A linear regression filter was next employed to
statistically rank target sequences that followed a trend of either
increased expression with poor prognosis patients (i.e.,
SYS>PSA>NED) or increased expression in good prognosis
patients (NED>PSA>SYS, alternatively decreased expression in
poor prognosis patients) (Table 4). FIG. 1B depicts a two-way
hierarchical clustering dendrogram and expression matrix of
top-ranked 526 target sequences and 22 tumor samples. Patients in
the `PSA` clinical status category displayed intermediate
expression levels for genes expressed at increased levels in SYS
(n=313) and NED (n=213), respectively (Table 4). FIG. 1C depicts a
two-way hierarchical clustering dendrogram and expression matrix of
148 target sequences and 22 tumor samples. These target sequences
were a subset of the differentially expressed transcripts (Table 3)
filtered using a t-test to query `recurrent` (i.e., `SYS`) and
`non-recurrent` (i.e., `PSA` and `NED`) patient samples (Table
5).
[0222] The expression levels of these genes were summarized for
each patient into a `metagene` using a simple linear combination by
taking the expression level and multiplying it by a weighting
factor for each target sequence in the metagene signature and
combining these values into a single variable. Weighting factors
were derived from the coefficients of the linear regression fit
analysis (Table 4). FIG. 2 shows a histogram plot of the metagene
expression values for the summarized 526 target sequences in each
of the three clinical groups. This 526-metagene achieved maximal
separation between clinical groups and low variance within each
clinical group. Metagenes comprised of smaller subsets of 21, 18
and 6 target sequences were also generated (FIG. 3, Tables 7 and
8). The distinctions between clinical groups with respect to the
metagene scores were preserved, although increased within-group
variance was observed when using fewer target sequences (FIG.
3).
[0223] Next, Patient outcome predictor (`POP`) scores were
generated from the metagene values for each patient. For the
18-target sequences metagene, this entailed scaling and normalizing
the metagene scores within a range of 0 to 100, where a value of
between 0-20 points indicates a patient with NED, 40-60 points a
patient with PSA recurrence and 80-100 points a patient with SYS
metastatic disease (FIG. 4). In contrast, Gleason scores for
patients could not be used on their own to distinguish the clinical
groups (Table 1).
[0224] Using the Nearest Shrunken Centroids (NSC) algorithm with
leave-1-out cross-validation, smaller subsets of RNA transcripts
were identified that distinguish `recurrent` (i.e., `SYS`) and
`non-recurrent` (i.e., `PSA` and `NED`) disease (Tables 9 and 10).
NSC algorithm identified 10- and 41-target sequence metagenes used
to derive patient outcome predictor scores scaled and normalized on
a data range of 0-100 points. FIGS. 5 and 6 depict box plots
showing interquartile range and distribution of `POP` scores for
each clinical group. A 148-target sequence metagene (Table 5) was
similarly used to derive `POP` scores depicted in FIG. 7. T-tests
were used to evaluate the statistical significance of differences
in POP scores between `recurrent` (i.e., `SYS`) and non-recurrent
(i.e., `PSA` and `NED`) patient groups (indicated in the figures)
and show that increasing the number of target sequences in the
metagene combination increases the significance level of the
differences in POP scores.
[0225] The data generated from such methods can be used to
determine a prognosis for disease outcome, and/or to recommend or
designate one or more treatment modalities for patients, to produce
patient reports, and to prepare expression profiles.
TABLE-US-00001 TABLE 1 Clinical characteristics of different
clinical status patient groups evaluated. Note Chi square tests for
homogeneity reveal that the three clinical groups do not show
significant differences in terms of patient composition based on
known prognostic variables such as pathological TNM stage or
Gleason score. Also, the block age of the samples was not different
between clinical status groups; so that sample archive age effect
is mitigated (i.e., older samples have more degraded, fragmented
nucleic acids that could skew or bias results if not evenly
distributed in clinical status patient groups). NED PSA Systemic
X.sub.2 Tests for (n = 6) (n = 7) (n = 9) Homegeneity Pathological
T2N0 2 3 3 p < 0.07 Stage T3aN0 1 4 1 T3bN0 0 0 3 TxN+ 3 0 2
Gleason Score 7 2 7 4 p < 0.06 8 3 0 2 9 1 0 3 Block Age 10-14 3
4 5 p < 0.9 Group (years) 13-15 1 1 2 16-20 2 2 2
TABLE-US-00002 TABLE 2 Comparison of differential expression
between patient clinical status groups. Two-way comparisons for
differential expression using the following statistical criteria:
a) at least 2-fold mean difference in expression between comparison
groups; b) expression levels >50 intensity units of a normalized
data range (approximately the mean expression level across all
transcripts in all samples) and c) significance cut-off of p <
0.001 determined using a t-test. Clinical Differentially Status
Comparison Expressed RNAs* NED vs PSA 316 PSA vs NED 442 NED vs SYS
213 PSA vs SYS 194 SYS vs NED 269 SYS vs PSA 323 SYS vs NED &
PSA 310 NED & PSA vs SYS 77 *Differential Expression is
indicated by at least 2-fold change expression between mean of
clinical status variable and comparison variable; also mean value
>50 intensity units of a normalized data range and p < 0.001
calculated using a t-test
TABLE-US-00003 TABLE 3 Differentially expressed RNA transcripts
identified from comparison tests described in Table 2. Sequence
listings are annotated with the Affymetrix Human Exon 1.0 ST probe
selection region ID, proximal annotated gene from RefSeq, and
overlap with coding sequence (CDS). SEQ ID Gene No Affy. ID Symbol
CDS RNA Sequence 1 3509278 -- NO
ctggtccctctcctgatagagtttcaggtttgccctgatgatctagatgaagcaaagtgtggtgacacttcgc-
tgaatgctctgtcagtgtgcctagaaatagag tctctatcagggccgtttgcttcctatcacactc
2 2750440 -- NO ggcatgatctaggctaactccctggc 3 3498665 -- NO
tgggcaagagcttttgtatgtttccag 4 3159532 -- NO
cccaacacggtgcagccgatttatttatttttccctcagcatttttaggtggattgactgggatgctttattc-
aactcagggacgcaccacgaatatgttttttg 5 3521600 UGCGL2 YES
tggcgccagcgaaagccacgaacgtg 6 3820597 -- NO
gctgggcgcagcgttctgaggggatgtggggtctgggaggtgtctcgaggtgagagctccaagtcacgg
7 3955349 -- NO
gtggcgcaatattgcaatacagctcactgctacagccccaggcttaagtgatcttcttgcctcagtctcccga-
gtagctggaaccacaatctcataccaccac
gccccacgcctggtaaatttttaaatgtttttgtaaagacagggtactgctgtgttgcccaggctggtct-
ctaattcctagtctcaagcgatccttccgctttggcc
tcccaaagcactgggattacaggtgtgagccactgtgcccagccctgctctaggttttcatttggatttg-
ctgcctagtggaaggcacaggatggggcagtg
ccttctgccagtgagggaggctccaggtagatgtcattgctgaactggagctcccctgg 8
3204523 PIGO YES
tgcttcctcttctacgctggcattgccctcttcaccagtggcttcctgctcacccgtttggagctcaccaacc-
atagcagctgccaagagcccccaggccctg
ggtccctgccatgggggagccaagggaaacctggggcctgctggatggcttcccgattttcgcgggttgt-
gttggtgctgatagatgctctgcgatttgactt
cgcccagccccagcattcacacgtgcctagagagcctcctgtctccctacccttcctgggcaaactaagc-
tccttgcagaggatcctggagattcagcccca ccatgcccggctctaccgatctcaggtt 9
3373899 SLC43A1 NO
agccatggccgtagatttataaataccaagagaagttctatttttgtaaagactgcaaaaaggaggaaaaaaa-
accttcaaaaacgccccctaagtcaacgct
ccattgactgaagacagtccctatcctagaggggttgagccttcttcctccttgggttggaggagaccag-
ggtgcctcttatctccttctagcggtctgcctcct
ggtacctcttggggggatcggcaaacaggctacccctgaggtcccatgtgccatgagtgtgcacacatgc-
atgtgtctgtgtatgtgtgaatgtgagagaga cacagccctcctttc 10 3707645 RABEP1
YES atggcgcagccgggcccggcttccc 11 3860354 LOC100127980 NO
ttcagattcacgagggtaatccagatgaaggtatatcattgtacctggcccgcatcactcagtaactgtcacc-
tttgatttattgatttacttgagatggagtttggt
tctgtccccgaggccggagtgcaatggcgtgatctctgctcactacaacctctgcctcccaggttcagag-
tgattctcctgcctcagcctctttagctgggatt
acaggcacccaccaacatgcccagctaatttttgtatttttagtagagaggagctttcaccataatggcc-
aggctggtcttgaacctcaaatgatctgcccacct
tggcctcccaaagtgctaggattacaggctggagctacagagcccagcctgtcaccttgatttaaatgaa-
tgcagctttcttggtgtcttgatgtttgtgaatttct
gtggagtttgatactgctccttttgctgcttgtttttccagagtccccttatcacttgacgtgctgttat-
a 12 2406772 MRPS15 NO
tgtcgtgacagcctctctttggggccagcttctgcttttgcccccatctttgcagtacagggggtaaattaaa-
caagaggatgcctgaatgaacgatatcctgg
gttcttgagagacaagtgggagctgataattctgaaaattcattagtcaaagcatggagataaaggtggc-
agcaggaaggggagaggcaaggagtagacc
cgtgacagttttagaatcttatttgtgccaaaatactttactgcattggcttggacctctaatacaatgt-
tgaattgttaaccatgatagcactgtatcctggtctaatt
cctgaattgaatggctagtcttaccattaagaatgctatttgcggccaggc 13 3881324 HM13
YES
ttatgaatttgacaccaaggacctggtgtgcctgggcctgagcagcatcgttggcgtctggtacctgctgag
14 3271321 -- NO
aggagcaggtcgtcaagtccaccaggatggaatgctcagtaggagaaattgcgctgtggggccatttgaggcg-
cctgtccatgcgggtccgtcctggccc ttctgaa 15 3316374 -- NO
aggcattacgccagctcccggatgcctcagcctcgtgaattcggggtaggacgctcagggcccatggtcagca-
cagcgggtgggtgggtttcagcgtggt
cacttctccaggggtgcataattgagcagcttctcgatcaggtccacgtg 16 3333695 -- NO
gttgaggagcttgatgctgcagtgagattgtgccactgcactccagcatgggtgacatagcaagactgcctca-
gggggaaaaaaaaaaaaaaacaccaaa aaaaaaggtatatggaccctagttttggccaggctg 17
3930855 -- NO gtggctcactgtagcgtcagtctcc 18 2945934 CMAH NO
ggacgattcgtttctatttgacccaagactgatgctgcgtggtgaaggagaggaactgcgttccaggcagagg-
aagtccagatgcgcaagagcagagatg
ggagggacagcacagtggcttctcagaattgaatatggtgttagacttctaaaagagctgtggtagaggg-
agaaaactgtcaaaggaaatcagtaactgtta
aaggaaaataccttaaacgtcctgttttcaggctgactaatgccttaggggagcaaatgagcaaca
19 2581405 -- NO
ttggtatgtagggttcgtatgaatgaaacgtgactaccagggcagataatgaaaggctttcaatcccagagta-
agagatatagggccaggc 20 2465840 -- NO
atgtggcacaatttacgaaaaccaaagagaggctatgctgagtccctacaccaccaagaccgtgatgttctgc-
ccactcgcctcctgatggcctgtggggat
agaccagcttccagatttcacacagatgggctgtatggaggaggc 21 3431367 -- NO
cgatctctcatggtgggctcaagtgatcctcccatctcagcctcccaagcacctgggactacaggtgcacatc-
aacacacccggataatt 22 3458114 NACA NO
gggccactgttcctcaagcatctaaagggcttccagcaaagaaaggccccacagctctgaaagaagtacttgt-
tgccccagctccagaaagcacgccaat
catcacagctcccactcggaaaggtccacagaccaaaaagagttctgctacttcacctcctatatgccca-
gatccctcagctaagaatgg 23 3875254 -- NO
ttctccctcagaccaagttaaactgtttttttcccaagagctaggaatcatatctgatcacactgggacttcc-
cttcactgtcagtctaagagtttgcatttttgaggt
ttaggaaaagggaaaaaaaaggaagaaagaaagaaattgtatctgagaacaaagaagctgccacatggtc-
cctcggtatca 24 2515646 ITGA6 YES
tgtgctcaccgatatgaaaaaaggcagcatgttaatacgaagcaggaatcccgagacatctttgggcggtgtt-
atgtcctgagtcagaatctcaggattgaag acgatatggatg 25 3202904 -- NO
tgagggcgttggaccacacacccttgaaaaaggcctcgccccgctcatctctgaagatcttcctccaacagtc-
gacggtgcccgtgtacatgatgtcagctc
ctttgcgccgggactgcatcatcgtccgccgccgcactgtgtcgaagggttag 26 2768304
NFXL1 YES ctgtccaccttgtgatcaaaactgtggacggactttag 27 3736631 -- NO
aaagcggtcactggccatatgatgcggagatggttttatctgaggcctgagaaccaacagatgtgcctgcgcc-
ctggcctgtgcagctgtgggcagatgtg
tccccaggggcctgccctcactcgtgaccatgcaataccctgcaacataaacattttcttttccaaggat-
ctgcaggggtggacatgatgctccaggcacag
agtaggaagaaaagggggtgacctggggttcccagcaaacaggtccacctcatgctcactgcgtt
28 2787529 INPP4B YES
tgtgccctggtatgtgaatgtacagccccggaaagtgtgagcggaaaagataacttacct 29
2980188 -- NO tttccccacaaattgctgatgtacc 30 3273235 -- NO
caatattcactgtgaggtcaagctcctagaggtaaaaactcaaaactgtggcagccctcccccgtgactgggt-
ccctctgaagtttctaactctcagagttgtc catactgggcatctagcgattcat 31 3402918
USP5 YES
gaggaaaagatcaagtgcctggccacagagaaggtgaagtacacccagcgagttgactacatcatgcag
32 3529227 -- NO
cgaagtgggtctccaaattccgcgcccaccccaccgcccgagaagcccactacgcatgcgtccgcaccccacc-
ggcgccccttcctattgagcatgcgc
gggagccccacctatttctctctaccgtttcctccccctacctggtaccccatccctagctcagccattg-
cttttttttccacgaccctccgctgtttcttccgcga gcttcct 33 3839571 KLK2 NO
ggagggaatggctgtgtcccacaggaataacagcgggatgcttcc 34 2697538 CEP70 NO
gagactcgttgggtgatcatttcattgagatcaacctgaatgaccaggtgtaaagtgcaagagtaatatgcta-
tgactga 35 2521076 -- NO
ggatccatgccagacaacgcacattctgcagacactggttactccagtggctccttactggaaacatataata-
tcagtgataagtgctgtgaagaaaataaaa
caatgatgtgctggtatggatttttaacttttttatgtgatgaaccacagaatgatggttttaaatgtat-
gaaatacatagaattgcaacagaaaccagttatgaaat
aatgaagatattaaatatgacatctatattttagtaaagcattagtgaggactgtaaatgatctttaaag-
aatttggcttaaatttaatctaaaattgctatcaggtatt
tcacatcgctgtaatttttgcctgcattcgtaactgaagagataagtaaatgtcagaggttaagataaat-
ctttttctttttttacctgtccatatttacaaacattctgc
gttccgtacatagacgcctggataagaacccctgtgcaagaatgactttggtgctactttaaaaaaagtg-
gttggggaagacctcataggaaatgacatcaat
aatagattgcatgataacctatactagttcttactgttaccaatttaaattctaactgcttaaaagctaa-
cacggtccttccctttttttgagcacctgatttgaagtac
tttgagtaggcctcaagtgtcgtatgcaagta 36 2811029 -- NO
ctgagttctgatttggagcagcctgtcgcaataccaaatcacctttgaataaacttatcctctcagcttttat-
tgttcagaattgatttcgaggatagaaattccattt
ccttgtcatatatacctgagccgttgcatcaaattgtcaga 37 2735920 -- NO
gggtgtagcgcaccaagcatgagctgaa 38 3843767 ZNF135 NO
aataacctagcatggggcggcactaaatggctgcaggaaagccgagtcttcttccacatccggcggctcccct-
cggatgcgagcgctggcccagggtgt
gtttacagaggtgagggcttcccgtggacccttctcgttgggagcgcttagcctcaggagcggattcagg-
gcacaggcagaggacgtccacaaacacca
caggaagccgccacccaggggcgtggaaaggcccaatgcctcgtctgggattcacggccggcaaagcggc-
ccctccggaacgggacagcacagcg
gctcacctctgcgcctctgggggtgcggggggagcctcgccctccacgctctctgggggaccgcccgccc-
tagcccccgcctgggcttcgcgggtgga
cggttgggggccccgggcgccccccagcgcgtagcttttctccttctcgtgggtcttctggtgctcggct-
agggccaggctgaagtggaaggtcttccagc
agccctgacaggcgtagcgcttccggccgccatggctgctgtggtgctccatcaggtgcgagagccacgc-
gaaggcctccccgcactcgccgcaggca
tagggcttcccgcgggacaagcccggctcgtcagccccagggccctgcccggcctccagccctgcgctgt-
cgccggagctagagacgccctcgaggct
ctgcccgtccccatcctcggggtgcggcctcttggttcccagtttcgccgtgcccctgtccggggcaggc-
tgctggatgacggactgcctctgcgatccggt
ggcagagtcggactccgcgtcctgggggtcctgcgggtccggggccttcccaggctgctcttcctcctcc-
tcagtggtgcccgacgggggatcggcaag
ggcgtccccagggggcgcctccgtaggcagctcaggcagcacccccgcgggggcggcctcctcgcaggcg-
cacccagcgctctcctgccgcctccc gccttctggaacaaggtcagagccctagcgtgagcgccc
39 3895275 ProSAPiP1 NO
tgggcactcggcattttgacacatgtcctgtcaaaaggccagagtccccagtgtcccctcccctccatctctc-
ttccccatagaccccataaccccagaccaa
agaggttctctaagcagctgtgaccaggttcctccctccccacctgccctcctagctccagcactgcccc-
cgtggcagcccacttggacccccctaaaagg
agggaataggaggagggcagggtgagtgggggcaatcctaggtggtgggggagtcatgctccctttctcg-
gcacccccttgttggagatggaggcagca
gacgtgcagtgccataaggtgccccagtccttctggaggcctgggctgctactgttggccaccctgtgtc-
tagtgatgctctctgtgctcacctcctaggccat
ggagcctgagggggcctgcaccaggtttgctgaaactgacagagcctgggctccagacctctctccctcc-
tacagtgctctccctccctgggcagattggc
aggacaagtgggagcagatggcctgcctttggctgagagggctacctgcccagcccctcccccaacaaga-
tctcttggactcaggcctcagagcctggc
ctggttgtgagtgtgtgtccctgtgtgtgtgttgcgggaggggaggactggggctggaagtccagcaccc-
agggaagatctgtcctcctgttcttgggaagc
gttgcctgacggcttctcggctctaccctcacccttctggccaggatcccgcagggcaacagccccatct-
gcttggctgaccccacacccaggaccactgt
ccggctctaacacagctattaagtgctacctgcctctcaggcactctcctcgcccagtttctgaggtcag-
acgagtgtctgcgatgtcttcccgcactctattcc
cccagcctctttctgctttcatgctcagcacatcatcttcctaggcagtctcttccccaaagtctcacct-
tttcttccaatagaaaattccgcttgacctttggtgcac 40 4031098 CYorf15B NO
tcacttaacatagtgccagggcatgcaattttgtttcttactctctggatgtgggatatgcgagtgtgtgtgt-
gtgtgtgtgtgtgtgtgtattaagctttctgtttctg
atgaaattttcatatgaaatttactggagataagattaaattagtggaaaaacaagataattttgctttc-
tatgtagtggtcaccaagttaaagaattgtgccagtta
ttaggcaagataggctttgagatttagggacagttaaattttacaccaacttagtgaacatgagacttct-
acctagtgttacatttcatttttaaataagcaatttaaa
aattggtaaatgatttgtttactttgattatattctggtataattttctgacaaaattatctgtgtcttg-
gtcagcattgttgctagaatatgtattcagattttgtctgtcca
taattgagaacacagaaaaaatctaatttgactatacccatttacccccatggaaatgaaactatattct-
atgaatgaaaaatgattttaataatgtggtgtattaca
ttttcttcattcaagtaatgtaggccctgagtagagcatgttatgaatatttagttccttagtgttttct-
cattcaagcctctcatattgaatgagtctagggtttggag
agatgtttcacacagcatgtctcttcagtgcaagctgacagatatcagtgcacaattaaagaaacttaat-
tgcacctttcaacttggagtataaattttgtatgtatc
tatgtatatctatgtgtgtattttgtggtttaaggcttatttacataatatgtgacattttacctcagaa-
attcagtgactgaatttcacagctgcttcccatgcatcttta
ttatctatgtttctgaaaaactcaaatactaactaatctcttttcttcccttagctgttcctttcctgtg-
gttttaaaaaagtgaccagaaactaggtctctattttcattg
ctttgctgcatattcttttaacctgcttttatc 41 2927637 KIAA1244 YES
gtcccacaggatttcgggaatcaag 42 3839575 KLK2 YES
ttctgaagcatcaaagccttagaccagatgaagactccagccatgacctca 43 2566620
TSGA10 NO
atccattgatggtttgatagtgggctgggaaggaaagctgtgttcctccacattaggcagcaaa 44
2959903 LOC728052 NO
tcatttatttgacagtgcatgtctgcaatgccgtgctcatcaatgat 45 3100926 -- YES
agtaacagctatccaccaatgtcaatccatac 46 3853655 -- NO
gcaggcaatatctccgcacctttaat 47 3947544 -- NO
ctgctggaacgacaccaactctttgcctcccatccttggttggatatgatttgaaatttggtaatgtgtctct-
acttgaaacagatgcactgtttggatgttttcagg
tcggtgatctacttgtccagtttgatcgctaccagaag 48 2466070 ZNF692 NO
ggattagtccgctccactcactgtcagcattaagtgggggtgcccaagacggggtggatggggggcgccctcc-
agacctctgaccacggcctcaccgcc
actcgacccaactatgaagagcgcccccagctgcacgccaggacacgacctttccttcccctagaaacca-
gtaaaggccgctgccctattcaagatgaaat
gtgtggaccgcccccagcccagttgaaatttcccgtgaaagtctctcgccccttccccacagctccactt-
cagtggactggagggcgcaggcctttgttctg
actgcttctgtctgcctgcctcccacccgacgacactcacatggtagcgctgagcttcaacaccctgta
49 3065818 RELN YES
ttcgataggtttgaggggaagctcagccctctgtggtacaagataacaggtgcccaggttggaactggctgtg-
gaacacttaacgatggcaaatctctctact tcaatggccctg 50 3332183 STX3 NO
ctgatttcactccagactggtgtggccacccttgtcttcagatgagaat 51 3681410 PARN
YES
ctgtcaataccagcaaatatgcagaaagctatcggatccaaacctatgctgaatatatggggagaaaacagga-
agagaagcagatcaaaagaaagtggac
tgaagatagctggaaggaggctgacagcaaacggttaaacccccagtgcataccctacaccctgcagaat-
cactattaccg 52 3873342 -- NO
gccacaggagggtttaaacacagcagtaatgagactttatttctgctgggaaaacattgccgttattgccc
53 2572055 -- NO
gtgcctgagagaaaacggcctaatcgaaaacgtccgcggcatacatccattcttaaaacttgagtggctgctt-
ttctgggtggaaaagagcggtatcagaca
gggtgagcagtcggggaacggatgaacaaagacttgcaccgtggccctgatgcctttgttccgagttcta-
ttcagttgtacttgtgcgttgttacaggacttta
gaatgcagccctgccccccaacccccacctcccagggccgacctgtgctcctaggaaggcaaacctc
54 3434549 MLEC NO
tggcacctcttgcatccaggcagtcttgtgagatgggggcacatagcactggggaaagcagaactccattctc-
acctctattttgagcttcagtgctttatttca
gtatgaggaaaaacaacaacaaactgaagtgcgctttccgtcctttcaaaggacaactgtcgggaaggga-
gagccgagttgcgaggtaggaggggagca
ctggcagggagagacattcttgactcctctcttccctggtgtgttgtgatccagggaatgaaaagaaatt-
tgaccctggattggttctctccttggacttaagga
atcttaccttttccttccacaaagttctcccaggcaaggaccagctgcccattctgagcccagggcagcc-
tcttcaaccattattgg 55 4007482 -- NO
tccaagcaggtcttcgtagtagagaacgaaccagccctcgatcaccaggtgaatgaacccacacactgcaaac-
cagcacagggacagtcgccgccaagt
ccccaatgggacaaccgcagcacgacctgacaacagccatgtggtcacgactaagacccctgtgacagag-
aagaggccagccagtatatgccaggtgg ggcggtcattaggtacaaagttgtc 56 2751391
CLCN3 NO
cccgagttagagcatggattcagttttagtcttaagggggaagtgagattggagatttttatttttaattttg-
ggcagaagcaggttgactctagggatctccaga
gcgagaggatttaacttcatgttgctcccgtgtttgaaggaggacaataaaagtcccaccgggcaaaatt-
ttcgtaacctctgcggtagaaaacgtcaggtat
cttttaaatcgcgatagttttcgctgtgtcaggctttcttcggtggagctccgagggtagctaggttcta-
ggtttgaaacagatgcagaatccaaaggcagcgc
aaaaaacagccaccgattttgctatgtctctga 57 2871645 -- NO
ctctgtggggttcggttccactttgtagttcgggtttgtaatgtaaagaataatgggaaactggtctaattat-
gagagttaagagagtagaggcctgtagttg 58 3629576 PARP16 NO
ttagccataatagggcccggtacgatttgggagtgacatttctgtaaagaagaggaaaaatcatttttctata-
atttgtaaagttgtgaaagagccactaccaca gtttttacattgattattggaacatttc 59
2545930 IFT172 YES
tggtggctacaacattggcaccgtcagccatgagagccgtgtggattggctggaacttaatgagactggacac-
aagctcctcttcag 60 2569734 -- NO
ttcccttggctttggacatgtgagggaagtaggtatccgctgcctggggaaagtcaacaggacccctcctccc-
cgtacctcttggtatacaaagctgagcgg tg 61 2832639 PCDHGA10 YES
ttactttgaagtttgcggcatgatggtggaaagtgtaaatgctaaaacactgatgagtagaatttg
62 3113343 -- NO
ggctgattgaccttgactggcctcatgtatgtgtctcaaagttggctggggctgtcggctgaaattccttagt-
tctactccacatggcctttccccatggccagc
ccaggctgagatctgagattgaagagggtgagaacagaaagtacaagatcttcttttgacttgaaagcta-
gcccagaatcgagggaaataaaccccaccttt
tgatggaaggagcttcaaagaatttgtagtcatttccaatccacgaagagtaggtacccactatttgttg-
aataaagccctattgaaagctttttagctatccaga
tgcaaattactggccaacctttgggtagaattataaaattctgcccaaaattctaccaaattactggtac-
ttgtaaaattctaccaaataactggccaacttttggg
tagaattgtaaaaattaagttgtaaataaagcctattgcctaacaggaacttcaaagtcagagaatccta-
aaatgattgtgctacacagggccacatagagcac
agctttgtctttttttttttgagatggagtctcgctctgtcccccaggctgaagtgcagtggcgcaatct-
ttgctcaaggcaacttctacttcccaagttcaagcaat
tcttctgtttgagcctcctgagtagtgggactgcaggcatgtgccactatgccccattatgtatttttag-
tagagatgagatttcaccagattggccaggctggtc
tcgaactcctgacctcaaatgatctgcctgcctcggcctcccaaagtgttgggattataggcatgagcca-
ccatgcccgcccgcttcgtcttttcactggacta
atgaagatacaggtgtggaatggtttcacagcatgcccaacctcatgaggcttgttgggtcagagcttgt-
gccagatgccagtcttctgccttccagtcttata
gttgttacgctatagccttctgcagtggatggtaacgtggccaaaataagcctttggttttggagtattc-
gtaaaatg 63 3875673 -- NO
gggaactaacgccttccagaacagaaatatgtggtccgatgagtattgaatgcaacttaaaatctagttggaa-
tgtgatggataagaagagacccaaagtcat
caacaagccttctcatgaactttcagtcattaaccttcctatatagtaaggacagaaatgatgatttaag-
ccatcttaggcaaggcagtgctaacaatatgctttt gtaaagtcaccatccggtg 64 3959071
-- NO
ttctctaattctaggcctgccgtttttctctgtgagtggacctgatctccttttgctttggctcccagagttc-
cctattcgcttctccttgtcccctgagtcctgctctcc
ctcctctggataaccccttccagcccttcacttctccctcctgttatttgctggaatggctaattggctg-
acccccccacccagtccccatgggagaccccctcc
agcaccagaagaggcagactaacattttctttggtagcagaatgtaaaattgtaaaatgtgaaagatagg-
agagaaacatcattaactgttctgttatttattaac
attttaatttatagaattatagacttaacagcaaaaattcaaacactgagggtcatcggtgaaaata
65 2864793 -- NO
gcctattggcttcaagttgtttacgctttggtaggttttggcttgttccctcaaaggatcccttcttcatgtc-
ctcccatgatgttgcaggcaagggtctcttgttatat
gtggtactaactcgggcccacctggtcataatttc 66 2976430 -- NO
gctcctacagtaacactcaatcaattcaccccactccagtgttcttcctgcaacatcactgatttagatggcc-
cactctg 67 3862771 -- NO gggaatctattaatagtggaggaagtatttagtgggtggga
68 3192159 BAT2L NO
tggatatatggcattgacccgcttgctttgatacgaaacaaaaaagcagacgactccttcatcccatctgctc-
ctaccgtgactgtgga 69 3062031 -- NO
gggtttgtcatgctacgctgtgccattcatgtgtttttttgctcatgctgttccttgtgcctggaaattctcc-
ccctaattcccctgagcagtggatgcagtggatac
cctccccagatcccccccaacttccctgagtgttggctaccaaaagctctgagtgcacccagggagctaa-
gtcctcctgcccacaggcaataatggactga
cacggggtagacttaaagaaataagaggcacatcaatcaattgaaatgtgtgggaccttacctggactct-
gaatta 70 2505555 PTPN18 YES
gagcagtacaggttcctgtaccacacggtggctcagatgttctgctccacactccagaatgc 71
2361309 -- NO gagccggacttccttgtcccaccag 72 3569829 -- NO
gtactcgcctcctgcatggagcacgctcaggggtgg 73 2946327 -- NO
ttactgttgctgtccgtaaactggaacctctgttcactcaag 74 2751432 -- NO
ggaactcctcagaacttataatatgttgatattctttgattcccagatgaggggatgggtaataggatacatg-
gttttccagacttgtttgaaaatgcaactattttt
gggttgcagggaaggatatagtagaactcatgggaactggtgtttcttggaacatgctttggaaatgctg-
ggttatgccctgttaactcttacatcattagttttta
gcccaaaaggaaacagcaaataatgttttatatgagccacattttgcgttgattttcc 75
3907608 ZNF335 YES
ggacgtctacggaagtggagcacctccaccaagagccaagaggaagagggaccagaggaggaggacgatgatg-
acattgtagacgctggagccattg atgacctgga 76 2316543 -- NO
atgagacctcagacaaagccaccagga 77 2453070 C1orf116 NO
tgcgaccagtacagaccctgtcctggctgaacaagaagagacacatgctccacttgggagcctttgccaccac-
gcaactcagggctcaagatgaatggga
gggagagatttgagtccaagcatacatttatattcagtgttgtgccattgagttcccatgtggatcattc-
tgaaggtgatctccacaagagggtgtgtgtgtgtgt
gtttggtgtgtgtgtggagggggggccgctggatacatcactgaagctattgatataacacaatgagtca-
ctgttcagaattttgctcttgttagatgttttcttac attgggtagagtccagcc 78 3119603
RHPN1 NO
tccagctggcagcaagcaccgagcatgccctccccacccagaggacctccgggcaatgcctgtcccgcctcat-
gctggaggctgcctcgggcacctgcc tgcccattaaagactggtcagacctgt 79 3908801
STAU1 YES
cactgcagaaggaacgggcaccaacaagaaggtggccaagcgcaatgcagccgagaacatgctggagatcctt-
ggtttcaaagtcccgcaggcgcag cccaccaaacccgcactcaagtcagagga 80 2525664
-- NO
gaagctgttttaatggaggccgagagttggacaattttgtgttatggagaattctgggaagaaggaaagaccc-
ggatgggactgtttattaaggcttatgactg gactggagata 81 2395926 CLSTN1 YES
tacgggaaagaacatcaatataagctgaccgtcactgcctatgactgtgggaagaaaagagccacagaagatg-
ttttggtgaagatcagcattaagcccac ctgca 82 2571145 ANAPC1 YES
ctcaaaagtgtttattacatctgacctatgtgggcaaaagttcctgtgctttttagtagagtcccagctcca
83 2836006 -- NO
ggatgtacactgatttggccctttaaatgacattataccaagaagttggtataagggagtaggagatgagaaa-
actttttgaaaaatcatttggtgcatgctaag
gtagcttgtaggacatgtggttttaaaaaattcatggattttgaagaaggatagggtggaagtaaaattt-
agctgatagcatagggatcatttgtgatttatataga
aaataattatatttttgagtgagaagcatcagacttaaatttttttcttctattttggttattaccaaaa-
ggaacagagaaactctcagaattctttgaatcatagaatg
ttagtgctggaaaggactaggaagtgacttgtacaaccccttcattttacaaaggatcagagagaattgg-
ttagtagagtcccaaatctgcttttagaagtaata
tggtgatcatcagtttagattcactgtaggaagggcagccctgttaaagtttgtcaggagaaaaagggaa-
ggtatcactttttgtatgttcacccagttgcttctg
tagttttcatacccctgttttctcaattttcttagaactgtctttaatggcccagctctaccagggcttg-
ttgtctaaggacattaacttgtgctcccctcagggatgg
gtttactactagctgtcagaaagctattgggtatcctaatgtgttaatagctgaaactcagctgtaattt-
ctcctaaatacttcagcattttgcattctgtacattgtgg
tgctttttccaccttgtattgttgtaactgtaagctcctagggggcagcaatttggtcttaggcgtgtac-
cctgtttagtgcctggcaatgccatgtttatatcaagg
tcttaatattacttttgagttatttctcccactcttcatggaagtgatgctccagccttgctaaaacact-
gagggtcctcccgataagccaggcattgtgattccttg
gcttcaagtgccttctgtcttccccgaaggtccactgagatctacaatcccccctt 84 2517773
-- NO
tagcggagaatgacctacctacttgattaatgatgtctgcatgggcttactaagagggtgtggggaatggtgg-
caggggtaactatcatcgagaatataggg
caatgggtatattctaactttgcataactttgctagattatatatatctttactcacaataagcaaagtt-
gaacaacttaaaattgattccctgttttctgttttcactatc
caactaggatgaactcttaagttcatacatatactttaaaatgggaacaaacatagcctgtcatgtcttt-
atttaggctaagtgcatatgtatgtataagtaatgtgt
atatccttcacttattaatagtgccttcatgaattcaaagacccttgtcacatggtgctcaggaaaaaaa-
aagtgccaatattctttttttttttttctctaagaagtact
agtttaggtaagtgaaattcaatagcatatcagtgctttaccttagtcactttttgtgttttgatcaccc-
ttagtcatcactggagagaagagtttgaattcatttgtgg
ttttgctttagtggcaaacctccttacagggatgagttgccctccattctccttgccatatttggttaat-
ctaggccatgacctttgaggggaaaaggcacagatt
gcaacttttctttcctgcttttgtgaatcaggccatgttcacgcagggtccttgaaggtgacttgagtga-
ggaagctatataccgatgacttaccaatttttggtctt
ataacattctctctctttttttttttttttttttgtagcatatggcttcctctactgtatgttggcattt-
gccacttttggggatttgactcctgcaggtattttt
ttttttttcttttgggggagtgtgacggcagtggatatagtcttagatgatgtttttaatagttcaagtc-
cattagtgtcttactctagagaaaacg
aaagactcactgtgtgagttttcttgccctctggttttcagaattctgtgtagtttctcaacat 85
3064957 -- NO aaatccacagccacatctttgaatg 86 3239181 KIAA1217 YES
tcattctcaccgcagagtcaaaatggccgagcaccccctc 87 3629017 CSNK1G1 NO
tcaccatctataaggtctcagagcagaggattattcatggtaataagtgggggtgtggtgcagccattccagt-
aacaccca 88 3709453 -- NO
ggtgggacttacaggtctcgctatagcaccagataaaatccatactacaccctatcattacctgggaatgagg-
gtacaggagaaaacagtaaagcctcaaa
aggaggaaattcgtaaagagtccttaaaaaccttaaatgatttccaaaaattattaggggacgttaattg-
gataagacctactttaggaattcccacctaagcaa
tgtctaaactgtttgctttgctgagatgggatccaaattcatgtagcaaaagaactctgatgcctgctgc-
agctgaagagttacaaatgattgaggaaaaaattc
aaagtgctcaagtccgtagaagagatcctagtgttccattacagctcttagtgttccctactctccattc-
tcctataggagtgattgttcaaaatgttgacttagtta
aattgtcctttttaacgcacagtacgactagaactttctcaatttatttagatcaaatagctattcttat-
aggccaaatacaactgagaatagtcagactcattggca
ccgatcgagataaaaatgtagttcctttaaacaaagcacaggttcgacaagcctttattaattcgtcaga-
atggcagtcaaatctggctgattttgttggcagtat
agatattcattaccctaaaactaaaatgtttcagttcctaaaaattgactacctaaattttacccaaaat-
aactagttccattcctttggagggagccgtaactatctt ta 89 2732012 FAM47E YES
ccttataagccaaagtgggtgaagatgaggtatggagcatggtatttgaaccccaagttgtggaaaaagcaaa-
gagtagacgagcctctggttgaccctga ggtctcacata 90 2787588 -- NO
ggttgctgcccttgagcattttgcc 91 3630110 -- YES
atggagcacctgttcgtgtacctcc 92 3738711 -- NO
gtagctaaacatatgcgtggggataaaaatcgggtggacaaggccagatacatgaagacatgctccactctca-
tctgtgaa 93 3675240 -- NO
cccggactgatgtgatttctttgacaattacaaaaaacaaaaaacaaacaaacaaaaaaacgcaaagcaatag-
cagggaaaggacagtttgagaagacct
gcaaggcctgccaggcggctcgcttgtgcagacacaaccgggacggctttgaggggacgtgcacacccaa-
g 94 3458922 CTDSP2 YES gggacctgagaaagaccctcatcctgg 95 2694337 --
NO gaggaagacttgtgcgcccggcccacacgaaccatagagccgatctccggg 96 2990414
-- NO
ccctccacacgtgttcagttaaagtgtgaggaataccctccccagacaaacatcacagatttccgaaatcaaa-
cacgctccagcaagtgttctgcacacccc actg 97 3190328 -- NO
cttctcagttgggtcaagtccattgacctttctgttacagcttgagttttgtgtcttacgtagaaaaggtgcc-
cctgctctcactttctgcacagctatcaggtccag ctcatagcagttcttcta 98 3745435
MYH3 YES
ctgagattgcaggatctggtggataaactgcaagtgaaagtcaagtcctacaagaggcaggcgga
99 3110076 LOC100134128 NO
gtaaaagcgcggcaccgacaccagctgtgtgcagcagtggcggcggcggccgaaggagaaatagaacagcgca-
ggcaaaagaagaaaggcgcgg gctgg 100 3471539 -- NO
cacgggtccgctagctttaagtacaacaggatttccgtgttcaaaagactatactaagtgcttaatcaaatcc-
cgtcacactaaagccaaatttagttctctagg aatcggagtctgcgtata 101 3918710 SON
YES
cagagcagcctgtagacgtaccatcggagattgcagattcatccatgacaagaccgcaggagttgccggagct-
gcctaagaccacagcgttggagctgc
aggagtcgtcggtggcctcagcgatggagttgccggggccacctgcgacctccatgccggagttgcaggg-
gccccctgtgactccagtgctggagttac
ctgggccctctgctaccccggtgccagagttgccagggcccctttctaccccagtgcctgagttgccagg-
gccccctgcgacagcagtgcctgagttgcca
gggccctctgtgacaccagtgccacagttgtcgcaggaattgccagggcttccagcaccatccatggggt-
tggagccaccacaggaggtaccagagcca
cctgtgatggcacaggagttgccagggctgcctttggtgacagcagcagtagagttgccagagcagcctg-
cggtaacagtagcaatggagttgaccgaac
aacctgtgacgacgacagagttggagcagcctgtggggatgacaacggtggaacatcctgggcatcctga-
ggtgacaacggcaacagggttgctgggg
cagcctgaggcaacgatggtgctggagttgccaggacagccagtggcaacgacagcgctggagttgccgg-
ggcagccttcggtgactggggtgccag
agttgccagggctgccttcggcaactagggcactggagttgtcggggcagcctgtggcaactggggcact-
agagttgcctgggccgctcatggcagctg
gggcactggagttctcggggcagtctggggcagctggagcactggagcttttggggcagcctctggcaac-
aggggtgctggagttgccagggcagcct
ggggcgccagagttgcctgggcagcctgtggcaactgtggcgctggagatctctgttcagtctgtggtga-
caacatc 102 2792431 TMEM192 YES
tccttggatatcacccagagtattgaagacgacccacttctggatgcccagcttctcccacaccactcattac-
aagctcactttagaccccgattccatcctctt cctacagtcatcatagtgaatcttc 103
3828963 DPY19L3 YES
gaagtggagcgagaaatctcattcagaacagagtgtggcctgtattactcctactacaagcagatgctgcagg-
ctccaaccctcgtgcaa 104 3874927 CDS2 YES
gttcattgtccccatatcttgtgtgatctgtaatgacatcatggcctatatgtttggctttttctttggtcgg-
accccactcatc 105 3012468 AKAP9 YES
ctggggtcagggaatttatcttacacacagtcagggatttgacatagcatcagaaggccgaggag
106 3541309 PLEKHH1 YES
gatgtcatccggaaacctcaaggccaagtggatctgaactcccgctgccaaattgttcgaggggagggttcac-
agacgtttcag 107 3543492 PSEN1 YES
gcaagtgacaacagcctttgcggtccttagacagcttggcctggag 108 3878896 -- NO
aacgtgctcagggagaatcagctggtttct 109 2669445 -- NO
atggctaaaactccaatagacagcatgtagtgcttgggtgacagactttgggacaatcacagccactacaaag-
tgaaaggggagaatccagaaagtacag
agccagaaagggagagccccaaattctatgtaaaaactgcccaaatctttggctgaccactgaactatgc-
atgcatggggcagacgctaagcaacctagct
aaggataaaataactaagccgagaattgaggtagtgcctc 110 3953763 PI4KA YES
gagcaacctggacataactgtcggctctcggcaacaagccacccaaggctggatcaacacataccccctgtcc-
agcggcatgtccaccatct 111 3529048 -- NO
gcccagtacctctccaagggttgtatatccggtgggggtggagggatcggcagaggtggtgtctcagcccttt-
cgttcaaggagcgggttgatggtggtgg
tgtaggaattgctgggtcttggaaactaggggcaccaggtactgcgttgtcccgaaaccactttagttgc-
ccatgcttcaaggcatagcgtgtgtcaccaaac
cactgaatgatctcaggccgaggtaaaccagtgatctgttctaacttttggtaatcctcacgccgtgccc-
actggcactgtaaaaaaaaggatttaaggatagc
cagctgctctttggttttgcgcttggtctttcgctggcgttgcatatctggggaaaggtactctgtgggg-
ccaactctacctggtactga 112 3691111 -- NO
ttgacgtggcttatcaacctttgtctcttacgtgctctttgttccggccatcgtcttgtttaacaaa
113 3845902 TIMM13 NO
gggtccgcatgtacgtactgcctgcccggggcttaggagggtggcaccggtgctgggacacacgggactgtgt-
cctcgccaccccccgccctgccccct
gccagccagtgcagcttggatctcgggggtgtggggccctgtgccttcctgaagtgctggcagcccagtg-
gcacctccttcaggcctttggggtattcccct
agtgtgcccaagtcagcctcatattctgggcggacagcttgtctggacttcggagttgggggtggtcaga-
caccacaggagctgtcacctcctgcggatgg gcaaataaatt 114 4009521 PHF8 YES
gaccctgctttgaaatctcgacccaagaaaaagaagaattcagatgatgctccatggagtcc 115
3817782 -- NO
catgcccggcccagtaattaggtttttttttaaaaagccccaaaccttaattttatttgcccctcatttcacg-
gagctcccagcgtagtggggagaagctggccc
agagaaccccacgtcctgcacagtgagggccagcccttggggaccccatgtcctgcacggcgggggccag-
gccctggggccacgtgtgttcccccccc
acccctattttctgccgcgtgctcgttctgctgcacgtggctgtcacttgaatgggaatttaaaaatata-
acttaatgcacactgacttcccttgattggtgcaatta
attatttgaaaagaaaaatatcacagtgttcttaaggactggcatttttccaagctgtgtcagttttgat-
tgatgtctgacgccgtggctggcttctgaaagcctca
ccagttctgatggcttattggcgacttcagtgtatccagcaatctctgctcatctttctgggggaatata-
taatgatcagcaggcctgagaactcctacaaatca
gagataagaaaacaaatggcccgatgaattcggcgtgaggggcttgagcagacgcgttacgaaggagctg-
caggaacgaaagccatggttcagtgccc
agcatcggtagaagtcagaggcagccagctgggagacaccgccagccccaggacggccacgtcagaacac-
cgccaccagatgccagtgaggaggg
cgcagctgcacgctgctcccagccggggtggatgcagggcggtgccatggccatggaaaaccgttcggca-
ttttcttggaaacggaagcatgtaccctgt
gccccagcgatgccactctgtgcatatttactcaggagaaatgaaaacatatgtctccagaaagattggt-
acataagtgttcttagcagttttcttcacgagagc
cccaaactggaaacagcccgcacgtccatcaacaggaggatagataaataaataaccatagatccacgcg-
caaccgagtactgtttagaaatgaaaagga gcg 116 3948736 -- NO
cgttgatcccacctccttgatctggtttctaagacctcatacaaactgggcccgttagtctttgctccctgat-
actatctgataccatctggtctcac 117 3104724 ZBTB10 NO
ctggtcggacggaaacgctccgccggctttattgtcgcttcgttatgtggcggagccgagcagtttagcgtgc-
ctctcaccctcagcgcctgcgaagccggc 118 3364565 PLEKHA7 NO
actggcctgtgctacttattaccgggcttgtaatagcggttcttgtctccatagcctgttgagtgttcccaga-
tgtgactcacctttctgctgccctatcatgcag gcctactga 119 3540221 -- NO
atgaggccggaaagatggcgaatttgcagggctgg 120 3458075 -- NO
ccaaattttagttgtgaggaaacagacataccaagtattctttttagcaatgagcattagttctgtttttctt-
aacagtgaggcaaactatgtatatttacattttgtag
aatatttcctccaaaattggtttctgcatactttttgtttttgctatcactgtttgggcttagagtagta-
tccttgaggctcgtctcatcttttttatttgttttgtttttttgttt
gtttggttttgttctttgagactgctgcagtacaatggagcgatcccggc 121 3773290 --
NO
caggctcatcattccttgttggatttcttcctggacttatttaaaagttgttatagctattatgaatgagctt-
ttttaaaaattgtaattcctaactatattactggtgtag
aagaaaactacagagctggtatccagctactttattgatttcttactgtttctattggcttttatttttc-
attagtagaggttgagaatttcagtatttcattcccagatcc
atatctcatttctttctcttgttttctttgcgttgctggagcctccaaaacagtctggggtaactgctat-
gctagcaggcctcctcatc 122 2835195 FLJ41603 NO
ttatcggtgtagcagagaggttcccaagactcttgactggtcctgggagtgggtgtgaccaagtcatagttct-
ggaatgtgtgtaggcaaattcagaggctgtt
ccagggaagaggggattttgatactgtgttaggtggggtgtgtgaggctgttggcagcaggtgaacagct-
actgctgtgttctcaggactagggaacaaag
gggtatgcaaatcatagaggaaactctgggaaggcggtgataaggcctggtgggtggggaggttagggaa-
tggcttgctttcctgtttctggttagaaggg
gagccagggggaacccccagtggtttcaggtggcccctgaggtcctggaggcagccgtggatgtgatgca-
attggctgtgggaccttagatgtaggaca
caacttcagtgttcccatccagaaagacctcactcacagggttgtgctgagaatgacgtggggctaagca-
tgcagagctccctgtaaactgtgaagtgtgat
acaaatgtaaatgacagcagtgatctcggggtggcccccggcatgctgccctcccccacgcccatgcctg-
tggcagcaaaccttgttcatcagtatagcttt
ctttcctgtaacccaggatctaccttggggggcttctcaatactgcattctatgtagccagcctctttaa-
cttggtaagtgagccaccccattctagaacctggaa
attggagcccctcaaaaacagttcctgttcaaggaggactgacctgctggggcaatgttgggtgcagtgc-
agtccctgcttggggtggtcatgtctaggctgt
tgctctgggcaaagataagagcaagattcacagaaatgggaaaatgtgaccaagtgtgatcttaacaact-
gacaaagtttgtaaccaacccaagttagaatg
tgtgtcaaacaggaggtagtttagatatgcttccaagaacatgtctgtgttataaccatagtgcctaagc-
agtgagctctggtttttgaagggcttttaagaa 123 2988321 FOXK1 NO
aggctctccgggcaaatcagaaggccacgagagagagaggagcggggagagtggtgaggaggattcgtctctg-
actgatgaacctcgccgtgcctgtc
tgtcacatccaagtctgtgccagctgctgggaggtcagactcctgccctgagaa 124 3632941
UBL7 NO
cccagcaagttgcagaggctactgcccttgggaggcactcatgaaggtgcctccatctctccatccccaatat-
acctgatggtcaactctc 125 3855574 -- NO
ggcagcaggggtcagattttcctcatggcctctccagcaggccagcccgggtttctcctggtggctgggagcc-
aggagagcggctcccatgcagagtgct
ggtttcacatttgtgggtggcccatccgttgaggccagtcacgtggccaggcccaggaccagatgggaga-
ggaccgcacaagtgcagcgtgagctgtgg
gaggtgtggctgaccacgcttagagagtgtggtgccaggaaagatctgatgtgtcaccattctatatctg-
tgatgggcagacgcaggcaggtcaaagggg
ccctggggacttaccgagcccctgcctattggccaggcactgtgattgtcctcggtgccatgtgccatgg-
aagccctctcagaggtcgaggggaggcagg
tggagacagagcctctgtaggcctttcaagctgtagccccagagcccagaggcagccgaattcatgtgtg-
cagtcagagagcacttagtgggcactgtagt
caatcagtgagcgcttactggacaccacaggcagcaagcatttactgagtacctctggcagttgatgcat-
acttcctgagtacctgttcatagcaggcttagct
ctggatgtggggtggtgaggaatcccacaggctgaggggtggcctgggagctttccagggggcctgaagc-
aggaggggctgcctgagtgggtcagca
gcccagcccagtgccctacgcagccctgcccacacccccaacccagcctctgtctccccagtcccatccc-
ccacaccctggtccctcctactttgtgcctcg
aggacactgccccgctgccctcctcacttcccagcgtctgctgtcccctccgctgctgctgcccggcagg-
attgctctgtgtctcatccacgtttgtccctgca
gagttcctcgcctctccctggaaccgccagcctcatgccgcatctcagaggctttttttttctctctttt-
ttttttttttgagatggagtctcactctgtcacccaggct agagtgc 126 2648215 -- NO
tttcgcagttgccaaaaatggtgccgtaaggctttcctggaattaagtagtcagaggtatttggttagcagat-
gctttgtaaaacctaatatattcccactatatttc
ctttaaaaatcaagggggggttaacacctttagattgtcatgttttattgagaaaaatccacttctctga-
aactccctattactg 127 2714009 -- NO
atctgaggccaaggataaattcatcaactgggtagccaccactatagaagaagccaaccacaatcaatgtcgg-
ctatgcgtccagctgccagaggccgcc
aggaatgagctaccttgaagaatcgtccgtgacaacatttctgaatggctatgtcactatcaatggggcc-
acaacaacaacacttgcaatccaacctgaactt
cctatgaccaaaccaagcaatctatttatgcccaagtcaagtgaaaggtgaactccaccttcaccatgca-
tcaaaagccttggtatcctgcccaatatgcctgg
aacggtatatattgggaacctgctgtgctggtggccggattccatatagctcc 128 3342827
-- NO gagcaggcagttggcaaaccggaaag 129 3494235 LMO7 YES
ggaaagaagccgcaggatcagcttgttattgagaga 130 3816344 SF3A2 YES
ggagctacctggcacatacgcaggggaagaagc 131 2340361 DNAJC6 NO
cggcggcttcgcctcgcccggcgaagcttctctccggtggccgctccttcttttccctcctctttgcgtcatg-
tcgggcacttaatttttt 132 3557286 HOMEZ YES
agagcagctggctatccttaaatccttttttttacagtgccagtgggcacggcgtgaggattaccaaaagtta-
gaacagatcactggtttacctcggcctgaga
tcattcagtggtttggtgacacacgctatgccttgaagcatgggcaactaaagtggtttcgggacaacgc-
agtacctg 133 3911399 -- NO attttcctgcattcacgatggcctcc 134 2612381
EAF1 YES
cagcagtaaaatccaggcccgaatggaacagcagcccactcgtcctccacagacgtcacagccaccaccacct-
ccaccacctatgccattcagagctcca
acgaagcctccagttggacccaaaacttctcccttgaaagataacccctcacctgaacctcagttggatg-
acatcaaa 135 3354739 -- NO
tttgagaggttatttgtccatgggatgctcgtgttaaaacaaaaa 136 3434425 RNF10 YES
taatcgcaaacgtgaactttcctaccccaaaaatgaaagttttaacaaccagtcccgtcgctccagttcacag-
aaaagcaagacttttaacaagatgcctcctc
aaaggggcggcggcagcagcaaactctttagctcttc 137 3734620 KCTD2 YES
aggaagcggagttttacaacatcgcgtcccttgtgcggctggttaaggaaaggatacg 138
3802333 LOC728606 NO
ttcagctacgttgtcccagcacttcactggttaaccttttatgtccaccatttgtggatttcacagctacttg-
tcaatggtgaatattgatcatcatcattatctactga
gctgctaccatatcccagctactccttgcatgttgttcattattttctcaacactcagcatatttgcaat-
atgttatgtaatatcacagacaaggaaactgaacgca
gaaatgttttatttcttgccaaacatcacatgaggatgaacaatgaaaccgatttgaaaccaggattgtc-
tgattccaacatctctgggtctttttcactctgatatg 139 2896736 -- NO
aggatctagctctcttgctcaagctggagtgcagtggtatgatcaaaactcactacagcctgcaactagtgat-
cctcctgcctcagctatagctaaaactatag 140 3053930 -- NO
ttggcacactaactccacttctagacatctatcctaagataataatcaacatataaaaatgcacatacaaata-
ttgactataagaataaaaaaatttcagcatttaa
gctgtacaggtgaatgtttaaattatggtacacccatttgtgttatttattttaaaaaatttttttgaag-
tataactatgtagaaaactgtcctagcataatgttaagcat cgttcccaatgtgttt 141
3459700 -- NO
ctaaggtgagacaggtctgtgaatccggggtctctgtcacttggggaaaaaaaacgggcagaaaagctctgaa-
gtttgaaacacataaggaaaatctgcta
tctgtacccccaccctcccaaaatatagttgacgcccccgcgtgatgaagagtttatgggggtggaggct-
tggaggagatgtcactgcgcctgggagcttgt
gtccgattccgggaggtggccgtgtccgagtgcgtggttgtacatttccgaaggtctcagtttctctcac-
tttcagcccgcga 142 3223562 MEGF9 YES gtctgccagttgcgatgccctcacag 143
3888086 ARFGEF2 YES
ggaaaggccttgacatggcaagacggtgtagtgtgacgtccatggagtccacagtgtcctcggggacccagac-
aactgttcaggatgaccctgagcaattt gaggtcatcaa 144 3378887 TMEM134 YES
ggattccagccgaacttccatccgcag 145 3280240 -- NO
acctttccctgaggttggataggcactgctccccttctctgtgcccctggctcccacatctaatgactcctgg-
cacttacgacactctcattcaaattttctagcc atgcaccttaagccc 146 3379391 -- NO
ttttgtacatgcacttgcagtattgaggttaatca 147 2351210 FAM40A YES
gcagcacccacctcaaaagccaaaacagactcaatcaacatcctagcggacgtcttgcctgaggagat
148 3758440 -- NO
gtttcactatcgagagtcggactgcttttggatttacgtggctttgtgggatgcggtatgaagatcgttgcat-
tcaagtttaccgcctctacttcactgcagaatct gactgccgtcagatctgtatgac 149
2617213 ITGA9 YES
tattgggctggaaccatcaaagtgctgaaccttacggacaacacctatttaaaactgaacgacgaagtgatca-
tgaacaggcggtacacc 150 3677835 CREBBP YES
aaccagaggagttacgccaggccctcatgccaaccctagaagcactgtatcgacaggacccagagtcattacc-
tttccggcagcctgtagatcc 151 2332491 -- NO
atccactaagaggcgcaagttggctgcctttccagaatcctctgattttcgttgatccaaggggctggaactg-
agcttcctttttcatgccaagtagggtccaaa
caacagagaaacataaagctcttcctttctccccaacctcaccagcccttaccatggctggcttcccagt-
gattcattcaaggcaaca 152 2932426 RBM16 YES
tggggtccggccatctaatgtttccagtagttctgggattattgcagcccaaccaccaaatattctaaataac-
tctggaatattgggaatacagccacccagtgt
gtcaaatagttctggacttttgggagtgctacccccaaatatacctaacaattctggacttgtaggagta-
cagccaccaaatgttccaaatactcctggacttct
gggaacacagccaccagctggacctcaaaacttaccccctttaagtatccctaatcaaaggatgcccaca-
atgccaatgttagacattcgtccgggactaat
accacaggcacctgggccaagattccctttaatacagcctggaattccaccccaacggggaatcccaccc-
ccatcggtacttgattcagctcttcatccacc
accccgtggaccttttcctccaggagatatttttagtcaaccagaaagaccttttttagctcctggaaga-
caaagcgtagacaatgttactaacccagaaaaaa
ggataccacttgggaatgataacattcaacaggaaggagatagagattaccggtttcctcctatagaaac-
cagggaaagcattagtagacctccccctgtgg
atgttagagatgtggttgggcggcctatagatccaagagaaggtcctggacggcctccactagatggtag-
ggatcattttggaagacctcctgtagatataa
gagagaatcttgtgaggccaggtatagatcatcttggtcgaagagaccactttggctttaatccagagaa-
gccctgggggcatagaggagattttgatgaga
gagagcatcgggttctaccggtctatggtggtccaaaa 153 3273785 ADARB2 YES
taaagtaagcatattgtcaaccttcctcgctcattcaagcacctgagtcctggcatcacaaacacggaggatg-
acgacaccct 154 4015409 TSPAN6 YES
tgagaaggctttgaagcagtataactctacaggagattatagaagccatgcagtagacaagatccaaaa
155 2428715 PHTF1 YES
ggccacagcgttcagttgatgtggttgtatcctcggttttcctactgacactttcgattgctt 156
3261500 NOLC1 YES gtctgccaaggtcccagagcgaaagttacag 157 3144008 NBN
YES
cagacttttgactggcgttgagtacgttgttggaaggaaaaactgtgccattctgattgaaaatgatcagtcg-
atcagccgaaatcatg 158 3527425 PARP2 YES
atctgtgaaggccttgctgttaaagggcaaagctcctgtggacccagagtgtacagccaaggtg
159 3836942 -- NO
taccaggagcccatggatggcgtgacccagcaggcagcacagaatgtacttgccaaggcgggcaaagagtaaa-
cc 160 2746889 -- NO
ggagtcaaacgtcagagcctgagacctttgatgaagggtcacatcgccagagctcagtgg 161
2853401 -- NO
gctgagagctagctttgctttataattttgtacttactaaaaaattaaataacttataaatggaggaaaactt-
ggatcagttgatagattttgggggagttagtgaaa
tttcttgaggggattttcaatcgaatgcttttattttctgtggcagtaatgatctggttggtttatctca-
taaataactgatgctgctgctttttgtgttctttgatgtctca
ccttatgtttttactaagtaaggacagcaatggattggcactgatgc 162 3593678 USP8
YES
tgtcctgcgcaatgagcctttggttttagagggaggctatgaaaactggctcctttgttatccc
163 2466363 -- NO
tgataattggtgacgacaaggaaattaagacgattgctcaaagagatgca 164 2961018 --
NO
gatcttccacacaaagatcaggtgaagaaatctatgcagctatacatgctaggacctgagtacaccatccctg-
caa 165 3307825 -- NO
ctgaggaatcttaaatctgggtataaacgtgaaatggttttattttttccttactgggtctccagtcatacag-
tgtaaaacactcctaacctctgtactttcctctgca
gtgcagtcctttaagaatcccttggtccgatgtaactttgccgccact 166 3375666 FTH1
NO gacccgcagggccagacgttcttcgccgagagtcgt 167 3510380 C13orf23 YES
gcagctgccaccgtttctggaatgaacctgctgaatactgtccttcctgtgttcccagggcaggtctcctcag-
ccgttcacacacctcagccatcaataccaaa
cccaacagttatcagaaccccttcattgcccactgcacctgttacatccatccacagtacaaccaccact-
cctgttccttccattttttctggcctagtgtcactgc
caggtccttctgccactcctaccgcagccactcctaccccaggacctacaccacggtccactcttggttc-
cagtgaagcatttgcttctacttctgcacctttca
ctagcctccccttttccaccagctcttctgctgcttctaccagcaacccaaattctgcttcattgtcatc-
agtttttgcagggctccctttgcccttaccaccaacat
cccaaggcctatccaacccgactcctgtaattgctggtggctctactcccagcgttgccggtccacttgg-
tgtgaacagtcctcttttgtctgcgttaaaaggttt
tctgacatccaatgacaccaatttaatcaactcctctgctttatcctctgctgtcacaagtgggctggct-
tca 168 4026959 HCFC1 YES caagccagccaacaagcggcccatgtcctc 169
2888352 RNF44 YES
agagcagctcccgtcgtaccgctttaacccggacagccatcagtcggagcagacgct 170
3320634 USP47 YES gagaaattgagcgcaatacatgcaag 171 3752442 -- NO
taggtgcatgacactgctcagtttgatgtgctaatctgattccagtaaagagaattgctgatttaatgttgag-
gcccgatcttccacaggtcctaaatgtttcccaa
aatacatggatagcatacgactgggtttttttaaaattatcccaggtcaagcatgagtatctc 172
3188731 NEK6 YES caggactgtgtcaaggagatcggcctcttgaag 173 3303115 --
NO
ctggaccaaccactacttccgtgtttcaagttcatttttagcacatgaacatgatcactgttagccagtgaag-
tagcttctgactagatcattgattagatctcaca
aaaaaccaaaaatagtatatggaaaccaagatgagagcaaaagaaaacgttacctgagtaggcagctaaa-
acatattttgacattatttttaagcagcattcat aaggttcacgga 174 3820685 ILF3
YES
ggttctggcatttatgacccttgtgaaaaagaagccactgatgctattgggcatctagacagacagcaacggg-
aagatatcacacaga 175 3882554 -- NO
ataatgggatggcaaatagtctccccagcccagagttcaatatcctcctggttgctggctgagcttagactag-
aattatgttgagtttccaggacacccatttta
cgaatgttattttgaattgcctgttgtatgtgataata
176 3054154 -- NO
ctacacgctgccgaggaaaacgcaacagacatggcaggtgcctcacgacaagaaacacttacaaatagaatca-
aaactgattcaagtcataca 177 2624472 CACNA1D YES
atccgcgtaggctgccacaagctcatcaaccaccacatcttcaccaacctcatccttgtcttcatcatgctga-
gcagcgctgccctggccgcagaggacccc atccgcagccactccttccggaacacg 178
3652530 POLR3E YES
gactgctgtgtaagctatggtggcatgtggtaccttaaagggacagtacagtcttga 179
3980537 ARR3 YES actaccacggagaacccatctctgtcaatgt 180 2808239 -- NO
cacaggtgaattgtctgggaagtcaggatgttgcacagaagctatgcaagtcatagattagaaaagcaagaat-
ccacattcatgctttccagcatagatgag
gagatactttttctccaccttcttagattcagtggctgggcagagagtgctgtgaattcatctgacaaca-
ggcagattaacacgagaaaaggaatataagtttttt
attttttatttttttatttttttgttttgagacagagtgtcactctgtctcccaggctggagtgcagtgg-
ctcactgcaagctcccacctcccgggttcacaccattctc
ctgcctcagcctcccaagtagctcagactacaggcgcccgccaccatgtccagctaattttttttatttt-
ttagcagagacagggtttcacctcccaaagtgctg
ggattacaggcattagccaccgcgcccagccaagttttttaatgtttaatctaatgtgcatggaggcatc-
atagaaagaactgaatatccaaaagtgtggtgaa
atttgagactttagataccatcttaatgatagtggcaggaggcagacaaatcctagggagacaagggtgg-
gtccctggtgaaaccccaccttcaaaccaaa
gacagatttaagcatgaaagccaagctacaagtctccagtaaatccatggaccggattaagaatctctc
181 2811059 -- NO
ccatcagcttgtgactcatggcttagctggtctcaatggggaacaaaccagagagtctatggatcaacacaaa-
gctataactgc 182 2858392 -- NO
ggcccagcttcatggatatacaaactatacattcacatgggttccacacctagatgggctcttacatcatgta-
gctggtcctacctgggagagagc 183 2779739 -- NO
tctgttcacggagcttagttctacttcctga 184 3298972 -- NO
gttaactataggtaggggacagagaaaggagcagagttaatgtatgctattgaagctgagttgctatcagtct-
gaactagactttgaactcagcatg 185 2933580 TULP4 YES
gaaactggccacgtgcgatgcggacggaggcatattcgtgtggattcagtacgagggcaggtggtctgtggag-
ctggtcaacgaccgcg 186 3528128 TOX4 YES
caactaggccaaaccagtacagctactatcc 187 3528025 -- NO
cggcgctacgttaacttcgactatattaatgagcatcacgatcttcattttcatgatcccgtagtcctcgcgg-
tcgtagaaaatgaaaggaaagcagccgttaa
cacaggaagagcgaaaaaaggacattttccctggcgatcgtggc 188 3581134 AKT1 YES
gatgatctctccacggtagcacttgaccttttcgacgcttaacctttccgctgtcgccccaggccctccctga-
ctccctgtgggggtggccatccctgggccc
ctccacgcctcctggccagacgctgccgctgccgctgcaccacggcgttttttta 189 3676391
-- NO tgggccatctcctcggtacaggtcagctgccgccggcggagctcctcatctgtctcct
190 2319003 -- NO
ccaagagcccggaattttcattacaactttcaaagagagcaagaggaggagggaaaaagatttcacaaaagca-
ttatcaaggccccaacccaggatgccc
tgctgtacaaccaaaatttgtaagaggtcagcctttcagggagtcaaaaacccagcatgtgga 191
2858313 -- NO
ctgcagagcaaaatatagaggcactaattttgttatatttgcagcccacatactgtaataccagatttgctcc-
tgttgttct 192 3048750 -- NO
cgggaaacttcggaagacagctgtgcctggctctgtggctgcatgcagtgcttcacttggccagcagaggtca-
gctgtgccgagctgccccagccatgag
aagagaagcctgcccttgctggcaggtggctatggccggcccagagccttcctgcccagctcctgcagcc-
ctgctgcctgggatcaggctgggagatgg
gccttcctgaccgccagccttcctctccccgagcacacgcacatgtagattcggggggaagctgcctgct-
cttccttagaggagccggggcagctatctgc tggtccctttctgaacaactgttga 193
3360848 APBB1 YES tgaggaggggacgttgaccttccca 194 3387192 CWC15 NO
gccaagagtggtaatggcgtctgtatgatcttcggagcctgctgcatcggacctcggc 195
3893880 -- NO
actccgcagggctggcacttcctgagggagtgggggctcaggcttcagacggactttattaaaatgtgtagtt-
tgtgtgaatcatttcagtcaaaagtttcagct atactcggccgttaagacaacttaatga 196
2393792 KIAA0562 NO ggaagggctgccatagttgccgcagt 197 2395248 RERE NO
tcacagcagcgagcatccagggtttgcagggacgatgttacagactctgttttctgcctggcgtttcacttgt-
gtctgctcctagcctgtgctctgccagcagc
acagacatctgctccatcagacctcttccattttgcacagggagtgcaggaggtgaatgttcactttctg-
ttctccagtgtcactgttctgtttccacgggatgga
aagcgcatgggcctgtgtccattgtagatttccttctagatttctgtgtacacacacttgattgttctgg-
atgaatgtcttttttaatactccgaaaatttcatcatcta
agaaaatgattccatacaaataactcagcacacaagtgacccaggacatatgcctgccaaagggatgtgt-
tagaaggctgccttctcatgcgcattgtcactt
ggatcttgtggtgaggacggccccatctttcttgccacagattgaggccacttttgagcaagggagatcc-
tggagttaagacaggtgttgggggcagcctgt
attttaccctaggggcaggtctgcatggtgaccccacattgcactggtaaaccatttgagtcccactctt-
catcctggaagtgggaactggagtcccacccac
agtgcattcagaaagcatgctgtgtgggggctgcttctcaggaggccaggcccttctgagcggaaccgtc-
ctggagagagcctgccctcgtttccaggctg cagccgtaacgcactttc 198 3403226
UNQ2963 NO ctcacccttgaggcccgggcacttc 199 3920956 -- NO
cccaaatgtgagttgcatcaaattcggtaaatgtagagtatgtttgttttctctgtacacaatactgacgtca-
gtgctagtgcctgcctaaactcagacaccagta gatccttttccaga 200 3970256 REPS2
YES tttgaaaagtactatcaatgaagccttaccaaaggacgtgtctgaggatcca 201
2724115 -- NO
gcaggccttacttatttccacaggaccttataagctcatacactctattgcttattacgttactggaatctat-
ctaagcagaaagaggctggcccaccttctgttat ctatgtttctatactctttggacttgcta
202 3351955 MIZF YES
caaccacatgcgctttcgtcacagtgaggaccggccctttaaatgtgactg 203 3133234
PLAT NO
ggaattctgcttcactcgcttaacatatacacaacacctgtaacatacaaggcaatgggctaggtgctccaga-
ccgggaaaaggagggacaggaatgcttg
gtctgatgggctaatatggcatttagagaagtaccaaggtacagtggagccggtcacaaaagggcagact-
tgt 204 2723089 -- NO tttgtggctgttaataggaaggatgctggt 205 3102652 --
NO
tgtggcaaactaccacggcagatgtttacctatgtaacaaaactgtacatcctgcatgtgtacccctgaactt-
aaaaagttgaaaaaaaaaaaaaaagaaaca
aataggctgggcatggtggctcaatgcctgtaatcccagcactttgggaggccaaggtgggaggattgct-
tgaggtcaggagttcaagacctgatatagtg agacc 206 3392531 -- NO
ttggacttgaatgactaggagaatgactactctaatgaacaaaaatgtaaatgttatatgtgggtttagtaag-
ggaatgcaatgaacttggttttggatatgttaaa
cttgagttatcactggaacattcaggtagaaatgtttagaaagcagtttgaaataagagtttagtagaaa-
ggttgagagcagcgctgcagatacagatttgaaa
gtcatctgcaaagagatgtgtcttagcgttctc 207 4015009 -- NO
tggaggcggccctacacctggcaatggaggt 208 2596170 INO80D YES
gatgagttgccggatgacattgccaatgagatcactgacattccacatgacttggaattgaaccaggaggact-
tttcagatgtcctgccacggctacctgatg acttacaaga 209 3591676 -- NO
aaaacctggaatgctgtaggacatgtacccactgaggcggatgcaaggagcgatggagaggaagga
210 3680412 -- NO tttaccccttctcggtgacatttgc 211 3906169 CHD6 NO
ctgcttgacttactgggtgatattgggctacaactgagactcactttgctcctgtgtaaagtggggcaacagc-
atctaccacggagggttgaagatttacgga
gatcatgctaagacagtttgttccaaactcaaaggaaatcatttgcaaacaacagaaaaggtcagaaacc-
gtatacctggccaagagagatcccttttacgct
ttgtttaatgtttcatgttgtattttgggttttcccatttactggattctgagctccaaaacaggaatca-
cattttatgttttcttattttaaaagcaataataataactagt
acttattgagtgcctactgcttaccatgttcaaggctttacatgattatcttgtttgttcctcacaacca-
ctctgaagatgggctttgttattcccattttataggtgag
gaaaataaggctttaaagcattaaataatttccccaagattatccagctagtaagtgacaaagcaggaaa-
ccaaaccaaggacctttttctctaggggctgaga 212 2803102 -- NO
ctatatgtagctaccctgtggcctccccctaaggtaaccactttactttttagtagtgaagaatgtctaaaat-
ataataaaggtatatctagaacacaaacctcca
agcaggaacaacccattatctctcctttgcatgccctgtcaatggcttcaaggtcaaagctagctaagtc-
tctgagtgtgtagggagctgacatcttggtgaaa
agtccttcagtacatgctagatcatagctgacttgcactatccttccaaactttggaatatctctctggt-
attggattggttacaatggaaacagaaagattctgat
catacaaaataaagattttcatttgtgagctcaaccattggatctgtcatcttccattagtagaaaaaat-
gaggaaatcaaatactttgttttgtttttaaccacgcag
agaaggaagagagtagagtgtgggaaattgatatatctgccttactgccccagcccctccctctggagtg-
tgcaagtggtcagaagtcagcaaattacttttc
catcatatttggccccaaactaccctggtgagtgaggagaaagggaatcatttgataaggtttggaaaat-
agcatctgtttttcttagtgtttctggatgaatttat
caggcatccggtaatttgtactttctgttgaaaactataatagaataccgtgcatagacatgaaaccttt-
tggtattagtcagaagctacatactgactgctgttgg
agaagaccacatttacagtcaagggtagaatcatctgaaatagtttcccctggaaaaaaaaaaaacatgg-
ccatatatgcctacatagatctcctctttgcttca
tgaatttggaactaaacctgggtgtttagataattccagttctaggattttctcaccttgagtttattcc-
ccttattcttactagttcagtttggccactgtacatatgga
gcttactagaggcaaagcactctgtgaggggcaatggttataca 213 4025793 -- NO
ttgtgtctgctccaagtgcgaaccctccatgcactgcagagaacaccagaaggagaggagcactacctgagct-
tctccttccgggtctaaaggtggaacttg
ctttgcagcacccagcatttcactgtactgattcctttttttggatcaccacctcctgcgtttagcagcc-
catatgctgggctcactcagctatacactgcttg 214 2616236 FBXL2 YES
aattttggaggctgcccgatgctcccatttgactgacgcaggttttacactttta 215 2959832
LOC100128757 NO
tccggtgcttacctctaactgataaaactagctccaacccaccaccctccactgacttccttcgcactcagcc-
cactcgcacccgggtgaataaacagccttt
gttgctcacacttagcctgttcaagttgtctcttcaattagatgctcgcataacatttggtgccgaaagc-
ccgggataggggaactcctccggcagacctctcct
ctatcctcccggtacccacgttctcccatgcaagagacttccctcgccctcaggacctcagaccagctcc-
gcgagcactccggcctctgtctatgga 216 3072195 -- NO
ttagtgtcgtcaggagactccctccatcagaattactcaggctgattgttttgagtcctgggacccagttggt-
atccagaatcttggcttgtttgcctaggaacc 217 3757471 ACLY YES
gggtgtcaacgagctggcaaactatggggagtactcaggcgcccccagcgagcagcagacctatgactatgcc-
aagactatcctctccctcatgacccga gagaagca 218 3986531 -- NO
gagggaggaattacgtggtgaaggatgaagtgaacagcggtgcttggcatataagccagccctcaaacaag
219 2696767 MSL2 YES
cttcctgtagctggtgcaaagactatgagcagtttgaggaaaacaagcagttaagcatcctagtgaactgcta-
caaaaaactatgcgagtatataacacagac
tacactggcacgggatataatagaagcagttgactgttcttctgatattttggctttgcttaatgatgga-
tcattgttttgtgaggagacagaaaaaccctcagatt
catcctttactttgtgtttgacacattcccctttaccttcaacctcagaacccacaactgatcctcaagc-
tagtttatctccaatgtctgaaagcaccctcagcattg
ctattggcagttctgttatcaatggtttgcctacttataatgggctttcaatagatagatttggtataaa-
tattccttcacctgaacattcaaatacgattgacgtatgt
aatactgttgacataaaaactgaggatctgtctgacagcctgccacccgtttgtgacacagtagccactg-
acttatgttccacaggcattgatatctgcagtttc
agtgaagatataaaacctggagactctctgttactgagtgttgaggaagtactccgcagcttagaaactg-
tttcaaatacagaggtctgttgccctaatttgcag
ccgaacttggaagccactgtatccaatggaccttttctgcagctttcttcccagtctcttagccataatg-
tttttatgtccaccagtcctgcacttcatgggttatcat
gtacagcagcaactccgaagatagcaaaattgaatagaaaacgatccagatcagagagtgacagtgagaa-
agttcagccacttccaatttctaccattatcc
gaggcccaacactgggggcatctgctcctgtgacagtgaaacgggagagcaaaatttctcttcaacctat-
agcaactgttcccaatggaggcacaacacct
aaaatcagcaaaactgtacttttatctactaaaagcatgaaaaagagtcatgaacatggatccaagaaat-
ctca 220 3188391 -- NO
caggggtacacccacatctattgtattagacaaatcacagagggattgcaacagaacacagatttttctcact-
gttttttctctggttgatcgggatgcattatcc
accagaaaacactgtagacgactcactcaccaggaaaagagcatatgccagttggaataaataaagggga-
agagtaaggaagaggctgtagaattatttta taaattatcaagtcttatgagccaggtgc
221 3846196 -- NO
tctggccaatgcatattacttaagggcaatgtcgtggccagctgtggtggtctgggctctccctctgtatcgc-
ctggggaggctgctgaggtgactttttggaa
gaaaacacgggatgagtgtatgatggtggctgtggagaccacccaaaatcccggggttgggggcaatagt-
gaatgaatgggaccatctgcgtgggtccct acacgagatgcttg 222 3070747 -- NO
gagctcattctgcgtttcttattgcttg 223 3821522 -- NO
gtagataaccatttgtcgctgctttttctgttaagtgttcaccacttgtatcattggctggcaatacctggtt-
tgtcatagttt 224 3875001 -- NO agctcctccccagaataccatgctc 225 3279450
C10orf97 YES
ccaaagtttaattaatctcctgctgacgggacatgctgtttctaatgtatgggatggtgatagaga
226 3541293 PLEKHH1 YES tctttctctggcctggtctacaagaatgtcac 227
3547709 TTC8 YES
cctggaacgtctttgaaactccctggaactaatcagacaggagggcctagcc 228 3875261 --
NO
gccaaccttggtttgtgcagtttaaggaaaaaagccatctccataacatggaagtgcaagatgaagcagcagg-
cactagtggggaagctgcagcaagttat
acagaaaatctagctaatgatgagggtggctacactaaaaacagattttcaatggagacaaaacaccctt-
ctattggaagaagatgccctctaaagctttcata
ggtagagagaggtcagtgcatgggcttgaaagaacaggctgattctcttgctagaggccaatgaagccag-
tgagttta 229 2584791 -- NO
cactggaagaatataggttggctcagacagtccataggaaggctaaataaccacgctcaggaaatgggcctta-
gagagtgggaagagaaaatgtatctaa
acttatatctcagtaacagcttgataggacattgtcactagcagtgccaccactaggtcctca 230
3204563 KIAA1539 NO ttgccagcactctgaacccatgcgggctaatgacctgcccatcctg
231 3356165 APLP2 YES
cgagactctggatgttaaggaaatgattttcaatgccgagagagttggaggcctcgaggaagagc
232 3650891 -- NO
tacactccctcagggacagtcttgccatttcccgtttttcattcttataaacaatgccctggtgcaggggtca-
gcaaacttttctataaggagtcagataatctttttt
ttttttttgtattcccttttggcaatttgtttaattgagataaaattcacataacttaaaactcaccctt-
ttggtgtatacgattcagtgctttttagtatattttcaagattgt
gcaaccaacaccactatctaattccagaacatttttatcaccccaaaaaggagccctgtgccaattagct-
atca 233 3829699 GPI YES
actgaagcccttaagccatactcttcaggaggtccccgcgtctggtatgtctccaa 234
3971251 CNKSR2 YES
cctcttatacctagaagtcccacaagcagcgttgccacgccttccagcaccatcagtacacccaccaaaagag-
acagttctgccctccaggatc 235 2359255 -- NO
agttgtggaggcatgtttataagcagatctgagttttgccacactggaatttatttat 236
2811000 -- NO
ctgggtctaggaagccaggtactttgtgctgtttcaacaagagctcttctgctttaactagttt
237 3391986 -- NO
gctggagaagttcgtctgggacaaagagctctggcctcatgcctgtgggtccagcagtcaaactgggacagac-
tatgtgaaaagggacccac 238 3888361 -- NO
agcagcctcccgcttagcggagagtgggatgagcacatgcgcggccgacagggaagagtgaatccagagcaga-
agtcaagggcaagactcgtgggg
gggggaagaaagggacagaagccagctcccagcaataaaggtcgggttattttgttcttttgtgacatgc-
cctatatc 239 3897502 -- NO
tctcctggggacttacatagctgtttggtttttcaacttgattgaagaaagttattcgggggatctgtccaat-
tcacaccttctgttccctgatcaaatactttagggt
caaacataaggttttattgatttttgctcaagcaaagaattaacatttttgataaggaactgtaatggca-
attataaggtaatatggtgtatggtaatattatgctgcc
agaggaaacatttgactatgattaaattcaagcccagtactgggtagctctagataattaaagataattt-
tatccattcaagtcccctctgttaagctgcacattga ca 240 3235381 DHTKD1 YES
acagtatattgtgagcatggtcataaagctgccaaaatcaaccccctcttcaccggacaagccctgctgg
241 3286657 -- NO
tccagtgaggccacatcatgacttcccccatgaagacatcgaattcacggctgccttcacctttgtcctgtca-
atgtctgatctttcctttcaattacagcacgag gctggggttcca 242 2714224 MYL5 YES
tggaccagatgttccagttcgcctccatcgatgtggcgggcaacctggactacaaggcgctcagctacgtgat-
cacccacggggaggaga 243 3331851 GLYATL1 YES
tgaaagtagagcattcgagagcactcctcttggttacggaagatattctgaagctcaatgcctccagtaaaag-
caagcttggaagctgg 244 3356559 -- NO
gccatggttctcttgtggtcagctcttgttctaatccttagcgcccatttggaaaccagttatggggaaagca-
caatgtaggactcttgggactctgcacctgac
tggctggctttccaagatcactgagatggctcttcctccagcatagaaattgatggctggttatccagac-
agcaacctcttttgcccatgtgcttggtgctctgtc
atggcgggaaaagtaactatgcacagatcatgattatggtattagattgggtacacatgaaattgctagt-
atgcacctattttgatgtatgaaaatatcattttcat
gagattcatcctaatttatgctatgtatggggcctgattgccctaacagctcatc 245 3636325
-- NO
atcagacaccgcctattcaccagctcatctataaaaccccctgcatttcaccgcagaactggaacctatt
246 2539613 -- NO
tccattcttgcgcttaaaaactgtacctaactccctcccatagcagacagaataggataggcttcttccctac-
ctggtgttcaagttctaccactgccctcctccc
ttcccccatttacctctctagaattaccaggtatctatgcatacatgaattctctgcttccattagattt-
acttgtcattccccaaatacaccatgcacttgcatattag
caaagccaagtttgtctttcacaaatgcagaggttaaataagagttaaggatgaaggtaaaccaaacttt-
atttatatactatattttaccaaatatgatttaaggat ctctaggcagtgttgtctta 247
2860647 -- NO
gcaatgtggaccagaccatcgacaacccctatgccacctttgtcaagatgctaccggataaggattgcctcta-
cgccctctatgac 248 3143676 MMP16 YES
cccgatgcggtgtacctgaccagacaagaggtagctccaaattt 249 3492475 -- NO
tgggctgaccacagactttaccacaaa 250 3698355 ZFHX3 NO
gtccgagcctccgtactgggtgcaatgaaagc 251 3364564 -- NO
attggcgtggttcttccccaggataccttatagagtctagtgaacttttcctgtttgtggaaacaatcaggct-
gggtttaaatgaggacttgtctctatttggagcat ttgtgagcgtgtaaggaaatgagtgttt
252 3101645 ADHFE1 YES
agggagcttttgatgcctatgttgctgtcggtggtggctctaccatggacacctgtaaggctgctaatctgta-
tgcatccagccctcattctgatttcctagattat
gtcagtgcccccattggcaagggaaagcctgtgtctgtgcctcttaagcctctgattg 253
3015159 ZKSCAN1 YES
agttcatggacctgagatgctcgcaagggggatggtgcctctggatccagttcaggagtcctcgagctttgac-
cttcatcacgaggccacccagtcccactt caaacattcgtctcgg 254 2686624 IMPG2
YES
atacctttcaagctgcatggccctcagcagatgaatccatcaccagcagtattccaccacttgatttcagctc-
tggtcc 255 2897644 -- NO
atgttgggtcccaccttacatttagtttcatgtccccttagtttcctccaatctgtgacagtttcttaatttt-
ttcttgtcttctgtgaccttgacacttctgaagaaaaca
tttccttgatatttctgatgaaaatgattattatgtagaatgtccttcaacttgaattggtctttttctc-
atgattagaatgaggttctgggtttttggcaagcagagaac
agaagcgatactatatttttctcagtgcgtcatatcggggtcatgatgtcagtgtgtcttatactggtac-
actaacccatgtctgctaggtttctttccaatacagtca 256 3909740 -- NO
ggtggagcaagagccctgttggctgatgg 257 4049026 -- NO
ggcacagaagggcaaattccgcacattctcatttgtggg 258 2321582 -- NO
atggagccagaaaaacgcgtgcagcagctcatc 259 3304498 ARL3 YES
ggcttgctctcaattttgcgcaagttgaaaagtgcaccagaccaggaggtgagaatacttctcctg
260 3533002 -- NO tactgaatgtgcttggttttggacag 261 3568039 PPP2R5E
YES ctcttgctgccgctgcagatccagtcttcctcc 262 3764440 RNF43 NO
tgcggaatttctcggcacctacctgtagtatggggcacttggtttggttgcagagtaagaaggtggaagaatg-
agctgtacttggttaagcagttgaaacctttt
ttgagcaggatctgtaaaagcataattgaatttgtttcacccccgtggattccagtgggcccgaca
263 3790080 NEDD4L YES ttgggaaagcagataaccctgaatgacatgga 264 2658005
-- NO gtattatcacatgactgccaggtgc 265 3029676 -- NO
gtctgtgggtggatagatccattaatggataagtaaatgagcaatgcttcctgggttgaggttttggattact-
gtggtcatgcactgcattggagatgaggtgga aaaaccatc 266 3390272 -- NO
gagtgggcactaggaaacggattcaaagaggcgatgaataatctgagttttacaggtttaacaggaaggcata-
acattgtaagcaaagaaagaaaagatatt ccagacaaagcatatgtgg 267 2642810
DNAJC13 YES
ctggatggagtaagagcctctggtaatagagatgtttgtgtaaaaatgacaccaacccataaaggtcagcgat-
gggggttactcagcatgcctgttgatgag
gaagtagagagccttcacctcaggttcttagctacgcctccaa 268 2811129 -- NO
gatgagatattaactgctgcactgg 269 3070222 AASS YES
tgagaaaatggtggatcatagaggagtacgggtagtggcatttggaca 270 3907114 TOMM34
NO cctgcctgaccttacccagagaagccatgggccacctgctctgtgcccgctcctgaaaccca
271 2790942 -- NO
atgttcccataagcaacagcctgtaaattgtcacatgtaagtcatctaataagtttagaacaatgaacaactc-
attttctgaactgggacaaacaaggaagctaa attca 272 3043075 -- NO
aatcagtgttgcctggtggatagcaaatcaagtttcaaggttacaga 273 2354095 WDR3
YES
ccatggtgaaatggtgggaccttgatactcagcactgctttaaaacaatggttggccaccggactg
274 2713294 -- NO
tggattgcgtaaaggtggggacctccagatcttccacgggaaaggtacgtttttcttgttgatattgtgaagt-
gtgtatggggttgtactttggcaccttgtagtg
agtcagtttccccccattggtgatcattgccaaatca 275 3220577 KIAA0368 YES
agatgttgcatcaaagggccttgggttggtttatgaactaggcaatgaacaagatcaacaggaattggtttct-
acacttgtggaaacacttatgactggcaaaa 276 3531076 SCFD1 YES
tgttactcgtattttggacaatcttatggagatg 277 2505303 RAB6C NO
gcaggaagaaaacttcgagttacaggtcaggaaaagc 278 2644040 PCCB YES
gagatcatgcccaattatgccaagaacatcattgttggttttgcaagaatgaatgggaggactgttggaattg-
ttggcaaccaacctaaggtggcctcag 279 2938530 -- NO
gagaatgccggtggggccttcagcagcagcatcctaacagtgttgca 280 3625346 CCPG1
YES
gaggccctactatgcaaaatgatggaaggaaagaaaagccagttcactttaaagaattcagaaaaaatacaaa-
ttcaaagaaatgcagtcctgggcatgatt
gtagagaaaattctcattctttcagaaaggcttgttctggtgtatttgattgtgctcaacaagagtccat-
gagcctttttaacacagtggtgaatc 281 2971361 -- NO
ctgcctagtattgtgctacagtaccagacaaaatcactttagggttttggggttttgtttttttaaacaaact-
ggtatgtaatataaacttaggaaccaccaccac
catctcgagtatcaatgtttcagaatggaggcatagttcagtgaaaaaaatgccggcattggttttagtt-
ttgattcttgtttcaccagaaagcatggtggttggg
ggagctgtcaaagtactccggatagactcagcgccattaaataagctcaggcatatacggccaggagcaa
282 3026661 TRIM24 YES aagtgtgagcgcctacttttatttct 283 3108906 -- NO
ctgcatcgaaccagcgacctgggtgcctccccacccaagacggacctccacatcgggaa 284
3649134 MKL2 YES
ccagcagccctttatcaataaggcctccaacagtgttcttcaatccagaaatgctccgcttccatccctgca
285 3729183 CLTC YES ttattgaagttggcacaccacctacagggaaccagccct
286 3900156 C20orf74 YES
tcccaacaaaatcgtggcccaggtagcttgcgatgtccttcagttgctggtttcctactgggagaagcttcag-
atgtttgaaacctctctgcctcggaaaatggc 287 3907653 NCOA5 NO
tttcctctttggaactcttgtgttgtt 288 3102604 -- NO
ttggtcttcacgcactgggtgtgtctgtaaatacagcgctgtccacggtgtctgtcctgcttccatcccaaat-
tcaggctttagcttaaaacatctttagtttaatttt
ttaaaaaattcttttctttcccccagataaaatcttaatcttttgcactagactgttagccagggaaa
289 3863282 -- NO gaagtgtttccagacatcccaattc 290 2920506 -- NO
gcttcttcgtggtcttttccattat 291 2319069 -- NO
ctgaagcagggtgcccgtttctacaccaaagagcggcaaaatgaagaa 292 2573693 CLASP1
YES gcttctgggcctgcagaacttactgaa 293 3022667 SND1 YES
gtgcccgagtagagaaagtcgagtctcctgccaaaatacatgtcttctacattgactacggcaac
294 3570810 -- NO
atgtgggtggagatgatctttgctttgagaacaggattcattatgtgggctggtcaggagtgggaacaagagc-
aggaaggccacaggggattgagagtact
tctgtccccaacacactcatcaaggacgtgcaatcgggggccaaggctcattatggtgattttca
295 3847162 -- NO
tggccagctccctagtttgtgcttactatacctggccacgcctccctacctaaggccgctggcttaaccctag-
gggcaggcagtgttagatcagacccagac
cttctcatcccaccctcatcacatcggggagaggggactccaggggcgggaaggcaggcgtccctccatt-
tggccagggtgggcggcgaggaggggg tcactctgcaggaacactgagctctgaacacctct 296
2535304 -- NO tcaacaacatgaatggcggcaacactaggagacatcc 297 2697615 --
NO tgcagtggtactattttagctcaatgcagccttagattcttggact 298 2931795 -- NO
agatggcatgctgcacaagggattcatggttacagcgggcttgtgggactggggctctccaatacgtggttgg-
gtttgtaaagaaatcaga 299 3011882 STEAP2 YES
caggttattgaacttgcccgccagttgaatttcattcccattgacttgggatccttatcatcagccagagaga-
ttgaaaatttacccctacgactctttactctctg gaga 300 3464921 -- NO
cctgataataagaggaacgaggacagctcagaaagtacaagtcaagaagccctgagaggggagtgaattcagg-
aaaccggacatttcaggtttgcctca
gcattgcatgagtttgaggaacaagaaaagatgaggatggattgtgaatgatctcgaatgtgttttgaag-
gtttttggaggtatttggattcaccctaaga 301 3541610 -- NO
aggtcgatgggctcagaattcactgacaggttcagatccagccgagaagtggagcatgtatggtattagtggc-
atttgaaggtcattagtggcataactattgt
agtgtaaattcaagttttattggtatattgtgtatagccctgcaga 302 3872499 -- NO
ttaggagccatcaacgagttcacgccggagaaagacctttcaagtgtggagaatgtgtgaaatctttcagtca-
taagcgcagccttgttcaccatcagcgagt
tcacagtggagaaagaccttatcagtgtggagaatgtgggaaatctttcagtcaaaagggcaacctcgtt-
ctacaccagcgagttcacactggagcaagac
cttatgagtgtggagaatgtgggaaatcatttagttcaaaaggacatcttaggaaccatcagcaaattca-
cactggggacagactttatgagtgtggagagtgt
gggaaatcttttagtcataaaggcaccctcattctacatcagcgagttcaccctagagaaagatcttatg-
ggtgtggagaatgtgggaaatcttttagttcaatc gggcaccttaggagccatcagcgcgttcata
303 2470335 -- NO
aaggcgttcgttatgtgggatatgctgttaccactgaacttgaagttatcaaagaagt 304
2887649 -- NO
ggtaagtggattgacctctaaactccctagaagggctgtagctttgaaggtggacatttattgggctcgcacg-
tgacacttattggggctaa 305 3522210 -- NO gtgagaacctacatgttgggtgcccacc
306 3674221 -- NO
agtgagcgtttgagtgaaccagccacagtctctacgtgtcatccaaggagcccggcacagaccccgtgtcacc-
cccatgtcacccgcagaccccgcgtca cccatagatacgcaca 307 2560167 -- NO
gggacacagagcagttgaggatatctcttttctttcactctgttctgaaatctgcctcttcccaaaggtactc-
catgacccctaagatactcactctg 308 3041159 -- NO
ttaattcagcacaactcaccattcccactggaaacatactggcaattcacatcttccaaacaagg
309 3183335 FKTN YES gaggcactcaggccaaaacaggaaaaa 310 3204049 -- NO
gggcgccatcggatggggcaaagagatccctgaaaacgtattgccgggggacggggacttgcaggacaagaaa-
accgtgggagaat 311 3393003 KIAA0999 NO
gttgattgtaaacccacagtatctagcagcgttgtgccaaattgcccttgtgtttctctccacccaaaatatc-
acagctgctttcctcacatttggttcatccgtgtg ctgttctttt 312 3598130 -- NO
gccaagtacaaagtgctgtcccatatattacctttatcatcatgacaagcacttgagatggtaattaacaact-
ccactttaagtctgagaataatgaagcaactg
acccaaggctccaaagacagtgaatggcagagatgagattcaaacccaggtctccctgactcgaaagccc-
acgctttcccccaacaccatgttcttttccttc
cctgtcagaaagggaaataccaaaaacaaatgagggtatgtatgagggtttggctggagccccagtcagc-
caaagtctgattccaagtggactgcagggt
ccgtgttatctcccttgggcacaatctcaaaagcccagaattcagctgccttgctaaccttccatcccag-
tcttagtgagaagctaaactaacttctgggcctca attacagcagatta 313 3681604
LOC728138 NO
tgccatagaccctcacgtgtttgttgcattaattggataattcaaaatataaagtattatccagtttcaggat-
aatattaagatctaaaccaatgaatgctctatgaa
aagttgtagattaactgatcccttaaaactaaaaacagcgtcttcataagcttctactgggggcagctac-
cactttcttcatcacatttcttatcctcaatagctgtg ggcaatgccaaaatagc 314
2410882 ATPAF1 NO
gttggcccttcacctagttgactcagccctcgatagtctagagcccaccccctcctcaggaactcaagagctc-
agcatttataatgagcagttggtaatgagtt
gccctatgtgcttgtcgcaagcagtcacagagatgagccctattacttgatattcaggaacaaaggtacc-
tgaacattctgataattatctcagcatacttgagg
tttccttttttaagtgttcgaggttataacaagagacagccaaggacctacaagacagttgacttgattt-
tgcacagtgtaacagcgcagttgcattctggccact
ttgaccttatagctcccaaatgatgagtttgtcatctttatgaactcatgacaggataataagcttgaag-
acctgctgtagttagatatgggctttaatccttcccag
gcaccagtcagctgaacaaaagcataagccaaacatcctgtttaaactgtagaataaccagatattccca-
tcaggttaaagacttcatctagatgatgccccc
cagagatgcctttagtgtaagtagctggcttggggtatcagcaaatttcaggtatagttagataaacagg-
tacagggcctgcatactattaaaccatagtttgtg gcacccgcttttcta 315 2821250
CAST YES
agggccagatgatgctatagacgccttgtcatctgacttcacctgtgggtcgcctacagctgctggaaag
316 3134070 PRKDC YES gattggagcaatgatgtaagagctgaactagcaaaaacccctgta
317 3888286 -- NO
agctccagttacatgggcctgttaacatggcagctttgtctataagcaaacccaggagagaaagacatagcag-
agatggatgtttgaagtctataccttccac
cccctttaaagagaaagtaacaccactccttttctgtgtcccttggggacactacctccatgtctggtca-
catggctggactttacagcagataagcatactgtg
gcctgagaccatgattgtatgctttccttctgctgacctttacaatccctcaataaattgagctaacaca-
gggaagcttttttaccaaataactgtgttgcatcatcc
tccagtttgcctggtgtccttaatcaatggaaggggaataagcaaactgagttttcttacaccttttgag-
tatagtgtttttgccatcatagatgtggctcctcataa
ttctccaacttttatattaaaaaaccaaaacctcaaaaattgtagttcatgtcagtcagtgatgactcat-
cttagaagtattttgtttttggatgtgtgaatgtgcatag
ttcttaaagtccaacattcatgtaataagacatcttgcatataacaatgacccttacgtctaagatgtta-
aatagatcctaagcctggtataactttattcaagtatcc
ttatttgcccctaaaatgtctttaatacacattacttgggttatttcttgaatgaacatacaggtatccc-
aatttctgatttttaagagaatggggtcttgctctgtcaccc
aggctggagtgcagtggtgcagtcatggcttactgcatccatgatcctcctgcctcagcctcccaagtag-
atgggactgaaagcacacactgccatccctgg
ctaatgttttcatattttgtagagttgcagccttgctacgtgacccaggctggagtgtagtagctattca-
caggcatgattgcttgaaactcatggcttcaaggga aactccca 318 3919790 -- NO
gcagggagtgcagaaaccttggagaaagtgagagattttccagccaaagggaactttgtgtttccctggctgg-
gactcttggggatctttttcaggttttctgca
gtttttctgaattgagctttaaggcaactggatggattttgaact 319 3948965 -- NO
cttagctgttccagcggcccatgtttaaaagaatgtgcttctttttccaagtatttctgccgcttgcatgcac-
tgagcttctttggaaaggagcaccatgcaggca
tattttccagacaggaccggatttgctcgttactcaga 320 2738676 -- NO
ctgagacctgaagcacgagagccaagtgtgtaagcaagtcgatgggattgggaagaagtttaggctgctaaaa-
aatttttacataaagcttgataagaggg
gatattgcatgtgaaataaacagaaattcagtaaatatggtggaagtgcaggatttaggggatggaaaaa-
aatactagtttcaaaaattgaggctagaagtga
aggtaggggccagattatgaaaagccttgtaagcaatgctaagaaacaatagatgtcagaaggacatgcc-
accatctaaaaagcagtcttgagaacaagta
attggataaaggtgacctgactaggtatttgtttttttaagtaaattgtgttaattttgttaggtgtaaa-
aatggcattagggtcatgttggggaaaaaagaatctctt
tcttacagatgaaattacatggtctctgagactgcttccaaaaa 321 2929182 -- NO
tgggtgtaaacattgatgatccttctaatactctgtcctcttaatttctctaagttctctttctagtgatctt-
gtctcccagtgtggtgggtatattctggctagaccag
gtcattgtttatggtggcagcccctctgtcatctgaatttaagcgtcccattttttcggtactagcatgg-
ctcactgc 322 3004581 -- NO
gcaaatgttttaatgggccctcctaccttacctgacataagataattcatactagaaagaatacctacaaatg-
tgaagaatgtggcaaaagctttagtgtattctc
aacctttactaatcataaagcaattaatactggagagaaatcttacaaatatgttgaatgtgacaatgtt-
tttaactaggctgcaactcttgctg 323 3300811 C10orf4 YES
tttggatttaggtggcgagtagaaaaa 324 3426258 -- NO
atggagattaagcaggaacttcaagaaagccaagctcttcttggtagcacaccagagtctgaagg
325 3645807 -- NO agtggaatctctgaaactcaggtgtggcatcaacaaag 326
3976960 -- NO
caaatcccgggtggcagccataatccccaaagatgacccccaccccaagattccaaagaagctagtggtggtg-
gaagcaaaaggaatgcagcaaggtc
agggtttcattgtccaagccggcctgacacctgccgccctgcccttgcccagtgcacaccctagaccctg-
ggccggcctccatgcagctggaggccagaa
gacagcaacccatatctttgcaccctcctccatgccccatggcctgcctgcccagaaagatgccaccttc-
acagagccagtgctgtcgtctatatcattt 327 3981121 OGT NO
ccgtcgccgccatttcaagaccgtactag 328 2391399 CPSF3L NO
gtatgcaccggcttatgaacccaccaggctctgtccgagcggcattgaaatggccagagtgggacaggctggt-
gccctcagagcgcttggagcggccag
agactcgctggagctcccggggtgttgccgggcagggaggcaggggctggaggggagatgggccagctct-
ggagggtgcctggttctgggtgtgggt
cagggaagaagtgaaggttaaatcagcgagtgacaggtgaaattccatttctgacaaagattatgggttt-
gtctgtgtctcactcgaatctctggg 329 2748879 GUCY1A3 YES
tgcgaattggactgcactctggatcagtttttgctggcgtcgttggagttaaaatgccccgttactgtctttt-
tggaaacaatgtcactctggctaacaaatttgag tcctgcagtgtaccacgaaaaatcaatg 330
3063716 -- NO
gtgagtggttagagaacaatggcaaacaaagggcgaggcgtttaagcttctgtagagagg 331
3361874 TRIM66 NO
tgggcttccgtgatcccgttttctagtttggggtaactgagtcttgaatgctttactagtccggcaatctttg-
gacttaggcttctgccctttgagactcacatgact
ttctggtttggggtctggtcatttccctttcaatttttgaatctccttctctgttcagttggcttggcaa-
agtaccctctgttctcatg 332 2812780 -- NO
tctggaatgaaacagcgtaatgagatgagccctga 333 3065419 -- NO
ctacaaggatactcaggtcagaaaggcccaggagtacctacctcattcagcaacagtccagtcaaaatcttcc-
tccccgacaatggcctatgaccagcctgt tctacacattcctctctgg 334 3077669 -- NO
aagagcccttctcaatggcttaacccatagagccc 335 3652961 -- NO
aagcggaggttggaggaagccgtgattgtacc 336 2895678 SIRT5 NO
aaagcagccgtggagacaaccatctt 337 2978057 -- NO
ctgtgttgtctcagtcaagcctagaactgaagctacctgacatcaagccaattgtccaggaccagcatttcca-
gcacttccagttgtccatatctgcacttccag gagtaaacaggca
338 3595946 RNF111 YES
caaggccacttcatcatcaagcttctgcctgcccgcattctcatggaaacccccctcctcagactcagcctcc-
gcctcaagtggattatgttattcctcatcctgt
acatgctttccattctcaaatatcttctcatgcaacatctcatcctgtggcacccccaccaccaactcac-
ttagccagtacagctgcaccaatccctcagcatctt
cctcctacacaccagccaatttcgcaccatattccagc 339 3628693 HERC1 YES
tataggaaatcatcaggagccaagtgtgtttatcagctgcggggacacatcactcctgttcggactgttgcct-
ttagttctgatgggttggccctg 340 3734777 MRPS7 NO
gtgagctactgccacgctgaaaactacctgtgggttaaggatgtagttcctttgtaagggtgggcaggcctcg-
taagaaagatgtagcagcatattcactatc
cgttaatccttctttctttgaggctggaacttgctctctctgcccctatttccttgtaaagagggagcac-
attgacttgggaatttcctccaggaaactcagggctg tttt 341 2806269 DNAJC21 YES
acagagctggatgactatggccaatttggagaaagag 342 2849121 DNAH5 YES
atgaatcccaaagcgattactgccccacagatgtttggtcggctggacgttgccacaaatgactggactgatg-
ggatattttctacgctttggagga 343 3012989 -- NO
tcttattcttggccacgggaccaaccctcacaggggcactctatgcagaagcttccttcctaaattggaactc-
ccactttgaccactctccttt 344 3184655 -- NO
ttgcaaggcccacaccacgtggctgagaagtcaactactacaagtttatcacctgcagcgtccaaggcttcct-
gaaaagcagtctaacagcaaaagaaaag
cttatattaaataaatagttaaatattaaaccttcaaaagaaagactcgacacaatgacacaaagcacat-
tctggaggtcctc 345 2428776 RSBN1 NO
gctgcccaagatgttggaacaccatgtgcaataaagggcttcgtcttggattttggccttattaccacaacca-
g 346 2502833 DBI YES acggcccgggatgttggacttcacgggcaaggccaagt 347
2608589 -- YES ttccattgatgaattggataatgctgag 348 2781610 -- NO
cttacaggagaaatcgaaacacagctgctac 349 2810989 -- NO
ttagagtttatggaccttgctcttggtta 350 2489148 -- NO
cctctgccttcgctcgcgccgctctccttcagtctccccagggcctgtttcatggatagggtccccttgcccg-
cgtgaaagtctcattcctc 351 3239162 -- NO
ccactggctaataagcaggtctttattgagtgcccaacactgagtttagtcacaggtgcttattctggataat-
taatctcagtagattaaccttcttcagaatgacc
atgtatatcagacttctcttatccccaattctgggtccttattaacctcttccagggctaagtatttacc-
cttccataaatcggatgttttcttaagcattttttctcctgt
catcactgaaactccagcctagttcttcacttgtatgcaattttcttgtaaccctgtctctcgttttggt-
tttattgtccatatgcctattgagtgcttttccagttg 352 3573019 POMT2 YES
ctgataggtcttgctggctacctgagtggatatgatggtacctttttgttccagaagcctggggataaatatg-
agcatcacagctacatgggaatg 353 3937196 DGCR8 YES
ttgtgcccccaaaaagaggcgaacagaggaaaaatatggcggagacagcgaccatccgtccgatggagagaca-
agtgtgcagccgatgatgaccaaga 354 3154331 NDRG1 NO
tgctgggcgtcaagcttgcataatgccgtactttgagggcggttgtcacaagtatcacaaaatgggtggctta-
aagcaacagatatttattcccttttagttctgg
aagctaaaagtccgaaatcaaggtgtgggcagggccgtgctccctctgaaggtgctaggggagaatgctg-
cctgcctcttccagcttctggtggctgctgg
ccacacttggttcaccttagctagtagacacatcactccagtctctgcctccatcctcactcagcactct-
cccgattgtatctctgcgtctatgtccaaatttccttc
ttcttttaataacatcagccgttagctttagggcccgctctaatccaatatgacctcatcttaacttgat-
tttacctgcaaagaccctatttccaagtatagccacag
tgataggtactggggttaggacttcagtatgtctattttggggacacaattcaaccacaacctacagcaa-
agggtaggtggcctgactgaggtggggtggcc
gatttgatggtagatccagaaacagaactcacttaggcctgattctggagacttccacagcgtcagtcta-
atgtgctgagtgccccgcctggaggaaaaattc gggcatc 355 3697772 PHLPPL YES
tcccagcgaatcagtaccgtggatctctcgtgttacagcctcgaggaggttcctgagcatctcttctatagtc-
aagatattacctacctcaacttgcgacacaac
ttcatgcagttagaaagacccggaggcctcgatacactctacaa 356 2611934 SLC6A6 YES
gctatgacctcgctggggagctacaacaagt 357 3127807 -- NO
caaggaagcgagtctccgtgacacgtggtacaatatcatgcagtacacacggaaccagaaccaagaagaaatg-
gctggaaaagatgaaagaaaaaaaa
agttgatatagtctcaaatgtagtgaaaaaacatcaacttatagattcaaaaagttcataaacccctcat-
aaaaataaatgtaaagaaaaccctacctggacaca
tcatagtcatcatacagagcaaattttgtgcattcacaggtaacaaagatatgaacgacagctgactcaa-
aacaatggaggctcaggatgtgtgaaatggtga
aagaaagctgttgactcactattcacactcattgagaatatcctttaaaaatagtaagtgaagacgttgt-
ggcaggttgaactttcc 358 3909039 SPATA2 NO
agggctacatcaaccgacctttcgggtttcacggtgaagaagtactaacgcattgatctcagaggcggaggcc-
tgcacttgaccatgtaggtggcagagat
cgtgggctggctgtgtccacgtgggagttcacttagcgactcagatatctcaaccaatggctgctttgtt-
gtctgacaagggagaaggtggcacttccgttca
gattcattttgctaatctctccactccctgttcagttggttctttttttggggttttgttttgttttgtt-
ttgttgttttgttttttcctttaaagaggatttctgtctctgggacc
ctcgctgcacctacccctcccattgcaaagccaacttggactgggaagggcccttcaggtcaccaaacat-
ccacctggagcggcgagctagaggcctgtt
ggcttgtgaaatgagccctcctgccacacggggcctctcccaaaggctcatcccttggccgcccccttcc-
taaacacaaggatccccagctggactcccca
ccccctggcttccccacctctccaggtgtcaaaggtgaaccgagtccagtattagctgaatgtcatttcg-
tacaccacagctcagtcagcccatggccttcgt gaactttgctcc 359 2412620 NRD1 NO
gtttctttgaggaacgcagcctgaa 360 3220615 KIAA0368 YES
gaccctaaactactgtcaatggcatattcag 361 3521230 -- NO
tgctgctgacatcacgggccctgggtt 362 2327492 SNHG3 NO
gacaatctttggcagacttggagcaaaagattgaggtgcatttcatgcctcctt 363 3557645
AP1G2 YES tgtcaacattcttggtcgcttcctactcaacagtgacagga 364 3709227 --
NO tgccgtcctcagtgaatcacagcagcttcaaaggactcaactggcaagatttcccacag 365
4021348 ZDHHC9 NO
gagagcaagtaagctgtcccttttaactgtttttctttggtctttagtcacccagttgcacactggcattttc-
ttgctgcaagcttttttaaatttctgaactcaaggca
gtggcagaagatgtcagtcacctctgataactgg 366 3030989 ZNF862 NO
agggcttgaccctgcctagatcctccttaccaagaaagggctgaaaagagagggcatctggcatgctttttgc-
cacttctgtttctaggttatgtacttcatgga
atatctgggcattgcttagaaacctgtgtcataaattggctttgggcaagaggctttgagttggaagaaa-
aggtggaaagaaagtgcttgggggcggagttc
agggatttgacgggattgccagcgcttccaggccgtgtcatccaagaccagtgtggttgtgggcacatta-
gcttggagacagtggcagcctcttgggacta acatcttt 367 3035657 -- NO
agtccggtggcttagatgacaaatggaggtagaggacgcattctcgcctgttatttcgatttttttctctcct-
caccctgaccgtcacgttctcaccttttccacctc
aatccccagtcacactagcttcccaggattaaaatggtctct 368 3626930 -- NO
tgctttcacttaaggcagggctgttgagtcggtgaggggatgagggcatctcaaaagaaggctggctttcagg-
attgcacagagatgttcctgctcccagca
gactggggtaaaatttcctgggaatgagggcatttctga 369 3091396 -- NO
caagtgagagtgattttgttacatgggatacattgcatagtagtaaagtctgggcttgtagtgcaaccatcac-
ccgaata 370 3323928 -- NO cagtgcatcccggaaaaaagagagcaaa 371 3326853
TRIM44 YES tggccaagaggaagtgtccggaccatgggcttgatttgagtacctattgccag
372 3402333 -- NO caaagtcctttgcaagtctcacccttaagcgcgtggggactgtgt 373
3796317 -- NO
tcacgttgctggctaccctcatatgtgtgatgactgttagttgtacaattacatttaagaaagaggattacat-
tgctagctggaatttcttctactattataaaaatag
aactgttttaccaacaagtctcttctccgagtgggacttgatggtaactataactgggatagggcaaatc-
aacgtcatgggtccacaggttttgctttaa 374 4020467 -- NO
tcccaacaagttgaaccttgcgttacgataaaagcagatgtggcatccaatcctaccacccagcaaagagaaa-
ccccaggcattcaactgcagc 375 3180404 -- NO
catcgctgtgtgcatctaactcttgattcacggtctgaccgacgccttggtttctggagaactgccctcgttt-
atggaagagtcactgtcatcaggagccatccc
agggagaggctcagtgggaagtgtaaaggtggagcaagtaaaccggctccagaagagaaggcgaagaagg-
actatttctgtttagatttgcttaaccgca
ttttcactttcttgggaacccctgatggagttcaaggtcatagaagagaagaaatcagacactgctacag-
gactcttgctcttggtt 376 3781848 -- NO
gaggaagtgtctggtccggtccctagagcatggcaggtatgcactcaatgct 377 3868844
KLK11 YES
tcaaggcattatctcctggggccaggatccgtgtgcgatcacccgaaagcctggtgtctacacga
378 2396267 -- NO tggggacggcaacaccgcgctgcaagtcgttatcattccg 379
2862752 GFM2 YES tggtggatgtagtaatgaaagaaaa 380 3869672 -- NO
ggagttgcatccttgcttgactaaaatggaagccgtattgattttgaaatgaaaagcttcatgatgtagcatc-
tggactttcactgtcc 381 3876038 PLCB4 NO
taaggatttcaacacacgtaaggccatgtttctgatgttatag 382 3879228 -- NO
ggggagggacatgacttcctgttacgggatgaggaagtagaggttcatggagga 383 2399914
-- NO
ttagacttgaaagaacctcgttcacctgccacatgctatcctagggaattaatagcttcccatgtggacactc-
actctatgt 384 3142073 -- NO
ggggaacgaagcctgacaactcctaagtttctggcttctacaaccatttagtgaaggtttcattaatggcagg-
caggagtacagttttagaaggtctggactgg
agagacatttgggggaatcatccgtgagtatcgagagttaaagacatgccaggaatagtgtatacaatta-
aaatagacaggggcttgggaaatgccagttcg
cagatatatatttgtcataagtgaactaaagaaaaggtatatggttggatgagcttaaacccagcatg
385 3777286 ARHGAP28 NO
cgcagttcatgacttgtaccagtgaaggtagcaaggtctgtgtgttggtgatgaatttgcaggggatcaggct-
gaagaaacaagacttgggagagaggatgt
gagacctttttatgacatgcatagagttggcacctcagcctttgcatggtagggagctagctgaaggcta-
cctccatgacagatgtacactttgaaaagacag
gccgggtgcggtggctcacgtctgtaatcccagcattttgggaggctgaggtgggcaaatcacttgaagt-
caggagttagagatcagcctggccaacaca
gtgaaacctggtctctactaaaaaaaataaaataattagccaggcatggtggcgcacacctgtaatccca-
actattcgggaggctgaggcagaagaattgct
tgaacacgggaggcggaagttgcagtgagctgagatggcaccaccgcactccagcctgggcgacagatca-
agactccatctcaaaataaaggaagata
cagctaatctatatttctttcaccagagatcaccaccactaacaattcatactggtcgtttttccctgaa-
tgttttacctatgtaggaaaattttacatcccaatttttaa
tttaacactatgaaaagcatttctttttataataaagacactctattagtatacttttgatggcttcaaa-
actacttttgtatagatgcaaaattaaaatatcaaattgttt
cttttgtttgtttgtttttttgttttttttttgagacagagtctcactctgtcgcccaggctaaagcaca-
gtggcatgatctcggctcactgcaagcttttcctcccaggt
taaagtgattctcatgccgcagcctcccgagaagctgggactacaggtgtgcaccaccacccccggctaa-
ttttttgtatttttacaaaacacaaagagagac
ggggtttcaccatgttgggcaggctggtctcaaactcctgacctcaggtgatccgcctgcctcagcctcc-
caaagtgctggg 386 3851492 -- NO
ttttttacggattcagtgatctggacgggcacatactaccat 387 2712928 -- NO
gtgagtaaaccatggcgtgtttgttggccaaaagccgcaagtctttgaaaaggtgaatcatcacttttccatt-
ta 388 3060349 -- NO
ctctggaggcttcttgtcagtactagaaactaatacttggtgaatatccttttctgcttccattaccttgtat-
gaaactggttccatttatacactgagattagaagca
ttcataagtgatgcggcaccacaaacacagaagatcaaactactcacagtgtggagaaccatgtctttta-
taagtgtgatgtgcctaaaaccatcatc 389 3504762 ZDHHC20 YES
aaaccccaaaactgtccaggcatgg 390 3543824 -- NO
agtcttttataagtgttggctatcattttttctcatctatttccttgcttctggttttgcacactttaccatc-
cacactgccatcagagtgatcacacctctcttcagtagc
tcccatcatctactgcataaagctgagactgttagctagactgttaggcacctttcccacacgatctggc-
tctgccccacttcccagcctcagcccacatggct aaacaa
391 3781951 LAMA3 YES
gatttgggcttaccacctactgaccacctccaggcctcatttggatttcagacctttcaacccagtggcatat-
tattagatcatcagac 392 3216926 -- NO
aacactgatctccacgagcacaatcatccaaacggagatgggaacccctgttctaactctctcagaggcctga-
a 393 3448246 -- NO
ctctttggtatattattgcagatgttgttatttcacagttaggtaaattagacataaaaaggtcaaacgactt-
gaacgtgctaccataaaaggtcagtgataaagc
cagaagtcatttctcagtgtccatcataagccacc 394 2693224 OSBPL11 YES
ggagatggctgggtttatcataaaccactttggaaaataattccaacaacacaaccagcagagtga
395 2672926 SMARCC1 YES
tatgttcatgcggatgctcctaccaataaaacactggctgggctggtggtgcagcttcttcagttccaggaag-
atgcctttgggaagcatgtcaccaacccgg cctt 396 2914136 -- NO
ccatccgttcttttagctgacttgaatgactctaatgcagtgggttgcaggtttggctacttacctatgtact-
ctgtaaacatccagaggcccagggatattctga
gccactgtgtgtgaatggagtttggccatctgtagatttccgcagtctctccaggtgatcgcactgtgca-
gcctcattgctc 397 3210858 -- NO
tttgctctgaaaggcagtttctgtataggttcctccgagtgaagatcagaatgttatcagacactggctgtag-
ctcagatgaca 398 3853401 AKAP8L YES acttggaactctgggacaaatagag 399
3605225 -- NO
tggacccatctcagcagtgctcaaaccaatgcccaaactctcctgcttaggacacttctccactggccaccct-
gaggccaccacacctcactggccactcct
cctctatcttctctgctggctcttcctcctctatggccacctaaaggatgggtgttacacactcaatcct
400 2377461 -- NO
tggagttggccttgttaactattaaacacaaaagcatgtgatagttacctgagagatccatgcaggggagagt-
ccaggggaaggtgactgatcactgcttcc
cagggggaggcagaaaatgcttcctggaggagatgatgggtggattaaggaagatgagttgagcaggagt-
tgtagctaccagccagggaggaagggta
ttcagagcagaggaagcaaggtgagcaaaggcaccaagatgtgacactactggactgccaagcta
401 2934549 -- NO
gtgtgctactggcttatggctgatacgtaagagaatctcatctatctctaaatgttctgccttaagccgcaca-
aagga 402 3185031 -- NO
tggcacatgtggattctataccttaattaaagccactcccttacatacacacatttaggtatcgccagactcg-
cctgatgaggaataattattctttcctccatattt
cttaactcctgtcttttccatgaaacggcttggcattaaactccttcccaga 403 3560964 --
NO gtaatgtggcggtcaaaaccggcgctggaaccacgggacatgtt 404 2732616 MRPL1
YES
aacgtggagccatttaccagtgttcttagtttgccatacccatttgcttccgaaatcaataaagttgctgtat-
ttacagag 405 3150536 -- NO
gccactcattcatggttgttctatgttccatgaactctaatagcccaacttatacatggcactccaaggggat-
gcttcagccagaaagtaaagggctgaaaaag
tagaacaatacaaaagccctcgtgtggtgggaactgtggcctcactcttacttgtccttccattcaaaac-
agtttggcacctttccatgacgaggatctctacag gtaggtta 406 3774169 -- NO
atcgctgtaccattctggggcactggagatggcagctgagaagcagagaagctggagacctgaagcctccacc-
cttggctgtggctgccgagagaggcc
cctgcagagggagccccaggccacacccagacaccacagccagctcacagtgcggccagagggcacaggc-
tgcttggggggtgagggtccccattc
ctgccacctctcacagaccatgacccacagggctgggggcttcccctgggagaaagtccttccctcccca-
tggcccagccctggggaaagaaagcagag
actaactcagggactgcagtaggctgaggacaagggaggtgggcttggggtgaaggccccccctcactcg-
cagagaagggacactaccggcagtaga
ggacagggaggcaggacgacggcagttagagacgaggcgtttcaggtgaactgtatgtagtgttactccg-
gacgtgagcatggcctgggtcagtcgaat
gaaatgagctgggcctcgctgccctgtgccggcggcccctgtgcctgcggttgctgggccacggggggct-
gctgctgggggggaccgccagagggtg
ccatctgtgcaggaggaaagcaggcatggccctggtcctcccttccccagcccagggaggaaggcttttg-
tcccagcagagccacagacccacaagtgc ttgtaatccatgtccacggactgcagctcatg 407
2987860 -- NO
cccgtgtttcgtgtacaacatatgatacatgtgacagttgacaagagtgcctgagtctcagagcaggaagagt-
tatcctgcctccacatgcattgaagggaat
atatgtcacacgttactagccaggctcagaggagaacacatctcatttacaagttcaaatctgaaaggga-
gaaatgtgctagtatttagtggatcttgaggaaa
ctagggatgtgttacccatctgtgcaggaacattagatctagatggggctctcctagtcaaaacgctga
408 3829652 -- NO
atgtgactttacaaccctcggtgtcctcctggctgctgggccccagcctcctgactgttcagctcacacacgt-
gaacctaacacctgccttggtcccctgctcc
atcttctagacaactcatgctgaggaccagcccacaggaggaggcctccgagttctctcttgacgtcttc-
accttgaccattttttgccaccattttagtctgtcca ggc 409 3900228 C20orf74 YES
gaccaaagcctgtgtacattactaccactcgagacaatgagaacatttacagtacaaagattccatatatggc-
agctcgtgttgtttttattaagtggattgtaac
cttctttttggaaaaaaagtatctaactgcaacacaaaacactaaaaatggagttgatgtattgcctaaa-
atc 410 2858280 -- NO
ataaaatacaaactctccaacaagaccttttggccatcaggaacgcagca 411 3088555
ATP6V1B2 YES aactgcccggttcttcaaatctgac 412 3850502 LOC147727 NO
gactgtttgccaatggttgtatttagtaagatttgtagactctgtttttcttttgacacagctgcaaggccaa-
cagctgtgcaaagccacaagttatgctaagtcag
cagttatgctatagattacatgacctgtgactgtatcattaactgcttttgttttgcttctgtaagtttg-
cctataaaaaccacactcagtctttgttcaatggtcagctt
ttcagatacaaatccactgagccggtgtacatctaaataaa 413 3946288 TNRC6B YES
tgtggacaagcgagcgatgaatctcggggattttaatgatatcatgaggaaggatcgatctgggttccgtcca-
cctaattccaaagacatgggaaccacaga tagtgggcctta 414 3430162 POLR3B YES
agtctggttgaatatttagatgtgaatgaagaaaatgattgtaacattgcactgtacgaacacacaattaata
415 3751732 -- NO gaatatgcatctttacaagcatccacag 416 2347259 -- NO
tggctgcctgacattattgggtgct 417 2421262 -- NO
ctccctgcttggcttgatgaccttt 418 3886689 PABPC1L NO
gtatggtcttgggtttctgctgagaaatggcttgtaggtggggggttaaagttcctcacacctctcctgaacg-
ggaggaagctgctgttcaccagtttccagtg
ctcaatgcgggcaggtggggcatctgtgcgtttggtaaatacatgatgtt 419 3951993 --
NO ttgagcccagtggcgggactccacgacgtagacctctctccttctgcc 420 3966982 --
NO
ttcctgctgaccaacctaattctggtttcatacagggcagccaggtgcccacctaaaagactgcacttctcaa-
cttccagttgtttctatggataatggttggaag
cagaaattgggttggggcttccagataatcccccctcacagggactgcttcaagagaaagggatgccctt-
tggttctttctcctttccactgcctggaatgtgat
gtctgacactgtggcagccatactggcataatgaggccaactctctgccatgctaagagtggcagagctg-
ggaattgaaaagagcctgctagccttgggtt gcttccccttgatcggctcattacttggaa 421
2756515 MFSD7 NO
tgagcgccttgtagtccaggttgcccgccacatcgatggaggcgaactggaacatctggtccacctgcgggcg-
ggggcgaaagggctccttgcgggctc cgggagcgaattacaagc 422 3261869 -- NO
tttttgtattctagtcgttcagccccctcccctcccatcttccagcgcttctgaacaactcctactgttctct-
tcc 423 3391839 -- NO
ccctatagattgtttgaggaccctattaaatattgtatagcctctaggaataagcctttccattgacttgctg-
tgataaacagatcttttgtcagcgactcttaaaata caaaacagccttgggcagtagagtaccac
424 2437406 C1orf104 NO
gcttccctgacctagacagtcctgactgatggtccaacctcaatcccacttatttttggctaggccttcctgg-
gagtcataaaagagatgaatccattctagagg
tgcacagcctgtctcttccctcacaaatgtcagtccccaagtcattctgatccaccttcctaatattttt-
gccacctccaacttctttcaagatgaaaaggaaatgt
agagaagcaaggtcagggtagacacttaatcccactgactgtctttaatccactcttctccctctcaacc-
tggatgatctccacactcctatccatactcagata
caggatatattgttcccctattatgtgctaagcactttcatatcccttgccttgcttaatctttacagtc-
ctgtgaagtaggaattttatccccagctgaggaaagag
actgagcgagaccgacttgctcaaggtcacacagtttttcaccaggggtagcagtgttcacg 425
2802671 -- NO
tagagttagagtcagggccctggtccctggtgctctttcctggtcgcttctcatagccaggacgcttgcttac-
attagttctcaaccccactgggaccaatcatttt
tattgccaatctattttggggctctgttctcgtggcaataaatcattctttcagagctccctatttaacc-
ttgtgagagcgtgtgtgtgtggtggaggtgcttacata
aatgcagtatttttaacctgcctggcacgctttaggttggcgtta 426 3415835 ZNF740 NO
aagtagggcacgctctcagagaccaggatagagagtcagggaacctgggaaagagtagtgccagttccgggta-
ggctgctgcaccaggccctaccagc
tcaggctataaacagtctgctttgccccaagtttttccgtccacccccaacagccttgtcatcacttagc-
tactgatcacgcccatggcttgacattggagggt
tacattagtggagtccgccacagcttcgaaccctctccccagatgccctttgcctctgctgtggccctgg-
ggttttatcaactg 427 3764797 -- NO
tgggactgtcaatcattggctctgcctctctgaccacagactaaatatatgaccagtctaacctgttaagcat-
aacaatatggacactgggagagaagcctctt
gaaatcctttgctgaacggatcatgtacaagctgccaagagttcatctc 428 2431813 -- NO
tgatgcacagtttaggagcaggaaagccatgtcttggatccagga 429 2468734 -- NO
tgcccaagtccttgaatcctacagaccttgctaatggctccgttcacgacacccaactggtcctgaactctta-
ggattaacccgtttgcttatggctgaggaa 430 2512616 -- NO
cctaactaggagagtgttttcaagggagagattgctatagcatcagcctcagggtaggagaatgagcttaacc-
atgagatttaggtttgagcatgtttactata
agtaaaaagcattttcctggagtctggcaaatattgtggaagatgtac 431 3242348 -- NO
aagagaatgggcaaagggagcgggtaggatggcggccgcaccaccagccacggactgggagaggcccttctgt-
gtttccagatgagaagagagctca
aggaatcccaggaatagactccatggaaaagaatgaaaaaaatcagagaaaagccaaatatccaaaagag
432 3316358 CD151 YES
tgggtgagttcaacgagaagaagacaacatgtggcaccgtttgcctcaagtacctgctgtttacctacaattg-
ctgcttc 433 3473828 TAOK3 NO
tcccactagcgatcagctgacattcctaactgaaggctgcaatgtgttgcttattcattttgtaccgtgggag-
ctgcggggactagcagagagctaaacta 434 2453074 C1orf116 YES
cccggaagctgccacctaatattgttctgaagagcagccgaagcagtttccac 435 3144603
C8orf83 NO
caggaatgcaagcactgctacctaactaaagaccttggctttggaaacatcttaccccttggcagctctccag-
agtttagacttggcagcatcaaagac 436 3035937 GNA12 NO
agcactcctcccacgggcctgggaaggcaaatgtgttttctgaactgtgttgagaccgtgtgtgtgtgtgtgt-
gtgtgtgtgtgtgtgtgtgtgtgttggggtgt
cttgtgaagtcctgctaacctcttgtcagcagaatattcgagaaatgc 437 3854106
C19orf42 NO
cttcaaagtggagtagtggcacagagaccatatggcctgcagaatggaaaatgtcacctgtttggcctcttac-
cagaaaaatttgccaaccgctcaactagg
gtgtgatggagaatcccaaggtgtcccttccctcccaaagccactcagggaatcatctgtacc 438
2604179 USP40 YES
ttgcaatggggagtgacgttcaacctgggacagaaatggaaatcgtagtagaagaaacaatatctgt
439 2625696 PDE12 NO
tagtgggacttttaagcatctctgaaataaaaaacttctttttacagacaagcattatagtttgagttacaga-
caacagtgtgtatatatgtaatatatatatagtaaa
atgaaatttaaatatgaagccaaactttttaaaattagaaactacaaatggttatactgattagtgtcta-
gcctagagtggtaaccatgctttactaattcagttatg
aaatacattatttataatgcattagctgtattagctgttgcttttttgatgttcaggataactatgttat-
ctcatttctgcatttaattaatagctcgagtattaaaagccc
actcccttcaagaaaagctttgattttccccagtcatgaaagcccttgtttcaaattctttaatctctga-
acctagtatcataagaatttcctattttgataacatctgta
ctttcatattctgctcactatcaaatgtattgttaacacttagtaagtttgaaaatgaaggggttttatc-
tgcatttgacattgaaccttgaagtactttaagtactcca
aggggaaaattaaagtggaagtttcttcggatcttgttta 440 2410545 POMGNT1
YES
catgtggatgcggatgcctgaacaacgccggggccgagagtgcatcatccctgacgtttcccgatcctaccac-
tttggcatcgtcggcctcaacatgaatg 441 2545098 HADHA NO
atgtgtgtgcagaattctaggcagcaccttagggagggactgggatgagagaaagtgggacctggtgggctca-
accacacacacctgtctgtgcagatgc tttgcccaggcttctcaccacggtgtaccgggatatta
442 2749561 ETFDH YES atgctggtgccgctagccaagctgtcc 443 2849125 DNAH5
YES
ttcttcggaccttgggagcagcaaaaagagccaatccaatggatacggagtccacgattgtcatgcgtgtact-
acgggacatgaatctttcta 444 3022356 -- NO
gaacacctgcccaatgtcagctatacttcagctctcatttgcactattcaaacttataaagttgaagagcaac-
ctacgcctgttg 445 2474026 -- NO
gtggtagcagttttccagatgtggatgcttcatgatctggtg 446 3160004 -- NO
tgctttgttgagggtgtaaggggaa 447 3795785 -- NO
aatgggaatgaaatacatgcctttttgtttttaggggtgctcagttataaatatgaaaggctgagaaaatgct-
aattgtacagtaagatcaactggacttgttttaat
aagacaataatttgaaattagtaaactattttatacaaatagtgctaaaactttggaaggtcctcaacct-
cctgg 448 2990169 -- NO
cttgggtatcacacaagcattactgacattgagttcatggaaaatacagaaaatatatacaaaattaatgcca-
cagaacatgacaaatggctgtgaggggag
gacttttgatcaattgcttgatcttaaacttactttagaagaggtggccagtgcctgccaattggctgcc-
atgtggatacttcttatgcttgatcttaagtgcttttgt
gtgtgacagctctacacaattccctagttaagagttacttctcaccaaccaaagg 449 3858632
-- NO gctgactgcagattcaaccttctgagctcacgaa 450 2481311 KLRAQ1 YES
gctgagttgcaggggaagtaccagaagctg 451 3726479 RSAD1 YES
tggccctggggctacgcaccgatgtggggatcactcaccag 452 3847164 -- NO
ccatgcgaagtaccaagccctagttgttctccatccaggaggccgtgtggctcatcccttacccacagaccct-
cactcaccaccttcgtccctaccatccaca
gcacccgctggccctgaagtgattccttggtcctggacctggggttttgcattttgtctctgaggaggag-
gtcgcatggagggggaggggatggggatgtg
ggtgtatggacgggtggtgggtaggggcacgtctgatccactgtcacggcacctctggtgagttgtaatg-
cgttcgtgactccaactgactggtcttcaccta
acctgcttatttctctgccaacacctgggatgggggtttgtaaatccagcagggctca 453
2945519 GPLD1 YES
cttcccatgaccacacacaggagtggggaaaccttacttgtacttcatcggttttcttccaaatcagcgacgg-
gagtaacatttttattcctatcaccaaaccac
ctgaaaaatggactcctaaacttcctcatatgacatcacattaggctaatcatgtaccctcaatatcatc-
agggtaagtgtatttattctgttattattacatttgtagt
gcaagagctggacactctagaatcttccatgcacactactttgggagg 454 2960606 -- NO
ctaaggctggatctccgtttctttccacctgctccaactgtacccacagctgtgtctgactggctgccgtcat-
tatgctccagtgtgtacatctctccactgacact ggtgctctt 455 3275073 -- NO
gaggaggttgactcaggagaacttggg 456 3392454 -- NO
gatgctgaattgaactgggatcttcttgtctgtcaagcccttgaacagctttccctttaagcaacaaagatga-
caagtttttgctattttggattagtgagagtgtac
gaaatggtttccctttccttccaggcaaaaataccaacagaatctggcttcggaatgaaagtgctaattt-
catttggtgactttcagatttgaaatacgggcttga
acaggcattgtgcattagtcagctgaggcagtggaggttatttttacgatgctaattattatttcctgac-
agtgatttactttatgttgtctactgttttacgcccccaa
actagccattgttttaggaacagaattggttgggttgtcatgctcttttcaaagacaaatcttactattt-
tatgcatagaaatactttcctgtaataaagaagaaagct
ttattgaagagaatcttgcatatgaaatgtaatctggataaatattcaaaactaataggtttatatttta-
gtcttgatttttaaagtatatttttctgacatcctaaccacc
ttgctttatgtgcattaaagttaaatctgttttactgggatgcggctgaat 457 3428624
MYBPC1 YES
catttgagatgcagatcatcaaggccaaagataactttgcaggaaattacagatgcgaggtcacctataagga-
taagtttgacagctg 458 3869530 -- NO
ccattacagcagcaggatccagtgacccgggatgctcacatctctccctgacgtgggcggagtagccccttcc-
tcccaaggtcactgtcctgtccaacccc
gtgctcccctagcccgttgggaggtggacagtgagacatcttccca 459 3180781 -- NO
tattgggagtcctgtcagaagctgcctgctacagggtctttagctttccttagattttcaaagaggtttgtga-
tccaagaagaatagagttttgaatctagattttat
actaaacgatcactttagattttcaggagtgtgtgcctagtttgtgattaagtta 460 3319155
PPFIBP2 YES
ccacagtgctgctagtaatgaaacctaccaggaacgcttggcacgtctagaaggggataaggagtccctcata-
ttgca 461 3428631 MYBPC1 YES
cttgatcctgcatatcaggttgacaaaggaggcagagtgaggtttgttgtggagctggcagatccaaagttgg-
aggtgaaatggtataaaaatggtcaagaa attcgacccagtaccaa 462 3435265 LRRC43
YES
agccgaaagccgtgattccgatctacgaaggcgattaccaccctgagcccctgaccgtagaggtgcagatcca-
gctgaaccagtgccgctcggcggagg aggctctgcgcatgttcgccgt 463 3697431 -- NO
ggaaagcggggcagacaaagtatccaaaagt 464 3928125 -- NO
gggcactcacccaagtaatgtccaaacaatatttttccatgtcccccctcccccagaacacacacaggcaaag-
gcagagatgtttactgtgaggtcacatgg
catgaagcaaatgcagccttatctgtttattattacaacagccagttagcattggcaaatgtgctttggt-
tacaaacatggtttctgctaataatttcatgaagaag
cttttaggatatgtgaccatttattcttagtataatcaatcattgaaggataaaaatcagagtataaaag-
tttatactctggcaaatataaatacatgcacagaagttt
ctgacagtttaaatttgagcatatttgaaatattaaaggcatgaaatttaaaaatacacatacgtgaaac-
tatggtgaacatgttatgggtttgtcccatggtttaac
tctgctcagcccacgattcttagctgggtcagtcaatagtctatttttatcattttctaccctgttgtac-
agcatgatcatatc 465 2769166 -- NO gtggggtcagagaagatattaggaaa 466
3545551 C14orf178 NO
tggcgcatatcagcagacggcggtcactactgtggctcatttaaatctgtgttcagctccgggcctctttttt-
caggaatccttgtttcgggacacccagtggaca 467 3899443 -- NO
gacttacctggagagcgcgagaactggtgtagcttacgtggagtgagaagagatggggaacatgtgaatgagg-
tcagagcggttgcaggaaacggactg
ctgctgtaggccattttaaagacttttgattttcctctgaactgccgagtattttcagcagaggagtaac-
atgatctcacttatttttaacgggcttactctggctgc 468 3182036 -- NO
aagattgaggagaagagtagtgacaa 469 3063084 -- NO
gagctgggtacagagtgcttcatgctgagcctccgggcatgcttcgtgtacactccgcacactctccacacac-
acacgttacatggcagcagtcc 470 3387617 MAML2 NO
gaaagcctgtgtatcgccgtgactccgggcgcgagccagtgtcagcaaagcggctaacaacagacgagaaaga-
gaaaggaaaatacaagctacttttttt
ttccatctataaagcggagcaaatacaggagatagaaccagattgcttattgcgagtccagaccctcaga-
tccactggccggggatggaatgtacaaaagt
ggacagaaaagtggctggacatgactcggtgcaatttgctggaagtttgtaagtttgaccatcgtttgta-
aattactctcggaagagtttgtctctcttgatactgt
attagaatagagccgggggtgaggaatagaaacgtaagcgggaaagaaaaaaatgtgttgaaggatctct-
ctcagtggctagcga 471 3566496 -- NO
cctaagtcacgcctctggaactttggcaagttctatagaagagtcagcagcaggtgtgggtcaaggtcccaat-
tcacttcctgcagctgtaccatcccttcctc gttctgcaaattttctcta 472 3088581 --
NO tgatctcatgatctcaaaacaaaggg 473 3120740 -- NO
gagcttggtttttggtcagaagccaagaaaaaagatcggagaagaaaagaaggaatgacctcaacttgctctg-
cacggaggacggggacggctcagaga taaatagc 474 3399570 NCAPD3 YES
cctggacgccagtgagttactctcagacacgtttgaggtcctcagctcaaaggagatcaagcttttg
475 4010188 SPIN3 NO
tgtatcaaagtaatgtgtccaccggtgtgagcaccagcaactcacttcttcctcagacatctctaaagctgga-
aagattttgagggacaatatggtttccttcac
cccacaccaatgttatgaatgagaccagcagaccaacagcaaacacctaga 476 2638236 --
NO tcagctctgcagccctacagttaccagctaaccttg 477 3683253 -- NO
tgaatgaatatggtccctggggctaaaagtaagaaaggagaaaaaaataaagcaacccccaaatttgatgaga-
accctatagtccctgactgattgtttcctg
gccatcatcatcatcagcttcaactttgtcaacacacccttaatatgggtgtaccttgttttacagtttg-
ccgagcactttcacacccattattggatatgacacaca acccggtgagagtgctctc 478
2502720 MARCO NO
ttcacttctctgctcccgaggtgtcctcgggctcatatgtgggaaggcagaggatctctgaggagttccctgg-
ggacaactgagcagcctctggagagggg ccattaataaagctcaacatca 479 3378495 --
NO aaaactgccctggaggatcggcacg 480 2642712 -- NO
atcattttgctcaggccacggccact 481 2798891 -- NO
catttcccagtgctgtatactcctatctcccagtgctgtttgctcccatttccca 482 3428610
MYBPC1 YES agagaaggaggccggaactacaccagcaaaag 483 3691119 -- NO
ggtctcgcgcgccgtcttctcgagag 484 3821139 LOC126075 YES
agaccattgtgatgattcccgactcccagaagctcctgcgatgtgaacttgagtcactcaa 485
2349300 -- NO
gagaattgggaatcaagaatcagccctgtttccatcttagccacaccaacttatatctttatgattttcaaag-
cttttgccatgtgattctgcccccacaaaggcat cggtatttccta 486 2638933 -- NO
tgcggatctccaaagcctagggatttttccgtaaaagagagtgggccgttctggttacccttttattagaagg-
gtattccaccacagagagccggaggttttcc
agatgtgtgtaagagagcaggtgcgcaaggcaagcaaatgagcgcaaacagtattatggaaaacatttga-
gaagttagctccatgaggactgtgggctcc
acaagaggactcgactgggtagcctggtctgacacaggtacgtgaaagcagagtattgcttcaaagctgg-
aaaccttccataggagcctcacactgttgga
agatgtactgctgctggttaaggtcaacctggggtgcaatgctgctgtcttcatcttcggtcccgaagta-
atgctcaataagatcaaaggccttttggtagatct cctg 487 2661085 -- NO
ttcctcacaaactggccttccatttccagcagaggcaaatcaaattgccttttccgccctcatctctttg
488 3037551 -- YES ggcagtgaggagatcggtaacttgggagt 489 3215176 -- NO
tggccgtctgtacagaacccacctgcaaccaccacaccctgagcccatgtggccgtctcacctctaagtcacc-
caa 490 3410744 DNM1L YES
gcattacaaggagccagtcaaattattgctgaaatccgggagactcatctttggtga 491
3439960 -- NO cagagcgccagcaagcggccacagaa 492 3461262 -- NO
tcattttaactctgtgcagagtatcaaatccatccatt 493 2316284 -- NO
atgccaacgccgacgtccctgcgggg 494 3882865 -- NO
tcctagcagcacacatatgcagctctt 495 3685651 -- NO
aggggagcttcgtgatcctgtgcaccaagtctccatgccccttgttgtacccagagcaccatgctccccgcca-
gccccctgtccacccctgcttagttataca
gccattgtccgttttgtgtagaacagtggctttcaagcttttgtcaccatgatccatattttaaattgca-
accctgttccctatgatacct 496 2854135 -- NO
ccgaggactgttgaattgtggaacatctggtggaaaatagcaagaggtgacagaaatgctaatggggcagtga-
gatgtagacttcaggcagaattgttgtac ctgtcgagttggag 497 3314277 -- NO
gtctaaggaaaacaacaggctgcgcgaaatcagccctcagggtaacactgaacctggcgctcttccggcacca-
cacaggaggcgacgcccgggaaag
aagactgagcggctcctgtctgaagacgtctccatcagtccagcca 498 3724236 NSF YES
tgatggcgtggagcagctaaacaacatcct 499 3746906 NCOR1 YES
cacaggtatgaaacacctagcgatgctattgaggtgataagtcctgccagctcacctgcgccaccccaggaga-
aactgcagacctatcagccagaggttgt
taaggcaaatcaagcggaaa 500 3909730 ATP9A YES
gaccacttcagattcgatcgtatgtgtacgcagaagagccaaatattgacattcacaacttc 501
3428460 UTP20 YES
ttggttgtacagttggcacgagatctgcagatggatttctacccacactttccagagttttttttgactatca-
cctcgatcctggagactcaggacacagagttgtt agaatgggctttcacctcgttatcatatc
502 2751975 GALNT7 YES
gggattatttgccattgaacgagagttcttctttgaattgggtctctatgatccaggtctccagatttggggt-
g 503 3894100 C20orf96 NO
tcccagcacctggagccttggatcatttacttccaggaccggatctccattcagaccctgatctacagtctcc-
ctgctccctctgcccttcctccctctttctttcc
ctccctccctccctcccttcttccccccttcccttccctcctccttccttcctcctctccctccctccct-
cctttctttcttcctgtggttttttcctctcttcttcccttcttt
ctggttggtgctgctgggccaggtgggaatttctgatta 504 3908236 -- NO
accttcagggtgctttcacaaatgagctactggagtatttttcgtatctttggttgatgaaaaggctcatctc-
caaacttaatggttgtaccaaggtgttttcattcct
tcaacaagtcactgagtgctttcttggaacacacagccttgcactgggggttatggggagggaggaagag-
gctggacagggttactgcatactgccggaa ggagattctcatttggctgcagagtgtcgcaca
505 2407923 -- NO
gaggtctcccgtcactgggcatccagctgggtgctacggccgtggctcctgccttctgcagccctgtcagggc-
ccaaggccttcctcatcagcacttgctcc
agcctactcactggagttgtgttctgggtgggtgtgtagaatactcgcactcctacttggggcatcaggg-
agctctctagcaatttc 506 2571603 -- NO
ttggaagctaacctgccacattgacttaactgagtgaccccagttccaaggcagggcctctacaatttccagt-
ttatctattgtttcctgtgtaagagcagatact
tactgtaagtccgtaagtgctactcgtaggtcaaacaaccttgatgatatcacacttcaattgtcttata-
aatcccatctgaaccactcctaccctatggtatatga
gccctgggtttgggtgctaatgcggggatccaccatctcatctcattgccgcctgagacacctacatggc-
tt 507 3634205 -- NO agcagatgtcagcatccgggtcacctag 508 3746967 NCOR1
YES ccactgtataaccagccatcagataccaaggtgtaccatgagaacatcaagac 509
3675286 WDR24 NO
ccgcctggtcttgtgcccgagacgggcggaggctggaacttgagacctcaataaaggaagtagag
510 3809651 FECH YES
agctggcaccattcatcgccaaacgccgaacccccaagattcaagagcagtaccgcaggattggaggcggatc-
ccccatcaagatatgg 511 2793478 AADAT YES
catattgagcagaggaccaaaatcgatgatctccttggctggtggcttaccaaatcca 512
3139792 -- NO
tgtgtcacttctgcattgcccagtattttgagttgggggaaaaatgaactcacctggccccacctcctgttcc-
agtgtgaaatactgacacttgctgccagccca
gcctcctcacataagcattagaaatatcagacagtccactaggttagagcacctcattcatgaggttctg-
ttatttattcggctctcccactaaaatgcagggcat
aaatttatgtgtctgctctaagactgcagctgtctgccccccctccaccctcctcctgcccttcctgtgt-
cagtgttacattcgctccccccacttttggtctcaggt
ctgtctcctttttgtttttatgggtgatttgcagtgattcagacagggcatccttgcatgttggcacttc-
ctggaggttaccaggaggcagccatccttccttggctt
ggccaggcatccccgactccaccccactttccccttggtggtggaaaggtgggttggaggtgtgtactgg-
ggcacatagcccaggaatgttgctctgagaa
gaggacatgtgcagtagacacaaaaatataaggaagcaattatgttcatcaagccgaaagttgcagattt-
tgaggaaatgtgtttagataccactacataata
aaagggaaaaccacttggcatttaaataacttacttcaagaggaaattatgatattttcagtctacaaat-
agagtggtttttaagccaaccttgagtaggtacaag
caaattataaacagtctgctcaaatgattttactatacttagactagaaaatggctcctcttctctctcc-
ctctggtccctatgtcccagtgctgtccctcatatgtta caa 513 3296171 -- NO
acatggctctggtcgaaatgtgactgaagctttgcat 514 3470058 PRDM4 YES
cttatttagctgacagaccacctcc 515 2830812 -- NO
tgggtaacagaacgcaactttgtctccaaaaaataaataaataaattgttacaatgaaagtggctctgtgtta-
gccgggagtgg 516 3151504 -- NO
cttagggaatctgtttcggtggctcagagaaggatctgttgccaatcagccgatgccaggtctccggtgct
517 2978822 -- NO ggcaggtccaggaactgggtctggagccttgaaagcagaag 518
3432174 -- NO
gtgcgatggaaaaggtatccaaagtgatactccctttgactctgagcatcagttgcccgtgtttcagtcactt-
caa 519 3922854 PDE9A YES
gaccaactgcccctgtaagtacagttttttggataaccacaagaagttgactcctcgacgcgatgttcccact-
taccc 520 3225896 -- NO
ctggatctgccacctcttctttcggctgtggatggccctgggagacacgcctggcctcagatgccccttgacc-
caactggaggaagggtggggggcccag
cagaaaagcctgcagcctccctgggcaccgtttcaaagctgatgctgctctccctgctctgggtctcagc-
tcctcccctcttctgcattgttgaccaacagcct gggtctgacgcggaagcagaagaattcc 521
3981141 OGT YES
aatcacgcagtggtgcacggcaacctggcttgtgtatactatgagcaaggcctgatagatctggcaatagaca-
cctacaggcgggctatcgaactaca 522 3040366 TWIST1 NO
cctctgcattctgatagaagtctgaacagttgtttgtgttttttttttttttttttttgacgaagaatgtttt-
tatttttatttttttcatgcatgcattctcaagaggtcgtgcc
aatcagccactgaaaggaaaggcatcactatggactttctctattttaaaatggtaacaatcagaggaac-
tataagaacacctttagaaataaaaatactggga
tcaaactggcctgcaaaaccatagtcagttaattctttttttcatccttcctctgaggggaaaaacaaaa-
aaaaacttaaaatacaaaaaacaacattctatttattt
attgaggacccatggtaaaatgcaaatagatccggtgtctaaatgcattcata 523 3847114
PTPRS YES gagtaccagttctgttaccaggcggcactggag 524 3903914 -- YES
aattccagagaagggtttgagtttggagttttatctgttgtaaaatggccctgcttttag 525
2545695 GTF3C2 YES
attcattatattgacgctggttaccttggtttcaaggcctacttcactgctcc 526 2468742
-- NO
ggaggttcgttcataacacaccctagaaaccatgaaaaacatggagagccaagtggagtgagtgacccgagtt-
tacaaagcctgcaatgatcattcttttatt
acctgacaggatttagggtaactagaaaaacaaatacaacttatcttaggcaatcacttctctatgatct-
cagggaggctata 527 3332623 TMEM109 NO
ctgtctggggttggctctcttaaccctttctctgctcccagcctgcctcaccagggaaggttggaggggcctc-
cctctggcttctgcatctgcgccagcaaac
atcactgccgttggtctctcatgacttaactggcttccctctgctgctgccttggcttcctcctaatgct-
cgtgctctcctgtccttctgaagttgctccttggccaa atctccagct 528 3457669 -- NO
ggctttatcggatagggacagacgaggtaaggaaggttgtttaatgagaggccttgcttgccagcctaagctt-
ttaaatttgatgccagtggcaacaataaag tgta 529 3575429 EML5 YES
gtggcagagatggttgtattcgtctttgggattta 530 3676065 -- NO
atgggggacgaatgccggctggattcaag 531 3541353 PLEKHH1 NO
gggccctgcccagataaaattgttggtcttgtctgtaattagtattccaaaggttcaggtggtgttgcatctc-
cgtatcaatgttcagctagtaggtaaagggaca
tatttggagggaactaactctggcctagctactattatgctcttcactttttcttttttattctctcaag-
ccccagcatcatgcagtcctcagttgggtgcttacgtgct
cttctcttccttgcagcagtcctcaaggcagggcagattcctctttaaggtgctcgcatgttacccctgg-
gttctgctgacccaacattagctacaaagtgggac
agtcccacagtgctccctcttccttgttgtggggaagaccgcaaaaagacctcttttgctttagtgactt-
tgttcctactcaatacaggaagtgttgaccagcaaa
aataataattacaaaggctaagttctgatttattgttcctgactcccgtgtgattaactggaaaccctg
532 2428388 -- NO
tggagctctccaaattaagaatgggtagtgacaaactttgaacaggtaacaaacaataaattcaaagtatatt-
taggattaaacagtcaatttctaaatgggagt
ctatcatgtctcccctttgcaatactggccttcccaacaggaattctatacttgtccagtccaccataat-
gggta 533 2883068 -- NO tttctatctcttcaccttacacacac 534 3686201
GTF3C1 YES
agggctcgattccagcttctacggacacctcaagcgcaactggatctggaccagctacatcatcaaccaggcc-
aaaa 535 2933137 -- NO atgagcaaggctggtatctggagttttgataaagt 536
3098268 -- NO
agcctcagattctaccgaggcaggcgccccaaataccctccggacgctggcagcagttgcgtgcttcatctgt-
cct 537 3804158 -- NO
cagtgtgccattgtaatttattggtggagtgctatcattggtaacaatatcatataaatgtatttaacccctc-
ctagcttttgaagtaagattcatgttagagctagaa tttgtctgggtgc 538 3570485 --
NO tggaggggcaggattacacactgaatcattggca 539 3666058 -- NO
ctcttggcttcaagtgattgatcctcccacctcagcctcccaaaatgctggaattacagacgtgagccactgt-
gcccagccagctcatcttcgaataataacag
ttttacttcttccttcttaatttttatactttttcccccctttttcttgcttcattgtattgactaggat-
ttctgatacattgttgattagaggtggtgatggaggacatccttg
tctttttcccaaactcagggcaaaaaaggattcatagttgtgccattaagtaatttgctagggtttg
540 3692317 -- NO
acaatgtggctgtgtttgatcccgcgacgtgtcacttggaatctcaatttattgccaatagacgacgttgtca-
ggcactaattttctggtggcgctccatc 541 3749798 MGC33894 NO
tcgggggtcacaagccaaagccacaccgctagaagggctcaggacccagcccagctcccgtcctcttggtggc-
atcaagcttgtgtgatatgaggtcttat gtc 542 3965785 MAPK11 NO
atggagctgatccagtaacctcggagacgggaccctgcccagagctgagttgggggtgtggctctgccctgga-
aagggggtgacctcttgcctcgaggg
gcccagggaagcctgggtgtcaagtgcctgcaccaggggtgcacaata 543 4051547
LOC100129722 NO
tgaccttggcccagaatccaccagggcagggcctgtgaacagggccaacttggggccctcctccgccctctct-
ggatgcctccccttcagcactgggcct
gccaggcagacagatggacacgtgcttgaggaaacacgggttttatctgggcgaggggttcacgcctgtg-
ctccggggcccctgcccaggttgtgccgg
gttcagagttgactggctgccagtggaacagagtgtactttgctaatgaagcccttgtcattggacagat-
aggctcctccaggtcctccctgccctgtaataaa cgttgccaccg 544 2849256 -- NO
aagacaggctggtgctttcaaaatcagtattttattgtgaggtcaagcagaaatgtactagcagcacaaccac-
agatgacacttgtttggcttaaaacaagaca caca 545 3166772 -- NO
tttcttgtctcttgagtggcggatcatgcgacacctcccgaccacagcatttgggcgagatatagacatgcct-
ctaaa 546 3886907 PIGT YES
acaacgagacattagaggtgcacccacccccgaccactacatatcaggacgtcatcctaggcactcggaagac-
ctatgccatctatgacttgcttgacaccg 547 2474079 -- NO
agggcacagagagttcaacaaacactgaaacttaagtttgtcctggacatcttcagcatccgactttctggtg-
gaaag 548 2661946 -- NO gccatcttcctatcctggtcctgat 549 2963039 -- NO
ttggtctctatctgggcacagtctctttggtactgtgtgttaggactagatgtttttaacatgaatgaaaacg-
tggactcaaaagaaacacttttcaggtgtctataa
atcttcttattttcaagtttacttagtatttggtcctggggtgtctacatgtcactcagttttgaggaaa-
aaatgagatgaccttagaaataacatagaaattaatgtg
attgatgaatatccttagaaatttaatgagatttatacttggaatatggcaattacaatattttattgaa-
aaatgaataggtcaccagcctggcc 550 2991676 TWIST1 NO
tgaatgcatttagacaccggatctatttgcattttaccatgggtcctcaataaataaatagaatgttgttttt-
tgtattttaagtttttttttgtttttcccctcagaggaag
gatgaaaaaaagaattaactgactatggttttgcaggccagtttgatcccagtatttttatttctaaagg-
tgttcttatagttcctctgattgttaccattttaaaatag
agaaagtccatagtgatgcctttcctttcagtggctgattggcacgacctcttgaga 551
3535849 -- NO
ctgaatgctacaacctcggagagagaataggggagtgttggtgtttgtggtgaatcggaaagcacgtgtttaa-
agaggacaatcacattaattcagttccagc
tatgagattacattgtcaaatcatctgatttttcaagagaaatcacaaatttgaatttcttaaaatgaga-
aatctactttttaaataatgacgggattttcaagtatgtta
aaaatactgtaggctaataccgaataagctaagcaaaacttttgtggatcaaaccgaaaccatgggctat-
tttcttctcctcctcttcctcctccttctcataggaa
taaaacaactaaatataatcctgtctttataatttccatataccaagctttaattatatttaatacccat-
caaagttagttaaaatgaactctgagtaatttataccttat
ggaaaaattacggtgttctaagtctgaccaaatgtgtagaaagtacc 552 2488753 CCT7
YES
agccagctatggtgcggatcaatgcgctgacagcagcctctgaggctgcgtgcctgatcgtgtctgtagatga-
aaccatcaagaacccccgctcgactgtg gatgctcccacag 553 2575232 SAP130 YES
gtgatgtccagttctaaagtaaccacagtcctgaggccgacctcacagctgccaaatgctgctactgctcagc-
cagcagtacagcacatcattcaccaac 554 3076375 BRAF YES
cacgccaagtcaatcatccacagagac 555 3187656 CEP110 YES
aatttgcagcagatatcccagcagcagaaaggggaaatagagtggcagaagcagctccttgagagggataaac-
gagaaatagaacgaatgactgctgag tcccgagctttacaatcgtgtgttga 556 3286398
ZNF32 YES actgaagcccaccacaaatatgaccactct 557 3840338 ZNF808 NO
acagatgtcggccactttcgccatcctgttttttgt 558 4019888 -- NO
ggaacagagtgtgccagaaccctcagggtgtttctcagctcttgtttacgggccaccag 559
3831504 -- NO
tggtttgcgaatatgctcaagtctctggatgaattgtatgacagtgaaggggtatgtgattagactgttgtgg-
ctttgaggttgatgtgtatgttttaaaggattatg attgagttggagatca 560 2540638 --
NO
ctccttctatcccaatcggacagtgatatgaccctggggatgttccatgaatcatttgttcctctttggcccc-
atctgattgtgtacttatctccttacacagtccttc
tgaccttgaaatgatccagaaaagatgtaaaagagtaaattctatagtcagtttaaaaggcagcaggaaa-
ggattgggaagcattttggacaaggggtctag
gagacaggcccagctctgcacttttccgtgggacaaaggcctttgcattctctcctgta 561
3229612 UBAC1 YES
acgaggatgagcgtgtggacgaggctgccctgcggcagctcacggagatgggctttccggagaacagagc
562 3839570 KLK2 YES
ctcatccagtctcggattgtgggaggctgggagtgtgagaagcattcccaaccctggcaggtggctgtgtaca-
gtcatggatgggcacactgtgggggtgt
cctggtgcacccccagtgggtgctcacagctgcccattgcctaaagaa 563 2380069 KCTD3
YES
ggcagcaagtgtttacgagcccatatttggattggactatcgaacgagtagctttaaatgcaaaggtggttgg-
agggccacatggagacaaagacaaaatg gttgctgttgcctcagagagtagcatcatcttg 564
3428646 MYBPC1 YES tctgattgacaagacgaagttcaccatcacaggtctgccaac 565
2998434 RALA NO
agtaactgtccgctagaagtctgtccaaatttaaaatgtgtgccatattctggttcttgaaaataagattcca-
gagctctttgatcgcttttaataaactgcaagttc
attttaaatgaagggccagcatatatacttgcaagataattttcagctgcaaggattcagcaccagttat-
gtttgaatgaaccctccttttctctgagattctggtcc
ctggaaatccctttctgctagtggtgagcatgtaagtgttaagtttttaatctgggagcagggcatagga-
agaaaatgtcagtagtgctaatgcattttgcacta
gaacgcttcgggaaaatattcatgcttgccatctgttcatttctaaatttatattcataaagttacagtt-
tgatacaggaattattaggagtaattcttttctgtttctgtt
tataatgaagaacactgtagctacattttcagaagttaacatcaagccatcaaacctgggtatagtgcag-
aaaacgtggcacacactgaccacacattaggct
gtgtcaccattgtgtggtgtacctgctggaagaattctagcatgctacttggggacataatttcagtggg-
aaatatgccactgaccgattttttttttttcctctttgc
agtggggctaggacagttgattcaacaaagtatttttttcttttttctcagtcctaatttgaacaggtca-
aagatgtgttcaggcattccaggtaacaggtgtgtatg
taaagttaaaaataggctttttaggaactcactctttagatatttacatccagcttctcatgttaaatat-
ttgtccttaaagggtttgagatgtacatctttcatttcgtat
ttctcataggctatgccatgtgcggaattcaagttacc 566 3544955 -- NO
gctttctcctcttccgggtcttggactg 567 2981913 EZR NO
cagctaagatgccatgtgcaggtggattccatgccgcagacatgaaat 568 3013230 CASD1
NO
agactgtctgcacctgtattcattgtggaacttcctctttcattggaaactttcttactcaagaatgacggca-
gtattgttttcttatatgtgcaatgaagtggaatga
taaacagtatgcctttaatttatatgtgttcttgttctgatgttgtttcctgaaatgatttttcttccta-
actgtggttttcgggtatgcaagcctaaatctttgtacactttg
tctcacagaatagttctgaggctccatgacagggttttgtcattgttgatgttattgttgcttcgtttta-
taaaaaagccaaaattttttttccaatccaaacgttcacct
gtttcctttcctcaagctataccagtgtaataccagttaccctgtggatccatttaa 569
3739279 -- NO gtggcagtatctgtgacgatgggaagt 570 2409084 -- NO
agattttttgccactgccttgaggatccctgattcctattgattttacctgcccttggacctgtccacctcta-
tcttcacctccacctccctgatccggtctctaatca
actctcacctggacaacagaaatggcagcccaaattgtctcccacat 571 2848243 -- NO
tccacaggactagctggcagatctaacgttggggagagagacaaaggtggggtcacaggcagccccagcgtgt-
tggcccaagttactggaagtttggag
ttgccttgggaagtggaagcttgtgtctagcaccttagaccaccgggccatcctgccacacgcttggagt-
tgctttgaactatgctggggaaggtgcaggcg
gagctggctgggaaagtcagcatgggcatgtgaagtttgggtgtacatgacatcaggctggcagtggtgg-
gtgagaaggagtctggggttcgggccaga
gggtgggctggagatgtaggtttgttgggcatccgcacagatggagcctgggagtagctgagactccatg-
gggagcacgaggatgagctgttgaaggca
tgagctctggaccctggcattagaggtctaggaaattaggggcaaccagtaggacttgagaggggagcct-
ggggaggaggaagtgccaggagtgagtt
acactggcggcccagtgaaaccggggttcctggggggcgggatgtgtgtgtgtggcagggctgggttatc-
ttatacctttcagaactatgtttaaagttttgta
gatgtaattagaataggatgagttcatgccactttgaaacctataattgtatgaataattttgaattcat-
tacgcagacatgacacatcacggcttctctttgcgtat gatatca 572 3775781 -- NO
tgactgagctgtggaccgcaagcagtggcagccccttggctgctcgctattttgagtctggagagattgttca-
cgaggagcacaggctgtttggcaacatca gagct 573 3990538 -- NO
ctgggtagtctacgagaaatgtcaattattatctctactacaactacttacatatatctaatgggaaaagagt-
ggggcttaggtgtcagagtggatgggagaca
aaggagaagctacactaataaatacaacaagtggaaggtacctgtcccattcctaaaaggatttgtgggc-
aatgctggcacttggtggccaggagaatcttc
tgaccccactctccctcctcttcagtcctgaagaccccaagaacccagttaggatcccctggccagaggt-
ctctgtgactgcctctggactcagcacgtgca
gcagcttgggaggatttgagccagtctcaaaaacttttagccccagaatgagaccagtgaccccaagcag-
gagggctgggatctggagggaagagagg
gggtccaaggggaccctgtggctgaggccatggagaaccagtgccagggcccaagagacccatttttcca-
gttatcagaggtgactgacatcttctgcca
ctgccttgagttcagaaatttaaaaaagcttgcagcaagaaaatgccagtgtgcaactgggtgactaaag-
acca 574 2411004 KIAA0494 NO
ggactgacgcgttcccactttcttactctgcacctccccactctcttcccattcaagaacgagtttctcttcc-
ctctccattggaaatcttgctccggaggtccgaa
acacgtattttaagcgtgcccttcctcacctcctggagcacccttagaagtattgcctacttatccgggc-
tgagaatccttcatttttgacctggcttttttttcgccc
tttgggagataaaggtccctctccaccctctactaacactctgcacccaaggccttatcctttggggtca-
ccag 575 2642748 -- NO
acaggggcgcatttgcctcacaaggaacatttggcaatgtcgggagatattctgggttatacaagtgggagat-
taggaatgctactggcatctagtgggcag
aggccaggatactgtgaaacatcctataatgcacaggagagctccctacaacaaacaatt 576
2661956 -- NO atggacacccactttccatgcttag 577 3307945 -- NO
aaaatccagtcccaactgcagatccctatgcactcccccaac 578 3789999 -- NO
ctctcttcttgtggtaggtcccagaaacttctacttgggggtacatgaggcccagctgggattgggcacagaa-
ggtcatggctctgcacctgaccctcacctt
aggggtcaggagagagccaaggacacgagtgatgggttagggaggactcaggcaccatggaatactgtgg-
ccatccttccatagaggagaggtacagg tg 579 3963093 EFCAB6 YES
atggcgattataccagactggcttaggtcgcatcctcacacacgaaaatttacacattcaagaccccattctt-
caccgtgtagagtatattca 580 3589632 EIF2AK4 YES
cagagaagctgacgaggagagaagt 581 3816037 -- NO
tttccatcacccagcaaacgccgtcccgcagcacccgggaagctgcggagtcgggctggggccgccgcgttgc-
gcacatcggtccttg 582 3417925 LRP1 YES
cggtgaattcctcttgccgagcacaagatgagtttgagtgtgccaatggcgagtgcatcaacttcagcctgac-
ctgcgacggcgtcccccactgcaaggac aagtccgatgagaagccatc 583 3696235
RBM35B YES
acccgctgatgactacaccagtctgatgcctgttggtgacccacctcgcactgtgttacaagcccccaagga
584 3462998 OSBPL8 YES
aagaagcttatccaacgccaaccaaagatttgcatcagccatctcttagtccagcaagtcct 585
3962740 TTLL1 YES
ctttgaatgctatggctacgacatcatcatcgacgacaagctgaagccctg 586 2681997 --
NO
cccagagcgagacgactattccatggccctgagcagacaatttctcttttaaaaatggtggccctttaatgat-
gttattatgaggtttttaaatgacatatcaaaa
gttgtttatatcacaaaaacccaacagtcatttaattatactaatgaaggtctttatacgtgtcagattt-
tttaaaaaagacttctaatggccatgagaaatggactg
ttgctgctgcttgcatcacagcagtggtggcagcattctttgtagaggaagaacatattttataatgtat-
aagggaatttgcatttcgcttttcacggcaaacctttc
tgtgttttttgtaaatctaacaattgcaacaacatggaatatttagttgggagatgtttggagtaagtgt-
tgaaagcaactatgtttgcttgcttttttttttttatggtta
gagaacaactgtggcgactttcacagattgaactagtacagttcaaaggaaaatcatcgactttagcaca-
tctgatagctatataggcatggcagaggtgtctt gaaaaaac 587 2743344 PHF17 YES
ggtcctagaggaatttgagcagcgatgctacgacaatatgaatcatgccatagagactgaggaaggcctgggg-
atcgaatatgatgaagatgttgtctgtga tgtctgccagtctcctgatggtgaggacggcaatga
588 2992873 -- NO
ttcccaagcactgtacggggtattgggaaggtaagaacaaaaaagatgtagtccttgcccttacaggtctagt-
tgaggaaagaaagggggattgttttccagt
tgcactgaatatgaatcagaatgaggaagaaagtacttggaagcctctagctgactctggtaccattcca-
cggggccatgatacctttcttagtc 589 3568027 -- NO
acatattttatgctatgccctgggggtaaagggtgactaagacgtgtaaggcacttgcattctacaggccatt-
gcttttcatgggtataggttttctctccccagtt agactgtaagccttgttt 590 3830188
FXYD3 NO
ctggagacttcctatgtgtgcattggggtggggcttggggcaccatgagaaggttggcgtgccctggaggctg-
acacagaggctggcactgagcctgctt
gttgggaaaagcccacaggcctgttcccttgtggcttgggacatggcacaggcccgccctctgcctcctc-
agccatgggaacctcatatgcaatttgggattt
actagtagccaaaaggaatgaaagagagctctaaccagatggaacactggaacattccagtggaccctgg-
accattccaggaaaactgggacataggatc
gtcccgctatgatggaagtgttcagacagtttataatagtaagcccctgtgaccctctcacttaccccga-
gacctcactttattacaagatctttccaaataccca aatgtccctgcaagcccgttaaata 591
4011203 OPHN1 NO
tcccaggctcctatgcaagttttttttccccattatatcacacttatctagcaagggaccttgtggtttgtgg-
ctttagtggccatcatttctgggggttggcttttac
ccttttttcttgaatatttgccaccaagtgaaaaatgttaggacataaacccttgccaggtccctttcat-
ttgctatctctattattggaaaggacctaaaaattggtgt
aatggggcagaaatctgaggaatggacatttctaattcctgtttgttgaagggaagttgctggaaagagc-
atcagtacttgtttctatgcagatgcctgggccg
tagcttgtctgtagcgtctgtataattataatgttgcccagtgtgagggaaagagctttcctacttgcac-
tcttctaccaaggccctgttagtgcactgattatagta
ctgacagataaacctagataaagagatagagagtgagtacatgcacactcatgtgcaaacccactcagag-
atgcatttggaacagtgctactgaaaggcag
tagtcattttcaagactgaattccaaacatggtttattggtgagttaggaacatgtaaggccaagtacac-
tgagagcctttttgaaagtaattgagtggaaacttg
atgccattctaaatcaaggcatatccaggtggcccggttgaactcactccactgtacccagtctcaaagg-
ccaggttgctaagaaaccaggagtaaaagagt
caagtgaccatcatttcacctgctgcttgcccccaatagtagtctctgtgaggccttactgacctcacct-
aggaagtgatttttgagcccttgtttcagggctgtg
gcctccctgctctatcctgaataaagcagacaggtgtgcagattttggccatgaaagcatggctaatagg-
gccacagtccctttaaagaaacatggtttgact
ctggttttcttgggggaaaataccacaatcaccgatgcaaacattggaagattattgagagccctagaaa-
gctgct 592 3349796 -- NO tgcagaaaaggtggataacccaactctggtggg 593
3040457 TWISTNB NO
tgcctcagccattctagttttgttgtgtgttggaggacagtctaatgaagacaggataaatgtgattctgact-
agtgggaaatttcagattactttttaatgattgga
atgggctataagatattgtgctgaagagaaaacagttgttctgttcactgctttcattgagaaaatgtgg-
aatgtctcttgactaattgacaaagtgtaatgaaatg
acaagctggttgaagctggtaatcaatgcatggccatatttattcattttccacacacttgaccatctac-
tttgtataacacattctgctaaggcccagggataca
atggcaaacaagatagatgtagttccttcccttgtggcatgtcataagagaaacagatgtgcatatacac-
acaataaataagaaaattaataattgtattaagtg
gtatgaaaaaaagggggaggattgttcactcactgttacctgtgttagtatctgcaaatgcatgaatggt-
tgaactcccatgtcagcatttttgttgccatttattta
gtaccagacatagtgctggtctcacagcttaatatttggtaatgaataaattctgctagtggtatatgtt-
gatctgaacttacaatgatgggatatagaattggcag
agtggcagatgttcacaattgtctacaagtagatgtgctagacaatggaaggatgcaggccaacctcttt-
gattacaattgagattcatgtgactattgagccct ggaaatgtagcttgtcca 594 3895503
-- NO gtggcggaccgtagaagagcaagccca 595 3907654 NCOA5 NO
ccaggcccagctagccaagtttggaatggcatttgtcatgtcagtagccaccacctttgttcattgtgaacct-
accaaggctttccagcttcatacacattgacc
agagctcaagctcctgcctgcaactcctgcctagagttgaagaaaagcaaactggccttggcaggcacag-
tgtcatcataccctcaccccatatgtttgggg
tctgcttgaggattcataaatcagccactctggattgttgaggaatggccatggcagccacagaaaaaag-
aatttttctctctgagccaaggttgttttttgtttttt
tctcttttcttttttgttttcatttcattggaagatctccaatggactgaacagctccagtcagcagcag-
ttaccacaaactgtgaatctgggccccaccactcttcc
ctgttaaccagttctgtcagcatccccctctccagcagcacttccatgaagttggttctgagactctggc-
cgtgaacacccgtttcttcagtgatttgttttgggct
tttggctcaaaaccccaggctcttgtttttgtctagactcttattctgtttcctgagcagcaggaggtag-
ggaccactttgatgtcagacttctggtagctggacat
gttctcgagatgggtggctgttcgcgacttttgtaccagagtgaaattgttagaaggagggtttctggct-
gtggttctaaatggagccccaggaagctgccctc tccccagggtttgtgctcagtagagcc 596
3679982 -- NO
aagagacacttttccctaagcaggaagttaataattaagttaaccaagaaatagaagtgcatgagtattgttt-
ggaaatatggagaagggaagaagagtaga
aacagctgaaaagattaaaagtgattgctttggcgaggt 597 2858366 -- NO
agctacacaggaaataacaccaccaaaaataacacattcaaactcagagggcaatcttccctaa
598 3048215 MRPS24 YES
accatgccgcagagcgaacggtggaggatgttttccttcgcaagttcatgtggggtaccttcccaggctgcct-
ggctgaccagctggttttaaagcgccggg
gtaaccagttggagatctgtgccgtggtcctgaggcagttgtctccacac 599 3168775 --
NO
atctgtagccgtagtaaattttggaagggcaaatcaatatggcgggtagaggctagttggtgaagcttattaa-
cacagattcttttccaggctaaagttgtcttca
gtggttaacctttgtttctcctagtagagaggtgggcaggataccttttgtctttgcaaatctatgtctt-
gatttaggcaagtggaaggcagagaggtttcttgcat ctgctccttcaaaactaccttcagta
600 3643388 -- NO ggaggtattactgagcgccacctggctg 601 2927513 TNFAIP3
YES
gtgacggcaattgcctcatgcatgccacttctcagtacatgtggggcgttcaggacacagacttggtactgag-
gaaggcgctgttcagcacgctcaaggaa
acagacacacgcaactttaaattccgctggcaactggagtctctcaaatctc 602 3911005 --
NO
atgcctgagggcatcgaccagaacgaaccagacacgagtccctgccctctggaagctcacgttccagcagagg-
agagg 603 3942797 INPP5J YES
ttcatcctgggctactatagtcacaaccacagcatcctcatcggcatcactgaaccctt 604
2802457 -- NO
ggcctatggtaggattgtaggcataagtgctggatcaggagtcatccctcttctacctctgctgccttctgat-
gtttcttttgccaaccagcacgccggaccagc
ccttcttgttttctcttttggttctaggtcacaactctttctc 605 2874851 RAPGEF6 YES
caacacctgagcgtctcataatgcatttaatagaagaacattccatcgtggatccaacttatatagaagattt-
tctattaacttacag 606 3147604 AZIN1 YES
gaaattggctttacgatgaacatgttagacattggtggaggattcacgggaactgaatttca 607
3822303 CCDC130 YES
tgccatataacatctggtgcgatggctgcaagaaccacatcggcatgg 608 2767313 -- NO
ctgtctttggattgatggctcagagaagatggcagcatagatctttaaagcagtttgagtggggaattcttgg-
atcttggggtacttggccatgtggacaggatt
ggctggagaaggagggtcaggtggcggtcctgctgccaaggtctgagggtaatactgctcctaag
609 3159245 -- NO
tgtgtgtctcaaacttcaagaagtctctaggataacccaaaggcaacaagggagaccaaaacaaggacgctgg-
agacattttagcctctgatactgacagct
gcagcaaacagaaaacgcagcctaaccgcgggccagataaaaacctcaca 610 3403122
PTPN6 YES gaagcagcggtcagcagacaaggaga 611 3849599 -- NO
tgggcacccgttatcctagttactcgggcggctgaggcaggacaattgcttacccagaggccg 612
3534950 KLHDC2 YES
tgcctatgatcaccttgcatggacagcaatcctgtaaacatcacagagtggcatcatttgtataattatatgc-
attgttgtagtttgcacctgttggttttaatgtgca tgtgaatggcctagagaacc 613
3631427 -- NO
ccctgttttgatatcctggttgtgaaatgtcttatgttttctgctaatctatttgtgttaaagtaagcagggt-
tggtttacagtaccgtggctcaaaagctagtgtagg cagctttcctctcctg 614 3779594
-- NO
acgccaagagtccagtgcaacgatccctgccacacggtcagccgaccccacttggtgccacagggtccagcct-
cggccactctgggctcaacctttccag
cacgtctgggagcccaatgaggctatgggacagtgtgcatttccctcaaggcctccggaaagtcacctgc-
cacccactgtgacctctgaggctgaaagga
ctaaggactcctttccccatcatttcagctgggccagtggctggctaaaatcagcgcagcattcccattc-
ttctgaaagccacagctgaaataatgcaccagct
gaaaccacagtggacagactgagatggcctccctctgggcctctagttggcaactttctcacccgggggc-
tcctctttctccttttcccgctccttgttccagtc
cttaaggccttctggaagtgaggtgtcctcatccaagctgccagtgccttccacaaattcttcataggta-
gatttttccgcaaatggtctggggcccaaaa 615 3931281 -- NO
cccgaggagcttgtgatgtcaccagtgtgccctgcgggatctggggaacaggagaagtaggccagagaagtcg-
ggttgaaaggtgtgtcgtttgcgtcct
ggatctcccttaatttaaccccataacattccattttacagataaggagactgatgctcactaagacact-
aatatgcccactcacacagcaagtcccaagtctct
ccccaaaatgatttgagaattttgaggcacacaaaagggagaaaattgagtgcccgtgatccaacgactg-
caactgtaggaaaccaggaaagtggagga gtggtagtacttctgaacccta 616 3110077 --
NO
tgggaagaggattcggactcgtcacactgcagagcagcagagcgagaaaggatgagaagaggcagagaaggcg-
acggcagaagaaaaaaggaaaa actgcggccgcgatcagagcctga 617 3419463 -- NO
gcgccctcgccctgggaaactcactggagtggggacagatctcaggcgtttggcagtcac 618
3903370 -- NO attgtatttctattggacgctgctgctctaggttactgagttt 619
3609638 -- NO
agaatcaggaaaattggtgcagggattggcacactgcagggagaatgcatgggctccatg 620
3227685 -- NO
tcttgggtactcaccttcagccctagagcattctttagcactcacagtttctcttctcgtcgggttattcttt-
atattaatcttttcctgtccaaattactctctatgtctcc
tgatcagtccttgactggaagcatcaag 621 3349840 -- NO
cataacctctagagtagaaagtttcagaaggaagagattccccaaactgtgtaattcccttgtaaatctcatt-
cattcaatgggatttgagaaccaaccacttgtg
caggtgcccgcatccgaagataacttgcccccaggagacagcagataagaagagggcagagacaaaggag-
gtctttttgcgacttgcatc 622 3035683 FTSJ2 NO
cccatgtgtgccttgacgggacttcatcttatagactgttaaactgtcacacacaaacaggctttccacccct-
gctctgagagcaccacgcacagatttccagt
tcttagtgtggctgtttaaagtagaaaatctgggggctgggtgaggccactcatgcctgtaaacccaggg-
ctttagaaggctgaggctgggggattgcttga
agtcaggagttcaagaccaacctgggcaacatagcaacaccccccatgtctacaaaaatgaaaaaccaaa-
aagcaaaccaaaagaaaaatctgaaatttc
catctggggattaacttctgtctttctggtgaacaatatagcaattcacgcattcttcaagcagcaaaag-
ttcccggaacaattagggaagacgtatggtctgaa
tttatccaggcagtgggtctgctttggtttttgctggaaatttatatcagtgtctgggctcccaagaaca-
taaatgtaattgccaaagcaagcagtgatgtggtgt
gtttattttcttttactcatctaggaacttgacgcagcttta 623 3439354 ZNF84 NO
tcaagaaagagtcccgattgtgttccagtacctggttcttctggtct 624 2812078 -- NO
ggcagtgctgtagggagcttcattaattatgatagtctcgctgtgtcaaatggattacaaatggaaccacctg-
tggggagcctgcaaggttacggacagagg cta 625 3038635 -- NO
gatatgaaaaagcacgcatgcaactaactactgttgatctgctttgcta 626 3088092 -- NO
acaagagggcgggtacaaacgcacagcttccagggctgaaataca 627 3337338 ALDH3B1
YES atgaaggacgagcgtgtgcccaagaacc 628 3420557 -- NO
gtaagttgcctgtcgctcctctgaatttt 629 3841267 CNOT3 YES
atggcggacaagcgcaaactccaag 630 2929962 STXBP5 YES
tcaaggagccttgcacagcatattcctggccctggtggcattgaaggcgtaaaaggggcagcatctggagttg-
ttggtgaattagcacgagccaggctggc
actagatgaaagagggcagaaacttggcgatctggaagaaagaactgcggccatgttatcaagtgcagag-
tc 631 2387074 MTR YES
gttgaggattatgcattgaggaagaacatatctgtggctgaggttgagaaatggcttggacccatt
632 3388958 -- NO
gtaggtgccgaacaccgcgagtctccgcgcccgacccgacctcgtgttcgagtgtgtgcacgctggcgtttat-
ggagagactagaagagccgcccacgtt aagagtctacgtgccctgcagg 633 3620562 --
NO cccaaactgaaacatcatacctatta 634 3870278 -- NO
gtttgacttctgactaaaggtcttg 635 2833045 RNF14 YES
tacctgcaagcggatgaggctaataaaag 636 3030300 CUL1 NO
gattgctgcactggacgactttagaacatccctcaca 637 3767510 -- NO
agatcgaggacagtgttgagacaccaccacctc 638 3039444 -- NO
gttcaaacagtagtttactcctgcctcag 639 3067653 -- NO
agtatgggagaggggtaatgctgagca 640 3139926 TRAM1 YES
aattaacaggcgaatgcacttctccaaaacaaaacacagcaagtttaatgaatctggtcagcttagtgcgttc-
tacctttttgcc 641 3203423 B4GALT1 YES
atgtctatatctcgcccaaatgctgtggtcgggaggtgtcgcatgatccgccactcaagaga 642
3875984 -- NO tctttctctgggttcatttcctaactgtctaactttggg 643 2848542
-- NO atggtgtggcaagttgactgtatcgtgatgttagccgtcttgtggcagaga 644
3134299 -- NO
agaccacagaaactgggcgggcagcagatgcagacacagccatcctatgcatttag 645
3538031 -- NO
tgaccacgtgcgcaaattatttttcttttttagtagaatggtgcattttttgcctttgtatttgaaatttagc-
taaattacaatagctatcagaactacaattgaccttagt
aatttcaaaaccatagttataagggttttaagttgatttttaaaaatcttaagatatgatagggatttca-
aaactatgtgtgtgtatctctgatagggaggggttggg
gcacagactaataagtgtgccaaaaatctgtgaatccaaatgtgtaacaagtgttgtctgaataaatgtc-
cacaaatccatgctattattg 646 4037525 -- NO
tgtattagaatgtaatgaactttaatggaatgtactcgaatggattcgactggaatggaatgttctggaagtg-
aatggactccaatggaatggattcaaaagga atggaatcgtacgga 647 2814589 BDP1
YES
agcttctgacatctctggaggtttcagcaagaaaagattgtgtaggttccaaagagtctgctttggcaaaaat-
agatgcggaattagaagaagttggaccatc
aagaagggttggagaggaaactgtaggagataattcaccatcttc 648 2823139 -- NO
tcccaacctggcagtgctgagtggg 649 3113389 COL14A1 YES
ggacagaaccagctacaaccatagtgcctaccac 650 2853728 C5orf42 YES
cagcagtgagagtcgtccagtccatggctcgtttcatggctgcctatttcaccaatcagcagctttgcatttt-
gccccctca 651 3895815 RNF24 YES
gctcggatttcccacattacaacttcaggatgcctaatattggattccagaatctgcctctcaacatatatat-
tgtggtttttggtactgctatatttgtcttcatcctta gtttactcttctgttgctac 652
4013748 BRWD3 YES ttgttgatttagattcagacggtcctggtacttcat
653 3384440 -- NO
ttgtccttgggcaaacgtggtatactttctcagtggtggttggaaggaaatttgttgccctgtcatttcgcaa-
gtatggaaaaagacctaaaggagaatttagca
gctgcagccgctgtttttattgcgtactttactagcgccaactctttaataatcgcttgttagttgttac-
ccctgttttatgggtcaagagactcaatatatcagtactt tggtaaggccaggcagc 654
4026568 FAM58A NO
aggccgggagtgtactgtgtgcagctgacccaaggcagccacatctgcgtttgtcctttgagaggactttgac-
tacaatacaggcatgacatcaatgaaagg
aaagtcatgaaatcgatgagactgaatccctacggatttcttaaaagccagatttgtagggagaatgaat-
gtgca 655 2675946 WDR51A NO gccagggatttgtaccatgggacttgg 656 2941689
-- NO tctccaactgcagcgacctgtggctcttcagat 657 2330052 EIF2C4 YES
gaaggcagtcatgtgtcaggacagagcaacggccgggatcctcaggccttggctaaggctgtgcaaatccacc-
atgatacccagcacacgatgtattttg 658 2726487 OCIAD1 NO
cgcagtgaggtctgacgtcatttcc 659 2902605 LY6G6D YES
ccccagtgaccttgattcaccaacatccagcctgcgtcgcag 660 2732332 -- NO
tcaaaagatttggagtctagagggcagaaattgaagaggttggtgctctgcacgtctgagtccgcccacagac-
tgaataaat 661 2329455 -- NO
ttcctggatcacaaagggctgtaggggttccagagatgctggagctctggtacaacaggagggccacaggc
662 2373856 PTPRC YES gtatttgtggcttaaactcttggcatt 663 2465069 SMYD3
YES
aaaaagcttggccagaccacaagcgggaatgcaaatgccttaaaagctgcaaacccagatatcctccagactc-
cgttcgacttcttggca 664 3046899 VPS41 YES tgatggcagctgaaattagccaaaa
665 3418387 GEFT YES
ttgccgctttgcactgacctccagagggccagagggtgggatccagcgctatgtcctgcaggctgcagaccct-
gctatcagtcaggcctggatcaagcatg tggctcagatcttggagagccaacgggacttcc 666
3568670 -- NO
ttcttgcagtagtgcgtgagctctcactcttgctctggggagtctggattagtccttgagggaatggattagt-
tcctgcaagggtaggctgttataaagccagga
tgctctcaggctctcctctgtttgcatgggttggcttcc 667 2824307 -- NO
aggcacaggctcaattagtttttcaaactctagccaaggcagtatttcatttgggaaatcatgcaacagaact-
gctcaattcttaacttctcctgctgttaacattta
cacttagactgccagcaacagttaacttaaattttggtctcaagggaacaaaaaaaaattgcattcagaa-
tttaatatagtattttaaaactaattttagcctgtaag
tcattatgagcaatagtaacttttgtacctcctcatcttgtctgataatatattctatatgctgtcaatc-
tgattatatagtctatatgctagaagttgctgattttcattct
gccaccaagaaaactgtacttttatttatgggaaaaggatttaaatactcctagatacttaaaatttttt-
taatctaaaagttgattttctcccaagaacaattttgtttg
ctttctacaaagttttaagtttaataaaatgccggtaatcaccactgttttcctccccaaaataaatgct-
ctgatccatattatattagagtgatactgtcacttagtat
tgatatctttaatattttttacatcatgagacattgttatgatcttacctgattgttatctcaaggtgag-
ctaatcatctttatttgccttaaaaaatactgtactggctgg
atatttaatcttgttagtttagttatacacttgttttagtcgagtttaattcaaaaggactcttaacagt-
atggtgtaaaactcagattttctagtccagacaaattgctc
tctataacgatttggcagatcaatggagacatccgttttaactttactgttctgtacttactatgtagtc-
atgtgcagcttatcaacacaaagaatacggatgaggg
catttaaatggactacaagtgactctgacttgtaaactagggaagcctcttgtgtttgaccttaaaggcc-
agagaaaaactgaagatagattgacttaactattg
ccaagcagattatgggttactttatacttcctttcattc 668 3204568 -- NO
agccctcaggccctaccaaccttgactgtcctgtccc 669 3410647 -- NO
cccaggagtactagttgagggccaggctgctgagaagcagttgaagtagccttgaagcaaggatgggagattg-
ctgggtgagatcaaagatacgctggg
atgggggtgagtgaaagtgtgagcaatgagtagaggcaagattgtagatgctgcatttggaggaatattt-
ctgactgcataatcagaggtcagaatggctag
agaaattaatacagaggtacaaggctagatttagaagagtaagctaagaacagactgcaatgggcttttg-
aatg 670 2555029 -- NO
catccacgtacacatatgagctgtacacatagatgttaatcaggttgcttttttcattttatttaaatattca-
aaatattgtgtgattgtgatccattgagatcattgaag
tagtattaatttagctgggaattagcagcttatgttgtgtgggcccagttcatcaatatgtgtgtcaaat-
atccaccctcagatatcagcagcctttgacttgcagt caga 671 3238290 MLLT10 YES
tagtaccttaattggcctcccttca 672 3490689 -- NO
tatagaggaaacctatcagggcagggacagt 673 3571835 -- YES
catccatggattgggcccactactcatagcagctcctgaggcaggtaaatggggcaaggactcacgccaaata-
ccacacgcgtatgtcaaacacccaagg
tcggattctggggcccctgccctcaggaggctgtcagactgttccccctaaacacacttctgaaggttgt-
agggaccttgccctgctgtct 674 2318698 PER3 YES
ggggcacccgttcattacttcgagaagcagctcacccttgcagttaaacttacttcaggaagagatgcccaga-
ccctctgaatctccagatcagatgagaag gaacacgtgcccacaaactgagta 675 2330382
-- NO
tggcccagctacatttgcaatgatgtgcacgtaaacactgttaagaggttaaagcttgtatacaatctgttac-
tgtgaaataactaaattgggctttaaaaaaatct
tagtatttattgatcttcattcacatatacagttgaaatttaaaataacagatggttattccaatgctgc-
tgaaaccttttctaaaaaatacttgttttgttggttgaatgt
gatgagaggcgcttctgggcagtctctcttctctcccacccgtctttcctcctccgagtaccccttctcc-
agctttgtactagccatgtaaaacccaaggttttctt
taaaacatcagaagagatctcgtcctccatgccccaaaaaagccaactcattggaggtgttaccc
676 3837059 GRLF1 NO ttgggtgttgaagtggaatcgtttcatcccagcc 677 2582942
-- NO
tcaatcaggtcaaccacaggtcatatgaaaccatcttcccaactcccccacctccactggttctgaagagtgg-
gtgtaaacaatgggttaaacaatccaggat gcagacagctgttaatcataactggctccaca 678
2876012 -- NO
tgtctcatctaccaattcctgctattataagatcaacttctgcaaaaaccttatccacctcaagtatccttag-
cagc 679 3372066 NUP160 YES
ctttgccttaacttccacggatatctgggccctgtggcatgatgctgagaaccaaacagtagtgaaatacatc-
aactttga 680 3781765 C18orf8 YES
gagatgcctcataaatttgtgatagccgtgctgatggaatacattcgttctcttaaccagtttcagattgcag-
tacag 681 3278980 DCLRE1C YES ctggatcacaggtgcataccgccatgcc 682
3435777 C12orf65 NO
gttcaagtgcaatgacacacgcctataatcccagcaccttgggaggctaagacaggaagatcacctgagccca-
ggagctcaagattgcagtgagctatga
acaccactgcactccacctgtccacttgttcttgtgtgacagaacaagaccctgtctctaaaaaataaga-
taaaaccataaagaaacacagtcagtactataca
agaataatggctacttctagagggaaggagttgtcattgtgatgaggcacttggaggggttctggggtgc-
ctgacaaagttctgtttcttcacctgggtggtag
ttagaagggtgtccccgtatttcaaattgtacctttgtgagattgtatg 683 3524572 EFNB2
NO gctaggctgtctgcgaagaaggctaggagttcatagaagggagtggggc 684 3790001 --
NO
cagaacaagtgcatctgctggcagccagcttaaggagttagcagccctcaattccaataacgaacgtgtaaat-
cagaattc 685 3301881 TM9SF3 YES
gaaggagatggataaagcagatgtttattggggcattccttatcccagctatggtgtgtggcactgccttctt-
catcaatttcatagccatttattaccatgcttca agagccat 686 2745373
LOC100130178 NO tggcagattatgtggaccatcaacaaactaccaaaa 687 2774241 --
NO
tgcacagacaattccctttactaggtgtcaccatagctaccatcttcatctccttcaaatgttgctttggcat-
tgaggcttaccctcacttccttatttaaaattacaa
ccagctgggcgtggtggttcacatctgtaatcccagcaattttggaggccaaggtgggcagatcccttga-
gctcaggagttagagaccagcctgggcaaca
tggcaaaaccccatctctataaaaaatacagaaaaaacttagctgggtaatggtggcacacacctgtagt-
cccagctattcgggaggctgagacgggagaa
tcgcttgagcccaggagatccaagctgcggtgagtc 688 2852754 AMACR YES
tacgacttacaggacagcagatggggaattcatggctgttggagcaatagaaccccagttctacgagctgctg-
atcaa 689 2390973 -- NO
tttgccagtagcctcataatgagcgtgaggtagtatctcattgtagtgttaatttgcatttacctaacaattc-
gtgatgtggagcatcttttcatgggcttgttggctg
ctgtgtctcttctttggagaagtgtctgttgaagttgtttgacattttttaatcaagttgttggacaggt-
tcccttgtttttaagtcagagtaggtgatgtttgtcttgaa ggttata 690 3457600
ANKRD52 YES accaagagaggcgaactccattgcatgctgctgcctacgtaggcgatgtccc
691 2853708 C5orf42 YES
ccttattccagggatgctgacattccatttctaactagtttttctggaaagcttagagaacatgaacttaatt-
ctttactttttgatgtacatacaacattaaaacgac
atcagagcaaaactaaaagccagaatgtgtttagagctggttcttgctttgttgttgctcctgagtccta-
tgaatcagaaaaatcatcctctttaaatgatgaatat
ggcatgcatttagaaaaccagaaactttcatcatcagtactggttaatcaagggatca 692
3055843 -- NO
cccagatggagacacccatagcagggcgccggatccaatctcttcctctcctccctcggccttcctctcccca-
caaaccccagggtctagaaagtagaagg
ttctcccctcttctctccttcctcataatgaactcgatgg 693 3139045 ARFGEF1 NO
catggtttgcggaggttagatttactggaaatgtattcatactgtgaattgtgctctgatggttaaaagacaa-
gattgtcaagcattccgtattaacagtggatgta
gaaaattttttcagatggacaaaatgtatatggtacagatgtaaagttttctatgtaaaaaattctgtac-
aactttctgtacaatattgattcccatctggca 694 3607791 WDR93 YES
ctgcctatttgcaatgccaccggaagtcaagggccc 695 2666907 SLC4A7 YES
accaagaaagaaatacgtggatgctga 696 3887309 -- NO
ccagcagggggttcccatccttcct 697 2333654 DPH2 YES
tggaagacgagggattgccatcgcctatgaggatgagg 698 3333566 LOC751071 NO
gtctgcggacgctgtataccctcctccac 699 3278417 FRMD4A YES
aagccagagaagctcgacaccgtcaagtgaaattggagccaccc 700 3986088 NRK NO
tcgacacggagcacccttctagcttcttcgtctccaggactgacgctcaggctcctctctcgccttagcccaa-
cttgctttcccgcctcgcaaactccgg 701 2558398 LOC100128333 NO
tgcccaccagccaactagacagatgtggcctgcattgtccccctggaggcaaaggatgtgtgggtatttattt-
atttaagatagtaagttatggccaggtgtgg
tggctcacgcctgtaatcccagcactttgggaggccgaggcgggtggatcacctgaagccaggagtttga-
gaccagcctggccaacatggtaaaccctgc
ctccactaaaaaatacaaaaattagctgggcatggtggtgcatgcctgtaatcccagctactcgggaggc-
tgaggcaggagaatcgcttgaacccaggag
gcggaggttgcagtgagccaagatcgtgccactgcactccagcctgggcaacagagcaagactccatctc-
taaaataaataaataaataaataaataaata
aataagacaataaattatataagcagtgctgaatacagcttcatcatttaaaaatccaaacagtttggaa-
atatatagacaagtatataaatgctcttcttgcaccc
cttcccccatcctaaagcctaccatacaggtaggcactgttaattatttggtggaaatgtttacactttt-
tgctttgcatttacacatgtgagtggcagggatagtat
ctgagaaattaatttttttctctcctgaattttctctttttctgccctcacatttatggagctcattacc-
tccagagcagcttttcaggttagaaaactgaatttatcttca
ggcatctctggcttttgtgtgctgaaagcttaagcatttagggcaactccaggatttgctgagtggctca-
tcaaaggatgaggattctcttgcacagactgaa 702 2830633 -- NO
gcattgtgtatgctgaagccatcatcactctcgctcacaggaggttcattatccatttctgacaagtagcctt-
ctccttgatcctcttccttaggc 703 2546259 -- NO
tatacccacatcactaagctgggaggcacattt 704 3615631 TJP1 YES
ttccgtgttgtggataccttgtacaatggaaaactgggctcttggcttgctattcgaattggtaaaaatcata-
aggaggtagaacgaggcatc 705 3729022 GDPD1 YES
gagctcccaccttaccttggcaaactggatgtctcatttcaaa 706 3729073 YPEL2 NO
tgatggcctcttgtcaggagagcagtggcacgggggcgtgaggaagagggaaaggggaaactctaagggtcct-
ggcgcggggaaggggtggaaggg
tggaggtaggaacaaaattgcgccgctcctggagacctgataacttaggcttgaaataattgacttgtct-
aaaagga 707 3043777 -- NO
tgcactacatcgctggcaagaattgttcagaaaggctggcctgctaacgacttctggggagattttc
708 3080463 -- NO aaggcacctacacaacatcaggccacttgg 709 2969705 REV3L
NO
ttgctaataaatgtaggccggaggggatggcttagtggtctaagcatcagatttgaaatacctagagtccctg-
gaactgcaggtttgaatgtcagcagagtca acccagc 710 2904894 MAPK14 YES
attctggattttggactggctcggcacacagatgatgaaatgacaggctacgtggccactaggtggtacaggg-
ctcc 711 3421016 -- NO atgcctccagtatcggatatgtgggcaggcacaa 712
3724753 NPEPPS YES
tgggttttatcggacccagtacagctctgccatgctggaaagtttattaccaggcattcgtgacctttctctg-
ccccctgtggatcgacttggattacagaatg 713 2600045 GLB1L YES
tgttgtggagcgaaatatgagagacaaactatttttgacggggaaactggggtccaaactggatatcttggtg-
gagaacatggggaggctcagctttgggtc taaca 714 2893581 -- NO
tgcatttcagcttggagtgcgcagcatgaggcatttgtggttcagaaaagaggtcttcctttttcctcctcct-
gttttcttttccttccttctccccaactccccaaag
gcttactgcctttcttctcaggccacgtgtgtagataacctttgaggaaaagatggtttccgtgctggga-
tatttggatattacctaaagggacaagatgagccc
tttctttgccttgttttctttctctggcctcatcagagtgaattatatctgactgtgtgacagttaattg-
taccatccatcccgtgtcctaagctgataagccc 715 3712473 MPRIP NO
gtgtgtcccatccaagttgagcacgcgccttccccagcttgcagcagcacaccccaagcgctgcttttcacct-
gtacctttgttttattattattattattattgctgt tgttgtcatcgttaactgtgggcatggaa
716 3026735 -- NO
ccatgatgtgaaaggtcgggtgatatctgagagctgaaggaggttaagcggatccatgccaggctgacaaggg-
gaacaggtgcctctgccctggactgg
agcctacgcaaccatcttctgctttatctagctgctgtctgtctcctgtctctgcgtgagtgtgtg
717 3603221 IDH3A YES
agtcgtgcagagtatcaagctcatcaccgagggggcgagcaagcgcattgctgagtttgcctttgagtatgcc-
cggaacaaccaccggagcaacgtcacg gcggtgcacaaagccaa 718 3820895 CARM1 YES
ccaggtggaccagaccggctccaagtccagtaacctcctggatctgaa 719 3183801 RAD23B
YES agaatgagaatttggctgccaattt 720 3420741 CAND1 YES
agaaaaaagtgtgaagacccgacagtgttgttttaa 721 2356132 TXNIP YES
cctgctatatggatgtcattcctgaagatcaccgattggagagcccaaccactcctctgctagatgacatgga-
tggctctcaagacagccctatctttatgtatg
cccctgagttcaagttcatgccaccaccgacttatactg 722 2625835 SLMAP YES
ctttcaaagagtggcggggactgcacttttattcatcaat 723 2996070 AVL9 YES
gtctgtcacctcgagatcttgtccttcatttt 724 3175548 -- NO
cctcaatgggaaccctggtgcagaa 725 3810034 -- NO
tagctgttcaggaaagctgtgtggctggagcagagaatatactggaaatcagagaggtcaaaaacaatgagca-
ggagatatcggaagaaatgttcctaacc acttcactcttc 726 2767097 -- NO
agtatttcatgacaactctaagaaggacagcactcaggggcagaatccgcaaatatcacctatttccaattat-
acttcacatgtgcatatgtgcacacacgacg gctgtc 727 2853747 -- YES
ttattctggggaatgcctgaagttaacatttctagcaattcggtggcatgagaatg 728
3016374 -- NO
cgcagtttgtcagcatcgatgtgggactgggagaggaaggatattgccagttatggttga 729
3845911 LMNB2 NO
tttatggcctgggaaacaatttgcatttgtccccaaatacgcttagctgtgtgccgcttagaacgatgcgaaa-
ccatccctctgtgtaagcccgtg 730 2642763 -- NO
gtggcaggagtattttcaccaaagaaattaaatgctacaaatcctaccaccacaccactggtttgggctcata-
gaaagtttgttaagagtctgtgacatgaggt
ggcctctaatacagtgagttcaatatttgaacttctgtaaagaaaaggattagatttattcagtatgatc-
ttaaagagggatgctaggggcagcaggtaaaaattt
cagggagacagattttcgttcagtgttgggaaactcctgaggtaagaagtgcccattaggctgggtggcc-
actcaccttagaagagagatactacagagaa
ggctgaaacatggaagattgtaggggttgagtggctcattagtttggccaccaaatc 731
3642784 PDIA2 NO
tgtcacccccgccatcactgctggacaggagccacccccttgggtaccagagggagctgtgcattgtgaataa-
aga 732 3178621 SECISBP2 YES tgttaccgaggttttcaaacagtga 733 3681988
KIAA0430 YES
cgatcggtgcagtgaatagcctccacagatacaaaattggcagcaaaaagatcctggtctcacttgccaccgg-
ggctgccagcaaatcactctct 734 2973750 -- NO
ggagcgtgggagttcatattttacactatgttggtacttaccatgcaaatgaacggccctgctgggaaaagaa-
cctttatccagagaggggatccgaggaaa
tagtaagagttgggttccgagaagctgtgctgcatcacgggagagctcggtgtta 735 3284084
EPC1 NO
atggtgcggaacctgctgttttatctatttattgtgccgtgtttacagttttttgtacactgtaccttcattg-
gttcctgtgctgtagtaaatgtgttaggtagctgtgga
ctccttggtattttgtaaatggtataacataacttggttcccctctgggtccttgagttttctgtgtatc-
atgtgaaaaaaaatggtgacatacatacagaattttaca
aaaaaaaaaaaaaaaaaaaaggcatcagtttttttaaaaatggggaatgtactattaaatggggatcttc-
ctggtctactatcattaggacaagtaacaagctaa
aaatgaagtctcttgaatctttccatccccaacttgcccacaaagctgtgggtggtttctggtacttaaa-
gcactaatattatgttgctgctctgcgaacagccca gtagtcccattt 736 3642301 -- NO
ccacaggagacacgaggccgaggtggcgcagcacccaccctacacagcagtggccatgtgccaattacacgtg-
ctgggaggag 737 3133236 PLAT YES
tgtgtctgaacgatggccgcatgactttggtgggcatcatcagctggggcctgggctgtggacagaaggatgt-
cccgggtgtgtacaccaaggttaccaac tacctagactggattcgtgacaacatg 738
2858415 -- NO
gctggtaataatcgcgtttttggtaaaaacacctcatggaatttttttcctttctcataaaatagctgatact-
gtaaaattgagatagcctctcaagtctggaacacc
tttcaattcatcaaaaagggacaacctaatattccaaagaagactcaatccttttaacacacatacattt-
tagggccagtcaagagaagtggcctgttctgtagg
aaaacatttcttggcacattattattttaagtgattgcaggagaccacagagggagagaaaagagacaac-
aacaacttctagcatgcctgggggatgacttgc
tctttcatatttgtggaaccctatgtcaagagagaaaacatctaaaaataaaaacgcatttactcagatt-
ctctagggcaaggtgcaa 739 3301253 -- NO
cttgtggcattgtgctaaagcaaaaaggaatggaatttgcaatgagagagcctttcaagttcaggctcagcct-
ttagctgtgtgaacttgaaccactcacaattt
ttctgaatctcaatttcctcatctgtaaagtttatctaatatgttggtggtgaggtaatcatattattat-
ctcaaataggagattgtatatgaaagggctttggaaagg
caaatcccattatttgtttaaatcaattttttcccctaaaaaagatagctcataaaagaatgtgaactta-
atctgtatgtgtaatttctttcaagtcctatctgatgttgct tgtgac 740 3068212 DOCK4
YES
aatgcctgtagtgtccagtaccgacgaccctttggctgtgcagttcttagcatcgctgacctgctaacaggag-
agacaa 741 3664307 -- NO ccagcaattctgaggcagggaccaatcaga 742 2357616
LOC388692 NO
atgtggattgtctaactggaggttgggagtccagggtgcagaaggagaagcttggagtgcaggatttggtggt-
atgtgtgtggcagtaggcactatgttctaa ttgccag 743 2824047 -- NO
atgaccagagtcataggtggtgatgt 744 3348756 C11orf1 YES
atttaagcgagagcctcactggttcccaggacatcaacctgaactggatcctccccgata 745
3561991 -- NO
cttatttgatgggtggccaagatactgggtagggtggtgtgatttgctatactgagtagatcagtaaacaata-
aagtataaatcttgctttgtagttggaaggtca
gttaacaaatatttagtcaatatgatgctggagttggctaatgtatcccccaggtctaattaatgaaaat-
aatcttgcattggtctttaggaaaatcatttttattctctt
tctgaatacttaaccatagttgtttacatgttttactgtggaagtaatatcttttatgaatgttttagag-
aaaacaattatggttcacttggaccattcagtaatttgtcc
agcctggctagtttctagttatctga 746 3051857 -- NO
agagaagaatcctccgacggcttcgttaccatcctgtctgaagcggattgcacgagccc 747
3459696 -- NO
tgagcttcacatggggtcaaactggaaagtatctctttgctatgctcccatttaattaaattaggaaatctgc-
ctaaaacttgaatcactcctcttttcagctggtgg
ccaggcaggaatgctccctgaagagtactctttcaatagacttcagaatgtgttacctgaaaagtgctca-
tgatgaatcaagacatcactgtgttttccatacttc
tgaagtagagattgtccactaacagcttagggaaagcagagtacccgctcagctgctctttttctggtgt-
ggtcagaccagctgggtcctctgaaacatgaat
ccatagtgcttcctttgttatactatttctgactcagttttctctaaacggctgtaaaatttaactgcct-
agctgtattttctttctgtggactttatgctctcatatttagg
agaaagaataagagaacaccaacttacatctctgtagctctggatgattattaaggccctggtctaatgc-
ttaaaggtaagcatctgttatctatattcaataaaa
gaggaaaatgaaccccagagagaaatcaagttactttagaatcgcaggctgtcccatgaccctggtgacc-
atcactgaatta 748 2614179 -- NO
gtgaagccatcagtgtctacagcttcagctattgcccgtgtgcagatggtgcttaatctctcttgtgccttcc-
agacctgcatt 749 3047613 -- NO
attaggtgatggtagcggactagccgacggagggcaggcaggggagggggagaggactttacagaaaaggaat-
tctcggtcgagctctgcctggagat gactggcttacacttactaaacccagcgggtca 750
3677890 CREBBP NO
atcaacagccgccatcttgtcgcggacccgaccggggcttcgagcgcgatctactcggcc 751
3177929 DAPK1 YES tgacaattcaagatagtttgcagcatccctgg 752 3211613 TLE1
YES
tcctggtcccagacagtctaagaggcacagataaacgcagaaatggacctgaattttccaatgacatcaagaa-
aaggaaggtggatgataaggactccag ccacta 753 3452723 RAPGEF3 NO
tgtgagaaggtgaagcccataaggcacagaaggagttcagtgagaccagtgacttcaggctcagtgtgggaga-
ccaggggaaggatgggcatgcagg
gggcgggggactaggctgtgggggaggcaggatgcatggaaggtagggaaggctgaggaggtggagccaa-
agtcggaggtgggagaagggctgtg
ggtccctgtgggaccctcatggggctcaggggctggaatgaaggaggtagatgagagggtctaaagctgg-
aacatcatgagttgagcatgggatg 754 2845333 -- NO
ggggctaacatggacggtcaggagctacgt 755 2852760 -- NO
tgaatgcctgaatctcaaacttgtacttcatcatggactccagtcttcctttcacatccaatttcaatgatca-
tcaatacagtcattttgctccttagcccactcggac
tatttctctccatacctgctgcaactgccttgacactggtgtgacagccttttaaaaactggtgtttggg-
gctggtatcactccagtggattc 756 2750640 -- NO
caataagatagacggaaatataatatttaaggttagagaagaaggctgagtgtggtggctcactcctgtaatc-
ccagcactttgggaggctgaggcaggaca
atcacttgagctggggagtttgagaccactcagactcacttgagacca 757 2807722 -- NO
ttcttatgcaaacaacaccatctgggctctggaacttcacaaaaggacactgttaagtcacac 758
3338718 -- NO tcatccatcaggctgtgtcagacgcacctgagccctc 759 3482760 --
NO tgaccccagacctagggttgctggtgga 760 3884900 -- NO
tgcttcgattgctttcgagtcatgagttggtg 761 3038653 -- NO
aaatgtgggcccgttaaagagcaagactctagaaaggaatctagccaaagaggacagcgttggtgggatgggg-
ataa 762 3340340 RNF169 YES
agtcagagctgtagtgacacagcccaggaaagagcgaagagcagagtcagagcagttccaggcaacaaagcca-
ag 763 3441973 -- NO
agtgctgtctacacgctgagtattaaatcctaaatgtgtatattagctgacaacctctcccttgaactctgca-
ctcacataaccaacaatctaaacctctccctcc
catatgctaccccatctcagtaaatggcaacttcattcttctagttgctcaagtcaaa 764
3629351 SPG21 NO
acccggtgtgttcttgtatagtcagtggcatcagcacccgtcagccggccttttccttcaggttcgtcaggct-
caccg 765 2611420 -- NO gtgctggcaccatcgagccacaactcaggggcctcatc 766
3371610 -- NO acagttttgagacaggtggttcaggtg 767 3795789 -- NO
gcctggctcttccttaccacccggattttgtttttgctttctgggtagagctctgatgttgccaaacagcctg-
tgctcctcgtgaacaatctctccagactcaaaat
agcgagcagccaaggggctgccactgcttgcggtccacag 768 3118031 -- NO
aggaaataactttacatgtgctcctct 769 2976043 IL20RA NO
tcctgtgcaaacaagtgagtcacccctttgatcccagccataaagtacctgggatgaaagaagttttttccag-
tttgtcagtgtctgtgagaattacttatttctttt
ctctattctcatagcacgtgtgtgattggttcatgcatgtaggtctcttaacaatgatggtgggcctctg-
gagtccaggggctggccggttgttctatgcagaga 770 3330211 -- NO
attactgaaagtggcgtgcactgaca 771 2397801 -- NO
atgccagagactgtgatgttggaaa 772 2537317 TMEM18 YES
aatacatcaatgaggcggctgcgat 773 2875953 -- NO
caatagtgcaatatcacgaccaggatattaacattggtacagtcaaaatacggggcattaccatcaccacaag-
gatatctcatattgcccttataaagccaccc
cacttccctcctacctcacccctcctgaactcctggtaaccacaaattatccatttgtataagttggtaa-
ttttgagaatcttacataaatggaataatacagtatgt
aacttttgggattgactttttttcacttagcataattctctgaagattcacctaggttgttacatgtgtc-
aatagtttgttcctttttaaattttaacttttattttttcgagagt aagtcttgcactccaggc
774 2882417 -- NO aggaaagcatgagaggtcagcagca 775 3095010 -- NO
catgcagtacattggatatgatataatttatggtttcttgtttgcagctgtttgtatctttttaatcccaaac-
cagacaaaattataaacattttatatacaatgttatctt
ggaaaaagttagatgtaaataattcatcttaatctatatttgagaaatctgaggggtattaggaaactca-
tgagtgaatgaacatatagattggatcaaaggagg
agagtatgagagtagggagaccaggtaaaaaggtatcatagtcatc 776 3450794 KIF21A
YES ggatgctcctttaaacagcccaggatcaga 777 3627349 -- NO
tcttctggctcttccgtgacgcattacaacagcca 778 2360857 FDPS NO
gggagcagctgatcaggtttctgac 779 3821204 PRKCSH NO
gtgcggtggatactgacctttgctccggcct 780 3665595 FAM65A YES
tggaggatgaggacgtgcagactcgagtggctgg 781 2852747 AMACR NO
caggcccacggctcaagtgaatttgaatactgcatttacagtgtagagtaacacataacattgtatgcatgga-
aacatggaggaacagtattacagtgtcctac
cactctaatcaagaaaagaattacagactctgattctacagtgatgattgaattctaaaaatggttatca-
ttagggcttttgatttataaaactttgggtacttatact
aaattatggtagttattctgccttccagtttgcttgatatatttgttgatattaagattcttgacttata-
ttttgaatgggttctagtgaaaaaggaatgatatattcttga
agacatcgatatacatttatttacactcttgattctacaatgtagaaaatgaggaaatgccacaaattgt-
atggtgataaaagtcacgtgaaacagagtgattggt
tgcatccaggccttttgtcttggtgttcatgatctccctctaagcacattccaaactttagcaacagtta-
tcacactagtaatttgcaaagaaaagtttcacctgtat
tgaatcagaatgccttcaactgaaaaaaacatatccaaaataatgaggaaatgtgaggctcactacgtag-
agtccagagggacagtcagttttagggagcc tgtatccagtaactcggggcctgtttc 782
3004680 -- YES tggatgagtgtaagggacaccaaggaggt 783 2722233 -- NO
tgaaattcataaaggcatgtgtgcca 784 2805960 -- NO
cccagggcattagagtgacctcacaagagtatctcagaatatttaaaaatttgaacacacaaacacaatgaaa-
ctcaacatctgtcagacatcacgtgaacta
ctagtgaggtagttcattctttcaacataagattgcactataatccttctgataatttcatatttttgtg-
agactgggttttccaggccatctgataaaaaatcaagta
ctatatggacaccaacatggagcagaaaatgagggcagcagtgtccaatctcattccaggtg 785
2952396 -- NO aggaatggaattaataggttgtggcaatatcaa 786 2612927 -- NO
caacccaatctacagttgtgggcagtggct 787 2640231 -- NO
tgcccggcctgcaataagtatttctaaataagatcacattctcagctacaagaatttaggatttcaacatctt-
ttgaggaggactcaatttaacccataagaatact
atgtgggccacacatggtgcttcacatctgttatcccagtatttcgggaagttgaagcaggaggatcatt-
gctcagggcctatggggacaccgggtgcataa gaccaca 788 3371122 SYT13 NO
agcaggaaatggaatatgcgggtcacactg 789 2972930 -- NO
gctgtgacacaacagtgtggcgatgtcccacagacctgaaa 790 3529011 -- NO
agcggctgcagcacgtagttggagaaggtgagggcgatgacagcctggttggtggggtagatcaccagcacag-
caatcc 791 3670860 LOC100129617 NO
gagccagccaccacgttagattttagagtctcctggagcacgtgaaaacaactgaaaaagggtaaccacacat-
catttcacttgtgatgtagcttgcctgtctc
cacaccatgcccctgaagaatagtatatcacctacagccccttccccagtcaggaatggaagtgcatgac-
acatgtgctcctctaccccttccatgctcatgg
cagacatcattaatcaattatagcactctttctgtagagccagagacagcatcacactctttcccctcct-
gcattccaggccaccactaccaactgaaatcgtgt
tagtaccataatgaatgctatgtaccattctctaccctaagcgattgcaaactgtaaatgaattgttgct-
gatttctgagcccctcctagatttggggtaaattcattt
cttgttttcagaacacaggggatagggacaccctgtgcagttctttctccaggacaaggagactccccac-
tgggggatggggcggggtttctgccttaatttg
ggcgctcatagtttcaaggaggagctctttctggctttggccagctagaaggaaaggtgccctgtttgtt-
aactttaaaatcactacgggtgtagtgtatggagt
gggctgtgccatgctggagttcagagcaaaggttcttcaggttttcttgcgaaggaccttaacttgtcaa-
tggcagagccacacccccgggacatacttggc
agaggaatgcctcttcaggcacataaacatttttgcatactccatgttagtcaataaaccgtttcataag-
ggttctttgaggacatctgacttcaaagggaaaaa
attcataattcagacaggctctcggggcttcaccatacaacgcctttcttgtatttggttagttttatgg-
gcctggagtgttgaccatgtatta 792 3844568 SHC2 NO
ttcctccgcatgagcctctggcatggtccttcctccagctggccccgggctgggcagagcctcctcctgccgg-
ggcccctgcccaccccctcctttgcctgg
agtgagggtgttcataccaaagacggaaccatttcgcctttaaagaaaatatatccagaagcagccgctg-
cctcggagccctggcccttgggtccccctctc
gcctggctggttcggtctaacgccccggagagtcagggctcccaggaccctggggaggaggcggattccg-
ggcctggctgggcttcctcttcccacctg
aggactgggtgcacagttgtctttgaggggggacgcttaaggtgctttggggttctcaggccaggataca-
tgctggcgctgaagtgcaggcagccttgagg
tcacctgggatctcggggtagccaggctgctccaagacagtggatatcgaggcagtcgtgaggcccctac-
tccacctgggagcaggggaaggacgtggt
tgcctggcctgggctgcgcccagcagcttccccccagtcctgccctcccagctgtcgacccagatgggat-
gttc 793 2810517 GPBP1 NO
cagcttacactgttttgcttgcagagtcatatctttttcgtacaatggaaatcctcaagtccactttgtgcgg-
tctccctctccttcccccaaaaaacaacaacaac
aaaacaaaaaccaaaaaggaaaatgtagcatgttggctaaaactggagcaaagtgcactaaaacaatttc-
ctgaactcacctgttgtactattcaccttttaaa
ccataaattgctctttagccatttgtagtgcagtaaatgttacaggaaaagacttggcacattttcttcc-
aaattttaagaggtgattttcaaaagctttattggggta
tgttgtcagaccagggttttcagagttgatggaaaagagtcttgtgagaaaacttattttgataaattat-
tacacacgcagaaaaactgatcacactgactggat ctgtccacgacatggaaaa 794 2377968
-- NO gtaagacacgttcccagaggcaggac 795 3020324 -- NO
tatgtaatgagcatgtgcatagtgtgtgtatgtgtttgtatgtgtttgtggggggtaatggtctc
796 3133424 -- NO
cctgagctggcaggtggcatcccaggctcgtgccaggacccagcagggctggtttccatgggcctgaaaaggc-
ccacatcagaattccagggcatagg cgaggattact 797 3225212 RPL35 YES
cttcctctttccctcggagcgggcg 798 3731955 -- NO
tggaaccctcaggtgttcgcaggtgt 799 4012443 -- NO
ggagtaggggtcaactggattttgccagc 800 3145052 KIAA1429 YES
ttgatgaccccagaaggagttggccttaccactgccttacgtgttctctgtaatgttgcatgcccaccacctc
801 3542308 -- NO
gggacggtgcacatgtgcattcacatgtgttttatggatgctacagaggaatatcagaagagaggaagagggc-
cccaaacagcccctttagctctgaaa 802 2385170 -- NO
atggcaggccccaatgtggcgtgcattgag 803 2617336 CTDSPL NO
ggtagaactgcccatgccacaaatatttatttggaaaagtagtcattaaatgaacccactgccttaaatgtct-
tgaatgttgcagtcaagtgtctgtcatgtgttga
tatccacacagaattaggccctaatgagagccttagaccctcaaccatgcccctttcgttggcatcacag-
ggccttatttggaagagcgggcaaagaggat
ggaaatcataaaatatttcatgggaatcgaacctagggatagtgctccacttctgacgatggagtgaaga-
cacttggcagacttgagccagacacttcaccta
gtagttcctgaaactgtgagcaccactgcactaagccagtgcggagctgttagggacgggcccagctcct-
gcaccacggacacagaatgtctggagagg
gccagcaggccctctgagggttctggaatctgtgcaccttatttgaccacactccaaaattctgttttta-
ttttaacccttgaatctgctttatgtacataatcaaaat
atctatatctatatctatatctatatctatatatttttaatcatctacatgtaaatgaagcaatagaatt-
ctaacataaggccaagaaatgagacgaatgtttggggttt
atgttttttaaggtaaatacgggtattgtttttaattattaccatgtattaaattgtgggctttgaaacc-
taatgaaacctgttagccacttctctgtgccatatacttcc
catgttaccaaaatacccccaactctttagccaaaagagaaccctgacctcctgagtttccatgctcctt-
tctgtaccaggtttaaatgtagtcttctggagaagt
atttttgacattgagctctgggacaggacaccttgggtttgtggactgcagcccactatgatgttattac-
ttctctggccaggcctccagtggaagtgcacagg
cactcccaatgttgttaatgctctgtcttccatttgttctggaatcctacgtgttggtctgtggttccat-
gcat 804 2982034 RSPH3 YES
catggggaagacacacatcagtctccagaacccgaggatgagcctggtggtcctggagcaatgacagagtcac-
tggaggcctctgaattcctggagcag
agcatgtcacagacacgggagctgcttttagatggaggctacctacaaagaacaaca 805
2335196 -- NO gtacaggaatccagctgtgtggagcag 806 3561721 -- NO
tccagctatacacccgtaacccaacagcggctcaaccctgggcgccaactaccgctgcgtcctccgccgcttt-
tcg 807 2819696 -- NO gataatagtagtatggatggcagtggcat 808 3408052 --
NO
catgatggttgtcttcactctcctactcccaatgattcctagaaaagaaactttaaaacatgtttctacttcc-
cattctgcagtttagtaaaatgatttggttaactctt
aaaactttttgtggaataatgttctgtgaattcaagtatacaaggcaggaggatcacttcaggccaggag-
ttccataccagcttgggcaacatagcaagaccc
cgtctctacaaaaaacaaaaagagaaaaaaaatatataatacttgaggtagttgaattgccgtgatttat-
tgtcaccaatatttttaaatcttatatttattataataat
acacattacatttttataactgggttataacattgattattctcacttattctagatgtgacttatttaa-
ataagtttagaattatatattaaatacaattatattaaaaacat
ttttgcttttatgtaaaacactatttgccatgacattttttgtcacgtaattttgtttttctttgtgttt-
gaatatgatcaaatacttcccaaaattaaacttacaaatgtatat
caacatattataattcaaaagctgtttttatttgggaaataaataacaatgtgtaaagaccgggaatttg-
ttctcctacctaagcctgatgattaaaagacagtgta
actatgcaggtgttaaacattttctatattcttacagccatctctgttcatatatccatttttaactcca-
cgcccctgtaagcctttgagtttgtgatccctggtgaaga
cagtgacccacattgattttttttttttttaaggtttctctctcttttttgctttttctctcgaatatag-
gacc 809 3628699 HERC1 YES
attcagcctcattgggtatctgccctggcttggccagaagagggtccggctacagcctggtcaggagagtctc-
cagaattgttgttggtgggacggatggat
ggatctctgggactgattgaagttgttgatgtgtccaccatgcaccgtcgagaattggagcattgcta
810 3350729 -- NO
tgcagacgtgcacattcccagtccgtgccccagccgtcctgggtccccttacaagcccgggtctgccacttca-
cccttgtttttccccatcctccgggtccac
atttcatatgcccctgccctcattcccttatgattccctagctgctggttccagagtcttctgggcttac-
agtctcccggc 811 3380411 -- NO
aaagcaaggaaggtattgaagacacaaagtcacatgtgatgggctcaggagccagtgtgaggaagggctgctc-
atacagcacagtggaggat 812 2377588 -- NO
cccatagagctcctaaccagatgcaacagtgactgcgtcaccattccccacttttcccaactacgcagtgaca-
aacctaccagctttacc 813 3219836 -- NO tgggagccgtggatgaaattgtgctc 814
2737650 BANK1 YES catcatgaaagcaggaagacatacgggcagagtgcagatg 815
2843633 -- NO
aggctcgccttctcaatagcgtgtatttggatgagatgagtttcactgtaaagagaaaaagatgttaaaacct-
cattgtctaaggcccctcatctgagaagtctt
gtctgaccctctagcccagcaggaccaaggtgtggtgcctggtcccagcctgtcctctgctcccctgggc-
tgcagttggcccagttgcctgcctccattagat
acggagttgctctggggctgagatgcccatctcaagtgcattctgtcggaagggttctctgctggaaggc-
ctttggttttagttgggattccatgagctttagcc caaaggtggcctcccatactagcatattt
816 3478420 -- NO
ccactgtccacagaccatctggggccctggagggagcgggctgggccagggaggaacaactgggaaggggcag-
ggaagaatcactgaacatcagtgt gaaggtggcctga 817 2749415 TMEM144 NO
agcttttcaagacacttcctgcatctctgacctgttgcacctctgttatcaggcacctctgttatcaagc
818 2921363 -- NO
tgacgcgggtcttacctgggctaaattcaaggtgctggcaggaatgcattcctttatggaggttttggggtag-
ggggcaaatccatttccagtttatttagttgtt
ggcagaattcagttctttgcagttaaaggatcaaagtctcctttccttgttgtctgttagctgagggtct-
ttactagcttctgaaggctgccttcattccttggctcat
gatccccttttcttcagagcctgcaatagtgggtgaagtccctctcccattttgaatcattcctgttaca-
ctatcatccctctctctgacctacccttctgtcttccatt
tccactgttaaatgtctatttgattactctgggcccactt 819 2703246 KPNA4 YES
tagttttgaactgtgatgctctttcacac 820 3226615 WDR34 NO
gctcgcagcctttcttcggagagtgg 821 3373866 SLC43A3 YES
attactttaaggatctgtgtggaccagatgctgggccgattggcaatgccacagggca 822
2852746 AMACR NO ctggtagcaagttctggatcttatacccaacacacagcaa 823
3023100 -- NO
ggctcctatccctacatttcaaatagcatttctctcacaattgattatgtattaaggcttgtcaacgaaaagg-
aaacttttttctctcagaatttctagaacttttttcttt
aaaaagttttttattctgtagccagaaaaatttaaagtttgtgctgggttgctttggttatagaactaat-
gaagcttgagtaatagtttcagacattctcagggtttttc
ttctgcagccagattttacacttctattatctcagctgtcttataaatgtattccctccatcacacaata-
taattagaatgtattgatgaacagatgtaacttcatcact
agagagacgttaaataaattatgtgttggtatcatgacttttatcaaatcatgaaggatgccatcacttt-
tatgtgatagtccattggtatagtactaaagtttgtaag
taaagaatgtcagatagataacaagataacttcattttcgagatctcataacctgggcc 824
3431525 ATP2A2 NO
tggtaccatccagttaagcccgtgacaaaaatggaaatttctaaatagcccaagtctccagggcaattgggaa-
cagctttgaacccactaagatggggtctg
ctatgccaaaacatagatacagaattcacagtttgtcctgcattaggacattctcttcaactttgccact-
gtagaaagtggaggtaggtcagcggatggtgcca cattaacagccgccttactgaagtgtagtcca
825 3695469 -- NO
tttatcctgatggaaagagtccagtagagaggaagagattgatgatgtaggagagagga 826
3761535 HOXB13 NO
ctgccaccgccactaacggagatggccctggtagagacctttgggggtctggaacctctggactccccatgct-
ctaactcccacactctgctatcagaaact
taaacttgaggattttctctgtttttcactcgcaataaattcaga 827 3823884 NWD1 YES
actgcagagccggtattccatatcctgggagatgcctctgatccttggatgtgcatggccgtgctggcctccc-
aggccacactgctgacagtgtccagggat
ggtgtggtcagtctgtggagctcagctacgggaaaacttcaggggaagcaacatatgtccagcatcaaag-
aagaaacacctacctgtgccgtctcagtcca gaagc 828 2475018 FOSL2 NO
ctcagctctcacaggggtaatcatctcaagtggtatttgtagccaagtgggagctattttcttttttgtgcat-
atagatatttcttaaatgaagctgctttcttgtctttt
atttctaaaagcccccttataccccactttgtgcagcaaagatccccgtgcaggtcacagcctgatttgt-
ggccaggctggacaaattcctgaggcacaactt
ggcttcagttcagatttcaagctgtgttggtgttgggaccagcagaaggcaaacgtccagccaacacaca-
ggactgtaagaggactctgagctacgtgccc
tgtgaagacccccaggctttgtcataggaggtcgttcagcttccccaaagtcagaggtgatttgatttgg-
ggaagactgaatattcacacctaagtcgtgagc
atatcctgagttttacttccttatggcttgccctccaagttctctctctcatacacacacacacccttgc-
tccagaatcaccagacacctccatggctccagctatg
ggaacagctgcattggggctgcctttctgtttggcttaggaacttctgtgcttcttgtggctccactcgc-
gaggcagctcggaggtgtggactccgattgggct
gcaggcagctctgggacggcacagggcgggcgctctgatcagctcgtgtaaaacacaccgtcttcttggc-
ctcctggccagtctttctgcgaatagtcctct
ccctggccagttgaatgggggaagctgctggcacaggaaggagaggcgatcccggctgaggcttaggaaa-
ttgctggagccggctccaagcagataatt
cactggggaggttttcagagtcaaacatcattctgcctgtgttgggggccaggtgtgtcacacaagcatc-
tcaaagtcaaaagccatctggggctgctgcttc
tgtttctcaggctctggggaaaggaatctccctctcctctcacttgattccaagtgtggttgaattgtct-
ggagcactgggactttttttc 829 2987324 -- NO gttggtgcccaacatatgcctgcca
830 3379421 SUV420H1 YES cgcctttccttcgaggagctcaaggcattt 831 3109159
-- NO cattcagcactctcacgggatggacagagcagtgttcatgcag 832 2480318 -- NO
ctctgacgcacttgaggggttggctc 833 2841516 C5orf41 NO
gcagggatctagacgtcaggccaactgagagctgacagggaagagagagctagctagtatagacatagacatg-
agaatcagctcagctgctgtaggaga
aagtcactgacagacagtagcatccaaggcatccagcgttatatgacccacgaaaacccccaaaattaaa-
tatacacaataaaaggtcaaatgtttttcttga
acaaaagtatatttatattgaaaacaatcaggtgaagagtagaccctaatcgccagtattt 834
3738805 FLJ35767 YES ggagcttcttacctgctcacactgg 835 2771466 -- NO
aaaagagagcaatcctgcaagccaatcccgactctgaaaatcatcacta 836 3322962 -- NO
tggtggtgatgcttatagtggagagcctctaccttgctgcagctc 837 3906050 -- NO
tagatctccaaaatgacctctcacca 838 3119642 -- NO
ccagagaaagccgctgacagggaggagaggccccagcccctattacaaacccagccatcaa 839
3125570 -- NO ccccaaaaccatctgcaacagccag 840 3933835 -- NO
ctgatggaccttctggccgcttctatgtttcttctctgattg 841 2802644 -- NO
gggatcacttgccacctgggatgtt 842 2854122 -- NO
aagttctgtgttagatagtcaagtagggtgactgtagttagcatccatgtattatatatttcaaggtagctag-
aagacttgaaatgttcccaacacagaaatgata atactcatgagataatggata 843 3147610
AZIN1 YES
gcaagagttgggtgtacctccagaaaacattatttacataagtccttgcaagcaagtgtctcagataaagtat-
gcagcaaaagttggagtgaatatcctgacat
gtgacaatgaaattgaattgaagaaaattgcacgtaatcaccc 844 3398488 SNX19 YES
gggtgaacaaatgccggctgagctggg 845 3629947 -- NO
gaccagctctgatgggcaacccaaactcaagaagtgtaacttttctgcagaacccttcagaacttaaaagatc-
actgatgtaaggtcactagctggcacctctt
cttataattacaattaaatgggcaataacttacccttacataatgacaactactattaaagagaaatcat-
ggcatttgagaacaatgacataagattaaatcaagg caccatggctaactattcagga 846
3677823 CREBBP YES ttttgtgtgcgacaactgcttgaagaaaactgg 847 3101370 --
NO
taggtgccctgaaagttattgttgctttttttgttttttttttttcagtttgtgcgtgtcacttgaatcagaa-
accaaacacatgtaaaaaaatatcatcctcaatgcccc
ccattaactctctctccagaaggtgacaatgttagtgaactcaagactctcactgatgatggtattttac-
aatgaaaacacaaggaaaccctttgaggtccaattt
tcacatcatattctccaaatagtaaaatagcagctctacatgttgatgaaaagaaatttcaatttcttcc-
tatttgtttttactcatatcaacattaatatgtatctggatt
tattaatttccaaaaagaaaattttagttaccaaatatttcagaaatttaataaagcattacatatatgt-
aattagcacttatctaccaaaaaaacatatgtgtatgtatt
tatttatcttaccttcactgaagttcttttttctggctggacatgagaaacaggattaagtgatcaatgc-
tggctttatttcttcataagcagtaatttgggtctttttcat
tcaacacaacgcagcattttcataataaattcacaaaagacaatacaaagaaacacctactgaatagaac-
tctgtcgagcaattcatgttttaaagttggactct
ataccaaactggcattatggtattataggcatttgatttttgttttcttattttcagtttgtcagtttct-
ttactaccattatttttttctagccggagataacgtataatca 848 2977512 -- NO
gccaagattagcatatgtgagtggcaca 849 2329726 -- NO
caagcacctcggtatagcattattactgaaaccacttaattcccagctttttgagttttttaaaaaaacccac-
tgcactaagattcacaattcattgctacatacaaa
ttaaagctagtaagaacacactaacgtcacaagtttctcattctaaagt 850 3626942 -- NO
tgcatgctcacagtaacacgtatactaaaat 851 3823576 RAB8A NO
gcccacggccaccagaatgcaattgagaaatcgtttattttagtaactgtctgatctttttcaactttggaga-
tggaataagttaaaaatttgctatttttcctgtaac
atctgctgaacgggcccacccacacgttgtatattcagagagagagagggagtcaaggtgtgaccgtcga-
ccacagccagtgtcaggcctctgcctctgg
gcctttgctttgtggcctcactgcaacacaaagctccaccaggaggctggttcacgtcccctaccacgga-
agcgaggtcccagaaggccagcggtggttc
caggagcaacagctcccaaaccctgagcaaggcaaccgatcgccaggaccaggaagcatcacccaggaga-
tttggcgcccacttc 852 3837475 GLTSCR2 YES
cggagcttcctacaatccatcctttgaagaccac 853 2802804 -- NO
tcgagtactatgtcttttgtggcactgaaaccttataacactatgatagctctgcttccacagcagtgaaaac-
cgaaagagccgggctgggcacctgcctcttt gaggtggaactcgggtcag 854 3410550 --
NO
atatctcgtctaacccctaccattgtgcctggccctttgaaatgtgtttcttgctgacgtgcttgtttctcct
855 2808525 -- NO
aaacagagtagcagttcagcccttatttgccttcaaaaaaagaaaagtacaaagtgttctctaattctggctt-
ttagaaagttctaggaagttaaatgaacactttt
ttttcactatgaattatatgagtgaattcatcagaacggctgcttctaagaaggattttggtggttttag-
aaaggtaggtgtttattcctttgcctgggaagcctcac
cagagatgttgactctacaacccatctcattcgttagtttttgtggacagcagttgcctcatcgggaatt-
tttttttttcacttccttaccatgtttcccttcggatggat agactagcc 856 3484743 --
NO
atttacactttaacaacttgctgggaatttaaacaacttgctgggaacatcctttgtgaggcactgtagcctt-
tttttatttgaaactacttaaactccaagacaggc
tcactaactctttttcaagtgcaacaacaaatgtgttagctgaaaatagctaatttaatgattatttgtg-
acacagacacgattatgtgagccaagaga 857 3765643 INTS2 NO
ccgaaggattttgcagtcctctgtcagtaacttccattgattaggcagacatattcaggtaaaccctaatcat-
taaaaaaaaattatcaatgtagaaagtaattcc
cttttttctctctgagatatacctcaatcacacacttccccacccccacttgaaacagacctcttcactt-
gtgttttttttttttttttcctgaggtggagtcttcccctgtt
gcccaggctggagtgcagtgggatgatcttggctcactgcaacttctgccacctgggttcaagggattct-
cgtgcctcaacctcctgagtagctgggactgc
aggcacgcgccacctgtatttttgtatttttagtaaagacgggggtttgccatgttgcccagactggttt-
tgaactcctggcctcaggtgatctgcccaccttggc
ctcccaaagtgctgggattacaggtgtgagccaccgcacctggccagaccgcttcacttgtaaaagaaat-
taggctaataagaaggtgtagtttttgagaaat
gaaatttaactttagccttttcactagtaaatagtcacatctcattttcttcctttgtaaaatggggtta-
ctactggccctacctcatattctatgagaatgagtttgtag
ctgtttcaaatcatgaagtgcatagtatcacatgtgatagaatatttataactttttattagatgcttaa-
tgttcaattaagtaattttgatgtgaaaaataaaagtaata
aaagtatcttaaaaatagcataagaattttcatatttttaaacaaggcagttttgtagtcccttaagatt-
aaatacaactgctccttttttttttaaactgaggccttgcg atattttgtg 858 3810029 --
NO
ctggtctcagctggactatcgctgaacagaggcgttggccgcacatccccttggaaggactctttgcttccac-
attcggaacactgtcctgct 859 2658003 -- NO
cttgaaatttgagcacatcccactgtattatttcactgtatggcaaaagtgaaggaggtaggcatgttctgtc-
atccttaattaagctttgggctgcttattgaagta
tcattttttctatagattggaacatggtttatatagcagactatcttgtccactgacattgcccagtact-
gagttcc 860 2788748 -- NO atgtagtacatttatgggctgtgat 861 3242486 --
NO ctcagctacttaggcaggagaggca 862 3540024 MTHFD1 YES
aggggagtggatcaaacctggggcaatagtcatcgactgtgg 863 3439941 -- NO
tgttgggaagcagcaacaatcagccatacagctttcaag 864 3457676 CNPY2 YES
ttgtggaggaatacgaggatgaactcattgaattcttttcccgagaggctgacaatgttaaag 865
3843592 -- NO
gcctggccagttgtaactatttatcactgtctggactcataaacattttgagatgactttgggagtgcctggg-
gagtttcattcagcctggtgcatatgggcagtg
aaaaatatgctcatctgtgatagtagatgtggtttggttcacaaatccaggggctgggctttaaacggca-
ttaggtggacagaggagggttgctacagctgag
gtctcagctggtgcagcacaaaagtgaaatagggccatggctatctgaagccatatgtggttctgtgtgg-
ctatggagtcattccaggagacgttcacaggat
gatttgggattaccactgctattgtaaaccatggaaattctgtgttaatattggatgctatttgtatttg-
tcaagcatagtctggatgcttatccacattttggtataag
gccagaattgaaggcccaatatgatgtgtcactttgacatcttgtgaaagtgggacaaccttaaaaggtg-
tgagtacaaatctcattcccactctgctctcttga
ataatgtatcctagcctaacagcccgttttatcaaggtgataaggcagggttccaggttgttatattttg-
tggtgggtttcaattccatccctaccagcagagttat
ggaaacaaaccattgcatattcccaagggaatcatgggccgttata 866 2518951 -- NO
gcaaccctgcagtggtagtagtggtg 867 3187461 -- NO
cctgggaatattggcgctagagaacagtgatataatttgaggtgtctacaaatgttgtctaaaaaacctctct-
cctctcatcccatgtttcctctgactctactctta
aaatctaggtatcactgggaagagtaacgcactaggcccacaggaccttagtattaatataaatgagctt-
tagttttcaaatgtcatttttttctctataactggag
aaattccattaataaaagaaccctaggggatagagggtagagggagcgagaggggagtaagggaggacac-
ggacatacttaacactacctagggcacc taaccatcagaaatg 868 3730738 -- NO
ggcagataaagtacccatactaaaaagatgtctttagcttggttgaaaaataattgtcagtcctaccactgtg-
agttcaaagaacttaagaaaatacagaacttc aagcagagatatagaggattg 869 2898998
SLC17A4 YES gtgagaagagatacattgtgtgttc 870 3397924 RICS YES
atctaaagagctggtctacctcgtgcagattgcttgtcag 871 2494772 -- NO
taaatgactgtggactagtgcgcgttttttgttttcag 872 3322617 -- NO
catgacccaccgtacatgcatgggcatgatctgattttttttttaattaaagttgtcacagttatcaaagtct-
catta 873 3735156 -- NO taaaattgaaatgcaggttgggcac 874 2346360 -- NO
gtattctctttcatgtggtcagtgtatga 875 3757401 -- NO
caccagtttagcctttgagtgtgcagagctctgccctccctcccacccctcagccccaaatccaagatttcat-
agccctaacacccacccaagcagcttccct
cacacatgccctttgttttcttcctctcttctatggttccttagggaaaggagccttctttagggatgaa-
aagctaactacagcccagtctggcctccagcagccc
agggtcagctcagcctccactggaggcgagggaggagggcaaagggcatgggagaggtagggctgccctc-
caggagccttccccttccctaggagcc
agtcaggattggggaggaaggcagaggggtcctagggagctgtcacatagaggaaaaggggctgggagtg-
gggatgacaagaagtacaaagaaaga
gaaagtttggggagatggataacaagctcagctgtgtcagtgatgtggaggggaggtatggtgggggacc-
agccatggccctatccaaccccaggctcc
acaggccccaaattggctttgcaaatccaaacattttaaggaagtggtttagggatggaagagaaacacg-
gtagaggtctgtgctgtggattttcatctaggg
tggtgggaacaccagagatgtctcctctgccattgttttagttggctcctggacctcatcccagcagagg-
gagggtgactgtcagcaggtcagtcccaccgc
cactgtccccctcgcagtgggcctctgtgtctcaggcctggccaggctccctgcccctcagagctcctcg-
tggacccgctcctcgtcctcatctgacttcagc ttgagctcgtcgactgtgatcttgccgtcctgg
876 2386080 -- NO
gggcgcttttatgaggcatgagggaggcttgataggggctttgaaggcactgatggcaattggtgaagtagac-
ttttatctaaagggggcagaga 877 3013608 -- NO
tttgcctcttcgagcttggcagtgcgagccacaga 878 3460675 -- NO
atgaacactcgcaggtggtcaggtg 879 2564601 MRPS5 NO
cacagcttgggatgttaccttgccttttgt 880 2939374 SLC22A23 YES
tgataatgcctggaaggtccatatcgctaagttctccttactggttggattaatctttggctacctaataact-
ggatgcattg 881 3320209 -- NO ccaccatgattgtgcttgccgggag 882 3852627
LPHN1 YES
gtgtaacaaccgcacccagtgcgtggtggtcgccggctcggatgcctttcctgacccctgtcctgggacctac-
aagtacctggaggtgcagtacgactgtg tccc 883 3349758 -- NO
aaacaggccatgtgactgaggagcaggtagcattcatattattcatatttcgagcttggtagatgtagaattt-
tgcagtggaggccaggagaggatgtgagag
ctgcaggacagaggcataggtttttggaggtggttgtggtgttccccgatggcaatcaacttcacggaga-
gaagaggttattttctacttaggttgcctggagc cta 884 3427503 -- NO
aggtccttcaggtgccattaatttttcttgttattcaacacatattattgagcctctgtaatgtcctaggctt-
gttcaagatgttcagaataaagcagtggatagaac
aggctttaaagccctgtactttattgcccaagtcaacgtccttagaatacaggtacctcacaactacctt-
gaggcttttattatgttattttcttctgcattcaggaatt
ccccagagccaataggatacaattttaaaatgtcaaaccatttttgatctcataccatttggcttcagtc-
cttctttccaactgtatcattgtctatttctaaataggga
tggtctacactgtaaggctgatttgctcattgcccccacaaaatttgtcttgcattttctctgttcattc-
ctgcacctgaaataattttgccactgccttctcaaagcc
ctcaaaccttcaatgtctgggtcaaagccgttggctcccaggaagcctgttttagaaattaaatccccaa-
gttcttttatctgcattgattatttaacacctgacagt
tgcaacaactaagatgatttgagcgagataatgctccacattttttaccgtgtctgtgtttgtaggtgtg-
cccaactgacatactggctaagagttcagggtccca 885 3835463 -- NO
gtcctggatcatcaacttggttacaacatggtgttaacatgtgggactgattgtgtttcttgttaatatttct-
gtttctcccaaccacgctgaatatt 886 2809576 -- NO
tcaaatctatggcttaccagagagaagaccagagcgcaatatctccgtggccttagtcctgact
887 3601075 -- NO atgggccaaagctggggcacaggaaa 888 3864620 C19orf61
YES
gacttatgttttccgggcccagagcgctgaaatgaaggaacgagggggcaaccagaccagtggcatcgacttc-
tttattaccca 889 3888182 CSE1L NO
ggaagttctccttttgaacttgtcacgaattccatcttgtaaagg 890 3558243 RIPK3 YES
cttcgggatcctaatgtgggcagtgct 891 3702633 -- NO
tttactcctaagcaccagtgatgacctcgtcaagcagggtgggctgcagggagatgacagcgggtatgaaagg-
gtgtga 892 3433106 -- NO
tagctcaatgcaaccgacgtttctgagcccccagaatctgatccagatcccggacatataaaccacgccaaga-
agacaggggctgtctctagcacattctct
cgagggagtccggggccccttcccagacgcaactgcaaaaggaagggctaacgccatggcgggcccgtgg-
tttattttatatccgacaaagtgcacggc
agcctgaactggactggaatgaaaagacgtgtctgggacgggtctacggggacgcgctgcgggacctgtc-
cggcttggcttccaagccgctaaccaacc
gctggatgctctgcagttcgctggtggccgcctctttctccgcgcagagtttgggcgacaa 893
3544695 TTLL5 YES ggggcggggcgtctacctgatcaacaat 894 3219716 -- NO
gtggcatctctgcttggaagtcctattcttagtctcagcttcagtacaccctcaagctatcttatttgcttct-
aaaaatctcttctagtacttctgtttcagtctttgtata
gttcctatctgttctttggatattaattatgtatagtcacgtatatatactgtgcagacttatttagagg-
ctttttgtcatattttgcttaaacctgctactgtgcaatctta
cattccagttctttcattagtatggtctttttttttcctttctcctctcttctacacttctattctactt-
ttccttcttggtccctttgcgtagcatcttttgcctggccatctca
gttttatcttttaagtcctttttctttgttcatcccctgcttcagtgagcttttgcttctctgaactttg-
ataacaagtattactgaaccatttatttctgggtgtagaattca
tccaaactgagcttttgagggaaccttattggttatctaattcattctcctggccagtacagctgtcatt-
ctctgaaacatccatgacagtatctacttgaatgtttaa
tggacatctcaaatgtaacgtcagagactgaattccagaccttcctccagttgtctgttcttctcatagt-
c 895 3442242 ZNF384 NO aaggagaaggaataagacggcaggagg 896 3293761 --
NO
accctccttaccttgtccttagatgcttaacatttttgtttggttttcttataaaaataacagatcttatgaa-
ggtagaggtcagatgctgaatgagcgtctggcaaa
agtgggatctgagcagctgatgcgggctgccagggccaagccaaggttgtccccaaggcctggccttgga-
gggtcccccccgaccggccctgtccctg
cccttgctccctgggaggggacggtggatgggtgctgctcacacccacaaggcttccctgtctagtcaca-
gctctgtgatctccaggggggtctccatgatc acgtcgcgaa 897 3829701 GPI YES
cccaggagaccatcacgaatgcagagacggcgaaggagtggtttctcc 898 3539958 SYNE2
YES agtgagaactacagaaggcgaggagg 899 3620286 EHD4 NO
ccctatattattctatccgtcctccag 900 3621069 -- NO
atgaatccacctaaaaggggcagaggca 901 2496816 -- NO
ccacccatgggaagctgatgagttttgtgtattgaattcgaagagcagagaatgggggaaaaggagattcccc-
cattgaaaacctagataatgagagaggc
ggaaccaaaagcagactcagaacttcactgagaataatgggggtgtagtagtcaggtgagagagactgga-
ctaccaaatcatcgttgctatccagtta 902 2644239 -- NO
tgaagaccagtcgaaggagtgcagaccaggaaaagcgggacgttgatttggatggga 903
2832085 ZMAT2 YES
tggactttcgccgaaagtgggacaaagatgaatatgagaaactcgccgagaagaggctca 904
3757844 STAT3 YES tgctgaaccctcagcaggagggcag 905 2943556 -- NO
cctcatctgctcctactaccttgca 906 2459948 -- NO
aaacttttctcgatacccttctgtgatgactt 907 3119958 GRINA YES
ctttgtccgggagaatgtctggacctactatgtctcctatgctgtcttcttcatctctctcatcgtcctcagc-
tgttgtggggacttccggcgaaagcac 908 2567115 -- NO
cctgattagcatatcacagtgctctaggagtcctggaacgccttcctcttccatgtgcactgctgctgacatc-
caggccattttggaacctgcaaatgtctcttccc 909 2893649 -- NO
taagtcttagtaactccgtgctggatgtgcattttgcattcagcttctttatcataagggaggaacaaagact-
ggggctcctgctgacatctgcagacacaaag
ctgagtcggaatttgtggtcttagcttcggttcagcaccaagtgtatttataagtttgcagtcataggtt-
ttgttgtccaaatcccaacaaagccctttcccacctcc
accccaccccggaagttatatagggttccttgaagggacaaagcctctagaaaaagaaaagtcactgaaa-
gttgtaatgtgaaaccagcaaagagaaaata catgtttggtttagttgtggtcacagtccatggtg
910 2346547 -- NO ccctgacagatctcggtctggggcacagga 911 2852745 AMACR
NO
ctggagcttccctggactcaacttcctaaaggcatgtgaggaaggggtagattccacaatctaatccgggtgc-
catcagagtagagggagtagagaatgga
tgttgggtaggccatcaataaggtccattctgcgcagtatctcaactgccgttcaacaatcgcaagagga-
aggtggagcaggtttcttcatcttacagttgaga
aaacagagactcagaagggcttcttagttcatgtttcccttagcgcctcagtgattttttcatggtggct-
taggccaaaagaaatatctaaccattcaatttataaa
taattaggtccccaacgaattaaatattatgtcctaccaacttattagctgcttgaaaaatataatacac-
ataaataaaaaaatatatttttcatttctatttcattgtta
atcacaactacttactaaggagatgtatgcacctattggacactgtgcaacttctcacctggaatgagat-
tggacactgctgccctcattttctgctccatgttgg
tgtccatatagtacttgattttttatcagatggcctggaaaacccagtctcacaaaaatatgaaattatc-
agaaggattatagtgcaatcttatgttgaaagaatga
actacctcactagtagttcacgtgatgtctgacagatgttgagtttcattgtgtttgtgtgttcaaattt-
ttaaatattctgagatactcttgtgaggtcactctaatgc
cctgggtgccttggcacagttttagaaataccagttgaaaatatttgctcaggaatatgcaactaggaag-
gggcagaatcagaatttaagctttcatattctagc
cttcagtcttgttcttcaaccatttttaggaactttcccataaggttatgttttccagcccaggcatgga-
ggatcacttgaggccaagagttcgagaccagcctgg
ggaacttggctggacctccgtttctacgaaata 912 3659213 -- NO
acctccaaggttacagcactttctaagaatgtgcctatgtagcatgtctgtccccccactgcctccaccaaaa-
ttctgagaacaaagacactgtagggattgaa
cctgaagagtattcgctggaatggtatgctaaggtttctttcctgctgtacacctcctctgccccaacaa-
ggtgctttaagttctgttttttaatttaggaaacctgtt
ctgctattatagaaggccatgaaaagagaccagtgatttatctaatcataagcaaaaatagtagaaggct-
attgtcttgtcacttaagttgaatgaatcccagtg
attgtagttgcttcacgaaaaataaccaatttgttctacagaggtagtctgttcccagagattgaaaaaa-
aaaaagatgtaggaaagtttaaataaataaaattgt
ttaaattcacaatggagggccaattcacatggccctctgcattttgatgtaattctaacagttttactag-
cagaatctaacaaattttgaaagtcagagcgtatgta
tagatatatatacacatgcacacatttttttaatgatacgttatccacttaaaaaaaaaagtctcaagaa-
tgtcataagaaactcccttaacctcaatgagcctcag gtttctaatccctaaa 913 3296517
POLR3A NO
ctcatgtaacctgggaagagccataaaggggtaccccccaccccaactgccttcctggaagcatgcctgggaa-
gtaagctgtaggcctgatccgagccag
gaccactgggatccgtgcaaaggccaggggagggtagaattgaatcataggagtgaactccggcacctgt-
tgtcttctgcgggtgacgcacactttaaatgg 914 3028090 -- NO
cttggtcgtcacattctgcttttag 915 3291113 -- NO
aagatctttgagttgtacttggtgtgtgctgtttttgtttgagatgcagtgaatgtgcaaatagcccagccgt-
aaatagttacttaaaataatctcttggtactgggt agcagcagtagaaagttgatctgttta 916
3616816 -- NO
gggccgaaactgctgccgtgcattagctctgtggaggggagtcataaattctggttgtcagcgttttccgtgg-
ctttgtg 917 3842744 -- NO
ctccatatattagctggggctgccataacaaaacatcatagactgggtggcttaaacaacaatttacttctca-
cagttctgaagtctggaagtctgagaacagg
tcgccagcatggttaggttctcgtagggttctcttcctgttc 918 3956320 PITPNB YES
tcccgagggctccttggtgtttcatgaga 919 2473315 -- NO
ctgggctgccaatctcttgccttgggggcagagcctcatctctctggctactggggttagctaccttgttgga-
gctggcaaagccattggtgttgacatcggg
ggtgactcctgaagccgccatatacgtgctgccaatggttttgatcttggtgatcacccggaacttggga-
ttgtccaggagctgaggccaggattcaggaaa
gaattgtcagcagtcaagggagaggaatgacccaacccagtgacagatgtacctgtttacaaggacccca-
ctaaacccaagagacactttcctatcaaagtt
gttacttagtctaccgcttatctgccacatgatcctgggagaacttc 920 2659117 -- NO
tgcctacatgctccttctagctttgtttccctgatgttccttgccacctgctactcctctctgagctactttt-
ccaggttccacagggagaggttcagctgtccgtgg
tagacatgagggtagagaatgaggtggttgggttccacttacctttctatcatcttgcagtatggatgtc-
tcttgactggtaccgtgta 921 2826873 -- NO gatatttatttgggtgcatgtttcct
922 3498544 -- NO
tggcgtctgatcaggaagggactctgctgcggctgtggatctgacctgggtatcagatggtgatgctttgtaa-
atagtgtgcctcataggggtctgttcttagtt aaaaggagcctgcttggtgattccttttg 923
2756844 SLC26A1 YES
caggccatcgcctactcattgctggccgggctgcagcccatctacagcctctatacgtccttcttcgccaacc-
tcatctacttcctcatgggcacctcacggca tgtctccgtgggcatcttcagc 924 3088854
-- NO atgtgccctacccagacagtgcctg 925 3173548 PGM5 NO
cgggagatgcttcactgatgccttcttgctacctgtttgtgcctcttatgactttggaaaaacaaaagatatt-
ttgcttttgggggatagagggtgggtgggaaaa
gaaaaaaaatccatttggttttggttttgtcctattcctccaaatgcagcagggcctttagttgtctgtt-
aaagctgcactataatttggtatctacattttatcacaca
aaggaacctccccttttgacaacaactgggctaggcagctgttaatcacaacatttgtgcatcacttgtg-
ccaagtgagaaaatgttctaaaatcacaagaga
gaacagtgccagaatgaaactgaccctaagtcccaggtgcccctgggcaggcagaaggagacactcccag-
catggaggagggtttatcttttcatcctag
gtcaggtctacaatgggggaaggttttattatagaactcccaacagcccacctcactcctgccacccacc-
cgatggccctgcctcccccatcccatccccaa
catccctgtaccaccttctctcacatcttctaaagctttgtacaaatcacaatggtgcacttccaacaaa-
atatatcaataggtgttttcctctcttattttgtaaatag
tattattttagctattaagctggataccttctttcaaattcagccattcagttgtaaagttgggaagaag-
tttcttgacaagactctgcaattaaatgcttaaaatttgg
aggggatccttccttgattacatcaagtatgttggtacatgggtttatacaagttcctcttgagaaggca-
aaaagaccaccatgtgtgagagctctttgacttgg
ccaataggggcctatcttaatgcacttgtttggacacatttctgatcttatttgtaaaggctgcaaaagg-
agaggatgaaatgctgtaaaagtaggaaatgaagt
ggaagctggaagaaaatgtaattggtggtacagctatgggccagatggtggaggggagggtggggacccc-
tgc 926 3200057 BNC2 YES
tccctcccaaccagtcccatcattccaaccagtggtaccatagagcagcaccc 927 2974443
MOXD1 YES
ggccatgagagtctggtgcaccacatcctgctctatcagtgcagcaacaactttaacgacagcgttctggagt-
ccggccacgagtgctatcacc 928 2385905 -- NO
tctaaaaggcgtggaaacatttataagaaataccaattatgcagtgttggtgtcagtgtggacttaactgccg-
agactgacttattgccag 929 3639566 -- NO
acaggttatttctatggacaggctcttgacagaaactctgaacatggatattactgtccccttcattcaaatg-
aggctgaactgaggctcataagtatttaactctc
acacctagttaacacagtaagatttgaaaccagatatatatgaatccacgaagtcttatctg 930
3200565 -- NO tggcatttcatgaggggaggcttatctgtgg 931 3083781 MCPH1 NO
atgtagtggcctatgttgaagtgtggtcatccaatggaacagaaaattattcaaagacatttacaacacagct-
tgtggatatgggggcaa 932 3829376 -- NO atggccgtcgtcaggagcattgtgga 933
2359017 -- NO gtaaccgggggatcttgcttgtcagtgcctggac 934 3180982 HABP4
NO
ggggagacttttccagctgggccaagggagtcagactctaagaacaatagatgttgcttttcccgtgtcatgt-
aaatttgttgcacttttttgggctgagctgtta
gaggggcttctccagaggctcgagagcaggccatttcccaagaagatgaagaatggtgactgtgttttta-
ttgaaggaatttcaaatgaagaataatgtttaaa
atgtgtatatagagatagtatagactcctccgcggaagcatggagggaaaggaggttgtaaaatagactc-
catggagactcttaggaagcagtagattcccg
ggggctgtgcctttagcgttagaggaaacacatagagctggaactgttaatggaaagcagtcacagctga-
gttttcggagaccaa 935 3915249 -- NO
ccaagctgtagatcttcccaagatatttttcaggaacgaagcatgtaaacttacatgagtgaaagacagtggt-
aaaaaaaaaaaaaaacagtctattttgggct ttggctcctacctaaatctagcttgtt 936
3263765 -- NO
tgcagagtcctacagctggttcaaggcagcatcaggctcagaacccctttctctcagctctctgttgtgatta-
tttcaggaccttgttctgttttccacatggcctc
taatctagacacctgacctggtgggagtaacctttca 937 3303272 ERLIN1 YES
ggagctcaaaaagtaccaggccattgcttctaacagtaagatctattttggcagcaacatccctaacatgttc-
gtggactcctca 938 2683681 -- NO
ggtgacccaggcacgatagctaagaaggcaaagtcgcttgttctattagctgtttaggcatctttgcagccat-
ccttgatttggagtttttgatcttgatctaattct
atccctcaaaaccagcccttacaatctcacgtgcccacctcttccatgacagtccttgggcctagaggga-
gggtgattgtatagttttagcagcagggcatttg
cagtgaaaaacagattgggcccagtgggatgccaaatgagagagggtcgcatct 939 2683865
ROBO1 YES
tggtgtgtggcttcatacatttggggaccctatttccactccctcctcttggcatgagactgtatacaggatc-
cacccgag 940 3781116 -- NO
ggcagctgccctgtaatgttctaccagtacttcagactcaacatgcacgaagattaa 941
3050281 -- NO
atgctgcccttcgatgaccatagtgaatgttccacagagtgtactacgagccacaaacaccagggagagaacc-
ccagcatcagtggagtagaaacaaaaa ggtgttctgtgtttcgcacttgggtcctg 942
3903591 -- NO
atcggcatagcctagatgggtcttctgtttcagggtctctcacaggaggtagtcaaggtgtcagccagggctg-
gtgtctcatcttagcgcttggctggggaat
aatctgtttccaaactaacttggttggtgacagaattctcttcttgaagggatgttgaattgaagggctt-
ggtttctcactggctgatggctggaggttgctctgaa
ttcctttccatgtagcttcttcaacatcacaaagctgagaaaggaatagcaagtctcctaggaagatgga-
aatcacaattttttataatcatggagtggcatccta
tcacattttccatagtccgttagttagaagcaaatcaccaggccagtccatactcaggagga 943
3115066 -- NO
gtctaggggttacaggatcatcatctaagttctgcttctgcctggacttgctgcgtaatttgaatgagtggct-
aaacctgactctttctcctcttg 944 2509773 MBD5 YES
cactaacagaaggtttggaagcctacagccgtgtccggaaaaggaacaga 945 2322410
NECAP2 NO ttctctttggtggtttctaaagtgcct 946 2837342 CYFIP2 YES
ttttgtgcggactgccattcctttcacccaagaaccacaacgagacaaacctgccaacgtccagccttattac-
ctctatggatcc 947 2936910 -- NO
ttaaaggtgtagagtaagaagaatcaataccgtgtgttggatattaagcaattggtaattaatcttgcttcct-
ttatcttgacaagatgtgctttttcacttac 948 3958553 SYN3 YES
atccttcaagccagacttcatcctggtccgccagcatgcctacagcatggccctgggggaagactaccgcagc-
ctggtcatcggcctgcagtatggaggg ctgcctgctgtcaactctctctactccgtc 949
2901722 -- NO acagtaatggaagacgggagttgcagtgctcagtcatggaattcctccta
950 3092902 NRG1 YES ccaaatgagtttactggtgatcgctgccaaaactacgtaa 951
2437102 KRTCAP2 NO
tgccacgtgctcagaaattcacagcagatgcaatctcatgtaaaaccctcatgtggtaaaacaaagatctatc-
atggttgcccttaatcttttctcttttttttttttttt
tttttttgagacaaggctttactctgtcgcctaggctggagtgcagggatgtgatcactgaagccttgac-
ctggtctcaagcaatcttccctcctcagtcttacca
gtagctgggactaccagtgagtgccaccacacccagctactgttttaagtttttgtagagatggggtttc-
accacattgcccaggctggtctcgaactcctggg
ctcaagtgatcctcctatttcagcctcccagagtgctggaattacaggtgtgagccactgtgcctggctg-
ccctcatttctttgcccccctctaggacttgctttct
ccgcatagcccttttgcaggcttcagagttctttccatccagtagccccgggacttctctctgttaggtt-
ttg 952 2657991 CCDC50 YES tatgccgagattttgctgtcctggag 953 2520359
-- NO
ctttgagcgatgaaaacagtttttatctttttagcaaagttgtagttaggatcttctgtctgtttttaggggt-
ctccactggtattaaaggcctga 954 2592274 STAT1 NO
gctgaggtttagctgtcagttctttttgccctttgggaattcggcatggtttcattttactgcactagccaag-
agactttacttttaagaagtattaaaattctaaaatt
ctattaatctctcattaatagtatttaatataaagattcttaaaattactgacgttatgaattggtttga-
tgc 955 2681309 -- NO
atcttctaagtgtccatgcagcttgaatcattgcacacagtcttctatgagttatgaaaataaataaaacccc-
ctcttttccccattttatggttgtgaaactgacac
agataacacaaaagggtagattagggaaagccatatcccctctgccacccacctccaatactgatccagc-
tttcctggatcaggctagtagggcgttgaggc ttcttactagaa 956 2961267 COL12A1
YES
ttggaatccatctcctagtccagtgactggctacaaagtcatcctcacaccaatgactgcaggaagccgacag-
cacgctctgagtgtggggcctcagacaa
ccacgctcagtgttcgcgacctctcagcagacacagaataccagatcagtgtttccgccatgaa
957 2854242 RICTOR NO
ggctgcatcctattaccacaatggggtgtgctataactgctggtattagagagggaactttggccctttcacg-
tttttcttaatgtttgtaacactacttcagaggtt
tataacctcaaagcagaagaagagcctcaacaacccgggacttataagttatttttatgttactagactt-
gcataaagattcttgttttccaactcttcattttgttgc
aatgtgttattacaggatatatgaaccaattaaggtttttcactacagttcttgaataaaatttaaaaat-
cattttttattttaattaaaaatatttcccatttatagaatgc
atatatttgcaatggacttccactttcatcaactttccatctcatcgctttaaacaggaacttgaacaag-
cactgttagtttagacctaaaggataggaaagcatta
aataatactttggatctcctgaggaaaagataagtttgcttgcaatttacacattccatggggaaagaag-
agccatatttccttaaaaaaaacattaataaagctt
gttattgagaaaaattgtagtgaaaagccttaagtaccaaattttaaagcagcagtaacttaatttttat-
atcagtgtttttgttttgcacaaactaaatgcagtggta
ggtgggtttatgagtatattaattgcctttatccatttgtgaagttaagttgatgagggcaaggtttttg-
tttgtttaatttgtatatgtctaaaggtatttggaacttttta
caggaattaaacatatatgcaaatttgtatataaaaatagcatggccatcatttgaatgcttgtaaatga-
aaggattatcttttttgagatctatatataaatagaaat
agaaaatccagctggactgattaggattcttttttaattcatttgtgtataacatttttattacaattac-
acatcagttttgacacagtcatagcaacattaatattttccc
atgatgcagatcctttttgtaatgggcttgttctttga 958 2957263 -- NO
tggggaggcacataacagttttttattctgggaagagccagttccccactcaacatattcaataggcacagag-
accaggggaccacggaaagctccagtga
cccccgacccccgccaactcttcctaacaacatttgactccttgccctcctccgttggaactgtgcttcc-
tggaaggaaagtgattgaagaagaagagatgta
gttctgtaaaaggcataaaaacagcttgtttttttaaaaaaataatatttttctgttatgatgcaaattt-
tttcatgactcttctttctctcactctccacagtcatttcatc
ggcaggtcctgccagctctgcctcccaaacacattgagactgtctgctgctttctgcctgcaccaccaac-
cctagtctagtgacctttgaccaggggaga 959 3429874 OCC-1 NO
aacagaagaatccgtaacagaagatgaca 960 3766915 -- NO
ctcctccattgaagcagattgattaaaacagcttaggaaagggcaaacttggatcacgagcagtggatttttt-
tcatatctgatagtgaatttaactttttcatttct
ggcgaaattaaagagatctgtgaccaaaagtggtcaagcactggagtctga 961 2691040 --
NO
cgcactggcattggaacataataaactaaaattaaaatgtttctttactgtgcctcaccattgcacaatcaaa-
aaaaatttttttgcatacactgtggtgaaataatt
tttaaaacttggacttgctactgtgaagactgatgtttaaagtttataactgtataaacattttctatgt-
ccccccccacaccatggatttcttataacattggatatatt
tttccttgctggactattctcttttggattga 962 2824389 DCP2 NO
agtgcactgctttcttacaggaagacaactcagaacacacagccataatctgctttggtgtcagtcacatcac-
agtggttatacatttgtcctgaatggtgattca
ttcctttccatctaacttccttgtgacaaatagcatttactattgaaatagtcttaaaatagggaaaaga-
gtgaaagttactcttatgcatgggagtgggcttaaag
ggttgacttccaccagctgagtacaaacaagtgtaaagaaaaactatgataaagtatggaggtcttgaga-
attgttcataatgaaatctttaatctgggttatca
gagtaatgaaatcaccaataaaaacattccatttatcttggatcttctgtggttagcagaggagtatggt-
ctagctatgttagcagcttgaaggcacaacgtaaa
aggaatgagctttcacaaggtgcttacgttagctgggtagtattggtcaaaggtactctgaagagtgaat-
gcagaaatcagttggctgtgtttgtaatcttgtcc
cacatggaccctaacctttagtagacttcagtcttttagtccagtagaagacaatggccctgaatatgtg-
ttttctgctttttggtggaaggtttcctgcaggtggtt
gggtggtttttgggttattggctactgttcgttcagtgccatttgaagacctgttgtttcttaatccttt-
ttcttggtgtgactggccaggaaaaagtccattgagtcct
ttttttctccctggtgtcttaccccttctgtagaataatccatattttaaaatttgtttcacatcattta-
tagcaaacctgccacagacttgcaagcagtgattttatctttc
cttcctgagaaggtgatctcacttttgatgtttgggtcacctgtggacacctgtgctcttttgagtctca-
aggcttatagctttcacattggcttgggaacaacaga
cttgtgtgtggttctagagtgaaatgggcagtgttctgctggtcctcagtctttgagag 963
4054485 GABRD NO
ctctgcaggatcgggatcagagcgtgggaggaggtgggggtggacgtccatccggtgaacagtga
964 2871027 EPB41L4A YES
cccggcctgatcagaatgtgacaagaagtcgaagcaagacttaccctaagcgaatagcacaaacacagccagc-
tg 965 3468170 -- NO
gctgagcccataacctgcgtcttctgctctagcctcttgtctgtctcattcctcctctgcatggattgtctct-
atttggaaggtccgtggtttttatgtgtaaaatgaa
agctgccgtgttccctttccaacaccaagtctagttctctagctcccattctatcagtgtcatacctccc-
agcttaa 966 2739471 ENPEP YES
gatactgcattcaaacgaaacatgtggccattctctgtgcggtggtggtgggtgtaggattaatagtgggact-
tgccgtgggct 967 3725508 -- NO ccagtgctttgcactgtagctgctcaataa 968
3946498 MCHR1 YES
ttcgcggtcgtgaagaagtccaagctgcactggtgcaacaacgtccccgacatcttcatcatcaacctctcgg-
tagtagatctcctctttctcctgggcatgcc
cttcatgatccaccagctcatgggcaatggggtgtggcactttggggagaccatgtgcaccctcatcacg-
gccatggatgccaatagtcagttcaccagcac
ctacatcctgaccgccatggccattgaccgctacctggccactgtccaccccatctcttccacgaagttc-
cggaagccctctgtggccaccctggtgatctgc
ctcctgtgggccctctccttcatcagcatcacccctgtgtggctgtatgccagactcatccccttcccag-
gaggtgcagtgggctgcggcatacgcctgccc
aacccagacactgacctctactggttcaccctgtaccagtttttcctggcctttgccctgccttttgtgg-
tcatcacagccgcatacgtgaggatcctgcagcgc
atgacgtcctcagtggcccccgcctcccagcgcagcatccggctgcggacaaagagggtgacccgcacag-
ccatcgccatctgtctggtcttctttgtgtg
ctgggcaccctactatgtgctacagctgacccagttgtccatcagccgcccgaccctcacctttgtctac-
ttatacaatgcggccatcagcttgggctatgcca
acagctgcctcaacccctttgtgtacatcgtgctctgtgagacgttccgcaaa 969 2818169
-- NO agacacagacgggtggacccaagcattgagggc 970 3092610 UBXN8 YES
ttttgctttgtggccggattttgctactgcttgctcttctta 971 2560754 -- NO
gcccgctatctgcatctgccttttggactccttgggggaaataaaacaatcgtgtacagttgggaggctcttc-
gttttcaccatcagttgactccatcagt 972 3850324 -- NO
gagttcagggagacgccagacaattgcagcagtttgtagagttatgtgggtcaggctaggattagttttgctg-
caggaataagcaatccccccaaatcttaat caaggtttacctaaaatcggccgagcaca 973
3209807 -- NO cttctctgaaaagaccagcggccctatgactatc 974 2639722 KALRN
NO
ccttcttctctactgggtgcaattcgaggttgctgagcttctctccaaagtctaaaatggtggggcagtaggg-
acctgtgagaggcccaatggcccaatgtact
tcccccagatcccactcagaacagcaggtacgcccaggctcctgctgccctagaggtctgcaacatgagt-
gaagaggttaattagagggacacacttatct
ctgaagtttttctccaggctgaacatttctattatcagtggcccctaatctggaaaaacccatcattcta-
atctagcttgtatccccacatcatgagaaagaggga
agaagaagaagggatgatgtgtggtagagaagatgagggttaactttagcctttcccaaacactggcaac-
aaccacttcctcaacaatttttctatttgcttcag
cctactcagattttttcaggtttttctagctcctccataacctcactccctcccgaggtctctggttcaa-
agaccaccctaccagcccctatttgcttcaggttatcc
tgttgagggtgggtgggaagagtgagaagatataaatgaaaaactggccacatgttgataattgttgaaa-
ctagatgatggtacgtggacattcattataccat
tctccccacttctgtatttgtttgcaatttttcataataaaaaagttttaaaagtcctccagtttccaac-
acactcaagagagagccccaaccccaaacacagagtt
tcatggaaaccccacaccaaggcaagaggcagagatgatgattccatttcatatatacactcattttcta-
actttttttaaaggcccactgctttattttcaatagat
taaacctgatttctgagaggtcctgaagttgggcttatttccctggc 975 2972483 -- NO
gtgatgactatgggccaggacaaca 976 2518314 ITGA4 YES
gcagttggtgcttttcggtctgattctgctg 977 3680796 -- NO
tgtctgcttcaacctcacacttctctcag 978 2329274 -- NO
ctgtgggaaggactcttctaggttttggactctctaattcttctgctgaacccagtgactgtgtaaacatcca-
gaggcccaccccacccaaagaatgtcagactg 979 3379673 CPT1A YES
ttcaggcagcaagagccggcaacgccatccatgccatcctgctttacaggcgcaaactggaccggga
980 3549257 -- NO tgagtcctccattccaaactctcct 981 2360474 FLAD1 YES
gacatctagggcctctgaactttctccggggcgcagcgtgacggctggcatcatcattgttggaga
982 2584988 SCN3A YES aaaataagatgcgggagtgtttccaaa 983 3630231 LCTL
YES
tcacatgcaaatggttacggagatcgtggtacccactgtctgctccctctgtgtcctcatcactgctgttcta-
ctaatgctcctcctgagg 984 3801606 -- NO
ctggtgccagggctcctctcactgccctacacttgcagggaggtggacttccctccc 985
2476381 -- NO
agcatcacatattcaggggaccttgaaaagtttggtgtgcctgagcatagtgtagctggaaggtagtggtggg-
agatgagcctggagaggaaatcagggg
ctagaagataaacaggaatatatcacagagttacttaccttaaaagtaatgttgagccactgaaaggttt-
tcagcagctctcatcaggtttgcattatagaaaga
tggtcttcaggtgtagttgaatggttggaggggaagttggaacaagaccaaactaccatggaagagactt-
tcatctgttttgtctcagcagatagagctgtatat
gtcttctccctgtcctactgttttgggggactgagattttggtactcatcagcactcttgctctcatatt-
atgga 986 2522188 LOC26010 NO
ggtgctgacccaattcgctgccaaaagagtgtcaatcagaatatacaaatcccgtatggttgtgtcatcctct-
cttaatcatttttactaattctaataatcagctct
agcttgcttcataattttcatggctttgcttgatctgttgatgctttctctcatcaagactttgcagc
987 2673516 UQCRC1 YES atgccagtgtggtacgtgagatctgctccaagtacatctatgac
988 3659195 -- NO gaagaagcagtgcatctgggtggca 989 2652475 -- NO
tctgtccctctgctagttagttctgtacagttatccccacagtcctcttcctaaagtagacattactttcttg-
ttcaggtctagagttggttgccttcgcatgtagttaa
agttctgtagcatggtgtataatatccataacactcaaccctgcttacctctcaagaggcacctttacct-
gtcaccccacagtctatgtgttaaatttctgttcccta
gataccttgggcctctttctaaatacacactttcatgtccattatttccccctgtctggaatactctaga-
gcctttcattgacaattcacttgttctttttggtgcccctc
ctcaatgtgacccttttagaaccttcatcacagaaatagttgttctgttttttcagcatctgtgattctt-
tccctccctgtcatagaataaaatgtgtatttatagtcatc
accaagaactcatattgcctcatggggattgtatctcagcatc 990 3198107 -- NO
atgaagcagcacaggtacgaggtgcaag 991 2994022 -- NO
gtagattcgatgggcccgaggctcag 992 3548367 -- NO
tcctgttttctgcattagctgtttgcatgtatttagtaggttagaggtgggaactagagatcagagaattgtt-
tatggcagcagagttagcagtaacttgagaggg catagctaagtcaaagacctact 993
2440185 COPA YES
ccaaaaaggtacaggtgcccaactgtgatgagatcttctatgctggcacaggcaatctcctgcttcgagatgc-
ggactctatcacactctttgacgtacagca gaagc 994 3480073 -- NO
atggggcttatccttactcgcagtcacctaaaag 995 3513910 KPNA3 YES
ggtccaattgagtgctgtccaggca 996 3978139 -- NO
gaaggcctcggcaaaggactgtgct 997 2540091 -- NO
cagctccagggtgaaatggtgctag 998 2896688 -- NO
tcccgagggctgatcactggaaacagggcaacctctggtgacctggtttttcatcaccagccagggcagaaga-
agtcaaagtgtgctcaagggctttgcac gctgctccctagaactgg 999 3022504 -- NO
actgtcttggtgttggtcaggattaatataagggagtg 1000 3104044 -- NO
atggcctgaaagctttaggtggtgcaacacagggtgaa 1001 3939535 SLC2A11 NO
caatcaatggtgagcgtggtattccaggctaaaggtaattaactgacagaaaatcagtaacaacataattaca-
ggctggttgtggcagctcatgactgtaatc
ccagcactttgggaggccaaggtgggaggatcaattgaggccagagtttgaaaccagcctaggtaacata-
gtgagaccccctatctctacaaaaaattttaa
acattagctgggcatggtggtatgtgctaacagctctagctactcaggaggctgaggcagcaggatcact-
tgagtccaagagttcaaggtagcagtaagct
acaatcacaccactgcatgccagactgggtgacagagggagacttcatctctttaaaacataataataat-
aattacagactcaggaaatgcagtgaaagaaa
aatacaggttggccaggtgaggtggctgatgcctgtaatcccagcactttgggaggccaagatgggaaga-
ttgctttgagaccagaagtttgagaccagcc
tgggccacatagtaagatcctgtttctaccaaaaaaaaaaaaaaaaaaaattagctgggtgtggtggtac-
atgcctgtggtcccagctactcaggaggctga
aatgggaggatcacttgagcctgggaggtcgaggctgcagtgagtcctaattgagccactgcactccagc-
ctggacaacagaaagagaccatgtttcaaa
aaaaataaatacaggttgtagtgggtatgggtatgcataccaggaggcccgacctcgtctgagaggggag-
tggtcagaaaagaattttctgaggaattgatg
tttttaatcaactttattgaggtataatttatacataaccaactgcatccattttaagtatatatttggc-
gagttttgagttctaagtatagttttggtgagtgtatacactt
gggaaacaccaccgtgatcaagatggaacctttaccctaccccaaggcacccacatgcccatttgctatc-
agtaacccaccccagtcccagacctggg 1002 2420794 -- NO
tagatctccacatgataacctgttgaactttttgagtatctgttgatcaagaaaataaagtcaaaagctacaa-
ttaattagtaatgtgctcaaaataaatttgtatttt
ataaatcataacatcttttccatgttactctgtctatatggagttcttaataccacacatttgcttaggg-
agatggaattagcaactagtctgtgctaccctgtatttttt
ttttaaccatgtagttggattttttaaaatacaataaaagagttcacttttccaggtttgacaacatttt-
tatgaattggaaattttctgtggctacagatactattaacat
tttggaaaggtgtaaagaacattgttttaatgtaaggctcttctctaacctccctcccctctccaaattc-
tccataatatgaagtaggaagatatgtatttttctgttg
ccattaaaatgttctggccatcgtgggagtggggatggggagggcggggatgggaattagaacttactag-
aataaaattccaaatagaggtttggggaaac
ctacttgtgagtgctttttaacctcaaaataaggatttggggtgggtggagaaggtgatggggcagaaga-
agttgtttttggaggagagaaagcagattgaaa
ggaaaaggacagctgatagccacttaaataatgtcatcgttagagtgatacctattttttgtaaaaagaa-
aacaatatgctccattcttacaaagcattgattgtat
tttaatatatacaatgtaaatactatcatgcagtggtgtccaagggagagaatacagtcatgagttctta-
gtttctgttattggttgggccaataaagccccttcat
catccttcttttctgcttatcactagagacagaaactaaaaaccatggcttcaggctgctaaaagcctaa-
aacaaaacagaacaacaacaacaaataaggcag
gttggacaagcttgctgagtatttgggagcctttttc 1003 2444781 -- NO
taatggggccaaaggggcaacacaaagcattgaaaacatcactggctcacaaaaacagtcaccttgttacctt-
ctcagttgcatttgtttatttcacaaggcttc
attcacacataaaaacaagatactaatccaattcaagttcataacgattataaaagtaaacatttgttgg-
gacaatgtacaataaattgcactttttagacaagcat
tacatttacatttatagagtgtactatacataatacatggaattacggaaacgtctaattggtcattg
1004 2537266 -- NO
tgatacacacttcgaaccacagccagggtccaggcctgaacagatgtcagcatcttcagggagcttttgccag-
gacgccgcccagccacatggccaccacg
ttcattcaaacacggggcttcctgtcaaactacactaga 1005 3061935 -- NO
aagaggtcacccttgccgtttgatggaatgcctattatttgatagctgctgataccacgataacacagagatt-
ccctttcaattaaaagtgcctggacaccacag
ccagacaacttctgtcccaccacatgtatactgaatttcagtcttcttacatctcatttcaaatatattt-
tgaaatatatttccagtttatataaatagtataacacctaa
caattcccatttatttgcaaatattattgtgaggatcgactgggacataaatg 1006 3893061
-- NO
ttcctgtccagctaaagatgctgcctggccgtggcctccacgctctgtaaacatgacccacaccccccagggc-
actccacggaagccttggagataaggg
acacatcacttctatgctcacctgaagtgaccccattgttaaaggacacagctcaactcaatcagggcac-
cagcagcgactccaagtcagggtgcaaactct
ggaggctgctgtgtgaggggggcactagagatggtggtaaacagaaaggggggcttccttcaccagccag-
gtgaccccaggcaagtcacaaggaacc gctctgatcca 1007 3996137 -- NO
ccatggaatcctgttggagctggtctacagaa 1008 2424640 DPYD YES
tgggagaattgttgctatgcagtttgttcggacagagcaagatgaaactggaaaatggaatgaagatgaagat-
cagatggtccatctgaaagccgatgtggt
catcagtgcctttggttcagttctgagtgatcctaaag 1009 2823618 -- NO
ttcctgctactggttggttaatgaggcactgagctaggaaccctgtaagtgttcaagtgttaaaattgtgttg-
ttgtacctttaaatataaggagaagaaattggg
agagatcagattaaaatattaaatacttatatggtttagaaaagtgacagcataagggagatcaaccagg-
tttaagggtaaatacttaggtgaccagaagatct
acagtaaacttgaggacatatcccaccaagacccacaactcagctccagctgattgtttccacaatagga-
ctgaatgcctgc 1010 2491474 -- NO
atctggcgtggagatcgttcaaaggtgggaaactacgggaggaaggtactcaggtgttgagtgcagccatggg-
gccacttgaattagcatccaggcagcc cgcgcccctccccagagacaatcagcggtgtttca
1011 3780190 -- NO
cccatgatgtctgtcgtgcagatgaatgtgtccacgcgtgctgggctagtacagaagatcg 1012
3443271 -- NO
ccacagtatggtcattcagcgaaagaagtaccaagtatttctttctgttaatgagtcagaggtattaatatat-
gtatgtgagtcccccatttaccctgcgcaagat
aagttcttttaaatgcaattagaatatcctaagataaattacaaactcctcttatgtatccttttctctg-
aggtgaaatgagacactgcacagatgagaggtactatt 1013 3249840 -- NO
gcactgaacgctaatccctttttctatttccgcttctcacaggcacaggaacacaggcacaaatgcacaccac-
aca 1014 3365366 HPS5 NO
ggggctacttttgtcagtgtctgtacccttggcatcggcatctgtgactctttatccatgacctcagtgtttc-
ttaaccaaagttgtactcagcatttcttaaccaaa
gttgaattttgaaaagagtcagtccttgtttgctggaattagaatgttaatgtcctagtattattccgaa-
ctacagtattaactgcttgttgctagtggattagacaga
ttcttttcttactgtggcttccatgttgggagcagaagcttttcatcctggtcacatgaagacagatggt-
attattgactggagagttgaattatttttatatcttgtctgg
cacaatatggaaattactgaaataagacggtgtataatggaattaacacccaaaataagtagaacactga-
agatttgaatttgatatttaagtaaaatgggactg
ggtgcagtggctcaggcctgtaatcccaaccctttggaaggtaaagacgggaggatcacttgaggccagg-
agttcaagaccagcctgggcaacatagtg
agaatgcatctctacaaaaaataaaaaaaattagctaggcatagtacctgaggccaggaggtccaggccg-
caatgagatgtgttt 1015 2883453 ADAM19 NO
ctggctgtatggctgcatgtgacaagccacgtcccctcccacctctccccaaacccctgcatccctgtattca-
cacgggtcactctgactca 1016 2924473 -- NO
agcagggactcagcgtgaggcttgaagcaaacagtggaatctttagaagcctgctttgtgtgc
1017 3378661 -- NO
ccctgggtgtaacgaggccattttgcaactacatccagccaggctgaaaacacttactttattccgagtccat-
cagaattcttgaaaatcagaggatctctcaa
gccaccccgctgaatatactctacattaaaatctgtcaccataggaaaatattagaaagataagtggtat-
aattaaaaacgataaaaggaccataaaaaggat
cctaagtaatacagtataaatggtgtttgttattctgtgtatatagttatgctgttagtcaataaaatat-
atgcttagtaagaagcatctcttagaaaatatggagagc
acattgagaagcaacgcttgaggggttttcca 1018 3754749 DDX52 YES
aggctgggtgtcctgtaccagaatacataaaag 1019 3150460 -- NO
gctgcccacgggactttgcaggagg 1020 2664515 -- NO
ttctctttagacttaccagttaggctctaatttaggaaaaataaaacaaaaacttacatgggtttggagtaaa-
attagctggagtaaaatccaaggctagatttcta ttgaa 1021 3123616 -- NO
aggagggcccaatatccctgggtcg 1022 3432252 -- NO
agtggtcaaacccagatgagggtcccgcttctggtttatatacaataa 1023 2593632 -- NO
ggagcgggaaggagattgactgttagtttctta 1024 3054956 -- NO
tgtgccagccacagtacgatgtacctcctccaatctatgtgtccaaatcagcgcatcctttaaggccctactc-
agatggcacc 1025 3096135 -- NO
gggacccagaagcaaccgttatgagcaacaaaaggaagacactggtttggatggacgggaagcggttgggtgg-
gctggactgacggaggcccctttaga 1026 3541539 -- NO
tgtgggctggccatctatatccatccatctatctattattccacccatccctccatccatccatccatttatt-
taattaagttatttttaacggttggctctggagttgac
attcatttattttaaaagaacagtgaatcatagctcttttcctcaagatgcttgcttttatttgcatggt-
ggcatattgattaagtactcagaacactatttgacatatgg
taagccctcaataaaagtttgttattattatgactgtacttctcccctctaatgtatagaggtaaacatt-
ttggttcctattgtgacacgtgggttataatgagttagg
gcctacttaagaagaaagtggaaagaaagcgggtaaaattgttgctcagatactagcatgtgggtgga
1027 3762591 -- YES
ggggcggtggtcattaattctgctatcttagtatctctctctgttttgctgcttgtgcacttttctatttcta-
ccggtgtgccagctct 1028 3305557 -- NO acctgccatcctcatagtcaccgggag
1029 2394713 TNFRSF25 NO
tggcaaaagagcaatctggatccgccttagccagatacataagggtatttgccttcactttcagccagcattc-
cccccagcgatcctagccagatattac 1030 2406204 -- NO
ctgatatgtatctgttgggcaagtagttccatgaggagtttgtttttgttcagaatgatctttaggaaaaatg-
gaaataccacggtgaagggaaagaagtcagaa tatgtacacaaagccta 1031 2722321
TBC1D19 YES
tgtttttcccgggatacatctgtgttgagtcactttgcattcaacagtgcctcgccaccaaaatcatacataa
1032 3532235 -- NO
atagtgttatatccgtgctgccatatcactaaaataggcttgccaaggcaggtgaggtgtatgaatgctcaag-
cctcacagaactgcaatcaagtgccaactat
aaataatactgaaaaaagttgaccatctgaccagtggataatactttcaaggcattcaattagcttatcc-
tttgcagtattctaagctattcacattgacgatcacat
acattgtagtgcttgctgcaagggaggcatataaccagttgttttggctaaaatatgacaggaaggcatt-
ccttgggttctatataaaagtaacagtattcaaca
gtctaatggcaatcactgataggctgcttaaa 1033 3053937 -- NO
tgcacgctggaatcatggctcattgcagcctccaactcctaggctcaagggatccttccacctcagcctcccg-
agtagctgggagtacaggtgttcgtcccc
accatgtctggctaatttaaaaaaatgtctttgcaggatgggatcttgctatgtttcccaggctggtctc-
aaactcctgggctcaagtgattttcccatcttggcct
cccaaaatactgggattatacgtataagccaccacgtctggcctgagtcatctcttttgacccagaacaa-
aaccagtccaggagtggctgtactccccagga
gtgtacactggggaggcccacagctccggggtgcagtggggctcttgcaatttaatgactgattcatctt-
caaaaaagcacaatctcagccaggcg 1034 3304915 -- NO
tgggagactgacctaactgagcatcaactatgccaagcactgcgcaaggtgtcgaggctataggaacgtgcct-
ttctaccctagagaagtttgcagtctgct
gtgggtgatgagctatatagaagaatgtactattagatggagggaagtgagggagcaacatggttacctg-
aggaagagcagtccaggccaagggcacag
caagtgcaaaggccctggggtgacggtgtgtgctggctgctcatgatgcagtagggaggcctgtggctgg-
gatgaagaatagtggagggtaaagtggaa
agaggtgagagcagagatgtagctggcagtggggagggaatagggtgaagcagcaccatgtagggccttg-
caggacattctaaggattttgactttcatc
gagtgagatgaagattcactgaggggttctaagtagaggcagggacatgatctggcttcaatcatagaat-
gatggggattgactaggcaggatgggttatga
tgtgcaaggtcgcagggggctgctagccaggtgagataggatgtgggctctggcagcagtggagggggca-
aggcactgcgggtgttggacagactctg
atgattggatgtgggcctcaagggagagtttgtgtgggagctgggaaacaactgcatcaggttgcctggg-
gtcccactcttaggccgacaacttg 1035 3545436 -- NO
gcggtcactcagctatccaatgggatgacacacagcaaatcagctcttcactgcctcaacagacagtcactaa-
aataatttctttaaaggtatataaatgttggc
cagtgtaatcctctacaaaacacatttgcaaatataaaataatggaggtatgatgctgctcagagaatgg-
gaatgctctggcagtccccaacatcctatcccac
ttggggctttgctccgaggggaagagcaggtgcaggatatattgccctttgatgtgatgtagatgctact-
agggacccactgggaagagtcccgttccttga
gttatgctactgtagggatagacccttggtgtgaggaatctaacaatgagtcaaaggaaacatcacaaag-
aaggtgacacctcagaggagacaaaggact
ctgaaatcctggaatcacgggatatctctgattggttagggaattcctctgcactcaatctccagcaaat-
gggcagattccctcacaacttagaatttttcatggg
gagtgctggactgtaccccaaacatggagtaaggtggcatcatccatctctgaagggccatactcctcgc-
aaagc 1036 2632506 NSUN3 YES
tgaatatgatagtctgagattgaggtggctaaggcagacgttggaatctttcatcccacagcctttgataaat-
gtaattaaagtgtctgaattggatggcaga 1037 3333132 -- NO
cctgagttcctgggcactctttcctgagcttgcttggggctgatttgaattcag 1038 3459329
-- NO ctctggattttgccactcacacagttg 1039 3597530 APH1B YES
gccagtgaaggtttgaagagtataaacccaggtgagacagcaccctctatgcgactgctggcctatg
1040 2757682 -- NO
aacagtgcaagaaaggacgcatcactctcttctggtgccgatgtgctctcttgttaa 1041
2811303 -- NO
tcacgtggctttgtgtaccaggcgtccagggagcaattaggagggcaatctgttaagtcttttgcctcagggc-
agaaccattaggtgtgctgtgtatgtgcctc
aaggggtgtaaataactaagctattcatgtactcatcagtttcctttcaaggcatctgtgaaacctttaa-
tctgtggaagaatcagagaaagttgacctattgtatt attatcctccctcacctgaatattttga
1042 3611032 TTC23 NO
gagtccttttgtcctgcggtccatataagagggtctggatctggagacactgtagaacaccaagcagctatca-
tgaggctatggaagtgtcgctgagagcag
gaaactaaggtctcccttgaatgagagaaagatgacctcattcttaggccctgctgtgatggaattagca-
tgctcctgggatgtctcctagtgactgacctttgg
tttggatgttctgagggatctaggcaaaagtgaacagttttagcactatttcacaaaactctctgtgact-
atctgtatgcaaaaaatagatttaaaagtagtattttt
aaaaataaaggcaagaaccttggtactgaccagaggatgggctccagtttctatttttaaatgtggccct-
tgttatagcctggaaaagatttaaaaaaatagtttt
gttttttttgtaaacacatactctacttttattaatatataggctgtctatactcttgactacacagcaa-
tgtcttagttattaggaaccaaatattcagcttatggacta
cccagggctggctttggcttgatttctcccttctgcttactttaagtcttgccatttgattgcttgtagt-
aggctagggcaaatcaaggagaggagaaagattaaa
gttgtgcccaaaatggccaaaataattttgagaaagaatgaggtggagaggtggaggaacttgctttact-
gaatgccaaagacccttttatttttttaaataaagt
aattaagacagcatgtttgtcacccggggtagacaaaaagaccagtggaacagggcagagagcccaagcc-
ttgacagatgacagaaatggccttgcggg
attggtgaggaagaggtgggctagtcaataaatgggtactgggaccgctggttttccaaatggaagaaaa-
tggatcactaccccaaatcaaacacaaatatt
aagctcaagaaagatttgaaggactaagtgtgaaatgcaaaacttggagcttttagatgaaaatactgga-
aaatatata 1043 3977071 -- NO gtggctggaccatgcggaactggat 1044 3363301
DKK3 YES tgatggaggacacgcagcacaaattgcgcagcgcggtggaaga 1045 3644748
-- NO tgggccacgtggtgctctctgaagttagaa 1046 3799937 -- NO
catgcagtccccaaggctatcggtcctcctcag 1047 3336773 FBXL11 YES
gaggagcttgccaacagcgatcccaagttagccctcactggagttcctatagtacagtggccaa
1048 2822962 -- NO tgtgagaacagactcggcagtgacatccactccaaatgga 1049
3627325 -- NO ccagacctgagccacgtagctatcaaacac 1050 3780263 -- NO
catctgaaattaatgggactaatgtaaggattgatattttcatatttgctcaattgcatcctgggttaagcac-
attcaacag 1051 2656010 VPS8 YES atggcgctatctctgccctcagtatc 1052
3028587 -- NO
tcacccaggattctcctgtacctgctcccaatctgtgttcctaaaagtgattctcactctgcttctcatctcc-
tacttacatga 1053 2419066 ZZZ3 YES gttgcctttgagtgatggtccagaag 1054
3081481 -- NO atggccacctgtgttgacgtggaga 1055 3935290 -- NO
atgatgaaagcgtggaggtaccagct 1056 3051677 ECOP NO
ttgatgtgtgaacgctgacctgtcctgtgtgctaagagctatgcagcttagctgaggcgcctagattactaga-
tgtgctgtatcacggggaatgaggtggggg
tgcttattttttaatgaactaatcagagcctcttgagaaattgttactcattgaactggagcatcaagac-
atctcatggaagtggatacggagtgatttggtgtcca
tgcttttcactctgaggacatttaatcggagaacctcctggggaattttgtgggagacacttgggaacaa-
aacagacaccctgggaatgcagttgcaagcac
agatgctgccaccagtgtctctgaccaccctggtgtgactgctgactgccagcgtggtacctcccatgct-
gcaggcctccatctaaatgagacaacaaagca
caatgttcactgtttacaaccaagacaactgcgtgggtccaaacactcctcttcctccaggtcatttgtt-
ttgcatttttaatgtactttattttttgtaatgaaaaagca
cactaagctgcccctggaatcgggtgcagctgaataggcacccaaaagtccgtgactaaatttcgtttgt-
ctttttgatagcaaattatgttaagagacagtgat
ggctagggctcaacaattttgtattcccatgtttgtgtgagacagagtttgttttcccttgaacttggtt-
agaattgtgctactgtgaacgctgatcctg 1057 2699603 -- NO
aaagaaggatctgtcagccaagtcttttct 1058 2836754 -- NO
agtgtggccgtttgcattactgctggaattttgaagactactacatattccgtcagtgtcaggattttgttct-
tcagtgtggtacttttttttttttttttttaagatggagt
ctcactctgtcgcctgggttggagtgcagtggtgtgatcttggctcactgcaacctccagctcccgggtt-
caagcgattctcctgcctcagcctcctgagtagc
tgggattacaggcatgcgccaccacacctggcttatttttgtatttttagtagagacggggtttcactat-
gttggtcaggctgttcttgaactcctgacctcgtgat
ccgcccacctcagcctcccaaagtgttgggattacaggcgtgagccaccgcacccggtagtgtggtacac-
tcttaaaatcatagttcctgctgtctg
1059 3504560 -- NO gcatggccatggatcgggcaagttggttttact 1060 3924596
PCNT YES
agacctgaaggcacaatcacaagaagagatcaggcgcttgtggtcccagcttgattctgccaggaccagtaga-
caggaatt 1061 2408919 -- NO taggtgacggattgttaggtgcagtaaacc 1062
3219942 PTPN3 NO
ggaccaggcttctaccattaattcacatgctttaaaaaaattaaaaattaaaaaaatgaaaaataaaaaaact-
taaaagattttacctatattcctggaacatagtt
atcttaccccagctttgtagttcctgtttaaggaaattccctctgaaggaaattttagctctcaagagtc-
aaagaagatgtatagaggtggtatctgttagtttttgtt
tgtttgttaaggatctaggcagagaggtcattacatttttctgaagttgaggtcacaggtggggtaccca-
caagagaggtcattacatttctgaagttaggcatc
ccaggcatctcttctaaagaactatcctgtattctaattgttaaataaatatcttcttcattgtgagcct-
ccacaactgctgtttctgataaatttagatcattctttgca
gaattttatatactggcaatctcaaaactaggctccttcaagattcctaggaagtctcccaagctcgggt-
tgggttccactattctag 1063 3240958 DNM1P17 NO
gtcaacaagaccttgctggacctcgtg 1064 2830809 -- NO
gtgcagattgttaatccctagtgtgcagggatagggagggagaggaaatgtccacacagacgaggagaaggcc-
tgtaaatgcaaatttcacactgttgatg
gtttgtcctgttggttgaccagcattcccaagataaccaggtgag 1065 3020549 -- NO
cctcatgcatgcttcgagatcattgtttgcttcatttccctaaaatctacagttcctttgaaagtagactctg-
gcgttatcacctttccccggtctttttgcagtttcctg
ttgacctctgagccattctccctcactcttgtttcactctgtttgcaacactacctcttcctgtatcctg-
gcctctcatttctcacagatcatcatgctgttcttgaaac
attttatttacttgattttagaaaactatactcttagtttccctaaaatctcataatctctttgcgggat-
tttcctcatctttgtgacttccaaaatttgaagtgtcccctgg
ccagtcctgggtggctacattcaatctc 1066 3282482 -- NO
aaaagaagtcgtttattggtgcatgggacactctgggaggtagtatccatttggatgtcctgctgcggttgga-
gacatggaacaaaa 1067 3192070 -- NO
cctgtcggtggactgaatgggccaagtgttcagaagtccttgggaagaggatagtgtcctgaatcataatgtg-
gtattttc 1068 2473609 -- NO
aaagtgtcctattctcggggtggcagggaggggggcaggccacaaaggacatgagtgttaggaaaagaagaaa-
gcacagggaattaaggcaggaagg
gataggctaactactgttctgtgcaaatgcaattgggtttatgatcaggactgactgcccttacgtataa-
agttgctaacccccaagacctgaagggaaaagtc
ttttgaagctgccagttttttgatcattcaacaagaagacctgaacactgagaatcctttttctggattg-
gttccatcaatactttgtccctgaaatcaggaaatacc
ttgccattatgggacagccctttaaagttcttttgatgttggacagtgcccctggccacccagaacccca-
tgagtttaacaccgaaaacattgaagtggtctact
tgcccccgaacacagtctctaattcagcatctagatcaggggatcatgaggacctttaaggttaataaca-
cacggtactctaacctcaatagaacatcatgaa aatctggaggaattacaccgctgaagatg
1069 2814779 -- NO
actctgctgactgtaatggctctcacgcagttcctaatgggcactgtggaaccactcagcatagacaggcata-
ggcagg 1070 3558342 -- NO gcccagtgaaggggtgacagaactagcc 1071 3611698
LRRK1 YES
atctcctgccagatcacggagctcgacctttctgccaactgcctggcgaccctcccctcggttatcccctggg-
gcctcatcaatctccggaagctgaacctct
ccgacaaccacctgggggagctgcctggcgtgcagtcatcggacgaaatcatctgttcc 1072
3701429 -- NO
tgccgcttttccctccacttgtgtaacagcatactcaggtttataccaactgggagacacgcaggcatctccc-
ctcacaagcagctgtctactcaattctgtagtt
atgtctgctaagtaatcagaatgcacaataggtttttagcatctgtatctcatcctcagagtagagagta-
cctgttttacgagagaaaactgagaaaacggtctct
cagggcctctggggcagccttcaattggacagcagtagaatttcggtccagttttcaaatcttttcttat-
tgttggattgactatgccatcctgcaaaaggaaaat
tactttaaattattatttcaaaaaaacaacacaacaggctggagtggaaacggaatgactgaaaacgagc-
acattttgtgaaatacttttaattaagagtttttcca
tctagtgtcagcagtaagagaaaaagagtatgagtagattaaacgaaatgtggtgagaatactaagcaag-
actctaaaattctgcattcatttgaccattactg
aattcctcttagtcaatttacattccagggagatgccccccttgtatgttcctaggctgtgaaatgctcc-
a 1073 3933333 C2CD2 YES
ttccgccggcggcatcaacagaaagacccaggcatgagtcagtcacacaatgaccttgtgttcctggagcagc-
cagagggttcccggaggaaaggcatca 1074 3799749 -- NO
ttggattccactaatcacccgatcacccc 1075 2487131 ANTXR1 YES
gaaagctgcactccaggtcagcatgaacgatggcctctcttttatctccagttctgtcatcatcacca
1076 3187719 -- NO
gggcaaacttcagcctcattagatagaggctggacttccggaagagctgggaagggggaccatagtttctggg-
gaggggtggagaactcacatttaccta
gctgctggccaggctattttcatacccacagaccgatttaattctcaactactgtactcatttagtagat-
gagaagaatgagacattgaaaacatgcacagtgga
ggtgggaatgaaagccagctctccaactctccagtcctctttcctgtcactgcatcaggctgcagggtga-
aggggaggtctgggatacaaagagaacttag
aggtggagcagttggattctgtgcagtgctaggagggaggagaggggttggagtaggtgggaagtaggcc-
tccttcagtttggatagcacttcccttaacc
caatgactctagtgggagggtggagggatggggatgggaagggagcctgggagtgaggaggaaaggcaaa-
ctctgtcttcccccaggggagtcaatg aatagtacc 1077 3474744 -- NO
ttagtgtacccttcggtgacaggtaagggctttctgaaacgcattgtctttttattatagccattctagtagt-
aaggtgtgaagtggtatctcatagtggtttgggtt gtatttccctgatattgggatgttg 1078
2489696 -- NO atgcagttacaaaatcggattcagcatcagaacag 1079 3195395
ARRDC1 NO gtgagtcgacagccagggcttggca 1080 3497381 -- NO
ggtggacagtgatggtttcaaaggggaaa 1081 3130174 GSR YES
tcattgttggtgcaggttacattgctgtggagatggcagggatcctgtcagccctgggttctaagacatcact-
gatgatacggcatgataa 1082 3180421 -- NO
gagaggtggatctgtctggacttcaggctgtgagaacctcacagcacagataggatgtgagctttaccccttg-
tgttcaggccgctcgcacggagtcagctt
gcggaagcacgttcccaggcctgctctgcgtgtaatggtggaatt 1083 2384882 GALNT2
YES
gaagtcggtgaagcacatggatttgtgccttactgtggtggaccgggcaccgggctctcttataaagctgcag-
ggctgccgagaaaatg 1084 2601621 -- NO
tctcctgcttcctagacgaaatctaagcaatattttatccacttctttttagtaaaagaaatacatattgcct-
gttggggtcatgagctatgtagggaatgaaaaaat
tttttaaaggagaattataaagagaaggaggatacaagagaaaggaaaacgaaagctggtgggaagttga-
gccatgtttatctctagtggaatccttaccttg tgttt 1085 2624206 ITIH3 NO
tggatggcccggattttatggcatctggaac 1086 2626149 RPP14 YES
tcaagattgtggagttggactgaatgctgcacagttcaaacagctgcttatttcggctgtgaaggacct
1087 3466862 -- NO
tgtcacttagtctactgccagtctactgtctgtgccaccatgggaaattgcatgagttcagacctgtgaaaaa-
tcagaataaagataaaaacacattttttgaag
gttacggaaattcttaagatcttggttttcttgaacttactactagtactactgatttagaaatggccta-
cctcctatagtaggaaagggcaaagaaaacaatagtt
aatagggaaggcttaaaggagcttgagggctgtcctggcaataatagaagagatccttgttttttaaagg-
agagttaatgtacaaagattctgaaaagtctaga
aacatgggtaaaatttttatgattgccgggcgcgg 1088 3400762 -- NO
tcaatgaccagcgtagacagagctagtagcagcaatgagatgagtgactagagaggtagagagaaaaccagga-
aagtgtggagtcatggaagctaagg
aagatggtgttgggaatagaggtggtgaacagagtcccctgttcttgctgataggagaggtcaaatgaga-
taaggacagaggcgtggcctttggattccga
gatgtgttgatcaccggtgcacttggcaagcatgcca 1089 3511392 KIAA0564 YES
aatcccgcttccctgtactttatgaatatgactgggaaaagtggcttctttgtggacttttttgatatcttcc-
caagaacagccaatggcgtttggcacccttttgtg
acagtggcaccgctgggaagtcctctcaaaggtcaagtggttctccatgagcagca 1090
3762555 -- NO
tgcacatgtggtaagagcatccagcaggaaagaagagggcaagttgagtgtgcgtgggcatgaaggattcact-
gtacgcatcccagccctgctcatctca
gccgcatggactgggcacacatttaagcatggagggtggtggttttcaggctgttttctagagctgtaga-
actcaaatgaaatgctctgagtctgtgaggggg
ggaggagtcaataaagggtggctaagtgcatggagtttgaggtacccgctctgctgtaacc 1091
3853067 ILVBL YES gcttgctgctctcacgggagaacgaggatcaggtggtcaaggt 1092
4015570 -- NO
ttcatggttgcctagtgctgcgaggagtggggaatggggaatgagtgcttaatgggtatgggtttcttggggt-
gatgaaatgttccggcactaagttgtggtaa
tgactgcatgactttgtactaaaactactaaattgtacactttaaatgggtgaattgtatggcatatgag-
ttatt 1093 2458440 -- NO tgcacttttgcctccgaactctcgtgtttaatta 1094
3333734 SLC3A2 YES atgggttccaggttcgggacatagagaatctgaag 1095 3379257
-- NO ggccgtgcagcttcttgacaaattgcaaaggtgcccacgagtttccaagt 1096
3662461 NLRC5 YES
ctcaacttgatcacgaggttcctgacaccgtccgagctcctttttgatct 1097 3670791 --
NO gtgcaggtctaatgggctccttccttc 1098 2689662 -- NO
ctcatggcaacttcttccgcttcctagtttca 1099 2698749 XRN1 YES
gctgggatcactatggaagcaactatgcattgggggca 1100 3940626 -- NO
tgcaggctttacctatgaccgaacatgcatggaaatgccctctgatggactcaggcatgatacatacatcaaa-
cagccttgcacggtggta 1101 2577438 -- NO
gagagcatggctacaacagcaatatttctggaaaccagttatcgggggaattcacagg 1102
2885881 -- NO atggactcatcccagaacaatcctcaggcactccgaaatgcagatgccc
1103 3473848 TAOK3 YES
atggctccagaggtgatcttagctatggatgaaggacagtatgatgggaaagttgatatttggtcacttggca-
tcac 1104 3721713 -- NO
agaacctggtcgtgtcttgagaacccagtccaaacagaatcaggcctctggactgggagcaacactcccttca-
cccgcaaagattcaggaaaagcacccc
aaggacaaggaaaccaatgaggtctgggctagctctgcagctttaggatactagctctagggaaggattt-
tttcctttttaaacagcgtatcactctgttgccta
ggatggagcacagaggcaccctcatagctcactgcagcctcaaactcctgggctctggcgatcctcccgc-
ctcagcctcccaagtagctgagaccacagg
cacgtgccaccatgctcctagggaaggagcttgagaagaaactgccaggagtgaaccagggctggctgct-
ctgtgatgttctctccccacctcccctccag
ctctcaacttggtggcagggccggcaccctgctctccctcctaactcccagcctgctgctgcccccttct-
gggaccctaattttctggactttgagaaatgggc
tgcccctgggggtgcctccaagagcccatttgagggatcgggtggggctgacctctctgtcttctttgga-
tcatcgccttctcacactgtcctccctcttgattct
gaaaaatggtcctgctgcccatggagaaccacagtaagatagatttctcatgcagctagtgaggggactt-
c 1105 2924660 -- NO accatgtttttgcctccagtctgtc 1106 3242466 -- NO
atggctatgggaatatcgggagttgaggaagaaaaaggctccagtggcactgaag 1107
3268238 BTBD16 YES
agcagctcaccaccggctgcgagaagtggctggaaatgaacttggttcctctaggggggacgcagatccacct-
ccacaaaatcccacaggacctgctcc acaaagtgctg 1108 3293847 SPOCK2 NO
tgtggcatgcgctgacaaatgtgtccttgatccacactgctcctggcagagtgagtcacccaaaggccccttc-
ggcctccttgtagctgttttctttccttttgttg
ttggttttaaaatacattcacacacaaatacaaattgacaggtcaaaatcca 1109 2416565
JAK1 NO
aatcttgctttttgtggcctggggattggctgtgtgatcagcattgaaatgggttgttgcagtttgaagtctg-
gaaggggtatgtccctgggttctaattctttccct
ctaggtttctgtactcagctcagagtctagaatggtagcttttaggattggaaaagaccaaagttaccta-
attcaactctttcatttttttttcagtggaaaaactaat
acccagaaaagggaagagagttaacccaaaaattacatctagtgaattgtctgattagctttacaattga-
ggcattgtagagctctttgaggcattagtcttggtt
gtctgagtgcctggctattaaaggctgtctttgcctgttccctctttctgttagctgcctggaagtgcag-
ggttgcttcacttttagcaccttgactctgtacctgac atggtgcttcaacaggatattgc 1110
3198506 -- NO
gtctacgcagctgccatagaggagggggattgtttgggagaccttcccgtggcagaatcaaagctcgtagttc-
agctgcgggaatctggtgtacttaa 1111 3384336 RAB30 YES
gggaagacgtgcctcgtccgaagattcactcag
1112 3649726 -- NO ttgtgcaacagaaaactcaacccaa 1113 2732288 -- NO
aggtttagttgtgtggccgtaatcacatccaacaccaagtcggccaaccatatgtgagcttaatcccacagaa-
ttcttatgttagacctccctcttcagataatag
aggagattttttttaagtatacgtgcacagaggaagtgacttctttctgcgcactctgttgtcactggaa
1114 3291868 -- NO
tacgaggaagtgaccagtgttcatctgaaacggatgccttgtttctcagaaatgtcattctctttatttcatc-
ttcgtagttctgtgccttctctcagcaatttctgattt
ctttatttactgccacacagatgacaaatgacatgcatgtccatgataccctttactcaattcacatgcg-
atttccaaggctggctataattcccaaa 1115 3572359 -- NO
gtggggggctgtaatctacaaaagccatcttcagtaccaggtttaattccatcattgtttttcgggttttagg-
tctctggactattgtcctttaacaacaaca 1116 3613987 -- NO
gcctgcctgttcatgccaaatatacatcctcacaatgcacagtacacaacatgggcacataggcacagaggct-
atgccgg 1117 3768275 -- NO
ggctttgaagggcaactgaccaacttttttatacataaaggatataaactacaactattttcccactctgtgt-
agaatgtggaacggaaacagtgtgtggcacac
tttaaatgatgctaaacttctacagtgtgtaaactggcttgttcaagaggccaaagtgcttctgttgaga-
aacactgatgaccaatctcctctttgtggtcctgtga
tactgtgaaatatatatttgatcttcctccctgtttcccagcatacaattcctaaaaccctcagaatctg-
caaaataagatttttttttaatgctaatgattgactgatg
gctggaggctcctagagagcctcaggattggggctgattctcagggctttc 1118 2367980
RABGAP1L YES
gaccatcttctccaggtggactacctgaagaagatagtgttttatttaataaactgacctacttaggatgtat-
gaaggtttcttccccacgtaatgaagtagaggc tttacgggcaatggcaaccatg 1119
3063344 ZNF394 YES gtgtgaagaatgcgagaagagcttc 1120 3147137 -- NO
tttaggaaaaggctgctatactgtggacgaagtctcagatcagaa 1121 3737089 CCDC40
NO
acgggacgctttctctgggatgcattgagtcagggaatagaagatggggtgaatgatgtttctgacccacaga-
ccgttgggatgcttttgctgtcactttccca tcatgctgcatgaggcatgacagcagctgt 1122
2686311 FILIP1L YES
tgccaagcatgcgatattcagagtctccccagaccggcagtcatcatggcagtttcagcgttcaaacagcaat-
agctcaagtgtgataactactgaggataat
aaaatccacattcacttaggaagtccttacatgcaagctgtagccagccctgtgagacctgccagccctt-
cagcaccactgcaggataaccgaactcaagg cttaattaacggggcact 1123 3307401 --
NO
gccactctgctcaaagttggcacgagttggaatgtaatcaccatctctgcactcaaggcatgcagaaatgaag-
tctacctcagccctcaaagacctcacctg
agaaaaagacaaggctccaaacagaaggcaaaacagaatgagcatagaaagagaccactttttcacatac-
ctttacaaagcactgctcacccctccttaac
ctcgcacagacagagcatggggcctcagtgtcactgccactgccaccctcccactgactagctgtactct-
ctga 1124 3648042 CIITA NO
ctctgaggacactaaccacgctggaccttgaactgggtacttgtggacacagctcttctccaggctgtatccc-
atgagcctcagcatcctggcacccggccc
ctgctggttcagggttggcccctgcccggctgcggaatgaaccacatcttgctctgctgacagacacagg-
cccggctccaggctcctttagcgcccagttg
ggtggatgcctggtggcagctgcggtccacccaggagccccgaggccttctctgaaggacattgcggaca-
gccacggccaggccagagggagtgaca
gaggcagccccattctgcctgcccaggcccctgccaccctggggagaaagtacttctttttttttatttt-
tagacagagtctcactgttgcccaggctggcgtgc
agtggtgcgatctgggttcactgcaacctccgcctcttgggttcaagcgattcttctgcttcagcctccc-
gagtagctgggactacaggcacccaccatcatgt
ctggctaatttttcatttttagtagagacagggttttgccatgttggccaggctggtctcaaactcttga-
cctcaggtgatccacccacctcagcctcccaaagtg
ctgggattacaagcgtgagccactgcaccgggccacagagaaagtacttctccaccctgctctccgacca-
gacaccttgacagggcacaccgggcactc
agaagacactgatgggcaacccccagcctgctaattccccagattgcaacaggctgggcttcagtggcag-
ctgcttttgtctatgggactcaatgcactgac
attgttggccaaagccaaagctaggcctggccagatgcaccagcccttagcagggaaacagctaatggga-
cactaatggggcggtgagaggggaacag
actggaagcacagcttcatttcctgtgtcttttttcactacattataaatgtctctttaatgtcacaggc-
aggtccagggtttgagttcataccctgttaccattttggg 1125 2568862 -- NO
tcttcttctagcagtgctcagtgggt 1126 3405549 DDX47 NO
tggcgtgagcgagataaacctcctaacagtaggtttgtacaataaggccatagggcaccgatgcctgtttcca-
taattgttgtaattttatgggctttgaagtgtt
gctctagatacttactttctcctttcagggtagcgagaggctcccattagaatatttcatatgtacctgt-
ctggtttgcaagctgttgagttgatttattcagccctag tggtaataatgactc 1127
3479324 ANKLE2 YES aactgaaggagcggatcagagagtattta 1128 3736140 -- NO
tggatgtctactttgcacgctgcgattgggagagctgtcccgctgcatgcgttccctctgtaatttcctcaga-
gctcacatacgtacctctctcacgagtgaact
cagattttccattgttttgctttattctatcatttgctttgtggttttgctgtaaatattgaaatcttaa-
tcatcatcgagaggcacagccaagctttccagctctccacc
cccgtggcccatccaagtctgttcatctggtaacttctgttgtctgggacggcagcaagaagatgccggg-
gcttgcctggagtcctggcagaggagtgcca
ctcacttttgcctagggtccagttggggcttaaaaaatatttggagagaagagtaatgaggattttttgt-
gtttcctagacattttatgcatctatttttgtaaaatcac
cttcgctaactttcaccaagcactttgagcacagtggaacttcagaagcacaaccagcctaaccccagaa-
tctcaggtggcacagctagaaattgagtccctt
cctaggacactggccgtggccttcagggtgaccagtcagtgccaccgggttggcattggtgttacagaca-
ggcctctgaagacaaaccgagcaccccag
cggcccctcaaactaagcaaggatcttttttctgtctgcgctccctggggcaaggtcaaaggtggacccg-
cccactgtgggtcaattcatcgaaaagatgg
gacccgcacccccgccacaggctggcccccccccacccatggggaaggtggtgtgctgctggctctgacc-
atactcttttggaaattgagaaggaaagca
ttgagtgggacctaatccggagaagaaattaaagaccagaaaaagaaggaagctgggaatgaaactcaaa-
atgcacttgaacctggaagcggcaaccct cagctctgcgcggccgagcctcagcaagagttcgttt
1129 3954953 -- NO
catggtctaaccacagaggggaatactactcagcaatacaaaggagtctctcctaatacgtgcaacaacattc-
atgaatcccaaaaactttatctggagccaa
gccagacacaaatgtgtacatacagtacggaatgacttcagattctgaaaaaaggcaaatctgaccaatt-
gaggcagaaagcaggtcagtggttccccagg
tctgggactggggtgggttactgatagcaaatgggcatgtgggtgccttggggtagggtaaaggttccat-
cttgatcacggtggtgtttcccaagtgtata 1130 2396759 FBXO2 NO
tcgagggtagataggccttaacttagtccatagcgtcctcaccttccccaagccacacatcctcctcccatcc-
cttgctccgatcccagcccctgagcaggga
gagagaagttttgttggcataggtttgcttaggtagccggcttctagaatgtagatccgtgagggcgtga-
gcttggactggacccactgctgattccctgcac ctagcacagtgcttgccacaaagtgggctctca
1131 2519281 ITGAV YES
ggtgagcgggaccatctcatcactaagcgggatcttgccctcagtgaaggagatattcacacttt
1132 3640619 -- NO
tctgttgtctcgcccttgctctgctcctacttcacccatcttctgagatccaagtcaaaatcatctgcacg
1133 3976861 HDAC6 YES acctaatcgtgggactgcaagggatg 1134 4048293 --
NO
ggggtagaacaatcaagcttattcctaaggattttcttttgacaaataaatgggtggtagtgttgtttattga-
gataggaaaaactatgggaggaaatgatttgaa
gtgggtggtttgaaataaaagttttgtttaaatatgagatgattgattgacatttatgtggagaaatccg-
aaggtcaatggcatttaagagactcatggtgaggcc
agggcttcaggtatttatgttggcagcagcaatacgtgtagtgtgttaaattccagggcgtg 1135
2393657 KIAA0495 NO
ccctgtttgtctgagccctttggagatttaggttgagtcatgagaaccggtcattggaacatacactttatta-
tgttacaaaaacaaaaatccccactgaaacaca
gctaaaaaaataacacattttcccaagattacattaccaaaaacagttgttatgtcattggagggcgtcc-
attaatactgctcggagaagcacgatcttaca 1136 3389355 CASP1 NO
aggtttttggaattatgtctgctga 1137 3584178 -- NO
attgtagtttgaagagctgcccttgggaactcatgggacaggcatcaggcctggaatgggatggacaagtggg-
gcctccaggagaaggagcattgcagg
agatgctggagagtggggagcagtacgtgcagcagatagggga 1138 2365984 MPZL1 YES
tcaccagttaagcaggctcctcggaagtccccctccgacactgagggtcttgtaaagagt 1139
2468456 -- NO
aaagcaatcttaacagtgagggctatgaaaccgttgaaaattctcccaagggaagtgatggaaacctccttgc-
ttgagtcatttcaaagtcgacaaaacaacg
aaaaatacatggagggagggatcctgtagtgttggggagcagactcgatgatttcatagttcttttctgt-
ctctgatttccatgttctgtgaaatagtattgcagct
aagaaacatgaaatccttcactccgacagtatg 1140 2954656 YIPF3 YES
acctgcttcggctactggctgggagtctcatccttcatttacttccttgcctacctgtgcaacgcccagatca-
ccatgctg 1141 3499189 ITGBL1 YES agatggcatattgtgctcggggaagg 1142
3102170 PREX2 YES
gaaggatattattacagagacaatgtttctgtggaagaatttcaagctcagataaatgcagcctcactggaaa-
aggtcaaacagtacaaccagaagctc 1143 3151372 -- NO
caggcactgtatcaggtgctgcgtacttctgctagctcatctcacctggtcatgccgctctga
1144 3153640 -- NO ttcttccttgatgcaggatctgaggttgaag 1145 3708351 --
NO tcacattctggggttagaaggggcccaatggatgggaattcttcatataaaagaggaaatgcc
1146 3793991 -- NO
tgcaacaatgggagctttttaactagtctctgtaaggcgttgtcatcacatctg 1147 2840186
DOCK2 YES
catgagttcatgagtgacaccaacctctcggagcatgcggccatccccctcaaggcgtctgtcctctctcaaa-
tga 1148 2945913 CMAH NO
ttgcctcccggagtgtgtaaccacatgagaaatagagggaaggttctgtccttaagaagttaaaagtgtgact-
gggaaggtaaaacatacttattaagggtta
actagcatcatgccattctgtgtgatggtgagtttgtgtgtgtgtgcacatgtgcgtgagtacacacata-
tacatttaaaaaggtcttgaatataccaaaatattat
gtctaggtgatgggtagcttgtatattttttctgtatccttgtctgtgtttgtcaaattttatagaaaca-
ataacagtaacagctctctgaccttctaccctgtatgttct
gcgtcctgtctaattcctcaagttccttcactgcctgtcactctgatgcttgctatatatcagcccatcc-
tgctttttgtttcttagacccaaagtgtcaagtgcacac
ctgccctgggtctttgtgtttgctgtttccatttcctggagtgcagctggccctgatttgcatgtgacca-
gca 1149 3706405 PAFAH1B1 YES tcgtcactggcagcgtagatcaaaca 1150
3898481 -- NO atggcggcagagtatctggttctctt 1151 3962245 NAGA YES
tgctcttgctgggacatgtggcccaggtgctgatgctggacaatgggctcctgcagacaccacccatgggctg-
gctggcctgggaacgcttccgctgcaa cattaactgtgat 1152 2877309 BRD8 YES
cacagagccatggtccatccgagagaagctatgttt 1153 2973720 -- NO
gtttggtgtctggtacttagagctccctgaaactgtggtgttt 1154 3091762 FZD3 YES
aatcatttgcctctcggccacattgtttacttttttaacttttttgattgatgtcacaagattccgttatcct-
gaaaggcctatta 1155 3418179 -- NO
ctgagctcatccagtaaaactctcaaaagatgaatagatgcccttttccttgaggagccttctgcctgatttc-
tttgtcactgagtttgggtccctggttggagtgg caggaggaaggggtccaccacgtcttctgac
1156 2685385 -- NO tttggtgtctttctgaagggattcggcccggag 1157 2912792
-- NO
ggatgaaatcgtgcacgtccctcttcgtccctctcaggacagaaattcttttgtccagcatatatctatgttg-
catataccaccagccaattagtcacttagtagct
ggtgttggttatgagatcaactgtcatagtatcacagtgcttgtttcaggtaacccttatgttatttaat-
agtggcccaagagtgcaagagtactgttgctgacaat ttggattcacgagaagc 1158
3590727 JMJD7 YES tctggtatgacatggaatacgacctcaa /// JMJD7- PLA2G4B
1159 2363028 -- NO gaaacgccgtcctgcggaaacatccaccatccggacc 1160
2374733 -- NO
tagagactggatcatagaaggagttgtttgccatgcttacccttaaaggctttctgagcagtcatcctgggat-
ggacagggcagggagtggagagaccagc
gagcaggtttttgttacggttcgagtgagggttgaacacaggcagtggtggtggagatgggttgcaggga-
taatcttgagagagatttaggagacaagattc acaggttg 1161 2448301 TPR YES
gagattcagcgattgcaggaggacact
1162 2596900 -- NO gaatggtgggaaatgtatgcttgactcaaaacagccag 1163
2713805 ZNF595 YES ctatatgttctcctttcagccaagacct 1164 3878694 -- NO
ggggtgtctgcgtggggagaaatcagttgtcggcattttaaatctctggataatgag 1165
2434634 ARNT NO
cggctgttgatacgattgtctgttatcgaacacattcagtgataaagctgggttactgctgcttttggtgctc-
tcaccttatctggaagatctgcaaacattaccta
aataggctggcaagataaacactttctggaacccgagacttggccataaagataatgctgcatttttctg-
tcagaatcacatatgatgtgtgttctgtagaggtta
tttctgcatggaaactcaacttcttggattagccgtcccagtgaaaatcctcattgttggagtgtaaacc-
aaatacgaagccctcttgcaaagtagcctctttcat
cccatactcaaaatacccagtttagcaagcaactgagatttaagtctctctggccctaagaggtttttcc-
tctttgctccctccaatcttgagattgggttttgcttta
gagtgcaagtatcataattccgtatgatagatggggcctggacacccatctcaacagggtcacttggtaa-
ttaacaatagccatataaatgcggatacaggtt
actaccctcaccctttaccttcctcaggtaacagtcgtagataccagcttttttttttttttttttaaat-
tggctttggccagtagctaaagtgcaagactgaattaatg
agaagatatattaaatgtagtcataggggactgaggagcaagggtggccttgaagaggccaaaggaatgt-
ccatttgctgagtttcccttccttatgtctccag
tctggtgccaggtagtggagtaaaaaaggagacagtttatttttttattctatgtgcacacttacagtat-
acatatatatttatatcacaatttacgaaaccaaaaag
ttgagtttccaatggaacccttgttttttaataatcgactttttaaatgtgatcaggactataatattgt-
acagttattatagggcttttggggaaggggaggatagc
gagaagatgctctgggggttttgtttttgcttttccttcagggttttatttttgactgttttg
1166 2502158 -- NO tgcactttcccagcgtttctgtctgc 1167 2511348 -- NO
agacaacagtaaagaaataccagcaatttgaagccctgtccctgaatcctactcctgttgccttcatatcgag-
agttccaagtgttggcctgcagttaagttctga 1168 2697262 DZIP1L YES
ggaactgcatgaagagcacatggctga 1169 3829727 GPI NO
gttctctgccaagtgctggccagaggcgcgtgtgttggtcctggtcccccgctttctcccccactgtcctgtc-
cctcccctccccgtgcagctgctcag 1170 2566885 -- NO
cctacgaggtccatggcagcgggtacttgaaggattta 1171 2644609 -- NO
ggctttgaggatctctgtgccactttg 1172 2681773 FOXP1 NO
tccttacgaggctagagattttctgacaacagtatgttagtttcatttggtccgtgaatggagatggcagcaa-
atattctcagaccctcccagatctggctaaga
catccccttatttaggaacgaccctcccctggcataccctactctccatcgcctgttggcaataaacgtg-
ccttgtggatattccttaaaagccttcctgccatcc
ctctagcagtcactgtaaagttcaaatctcaaagatgcttaggagccaagattctctctgctcgtgccca-
gcagcccctgctgtgagctcactgccttccccag
cacgacctcctaggctgctgccttcctttctgttggagtctggagtcaggctaactcctaaaaatctgca-
gagaggtctctggagggaggacccaagcctgtt
actacctaagccagaattttacacctagtttccttgaatagagaagtccaaccccagaggtgtgcacaca-
cacccgccctgcaaatcagtgacggggagaa
agcctgacttttcttgggttttgctagtgggggaaattgctcatttggaagggcaccagcaagctta
1173 2941811 -- NO
gtgtcgcttttattctaactgctggaactatttgttgtacctctttctgaagatcagtttggggctaaattac-
aagctccatcagcacaggggccatggctgcctcc
tgactgctgtaggctgagcacttggtagagcatcagccc 1174 3037970 -- NO
tcacctaaaaggacgaatccatctgcttctgtctctggtactgagggctttttagattccggaggctttctga-
aga 1175 3235439 SEC61A2 NO acactttgacggatcgtttttgtcagatga 1176
3670576 -- NO
ccaaggtcacacaatacgaggtggggtcagaatgcaaacccaggcagtgtgcctacctagcccagactcttaa-
ccactaagatgtcactaaagaagca 1177 2682104 -- NO
ggagatttggagtacttggagcatggag 1178 3809910 -- NO
gggaccttgtccctctttgcatggagggatggtttctttaggtcctgggggatagcccaggccacttccactc-
tgaagatctgtgttctttatcagtctttcaatct
agtatatttgcatttaataggtgacaaatgggcctggaagctgtggtgggg
atggagtgggaaaccagctctcagtctgacattgactcctggaggggagg
gtcacctctgttcctgggcagcctttcagtggcgaaggccaccatcccccacagcgtgattgagaagcct-
ggcacttctgcaatgagtactgtggagcctga
cctttggctagtagcttggtctttattgacagggctgtc 1179 2428310 -- NO
cccgggtctgtcataaccgcaaatttctataccactctgctgctttaagatatcaacaggcaaaagataacca-
ctgtccaactcacataaaaataggacatcaa
gttttgggggacttcatgtcctacctccagcttactaagcctgctatctctggagattccactactgcaa-
acctagttaggcaatgggtaatagcattacccatta
agccaaatgtggagtgaacaataataataatcactaggacttggagagtcactaaataaagatttgttga-
gtaagtggaggaaggctgccttctaagctgtgt
atcactttggccccaacctgcagtactccttcccactgtagccactgactcctgctcccagcttcaaagg-
ctaggatcctctcataaagaattaccaaagccag
agatccctacctgcctaatatatactgatgcctcatgtgggcccttga 1180 2429289 -- NO
tgtggtttgattagtaactaccctggagtgtctcaacttt 1181 3246430 -- NO
acccgatgttgacagtttctccctccctctctctctctgctgtttcctctatagagctaagtctggtttgcat-
tgaaataagcatgcagtaatatgccttttgccttac caacttgtatttgcacacaggcagca
1182 3314235 -- NO gtgtcctaagcgggtgcatgtccag 1183 2332841 ERMAP YES
tggagaagagcccggttgcattttg 1184 2452077 PIK3C2B YES
catggtgatgcatattcggggcttg 1185 2592323 -- NO
atagagggttcttgcagctgtccaaggtagaggcagtggaagcttgcgctcagtagaatcagtggaggtagga-
agaggtggacagattcaggttatgcttt
ggatgtgataccaatatagaaggatccttatgttgaaggattagatgcaggagtgagagcagaaagtcaa-
ggatggctctacagcagctactagaacccctt
gaaaaatggtaatgctgtacacggagctgggaaggcaaggagggggcaggggcaggagttttgtaggact-
caataggtttgtggagagaaaaggaggc
tgatgggaaaatcaagggctttgttttgagcaacatcaagatacctattaaatattcaaggcatcaaaca-
gtaaatgagtcagagttgtactagtatcaagatttt
tgatcattgttttattaatcctaatacaaaccttcctagttgtcagggttcagc 1186 2895598
-- NO
atgttctcggaacaaggaaccagtaaagtacagacatctggccccaggattttgctggctccagggacgtcac-
tataaacccactaacactaattgctttcac gtctgctcccatttcta 1187 3578431 -- NO
catgcgaaagcaacagtctgatctccaggttatgaaaactataattaaaaagtcactacacagaaaaggtcca-
agtttccagcttggcaaaacttgggtgcag
ttacatgaaacgtttaataaactgaattgttttccccaatgtgtaaacaaaatgacaagactaaatctgt-
gcctggtaatttcaatctaactctgaagctacacaaa
acacacagacaccttgtacatttcacctgttagtatgaccatcttttttcttcggtggtggaaggaaggg-
caaggtgactgtgtaaagcaaagatgtgggaagt
agaaatattgtttactagacattataaagtcatggtgaaaagaaagcttcgattaatgcatagcctaagg-
g 1188 3590373 -- NO
tcttgtggttccttaacttgtggcagcataactccagtcttcacatgaagttcttcctgtgtgtgtatctgag-
tcctaatataaggagactagtcatattggattggg
gtccatcctgctctgttaatgacctcatcttagctgctgacatctgtaatgactctattaccaaataagg-
tcacagtatgaggtagtaggggctaggacttttaac atacgaatattgggaggacacagttc
1189 3277334 -- NO
tgcctgcttcacacaagtcgaactgcaactgggatcttggcttcttgtcaagtcagtagcatgcaagccagtt-
taagtcaaaagaggacacactcctcttactt
gattccccttgccatctattttctccctcaatcttagccacttggagaagaatttaataccttttttttt-
tccagagtccaaaggctgtggatctaagtggggcattttg
tgctcaagcgaatctgccatgcactacggtttcaactc 1190 2323027 -- NO
gagcggtatcttgaaggtggctttaagtttgggaagttcgggaagagcagtaaaggcacgatactgggactga-
gcccagtaggagt 1191 2360843 HCN3 NO tgtcagcagatgtcttgggtcctgagt 1192
2834307 STK32A YES gaataaacaaaagtgcgtggagcgcaatgaag 1193 2890310
C5orf45 YES aagaagaaaacgtgggacaccagcaggc 1194 2510000 -- NO
gataatgaagccaacgcaaaaatccacgtctccaggctaa 1195 2575065 -- NO
tctttccagctcatgtctcccggggggctgggctgtctcctgtcctgcagccgcagcacttgatctcagcagg-
tggaatgcagagcagaggaatccgccag
acattacagggatctatctgagtataaaacgggactgctctttccactaaattgcttttggagaataaag-
ttaagtgaattaaaatttccccagtctcaattgctaat
atggtaaatattcgcagttacaactctcattaacaaaatctcttaggagtcctcagtaatttgagactgt-
aaagacgtcttgatactacaatgcctgagaacgagt
tctctggatcttacctgcccctcttacatgaggaggcaccctgatgtctgggtggcttaccctttggcct-
ctggcgggcattcagcatgagtgaa 1196 3336723 FBXL11 YES
tttaatgtagagtatattcagcggggtggcttgagagatcctctgattttcaagaattctgatggactcggaa-
taaa 1197 3660063 -- NO catgctctgacgctctatgccactgctgcacct 1198
4029263 -- NO
taaaagactgaacaagaagggcacagtgttcacggagattgaagtgaacaagaaa 1199
2663789 CHCHD4 NO
gatgaagatttggacccttccattcataatccctttctaagtgaagggagaggctggcttggctgttccttgt-
tattccgaaagccctggtttggggcccatgttc acactggctctcagtctagtcaggtgca 1200
3743045 -- NO gccactctcgtgctgcttgagctgc 1201 2826559 -- NO
agcaaagactctcgggaacaccctattacaggaaaatctctcatacctgacctctgcttaacccactcgtgag-
attaaatgatagtcttcattctctctgtagaat
ttgctgactgatgctcatgctacattgaatgacagtagactattctttagttttatcttgaacttttatt-
ccccccagttactgtagacttaccaagaaacatttgtgttt
gtacccaacacactgttatggcacttgatgttgtaatcacatagtttaatgaattattattcagtgaact-
ctgaagataaaaaggcgtttgtatgagaaccaattgg
ctactttgaaatcaagtgagtagccaaaatcaattatggttgaaatagatgagggttaaataattttaaa-
tgattagggaaaaaaaaacaaaaaacacctaacg
atctaaaaaaatctgcaataatattatttttcacgtttgtaaaatgtctttctgtgtttaagaaacagaa-
actggaaatcacaggtgttgttttatgggggtagtttttg
caagaaaaaggaaatagaactttcttcgatagacccacactgga 1202 2882611 FAM114A2
YES
gtgagccagccaagaattctgagtctgttgaccaaggtgccaaaccagagagtaaatcagaacctgtagtttc-
cactcggaa 1203 3044784 -- NO
gacccacggcaattttgaatacttggaagagcagtctaagtaccctcacacaa 1204 4016017
ZMAT1 NO
tgtaggtattcccatggtttcatccttgaccttactctacaaacacgatttctatttccctgatttcatttct-
catctgtatgcttatgacctttctgtcaagtattagattc
acatatccaaatggcagctactgcttcacctggatgcctcatagcca 1205 2872559 -- NO
ttggtgatgctttatcgacctctgagaatccctttgtgatctgcagtgctactgtggttcacaaaatctgtgt-
tcttgctctccctgatagcatctgacatttgtcatc aggggttggcaatc 1206 2810393
MAP3K1 YES
tgctagtgcaactactgctccatcgatcccttcacatttgtctcctggtttacgagatgtggcttcgttgttt-
agaacttc 1207 3309863 -- NO aagtgtagcggcaggcatcctggga 1208 3349873
NNMT NO
gaatgctgttagcctgagactcaggaagacaacttctgcagggtcactccctggcttctggaggaaagagaag-
gagggcagtgctccagtggtacagaag tg 1209 3849058 -- NO
gtacatcattacccggcacagacaca 1210 2609601 -- NO
cccctcaaatcttacagctgctcactc 1211 3489275 -- NO
tctcttgattagtctaggtggtggtttagttctgttctgattttttatttgttttagagatggcatcttgcga-
tgttgcctaagctggactcaaactcctgggctcaagt
gatcctcccacgtcagcctcccaagtacctgggactgtaggtgtgcaccactgcacctggctgtctgctc-
tgatctgcaccactgcacctggctgtctgctct
gatctttattatttcttccactaattttggatttggtttgttcttgcttttgtagttcttgagatgtgca-
ttgctagattgtttatt 1212 3490771 -- NO
tctccgtattgcttagggtggtctcgaacttctgacctcaagcagtccttcggccttggcttcctgaagtgct-
agagttacaggcgtgagccacagcacctggc
ctacatattacatttaagtctgtgatgcttttagaatttttatgtcaagtgtgagatttaacttgaggtt-
cctttttgtggggtggatagtatgttcgggtgttctggcac
ctatcttttctcattgaattgatttgcacctttcttaaaaatcagttgagcgtatttgtgtgagtctatt-
tctaagttccccactgtgttagattgagctgtatgtgatcta
tatgtatgttcctctgtcagtcccactgtcttaagctgtagctgtttaagtctgaaattgggcagactca-
ttcctcctacttta 1213 2353513 -- NO
taatgtcatcatcagtgggcaagtctagaaccctaatatcctggtgctcaaaattagtgttatcaattcagtc-
ttctccacattaaacaatttccaattcctttgagg
cctggtgtgatggattctgtctttcaaatgctttttttctttcagtgactctatcgttcataaatgttaa-
ataaaaccctcactctgttataaaaatatagactttaaaaat
tttccaaagtaaacactccagagaaaggtaggcgggctgaataggctgctgttgtccttcttactgccca
1214 2610157 CRELD1 YES catctgtgtgaaggagcagatccca 1215 3092298
LEPROTL1 YES
tggggagcttgtgcacttgttctcacaggaaacacagtcatctttgcaactatactaggctttttcttggtct-
ttggaagcaatgacgacttcagctggcagcagt 1216 3241630 CCDC7 YES
taaagaaaatcgaccagaagcagtgaaaagttg 1217 3489976 -- NO
ctctgaggtttaggcctcgatattcaggagagtggtgtaggaggaagatgaaccactgggttttagacacatg-
gaggcttagttcagggctttgggcctccc
ggttagtttgtttagtcttgttgatctaggaggagatcacaccagatga 1218 3671050
PLCG2 NO
ggagaacgtgccctattcacactctgggaagacgctaatctgtgacatctttctttctcaagcctgccatcaa-
ggacatttcttaagacccaactggcatgagttg gggtaatttcc 1219 2476149 -- NO
gtcagttagacagagtccacaagggagtcg 1220 2670672 -- NO
gaactcacggtcttcagccttcctgc 1221 2792848 -- NO
tggccatggtgaaacagtgcctcta 1222 3168127 -- NO
ttccaatcagcagtatcatggattaaat 1223 3227785 -- NO
gggcagtttgactatgtcgcatccagcttcccatgccgtccatccctaggagtctgtctcaccatacaagggc-
gcagacaggccagcttgagggtgttcatc
aacgcagcattgtttgaagagcagaagttagaatctattcattcgggggcctgactgcataaatacactg-
tggttgccgtccagca 1224 3367153 -- NO
cttgtatgaccctttgtctcggttgactagttgtttgctctaagaatatttcatgttttgctgtttctttcag-
tttgtaggtgctaagctattgaaaggtttagagactaat
ctaggtctttctaaattatggctgcttgcagttttattcctggagaaatggtttaacagcacttctttga-
gttggcactcttctgcctgtctcagctctaactttcccgc
ctccttttcagtagtccctctttcaccctccactccccaagcctgaaatggaaagaacttgctttgttac-
tgatgataatatttaagctctaaaattttaacagtgttt
cagttgcaaataaatggaaattgtgtattctgtttaatgtgtttcagaaaatccctgctatttttttttt-
ctttaaatacaagaaaacaggcgtgtaatgcctcattgaa aa 1225 3483227 -- NO
tttagtcaagtaggttgagagcaccagggatcattttttcttcacaaccttttagctcagtgatacccagagc-
aatgtgcctactcagtggagaagatagtatttgtgt
gaataaatttactgttctgtgtgttacatgtctagttaggagtggtcctctaattctgta 1226
3766878 POLG2 YES
aaaatgtggttccttgtgttctctctgtaaatggggacctagaccgaggcatgctggcctacctctatgattc-
taccagctg 1227 2555150 -- NO
tgggcgtgaataaggaagcaaaactcaattataataacattactattgttcaaacttcacatggcacttgcaa-
ccggaggctactttgtctgcctgtctccatact catgctgtcttatgctcatgttcttca 1228
2601747 DOCK10 YES
gataccacttcccactcgtcttccaaggggggtggaggagcgggaggaactggtgttttcaagtccggctggc-
tctacaaggggaattttaacagcaccgt gaaca 1229 2664745 -- NO
ttatccaccgcacatgaaagagagctcagcgccaactgccagtccactgaagggtgtcgcagtgatatttgtt-
tga 1230 2698409 -- NO
atgtgctactaacaggtcaggagcccagatcaaagagctggtttgggaggtggataatgaaggttgtgaagtc-
tgtgctccctctgagaagcctgaggaaa
atgcaggtggctccctcaatcaacagacatccaaaatgg 1231 2704917 PHC3 YES
atcagcagattcctcttcattcaccaccttccaaagtttcccatcatcagctgatattacaacag
1232 2823922 CAMK4 YES aaatgggattgtccatcgtgatctcaaaccagagaatc 1233
3717013 -- NO ggtctatatgtctgtacttatgctggtaccac 1234 3498270 -- NO
atgtccagcgcaaggacactgtccagccttctcttcctgcacatcagctgcctcccgtcagtcctgctgaacg-
gggatccttcccagatttc 1235 3737381 -- NO
cttcaaagggtgtccagatgctatgaagcattgggttcgacttggggtccacgtggtttgtgcctcagggtcc-
aaaaccacctgcattctaccggtggcgtct
gcagaagacgaatggcttgaaggagctggcactccgccggctagatgatccaaaccatttcatttctttg-
tcgtgtggaaaaggccctctgtgatgcacttct gttctctgga 1236 2512319 LOC643072
NO
ctgtagctttgagtttgcaccgttccttgtcccaggaaaaagttaagaaacttaaaatgttttgttttgcttt-
aaagaagacaggacagaaaacgggatttaaaa
cttagtttttaaaaaaacaaaagctacagagtagggagcataggtcaaccatctccacctaaattttttt-
tgttcctaaactcagaattctacaacccaactaaatt
aatatgccaagattttgcggatgttaaaactcaaaaaaagcagtatgcaagacggtcccggggtaaaatt-
ctactgcctttccacggacaagtta 1237 3596425 -- NO
agtcctcgctgtagcatggggtaaagccaggatatgacttcacatagtttaactccagaacttacactgtcat-
cttgttttgtttttctgttctcttgtgtgtcaaaa
gaattcctccttagttgttctcatatggggcaaccattaaattaggcagtgtaaaaaacaagttatgcag-
aataaagtagcaagagcaatctactctgaaattag
tgttttccctcactttagcacctttagctgacccagcttcctaccgcccagactttttacaaaatctctc-
tctggagttgcctcctgatctggattaggagtcacata 1238 3809494 -- NO
ctgtgtttaacacggctgtgctacttcaggctcccatctcgctgagggtgcccatgtcagccaatgacctt
1239 2442446 -- NO
gtcttttgcagtaggtcagggctaagaggactaatccctcaagagtgaagaaaaaaactattgatggtggctt-
gaaagagtcaactgctgtagcttttcttgga
gatgatcacaaaatggggagcagaaaacaggttgaaattacagaagattaattagtaagaaaagatgggt-
taaagatgtaaattagaggcaaagttaagaa
gaatttggtttcttcattatactcagaaaggtaaggatggaaaagttgatggagcaagattgtgaagtat-
cttatatgcaagactaagaagtttggactagattct
gaagacttaggagaaccagtgaagaaatcttaatagaggaatcggattagatcttagggtcagaacaatt-
attagcaagcagggtaggtgaagttcctgttg acccactttg 1240 3281111 -- NO
agcatctgtcgctggtgagaccctcaggaagcttcactcatgaggaaggcagtagggagctggcatggcttgg-
cgagaggcaaggaaggagagggga
aggctcttttccataagcagttctccctatggcaccaagccatttatgagggacccacccccatgaccca-
gtcacctcccaccgagcaccacctccaacattg
gggatcacattgcaacatgaggtttagaggggacaaatattcaaactgtatcactgggagatggggctac-
cggaagtcaagccattcc 1241 3770080 -- NO
ctgtactaagtgctgatgtgccagcgctatg 1242 3821078 -- NO
acagatgtgatcaaaaggcctaatatatgtgtaattggagtcccaggagtgaagagtgaaaatgaggcagaaa-
aaaattcaagtgagaatggctaagaattt
ccccaaactgatgaaaggcatccacccacaaatcccaattttgtacttccaaccactgttataccacccc-
cctcaacaatgcctataaatgtttgttgaaaatga
gtgaatgaatgtactccaatcattttctcacttggatgttccctactttttgc 1243 2531265
SP140 YES
ataatagcaaagccgacggccaggtggtctccagtgaaaagaaggcgaacgtgaatctgaaagacctt
1244 2719554 CC2D2A YES
actggtggctcgatatgtgtccttgattcccttcttgcctgacactgtctcatttggtggtatctgt
1245 3342924 -- NO
tgaggtccacaaatcagtcaagttgaataaagaggaaattctaaggaaaatattaaaaattacagaaagagga-
agctggggacactgagcataaactttgat
gacatcaattttaccgtgtgcctatccactattcctccacttagtttctcagatcttgccagcaacctta-
gggcttgcatcctccatttc 1246 3811421 -- NO
gtacgtgtgagtgcgctgtataaagtctggaaccacaattag 1247 2448106 -- NO
ttgtgtgattgcaatgctgaatttgtc 1248 2661177 -- NO
ccttgttcccacatcggcacattatc 1249 2748212 -- NO
aggcattttttgtccacacacttgctttggggatttttattaggtagacggtaattagaggtgtcagtcatat-
gaaagtaaatcactagtctttcgtattactgttttct
cagtggtccttatcagttttttttgttgctctgtaatcattcatatggtaagacttaacttttagtcatg-
taaatttgtttagggacaatttaaactattttgtcaaattagtc
gttttattccaagttgtacgtcttatgcatttatttagtatagtgaaagccttatatacacatttaatat-
aattagtctctggatatttggattattttttagtagtactttttta
gagtgtgggttttttcttttcttttctgtttttgagacagtgtctggttctgtcacccaggctggagttc-
ggtagcccagtctt 1250 3081649 -- NO
cacctttgtgcatgtatatacttcaagttgtatgaatttctttatgcaaagagcctttaaaatataaactgtg-
atttttgtttctaattttttactttggattgacagggcct
tttttcaagtgttggaatttccttttagatttcttatcagagtttatcttgattttactgaaattcattt-
agctatatgaaattcctttagccatagtcttgattcagatcccc
ccacctgagtctttccaggaccttgtgccatctgttattgccattgttgtattcacttacagcctcttct-
ccatgagtacaagcccaccatcatgctc 1251 3415065 -- NO
gagccattcctttggcaactcttgctgtcagccatcttccaaagagctttg 1252 3436225 --
NO
tgtctaccatgttgggcagcacagatctaaagcatttagaaccatggctagagctatgtgtttactatcattg-
cttcaatatggagagtcatccaaacaggtttca
tttgctcccagataaactgtcatgggacctgccgtggccagtgctcaccttgtactgctggaataattta-
acaatttttttcaactgccatcatcatcatgccatttt
atgtcttcgtagcatttatcactatctaaaggtaggtcgctta 1253 2546677 -- NO
ctcccaaactcttgaggacatgtggggaactacagctgg 1254 2723423 -- NO
aaggtagtgtgcaaagcgaaaagagggcacagaccaaaatcatgcaaaa 1255 3291647 --
NO gtgggttacatgttcctgcctggca 1256 3449366 IPO8 YES
ggacctcaaccggatcatccaggcgctgaagggcaccatcgacccgaagttgcggattgcagccgagaacgag-
ctcaaccag 1257 2935290 -- NO gttttacaacacccaaagcaacagaaa 1258
3296065 KCNMA1 YES
gttatggtgatctgttctgcaaagctctgaaaacatataatatgctttgttttggaatttaccggctgagaga-
tgctcac 1259 3414403 SMARCD1 YES tacggtgtactgtcctactgatgctggattacca
1260 3611215 -- NO ctagtctagggatagtggtagaagtacgtaatgtagatg 1261
2997513 -- NO cctttgctctctcatatgcatccggcacagcagc 1262 3180413 -- NO
ttcaagggcataggcgtcggaattgtgatttcgtgcgtgttt 1263 3732510 -- NO
gaaccactttgttgaccttctgctgcaa 1264 2572597 CCDC93 NO
ctggacggtgtctatcaaaagtgcaaatgcataagctctttgaactagcaatgctactcctaagaattgtacc-
tgtgtacaaggtacttgtgtacaagagtttttgt
tgaaacattgtaatagcaaaaagttggagagtgccaccaatacaggggaatggttaaatacattatggcc-
agcttaaacaatggaatagtttgtagaaatttaa
aacaatggatcctgtgtgtgtgtactaccatagaatgggccccaagatgcatgattaagtgaggaaaaaa-
gcccatggtatcctaatgtttggaatggagaaa
gtgtgtagatgtatgtgtgtgcatatgttttcacacagacgtatacacgtgtatatcatatgtccacctg-
catatgcctaggatgtctctgggaggatatctagca gcccggcagcctgaattgcctctgggaa
1265 3216409 -- NO
aggttctgaagtcccaggcaaatgtaatagggggtaggcagaggacttacttagagagatggtggtgaaagtc-
tcaaactgcagatttctagaacaaacag
gttacttgtaagaagcagacagagatacttagatcagtaaaatacttctgtaacactagaagtgagaaga-
catgagaacgttatctagaaactatcaagagga aatgactgcagaccaaaaatcctacgc 1266
3294290 -- NO
tccacagctcgatttggccaatttcgagttgaaaggatggtactggacccaggcctcataagtagcttgtcat-
caagatctctagtagccaaatcagaaaccc
acaatgaagtaaagatcagtatgtcaaggaagacaagactaacggggtaaaaagccttagactagaaact-
acatttagggggaaataaagcaaaaataaa
aacctttcaataagtaacactagtttccagatggtactctagctcaggcatgagaatctgttcttaaaag-
tgggacattatttcaatcataaacataatttactaga
atggacatttggcaaagcaagtccattatccacctgccatcacagtcacttttttagtcaccagtgaagg-
caagcctgaaggacacctactccaaagtgcttcc
caaaaatttgccacaggggctgattcctactctgtttgaggcattcttttgtgctgaaagattgtcacca-
gaaagacaactgaaagacaaatattgctgcttggg
agcagttgtggcaccagtgtggctcccactgtagcaattaaag 1267 3446505 -- NO
gtcttgtagcactcaaacctttgtctttcccacaagactgaaaactccatgacacaggaatatttcttatcct-
gtgaacctttgtgtcataccacctatagtagtgttt
agtataaaataaattaattgtttggaaatctatcctaaaaaaaaaaacctagattcagtaaaagctctgt-
ggccaaggatgtttgtgttacagtgaacaccttcga gcacttcagg 1268 3616936 -- NO
ctcatagcatggtggtctcgcagtagttagccttcttacatagttactggcttt 1269 3628351
MGC15885 NO cctccgttacccgtcagcccagcatccggctttgcttccataa
1270 2745112 -- NO
gcaaaattggtctggtatctgtctaaattggtcaatacaagtgttattctggaatcatgtaaaaatcacttac-
tttcataactgtttagaaccccaaatgttttcccttt
gaaggggaacatctgtggaatatgattttgaatagaggacttctatgaaatatatttcaaatcttaaaaa-
tatttttaatacttcctaaagtggtataggatttaccct
cgctgactatgccttccatttaagaacagtcttgcatttgtggcttttca 1271 2824232 APC
YES
tgtccctccgttcttatggaagccgggaaggatctgtatcaagccgttctggagagtgcagtcctgttcctat-
gggttc 1272 3101817 SGK3 YES agttctggtttcagtgggaagaagtg 1273
3129414 -- NO
cctagctgtctgtcaggtagaatgagggtgaaggagatctaggatgcttcaggcattgcgcttgaacttaaaa-
aacaggatcagcaggccctgacttcataa
ggcccataaatacaaatgactagctccctttctcaaggtcattgaaaatatacagtagtttcagacatca-
catgggtttgggcaaagggggcagatttccaagc taggtcacttaatggtatc 1274 3576514
-- YES
gtggccgggaggcaaaacttctctatgagtggaaacgtttgaagaatacatcacccattacgattttgctaat-
cttaggtttcagacaccacagacacattgatt ctatttggaaagatagccatcaatcagccagc
1275 3650814 COQ7 YES
ataaagaaatttcgggatgaagagcttgagcaccatgacataggcctcgaccatgatgcagaattg
1276 3723777 -- NO
gccaaagagcatgtagagcaaactaggctctattcagcatttccatttcttaatgtatctatttgatttcaat-
aaaatttcatcattttgaagatctctcccattagctt
gggaaactacagaaacatgcacataactactgagaaggtatcaagtgttcctacactagtttaaaaaaat-
cattcaacacccacataaattctgatatgcacta
ggctgaacagctgttaaccactgagaagctgggcactgcatcctctccctgggtcaaaactctatatgct
1277 2550931 -- NO atgcacatgggacagtctaagatggtagtggtgg 1278 2681842
-- NO accaagtgacattttgcattcagcctt 1279 2868846 -- NO
gctctagtgccacaggaagctgcct 1280 2880139 PPP2R2B NO
agccaagggagaacccaagacagagaa 1281 3309073 -- NO
attgaatgattgtttagaggcagtgtga 1282 3636536 HDGFRP3 YES
gcaattcagcaacagagctcttcagaa 1283 2347802 RWDD3 NO
gggatacattcaggtctcagttgttgaggctgttgagcagcaatccaggtatgaaaatgggaaagatttgact-
gcttctctcatgcaggggaataaagcaaag gc 1284 3202177 PLAA YES
tcctgcacttgacattcttcggttgtcaattaaacaccccagtgtgaatgagaacttctgcaatgaaaaggaa-
ggggctcagttcagcagtcatcttatcaatctt
ctgaaccctaaaggaaagccagcaaaccagctgcttgctctcaggactttttgcaattgttttgttggcc-
aggcaggacaaaaactcatgatgtcccagaggg aatcactgatgtcccatgcaatagaactga
1285 3945822 -- NO
aaggaagcgagagacttggcagtcctgtaggctttaatggaatcagcaatggacgctcg 1286
2682207 -- NO
ggggctttaattcttaatcgctgtgaggattgttatccgtgggatgtgagctgtcttagtggtattcaatcaa-
gtgtccacttagccatgactggaagtaattgctc ccaagtgggcc 1287 3263773 DUSP5
NO
agccattacgggagcacagcatgtgctgactactgtacttccagacccctgccctcttgggactgcccagtcc-
ttgcacctcagagttcgccttttcatttcaa
gcataaggcaataaatacctgcagcaacgtgggagaaagaagttgctggaccaggagaaaaggcagttat-
gaagccaattcattttgaaggaagcacaat
ttccaccttattttttgaactttggcagtttcaatgtctgtctctgttgcttcggggcataagctgatca-
ccgtctagttgggaaagtaaccctacagggtttgtagg
gacatgatcagcatcctgatttgaaccctgaaatgttgtgtagacaccctcttgggtccaatgaggtagt-
tggttgaagtagcaagatgttggcttttctggatttt
ttttgccatgggttcttcactgaccttggactttggcatgattcttagtcatacttgaacttgtctcatt-
ccacctcttctcagagcaactcttcctttgggaaaagagt
tcttcagatcatagaccaaaaaagtcataccttcgaggtggtagcagtagattccaggaggagaagggta-
cttgctaggtatcctgggtcagtggcggtgca
aactggtttcctcagctgcctgtccttctgtgtgcttatgtctcttgtgacaattgttttcctccctgcc-
cctggaggttgtcttcaagctgtggacttctgggatttgc agattttgcaacgtggtactact
1288 3497166 -- NO
cgccagcataccagctcatgtttcagaatttctgtcacaaaaaggaacacaatattttaagttgactactgtg-
ggaaagctatgatcattcaataacctacctttct
gatagctctttctcagataatataagctataaaccaaaatagtcagccttcacctgatttacagtgccct-
ttgaaacttcctaagttttctagcccagtaaatgctga
gctaccagttctacttccaagctagagaacctgtttactaaagttagaagtctagtgacttcctctgtca-
gactgtcccagaatgctctccctacccccaacaact
gtgtaagaaccgtcattagccatctccaaattgccaaagtgctcagtcccttcg 1289 3618874
-- NO gtaacatgcatctgtgtgggaacct 1290 3202840 -- NO
tttcactgctactgcgaactggtcctgaaggtgcagatctcttagaaggaggactcccacttcttggtggtgg-
tcctctttttactggatgtggtcccctggaag
aactcatgttaaaattcatggaatatccaccgtcatccatgtgtcctccccgtgagggaggtccccttgt-
tcctccacttcctcctcttccacctctaagacctctt
ggagggcctctacttcttggaggtggaggcggtccacgtctaccactttcaaatgatggtttgttggctt-
gttccacctcgatggcttttccatctaatgactttcc
attcatgtctctggctgcatccttagcatctgctgggctttcaaaggtgacaaaagcaaatcctcctgat-
ttgttggtttcatggtctttcaccaagagtacttccac
tattcgtccatatttgccaaatactgcttcaagagctttctcatttgtttccgtgttaagcccaccagtg-
aacggctttcctgggcaatctgc 1291 3755656 -- NO
cattaggggaccctgcctgaatctttgccaacctgcaaggaaactc 1292 2469949 -- NO
tgccagtgacatccagggttattcgtatacctcatgctttagattcgcttctggttcatggtgccagccctta-
gaaactctgggttcctacctgaagccggtcttat
caaaacgccacccctggttccagtttgatcagggtaaccttgtgaattagcaagcagcagtccccagtgt-
gtgctgacatggaggttggagagaaaatagat
atgtcccatgcctggtttccagccaatactgatgtcgcgggttagtccagcaggctgaggctgaggcctg-
tgacaaagtccctgcatggaggtcttcctgcgt cagagcctagccctgttcaata 1293
2830605 -- NO gagctttctaatgggggtgggaaga 1294 3235906 -- NO
ttggggttgatacccatcatcgctcttagactcggggttgatactcgtcatcgctgttacactcagggccgat-
acctgtcatca 1295 3616555 -- NO
aggcagacatcaaccctctaagacatttttttcctatcctctgggaatattactttttggacaatcttggtcc-
attggtaagctcatgggaatttgtcagagtttttttg
tttcttttggctcatgtttagcatcgattggcagagtgtttggagtcatcc 1296 3369121
ELF5 YES caggaattttggagcgggttgaccg 1297 3908978 -- NO
tcccatcagcaacatccgtcataccctgacgccc 1298 2338495 -- NO
aagagcaggggacctatgatgcagaaagtcctttgctggagctcacaggtcgaatttcagggaagctgcccaa-
gggcttgaacatccctgctttcaggttcc ag 1299 2452931 -- NO
ccacatagtacggtgtataacaaggagtggtcaaagagttgtggctggtggtttccttggcaaagccaaagtc-
agtgagtttcaggatggcgttgggcctttt ggaggtgtataagagattctc 1300 3448040
-- NO
tgttaagccttcctgagatcacaccaaatgtccttgatgggaattgtaaacaacccttacttctggtttctaa-
tgatattccaggaaaggagcctaactagagtca 1301 2823916 CAMK4 YES
gattgtggaaaagggatattacagtgagcgaga 1302 3799998 -- NO
gggcatcaagaatttggacatactggtgtctggtatcgaggttcttcagctactcaatgcacgtgatgatggt-
gatgatcatgatggtaacaacagac 1303 2978095 SHPRH YES
tcatgaatattggatggctctgaggaatcgtgtgtctgctgttgatgaacttgcaatggctacagaacgacta-
agagtgcgtgatcctagggagccaaagcct aatccgcctgttcttcatatc 1304 3475634
-- NO
gacacctcaggtgacatgctttatagttggcctgagccttgacccagtggttcaacctgagtttggtcttggt-
accattcaggtgtttgtgagctgagactgatg
agtaggaacaggtgttttatatctcgtcttttgtcaaaagtaaagactcattcctttggtaacccaacca-
aatcaggatcag 1305 3683092 SMG1 YES gtattctgagcacacccaactacag 1306
4022048 RAP2C NO
cgccaagtctctgggctattttttatttttgcaaatgtgctttctaatagccattgccaccatgttgtttacc-
taatcagcatatttttgtctgaatacttgaacattttaa
cagtaacgcaggtgtagaatcagaaaggaaacttatgcagagtaatattttggttcagttttaacatcgt-
gacaatgagggctttttctagcaatgatttttaaatt
gtgtaagtttgacagtattttattgttgggtttttatttgattttagttgtgtgcttttcatttgcagaa-
gttagtaactgcagctcacctactgcaccaaagttctcgattt
taggagcccagctttagtcatttgaacatgcttctaaataaaataaaacaaaaccaaaactatacttttg-
atctataataagagctcaataactttgtcaaggaaa
gctctaatatatgcagtgatggtttatgaaagggtgtggcaattttaaatttatattgtgtgtgatgttc-
aaataaagtggtatctacattcatgtgatttatgggtca
gcatgaccattaattactgagtagaaattgactaaactttgatttcctttttttaaatcgtgttgcattt-
gattcctgagcaaattccctcaaagtgaactcttgttctta
aattttgaattttatggtgagattgtaaagatagaggcaattgaaacattgttccttatttatgaactgc-
ttgaagtgaatacttaatttaagtttgcactttaatacca
aacttaaaaccaaacactcatttaaaagtaggttaagtgatcatggatcattgttattagctttgtggct-
ttgtgaaattctaaaggaatcaaataattcatcatgatt
taaattttctagagattttgatttttttataatgtttctttcctgtagattgtgttcttgtttctctctc-
tctctctctctctctctctct
ctctctctctctctctctctctctctcaaaattacagtgttcattgtcattgacc 1307
3153356 -- NO
ttttctgaggaatagggctcaatggtgggcttagaatattgagtacaccatgctgtaaacagatatgctgtca-
tctaggctttgttgtaccatttagagagcacag gca 1308 3529618 PSME1 YES
gtggatgtgtttcgtgaagacctctgt 1309 3830025 -- NO
aattcattcgcctccggtacttgcaagcctcgctcagtcttaagcaagaggggatggattcgcccgcagcact-
gagaatccaggggcaggcgggatggcg
ttcaggcgctgttgctagaaatctctgtctttactctgttttgaaggcagcatggcagggtgaacacaag-
cacagactgaaggcagcttgccgcggttcacat
cctggtcacaccacttcctgaccatgtcacgtgggcaaatta 1310 3866580 KPTN NO
agggatgatcccattccaccctgtccactctggatgagaattggccacctgatggttatttatacgtccagaa-
gaac 1311 2620390 TGM4 NO
gccacctgctgacgacccttgagaagctgccatatcttcaggccatgggttcaccagccctgaaggcacctgt-
caactggagtgctctctcagcactgggat
gggcctgatagaagtgcattctcctcctattgcctccattctcctctctctatccctgaaatccaggaag-
tccctctcctggtgctccaagcagtttgaagcccaa tctgcaaggacatttctcaagggcca
1312 2693884 -- NO cagtctgagttcctgcacccttcag 1313 2724817 -- NO
gatgatgctggacaaactgcaaatcctgaacttagagactgttgcagcaataaccattttgactgtgataata-
tcattctgctcaagttg 1314 3718581 SLFN5 YES
ccagtgacccggaaaaccttcatgaaaaacaactttgaacacatccagcacattatcattgatgacgctcaga-
atttc 1315 2645299 -- NO
ctggcagcctgctcaacactttaaattttatcagtttagtacctgctgatgcgtctaaaactgttggtcccat-
tctagttttatacttacatatgtagtattaaaagcac
ttaagagaaatgtagaatatataatctttataaaagtattaaaggaattatttaaattgaatttgtatcc-
catttatcttgcttgctaaatagatttaattggagcatcca
tttgtataacgtctggctatttctacaatgttaaaacagtgggttgaggaagtaaaatttgagttactca-
gttactgacatagaaaagaaccctgtgagaccaaat
tcagctttggaaacaatttagtgtaattattttgcatatgtagatacacctttgaaagccaagaaaggtt-
tatgattggatctgtactatattaatttaaaaacaaatta
ttcttaagtatattgtagcatttctgttcctgtaagtactttactcatcttaaatgtactgatcattagc-
cacctttataaaaagaatgtgcctgacccactagtatttga
tagaaatattaaaacagttaagatccttaaacatttctgcatataattttttattgagtaaatgtaactt-
aacgtaagtagttctatgaagtctgtgtaaattaaaaccc
tgttttgtgtagatgaagcaatctttataagtttctgtcatcaagactgtattttgtgtgctatttttcc-
atagctaggaaggtggcaagtaaaacatatgcactatcct
agaaacatactgttccaggtagatcttaatttactacctggaatgagccatcttaggtgaccacca
1316 2927067 -- NO
aatctgtagttgtaatgtagccttctacctaaataaaagagatcctaacataatggttctcattacttaagcc-
tcattatgatcaagctcttcccaaataatctgacc aa 1317 2434911 -- NO
ctgagacgatgattagtagaactgagaagtgcccattggttttggtgagatagaggtcagacattaccttagc-
actttttggg 1318 2916250 C6orf162 YES ggctcagaggggtgcgcacaacaaccttat
1319 3152957 -- NO
tctggcaaaacccaggtgcggtaaccctgcagcagcttccactcactcctgcaatgcctgaca
1320 3190622 SPTAN1 YES
gaagcttttgagacagacttcaccgtccacaaggatcgcgtgaatgatgtctgcaccaatggacaagacctca
1321 3508990 -- NO
ggatttctatgccacactacccgtaactttgaaaaataactttaggctgcagttttcagcaaacaggacagtc-
cttagctgccacatagctcaacataaagtgca
caaaaaacttcacggtgggacagtgaatcataaattcccaaactgacgtgtgtctacagaacagatg
1322 3567717 -- NO
ttttccatagcttggttctcaggggttatagatgcaagaagttcctggaaagagctctaaaccagaaaataac-
agtctgctggtcaaactcaaaactgtcttggt
tgatatatgagctggctgtctttactgttacctcctgtcatgatcattttgctaattttctgctataact-
agaggggaatgtc 1323 3780094 -- NO
tgcgttagaagacctgccgacaggccggataaggccaatgagagagggaacggagaagaggggcacctgggtt-
cacaggccttaagaaagaatttagt
tacttatttaacaaattaaacaatgtgtgtcacgcatgtaggtctgggaaatgcattattaaaaacacac-
agtgcagaggtgcagcaccagcatacgggtgga tt 1324 3799938 -- NO
ggacaccctcaaccagtaacacacactctccttcttcaatgacgtttgtgttcctagaatccattttcctcag-
tcag 1325 3932154 -- NO
tcttgccatacccaagtagggaatcacttccaggaaaacaagtcctcaagcactcaatgactttgtaaaccca-
tgactgaaacaagactcatctgaggcagta
ggactggtgggattctactgacttcttagtatcacatggcaccatcacaaatgcattgttagagcagcaa-
catccagagttcttaagcttgtaccctaaca 1326 2534308 -- NO
cctcacagtgacacgcgatgttttcaaaagtccatctttccacaggatgtttacagcacccagcgggtaggca-
gtgctatttattaaccctgttgtactgatgaa
caaaccagccggctcagggcagggggtgagcttgatcaagatcacagacaggaagtgacagcggggtctc-
agcccaggccatgcctgacacccacac
tcttctctggtgggggcgcttccacctttgtccctggaagcccagcctgacagcttctgcagtgcctctg-
gcagccgcccacaaacccagccaggcaaaat
cccagggtgccagacaccaggagaaatttccaggggaatttggccatttggctgtctcttcacttccctg-
aaaagccaaacagagaatggatttcttatcaca
ctgtagcaaggcaatcaactggaaaagagacaggaggagaagtgtgaggaccaacagtcacagggaccca-
ggaatcgtgttagccaca 1327 3696944 -- NO
gctcccaaggcccaatcagatacagctctccaaacctgccagtgctggtgaacgcgctgctgggagcact
1328 3712853 -- NO ggccgtgaaggaagaatgcggtgtt 1329 3916807 -- NO
ttcaccaggatacgactgttggaccagctgctggagatggacctgctacccctcagcagcctccccaccacaa-
gacaagtgatctcaatgtccccaaacct
gtgggaccctgttctacacacctcatttttgttccggcgtttcatcctccttgtgtgattgtactgattt-
tcatgagacacaagttacttctttacatccatattcccaa
agcagggttacatggtaggaaagaaaggaagttggaggtactaagctcattgtgtctcctc 1330
2381295 -- NO
aggaagtaactagagccggcatttgggggtgttgcggacgattcttacgaatccagacaatttgctcttttaa-
acgcggccttgcggttgtctaacagtgaga
atagatgactaactgaatttgtcagactccctgccttctgtcataataacgacgcagaattgccaccgtt-
atgtgtc 1331 2608169 -- NO gtatggggagaacgaggatgtgata 1332 2363544
-- NO
ccacaagaagggctagagaaatacagagatatttgaagagtgtgaggaagagtattaacacaccagttttctt-
gatcaatag 1333 2407863 -- NO
acatccttcttttcggccttgaatcctttcttgctttgcaaggaacaattttcttcctactataaactacagc-
actaaggtatggaccttagaaattatatagtctaatt
ctctgctgacacacaaatcccttcaacaacaaagaatcataagttcacattgaaaggtctctccaaatct-
cccataaatctacaatattcttgatgtttaaaattta
ggataatagagaattcactaattcataagacaaagtaccaatgtaataattctataaaatgtcataatct-
gctttccttgtaacttctgcctattgactc 1334 2920969 FIG4 YES
aggatcctcgggcttatttcgagcggtttcagcttttggtg 1335 2949119 LTB YES
tgcgtggtgcgagtgcgtgaatattgggggcccggacgccca 1336 3241194 -- NO
cattgggccttccatcatcagaaagctcctcatgccacatcttgacacattattcccgtcctcctg
1337 3447084 -- NO
aggatgtgagactgccgtggatatcagggaagggagacttataagaaggagaaatttggtcaactgtgtcaaa-
tgcttcagcgatcaggatgagtaatgag
gaacggccatttgatttgatttgatcattcagatatctttaaagacctttaagagggcagtttcagt
1338 3626136 -- NO
acgaccatgcgcactgagaaacaggcaccaggatgtcgagaacggcaatgtatttgctcacaaaaagctctac-
ttcacacaccacctgtgcatgagcgtgc cacatcaaaatga 1339 3800039 -- NO
cataatcaggtcctctgcaagtgggagtccaactgtgacgcagcccccccacgttcaaagcatcccttcagct-
tccggcaatctcctctccagg 1340 3887175 -- NO gccctggttgcaactctgctggtct
1341 4011861 -- NO
atgaggggaacggtagctgacaatagcagaggagggttttgcagggtctttaggagtaaaggatgagacagta-
agtaatgagagattacccaagagggtt
tggtgatggaaggaagccacaggcacagagaacacagaatcactttatttcatatgggacaactgggaga
1342 2320367 FBXO44 NO
ggtacaatggcatggcttctgtctaaggtacagaggggttggcatttcaggaaccaggccatcacagaaacag-
gttcatgggcagacccctcagtgagctg
caggtatctcacctggcagccgtccagtactgctggcttcctctggaggcccagccacaggctggggttg-
gggtgtgtggacatctctgggcagctcttga gtccaccttgtgccagatcagcagtgccaccc
1343 2680360 -- NO gagctgggtcagttgctccattatgtactttggtttgcag 1344
2866718 ARRDC3 YES
actcgctacctcattcgaaggccgacatggcagtgtgcgctattgggtgaaagccgaattgcacaggccttg
1345 3251759 -- NO
gacaaccttcaatgcactggtactttgtaccctgacctctactgtgatgaacactcaacttgggcaagga
1346 3742688 NUP88 YES tgtgttgagttggagcttgctttgaa 1347 3772092
LOC100131096 NO
tggctgtgcctctcgatgatgattaagatttcaatatttacagcaaaaccacaaagcaaatgatagaataaag-
caaaacaatggaaaatctgagttcactcgtg
agagaggtacgtatgtgagctctgaggaaattacagagggaacgcatgcagcgggacagctctcccaatc-
gcagcgtgcaaagtagacatcca 1348 2596545 -- NO
gacagcagagctatctatcagttcctctgaacttgttctgaatgagcttttcttactgttcagtattcactct-
cctattactgttttgcttcctcatagaattccagatta
gtgggcccctggaagttcagctggtagatgagaaaactgagcccattgaagttaaagtcacccagctagt-
cagggttgatcttcccaactcagagtcccctg
cttacttaaacttttatatccaacaggtttacttcccctggaaacttatttggtattttttattttccat-
ctccatgccctcgataggtttc 1349 2928626 -- NO
cagccgccaaagacgcctgagagcggcaggggagtgtgttgccttaggacaatagcaaactgggacgtggtag-
agtctgtaaattccaagcactggg 1350 4035053 -- NO
catggtatcatgtgcctgtaatgtc 1351 2487210 ANTXR1 YES
cagggtcaagaacaaccagccagcc 1352 2891955 -- NO
ggcccttgacaaatgcctgaaatct 1353 3061185 ERVWE1 NO
ctcttcaaacaacaaccaggaggaa 1354 3104349 -- NO
atggacaagttaggccctccacttcgaacgggaagacttgtgcaaaggttgtatgacagtgatacaaaatcag-
acagtgcc 1355 3915245 -- NO
aattgggttcttgaggtggattggaggagaacagcctctggatgtctgctgggcagtgacgatgtgtctggag-
gctttgacattggattcattaggcattgcta
atgtacacaaaaaatgtagcaaaaatgatgcctgtttctgggtgagaacatctg 1356 3961553
-- NO
ctcccaggtttacaggtcttgactcagtacttcatcagcaataggttgtggtcacaggaaatggaagctgcct-
caggacctgtagcaacttgcctgcatgctg
ggttatgttatcttttgagtggtgcccaatacgaggtgtctaggggaaagtcttaagtggttggagccca-
tgaca 1357 2523501 NBEAL1 YES tctcacagtggaattcgtccctttctt 1358
3601127 -- NO gtgtgtttgtgcaagcatgttaagcatttctctgtcttgtgttcatt 1359
3892321 -- NO tgcaggggtgtccagacggcctggtgcaggatccctttgatgtggagga
1360 3087823 -- YES
ggaggatgttcggactatagattcagctgtgggatctggttctgtagctgagagcacatcgctaaacatagat-
gtgcagtctgaggcttca 1361 3337295 -- NO
aaggctacaactgtgctcttagaggcaaaagaagaaaatgagactgccaggcatgaataatgagaaatctttg-
atggaattagccatgcagaacagata 1362 3528558 TRA @ NO
tctttggtcccggaaccagattgtccgtgctgccct 1363 3536444 -- NO
cttttctctgtagttggcggaatcagctcagttacattttttactaagttacccacattctgacactccttga-
cagttttaagatcttcttctaacacacttgaatagaat
ggatactggaatctattttgacagctgttgaaaatctattctgttgttacaggaggttaaggaggttatt-
tgtaacactgggattatttaatgaaccttttgaaaagg
tgtgcagactgttcaggcaaatagtattttttagaatttaaatgattttggttttcacagttaaattatc-
aaatgtaatgcttttaagaattatacacctagtaatatttttc
attaattttctccaccagtgtagtaatagtacattacaatgttctcaattaccggtgccttctaaaatgc-
aggtgtagagtctttaaatacagctagtctattgccag
ctgtcccatagataaccttctttaaaagtgacctttgagcaatttcataaagaataaatatttctagttt-
tttgttgctgaactgctaaaagatggttctatacatgt aacaggtggctttagttgggttgctt
1364 3823557 RAB8A YES atggcgaagacctacgattacctgttcaagctgctg 1365
2707806 -- NO
cagacccttgtggtcgagttgtttactttggtaattaagtacctgactctgctggacgctcttcgcgtttcag-
aagcgctgtttggcattgtacagtctgagcgtga gttgaattcc 1366 2849541 -- NO
gttcttcataaatcctccactcacaagcttgcagcctttcctatcacagtcatatccaatctcaattcccctg-
cccagtataatgggactcga 1367 3795889 -- NO
acgctgaccagtgaccgaggacacagttgtgtgttaggctccatcacctgctgtactttgagttgggaaattt-
tcatcatcttagaaactgggtcattttatcaga
gtctagagtcagatatagaaaaagtttgtggctatttctccaatttatatgactaaggtcgggtatcttt-
ttcaaagtgtctaattgaaattgaaaaggcagcaattt
aaagttgctattgcaagggcagaaaatggtcttaagaaagccagctttcaaattgaataaacatgactgc-
gttcactttttgagc 1368 3895772 -- NO
gaaacaaactgacaatactcgtgaaatcaacacccagatgaggtagaccagcactcca 1369
2920915 -- NO ccaactcacaccatagcagcgctcatt 1370 2971825 MAN1A1 YES
ctggaggcagcagtattctggcagaatttggaaccctgcatttggagtttatgcacttgagccacttatcagg-
aaaccc 1371 2990655 -- NO
ggtttcttgataactgctccacttagagaaatgagctgtgatctgtgtagattttggaaaatgggtagctggg-
gggatcatctttaaacaatctttttcatgctcatca
cgaaatgcttttacaataggtttattttgactttgtgtttagaatttttttttttttttgctttttgcta-
tagactctttaaaaaagttgttgttctggatattattgatagatgga
acaaaattcatgtccttgcttgaatcttttagcgagctattcagagattctatatccccatttactcatg-
gttttttcaaggtgaatgaaacaacataccctgct 1372 3198975 MPDZ NO
tgcactggtcctgacaatttttatgctgtgttcagccgggtcttcaaaactgtaggggggaaataacacttaa-
gtttctttttctcatctagaaatgctttccttactg
acaacctaacatcatttttcttttcttcttgcattttgtgaacttaaagagaaggaatatttgtgtaggt-
gaatctcgatttttatttgtggagatatctaatgttttgtagtc
acatgggcaagaattattacatgctaagctggttagtataaagaaagataattctaaagctaaccaaaga-
aaatggcttcagtaaattaggatgaaaaatgaaa
atataaaataaagaagaaaatctcggggagtttaaaaaaaatgcctcaatttggcaatctacctcctctc-
cccaccccaaactaaaaaaagaaaaaaaggtttt
ctaatgaaaatctttaaaaaatactgtcagtattttaaaattttcaacagtattataaaaacattgcatc-
tccccacctctaatatgcatatatatttttcctgctaaaatt
ggtttctacaattgagtaaatggcaaatacatgaagcaatgtccctaaattttataaagaaattatattt-
aatgcacatttcaattttcattcttattttgaccttttgta
aaatattttcatgttgctataagtaaatgatgatgccaccccatgttgactatggtttttctagaaagca-
actatgctgctaaccatagaggaacatagaagggtt
ccagaatctttagtgctggttttaacaaccgatgcaacattaaaaatgtgttagtgtgctgtgcaattgg-
ttttcaattcatattaatcttaatgacagagaacaatg
tgttactaattattttggttgtatgccattagtaaattgatagaaaaattaaggggattaacataacttc-
atttcattgacttatattaacatcttataatacaatagttta
agactaagggaaacagatggagctgtttattgagacaactggtga 1373 3652974 -- NO
ctgacatggtgtgtcacaaagagctcc
1374 3680296 LOC388210 NO gtagaccctacaccattcctcagcc 1375 2530462
COL4A3 YES ttccctgggttaatgggtgaagatggc 1376 2550272 -- NO
caggggcaagagctagttagaaaactgagctcgccctgtctctaatgtctggtgagctgctctcctctctcta-
caatatatcacgggtagtttcatgtcaacaaac 1377 3118585 -- NO
gaatatgttgttaagtgggcagcat 1378 3403090 C12orf57 YES
taagtttgctcgcttggtcaagtcctacgaagcccaggatcctgagatcgccagcctgtcaggcaagctgaag-
gcgctgtttc 1379 2524930 -- NO
tgtgaacttgggttgtgtcgtagaaaatgtgagtgtcagagag 1380 3125787 CNOT7 YES
ggttacgactttggctacttaatcaaaatcctaaccaactct 1381 3171102 -- NO
ccaaggactggcaggacgtcagtgatgctggg 1382 3250113 KIAA1279 YES
cctgagcatataggggaagatgttcttcgccctgccatgttagctaagtttcgagttgcccgtctctatggca-
aaatcattactgcagatcccaagaaagagct
ggaaaatttggcaacatcattggaacattacaaatttattgttgattactgtgaaaagcatcctgaggcc-
g 1383 3747008 -- NO
ggtgactggaccacgcaggtagtttctcatgaatgatttagcactgtccccctactgctgtctcgtgatagag-
ttctcatgagatttggttgcataaaaagtgtgt
agcacctcccctctcttttcctcttgctctagccctgtgaagatacctgctctggctttgccttttgcca-
tgagtaaaagctccctgagacctccccagtcatac
ttcctgtacagcccatggaaccatgagccaattaaaccttttttctttataagttacccagtctcaggca-
tttctttatagcagtgtgagattgaaccgatacagac
aacaataacaaaaagtagataaatatgaaggccagagaaatggcaacttcttcacgaagggaagctgctt-
atcctcaagcaagtcagttgaggactatcctg
tgagctattttccgtgccttgttttccactcatacagggaagtatgccctggtgtctcacagttgcttca-
gttcttctttactgggaccctaaatataataacacact
gaaccactcaacttctcagaccttcaatatccctggggctttttctcaaatggacacagcatagctttca-
gaaagctgaataatgtagacaaaagaagtctccct
caccctttgattatggaaaaccaaagatttattcagtgccaaggataagaaaggaaggacttgatcaaca-
accactgttaagattttgacccattcactacttca
cgtgaactcccagggaaatggaaaatgaaagaaggtctccgcggtagagggataacaatg 1384
2406715 -- NO
acagagccctgattccacatacatgagctcccatgtgtggctggggctctgctgggtcctgggggcaggagga-
ggatggagaggcaggccctaccatgg
aggaggttgtgatctaggggcaggctcctaaccagttaacatgtgcacagtttggcaagtctctcacaga-
agtctatagcatgtgggggaacccagtggaa
gaagtgatcgagctctaggatgaggaggagactggggagaacttcagagagcccttagaacttgaactgg-
gactgggcac 1385 2808962 ISL1 NO
cctccttggctgaaagagtcctttcaggaaggtggagctgcattggtttgatatgtttaaagttgactttaac-
aaggggttaattgaaatcctgggtctcttggcct
gtcctgtagctggtttattttttactttgccccctccccactttttttgagatccatcctttatcaagaa-
gtctgaagcgactataaaggttttgaattcagatttaaaa
accaacttataaagcattgcaacaaggttacctctattttgccacaagcgtctcgggattgtgtttgact-
tgtgtctgtccaagaacttttccc 1386 2849483 -- NO
cctgttggtgtgtcgataatggcaaggtctgcagtgacccagcagtggctgaggtggggctggggctgagaac-
ctgatccctgagaggccatttattgtaa
gaacaggcaacatggcagggaagtgaccaggaactaggacaggcagtaagtgggagagaatgacggcaag-
cctggagctgtcccagaggtgactga cggatgctgtacaaggtggaa 1387 2868168 ERAP1
YES
atttgccctacagatggtgtaaaagggatggatggctttgctctagaagtcaacattcatcttcatcct
1388 3082899 ARHGEF10 YES
atggagttcgagtgaatttgaaagttacgaagagcagagtgactcggagtgcaagaatgggattcccaggtcc-
ttcctgcgcagcaaccacaaaa 1389 3505964 CENPJ YES
gctgagaacgcatctttagctaaacttcgcattgaacgag 1390 3522535 DOCK9 YES
caaagctaattgagccactcgactatgaaaatgtcatcgtccagaagaagactcagatcctgaacgactgttt-
acgggagatgctgctcttcccttacgatga cttt 1391 3404455 -- NO
cactagacagcaattcagagcctccaaaataaagaatattcataaaagtaacaatagaggtaaatataaaacc-
cagaattactacatgtgtcatatagtttataa
cttctcctatttatagctttctatatttatatttatctataacttcataggcaaatgaataaaaattata-
aatatgatagtggtcatataatgtataaagatgcaatctgtg
acagtcttatgaagcagggatgaagacatataggatcaaaatgtttgcatagttattgaagctatgttga-
tattatgaaattatattgttacaagtttaagatgctaa
ttataattctcaaggtaaccactaataaaattaccaaaattatgcagaaaaggaaaaaagaaaaacaata-
cactataaaaaaccaattaaatacaaaaaaagtc
agtaacagacaacttgagaaacaaagacatataagatatagagaaaacaaatgattaaatggcaaaagta-
aatcttgttttagtaatcacattaaatagaaaag
gatgaagccatcctattaaagggctgagactgacaagttggctaaaaactaaaataaattaaaaagaaaa-
acaagactcatctacatgctgtctataagagac
ttgccttagatataaggacacaaagaagttgaaagtaaaaggactgaaaaagatattccatacaaacagt-
agtaaccaagatagtgccgagtggctatattttt
gtcaaacaaaataaactaaagtaaaatttacaagagaaaaagaagggcattatgcattgacaaaaatttt-
gacatagccaaataattatgttataaaatatatgt
acttaataatacagcctcaaaatatatgaagcaataattgctataatttaagggagaaaagaacagttct-
atgaaaagttagagaatgaaatattccactttcaac
atgagattaaacaactagacataagatcaataaggaaatagaaaatttgaacaacactataaaccaatta-
tcc 1392 3309338 -- NO ttccagctcatcggcgttgaggtgcac 1393 2475878 --
NO gctgctgagtctcaaaacagccaaa 1394 3032635 -- NO
gaggctcctcttcctatggatttgcttcaaggaggtcagggc 1395 3475556 VPS33A YES
attacattgaggattgtatcgcccaaaagcactcgttgatcaaggtgttaagactagtttgcctccaatccgt-
gtgtaatagtgggctcaaac 1396 2930679 -- NO
gatcaacattcttaatgacataagagaagggagttgcaggtggatctaagggaaaactgttccagtagtaaag-
gagcagcaaatccgatagccctaaggga 1397 3489376 CDADC1 YES
ggatcataaaacaggagttggggcag 1398 3933755 -- NO
gtttgcatttgaccatgtcgtgggcaggaga 1399 2430088 -- NO
tcattcttaaggctaaggtggcaagataa 1400 3420474 -- NO
atggaagcatgttggcgtcatcagcagagacagggaaattgggaaggagaggagagcataattagtgtgcaga-
aacttggaaatgctgacattggactcc tggcaga 1401 3956302 PITPNB YES
gactgtccccagatgtgtgcctataagctggtgaccatcaaattcaagtggtggggactgcaaagcaaagtag-
aa 1402 2334264 hCG_1820661 NO
ctgctcgctgagatagacacatacctgattgcctcctttggagaggcttgtcagaaacaaaataatgcaacca-
tttgtctctcagctacctgcgacctggaagc
cccctccccacttcgagttgtccccgcctttctggacggaaccaacgtacttcttacatatatcgattga-
tgtctcatgtctccttaaaatgtatgaaaacaaactg
tgccctgaccaccttgggcacatgtcgccaggactccctgaggctgtgtcacgggcacgcatcttcaacc-
ttggca 1403 2358760 SCNM1 NO
cagcctggtgccctattaataagactgtcaaaaagaggtctttgcccttcatgttgtctgcctgcttctccac-
taccactcaaagtcctttcccccttcaaatcaca
taaggactgcaggtaggcactagggggacctggccacatctggaaacagggctgtggctaagttccctgt-
gaaagtagaagagtcaaaaggcattggca
gggttatggggaacaccaagggagggaacacccccacctcctcctagtaacctgaacctccctgcctgct-
gatccccagagtataaataatcccctggtga
actggcagtaacccttgggggttagcgccaagattctcaccccaaagcccaaggaaggaggcaggcaaaa-
tggatagaagggcttttatttacaggaaag
gaggacagatgaggatttaagtgtccagtgctcccagcgctagttggtaaagggaaatgcagtgttatct-
cttcttttgctggcgacctgtaa 1404 4005886 CASK YES
tcatcacaaagcacccagaccggtttgcgt 1405 2440191 -- NO
ctcctcacccgcatcataactcctcttcaag 1406 2561968 SUCLG1 NO
aactgtggaatggatcacgtagacatgtaacccagcagcagtttgcttctgttgtccactgattaatcagcct-
atgtgcctgacactggtcttgca 1407 3216427 -- NO
atgttgagaaagcatatgcatgtgacagggcggatttgttagaagc 1408 3235909 -- NO
gttagactcggggttgatatctgtcatcgctgt 1409 3469137 -- NO
agcaacagaaagctcgtggtgttcctctgcctcaaaggccaaacgtctgtgggttttttgtcttggctgccga-
ccgcagcacgtcacactgtttgaaatttgca gctgcgatcatttatcttcaggggacaggggt
1410 2343471 -- NO gacagattgaaagaggtggtgaagc 1411 2464386 -- NO
ggtacacacattaggagactgcagttttggtgagaggtgatggaagctcgagactagtgaggaaaagggaggt-
gtcaacatgagccctagattcttggagt ccagaacttgaaga 1412 2672266 ALS2CL NO
gtgtgagcatgcacaggttagggtgggctg 1413 3730349 -- NO
tgggcctttcaaattgagtctaagtttaaaagatataaagaggtgtgggggaagggcattcctggcagaggga-
agagcatatgcaaaggtgtggaggccta
gaactacactgcagctttaaggggtggtgagtgatggccgggcaccgtggctcacacctataatcccagc-
actttgggaggccaaggcaggaggattgct
tgagctcagtagttcaagaccagcctgggcaacatagcgagaccctgtctctgcaaaatatttttaaaaa-
attagctgagtgtggtgatgcacgcctgtctact aggga 1414 3755723 MED1 YES
ggctcctccatagcagagaaatcttatcagaatagtcccagctcagacgatggtatccgaccacttccagaat-
acagc 1415 3861643 -- NO
ctggcaagcagacgggtttggaatagacattggaagaagcttttagggcatcctagacagcgttgcgatgctt-
ggggcaggggcaggaaaaagccactg
atggactttcagggcagagctgtaatcgagttgatgtttcagatttagtcgaagggtgtgagagggctga-
gacggagaaagtggtgtggcagaagaggttg
ctggtggccatgggtcggggtgcagattatgagagaactc 1416 3542787 PCNX YES
tttgatcctatgtgggagcgactgaaaatagaatgagcttggttaagcacctctcctttgcc 1417
2468417 RNF144A NO tgccaccaaaggcatggctgtgggc 1418 2520238 NAB1 NO
gggaggaacatttaagctgatggaagtggaagtggaagttgctgtacattggcagcaaggcctccgagttagc-
ttttgaatgcagttaactggtttctcttaac
tgtggaattcattgaaaagtcagactccgagtggtcgttccaggatatctt 1419 3129693 --
NO
cagcctgtgtgtactcatttccttctcttgagtaccactaatttgatagttcacgtatcctctactaagaggt-
agagtgagacagcttagggacatcagaagtact
actttcggttcttccacatggaaacatgaggaacgaggaataagtattctttccctaacacttacagtgc-
acttaagacaaagttttttttttttttggactgaatata
cgtcgatggacacaggcccagatatggagaaagggcaggtttcctctaggcaagatttgcacggggaacc-
tga 1420 3845840 -- NO
cctggatccctgaagactgctctgagatcgatcagccagagagaaacagagagaaagctggctcagccctgaa-
ggctttgagcaaaagtttcagaagga
gctggaaggagacaacagcccgttctccctgagctgtggccgggagggcccaggccagcaccacgatgta-
cagatggcccagggggctcgacatgag
tgagggctgaagttcgtgcaaccccaaccgccacccctgaattgggcagaaccaatttttttcttagcac-
ctgtctgactctgcttaccatgacaaccccaag
ggccccccagaattgatatccaagtgcctttagcctatcaaagacaggagggggtgcattctcggccagg-
ttagggttcacagagcatccgtatatta 1421 2621185 NBEAL2 YES
ggctgtagacctggaccatgtgacagatgagcgggaacggaaggctctggagggcattatcagcaactttggg-
cagactccctgtcagct 1422 2871234 -- NO
tttgctgccatccatagtcttttcctaagtatcacaaaaggatatgcctgccaatctcttaaaaaatgacaat-
gcagacttgtgctcaaaatgaagctacagattta
gaacctcagattcaatgaactaaaaggagaatatattaaatgttaaatttgacctcagaaattccactat-
actaaggatgttgcctaagacctctcaaagactga
ggaccagcagaacactgcccatttcactctagaaccacacacaagtctgttgttcccaagccaatgtgaa-
agctataagccttgagactcaaaagagcaca ggtgtccacaggtgacccaaacatcaaa 1423
2904825 C6orf127 YES ccaggggctcactttctccaacaaaa 1424 3133366 -- NO
gtgtcagtacagccgcgtggcagagctga 1425 2577848 -- NO
ggcttgcatcagcacacattgtacagccttgcaaattacacagaaattgaaaagaaggttccttgttcataag-
tgcaatgaatctttgatgtccagtgatccgct
gcaaacaatgaaaacaaactgtaaagcacttaagaagtttccagcactcatcaaatgcatttccttaggt-
gacaaaaaatccacaaggagaatgcaaataagt
ggcatttagttattagagagatacttgaaaaaaaaaaagtggaagtattttcctgcttagaatgatttct-
gttcccctttgaatgtaagtggtttaagaggcattaag
aacataatttattttatacttaatgttcacactacctaaatgaataaggaaagggccctacaaggaagag-
ttatgtattttttggtaattgtttctgagtttagagattc
aggggaagagtaatcctctatttgtgggctcttcttagcatccctaacccccaaggagatagtacatggt-
tttgacttggttatttcactcctgcattctttttcccc
caaattttaagttgggtcacattgtgctggctgcaaaa 1426 3332349 -- NO
ggggatgtctgcaatgtcagcactgattgcagcaccaaactcaaagacaataccactcatgccactgccaaca-
tacccctggcttcctcaacaactttagaat tattatattgccctaagtgcatctagaata 1427
2416733 -- NO
ggaaaagtacatgccagaagtcagctgtgcagtaacctatgagagagctactcctgtttcaccccagatcatc-
acctcgattccaaag 1428 2437457 ASH1L YES
aagcaccagttgagattcccagtccttctgaaaccccagctaaaccttctgaacctgaaagtaccttgcagcc-
tgtgctttctctcatcccaaggga 1429 2704212 -- NO
gagattgatgtggttgtcagctaaacctgctctttcagtagtggaaatt 1430 3888795 --
NO gttgtttgccttgacagtgcggctgcgcttcggcctgctcgggttaccagggaacaaggc
1431 2556326 -- NO
ttgcctcagctgactttaccaaaaattccctttcccttccctgctttaagtcatttcatgtaggttagtcttc-
atttattcttttgcctctctacagtagttattgctttgtgc
tgtacatttgggttaaaggagttgtatatgtgtatggtgacagcataatgcctctgaagcccaggaccta-
gctacttcttagctcctaacgtaatttcatccatg 1432 2878702 -- NO
gtcagagtgtataaggtgaaatgccgttctgtttttggag 1433 3328538 -- NO
gccatccggatgtcagctctgtggacattgactgctggttttcctggggcctcggttttcctctctggcctgg-
catggactgcctcttgccttggagttgctggg
atggtggggtgtgtgtgtgagtgagagtgtgttgttggggggcagtgccctggagaggacttcatagcct
1434 3496801 -- NO aggactgtgtggcggactatgcagcatagt 1435 3668198 --
NO tccacagggcagaaactattgcagagttcac 1436 3764547 4-Sep YES
agcagtatttccgagacgagagtggcctgaaccgaaagaacatccaagacaacagggtgcactgctgcctgta-
cttca 1437 2544277 ITSN2 YES ggagtgctagcaagtctggagcatcaaataaa 1438
2581567 -- NO agcagtttggcagccacatggattga 1439 2612556 -- NO
gcctgggggaatccgtgaacgccta 1440 2894809 SYCP2L YES
ggtgtattcatttccgtgtattgctgcttt 1441 3956007 -- NO
gacagtcttcagaaaagggcagctgg 1442 2407214 GNL2 YES
gaaacacacgtgtgattaagcagtcatcattacaaaaatttcaagaggaaatggatacagttatgaaggatcc-
atacaaagttgtcatgaagcaaagcaagtt
accaatgtctcttctccatgatcgaatccggcctcat 1443 2948537 KIAA1949 NO
tctttctcacatcctagagacggtctttaatacgcattaaccctgtgctgccacatctggctcctgccctcat-
tgcctccaatccggactcttcctctcacatca 1444 3991159 -- NO
acaggtggactgcagggtcgtcttacaaaatgacaag 1445 2444356 -- NO
tagaccctgacattcagctccaataatggatgtcccagtatgccctgaatccaaacaaatgcctgactgcaat-
aa 1446 2480997 MSH2 YES agacaggttggagttgggtatgtggattccatacag 1447
2671526 -- NO
atgttccttccaaatctcacattgaaatgtaatcttctatgttggaggtgggcctgttgggaggtgactggat-
cgtgggggtagatttctcatgaatggcttatcgt
catcctcttggttctgtccttgtgatagtgagttctcgtgagatcatgttgtttaaaagtgtgtggtatc-
cctctgccttgctcttg 1448 2673140 -- NO
aagaccacattgagccacctatctccatctgtgcttatgtactctgcttccttcttgttaggatgaacaatgg-
gcgaaccttccaagttcctatttaaagttacccc
aatctgtgcagaagatcctgtctcctcccacctactcaaggcattactctggca 1449 3394422
THY1 YES catgaaggtcctctacttatccgccttcactagcaaggacgagggcacctacacg
1450 2485881 -- NO ggggtgacattcagattcaatcggtctacggatgagaaa 1451
2572007 -- NO
aggcttctttgacaatcgtttctgatctttagctgagtctagatggtaaaagtgaactagtgaaagggaagaa-
tgagttttgttttggatggcatctcattattttttat
tttctttttatttatatatttgtttttcttatttttttttctttttgattttaatacctccaccctactt-
acagatattttttattttcttgacaactctgataaatg
atggattggaggatcagacttgttgacatcactgatgaggcttgtcttgttgcttgtcttctctggctaa-
cattccttagtaaaaatatttct
atatttttttctttattttatttggtcattatttcattttgagcttttttcatttattactagataagcg-
agttttgagtgtcaaatttgcacttaatttgttttt
ggtactgtcataaggactgtagcatacacagcatactacaactgtaactttttacgaaaatatacatttt-
ttgaagatgacttcagaaa
ctgagggagagagacccacttgagactaggcagcaaacagtgaagaagaaatgagcaacatggtgtgcag-
gagca aagtttcctactgtatatctctactctaagtgtacaatgccta 1452 2804366 --
NO
gatacttcatctagtaattcctgcccaggttttgaaacctcatgctggaccctcctgtgcaaggctgccctgc-
tcattctgctctcatctgatcctctcactgggcc agtc 1453 2369480 FAM20B NO
tcggcaattgctcattctagggagggcatcatagttggtcagtcttaattcccatgccaaaggacaaacaggt-
gtgacatttggatagatgaatactgggattg
gctctggagcatgtgttttgagttgaaccttgcagtcctttctctacgcccgtggattttgtggaaaca
1454 2556336 -- NO
agtcctgtctagtggtcagtcctaacagtgtggttaaaggggagctaaatttcaactttcaggggtcagctga-
gacaaccacctagattttccaagttagttcca
atttcaagtacaataatcctttgacaacatagaaaagaattatagttagcaaaattgcaattgtcacagt-
caaggtcttgttggtaatagagggttggggaaaaa
gttaaaacagcattaaatgaatatatttttaacataacaaaagttcccagaagacatccacttcaaattc-
aagccatattcatcaatgttaaaaaccttactcttctc cctgatagtgtgaggaaaa 1455
2589618 TTN YES cctatccctgtaaagcctgtcccagaag 1456 3405368 -- NO
ctggggcataaaaaagcaagtgttctcactgagggatgaatagtctactagcaactgtaagacagttgcacga-
ataatgatgatacaaagaggtatccgatg
aatataatgtagcaggataaacaaaatggcagtggaaaacaggagtaaaaccaaagggaaggattctgag-
aagactatttataatgggaactaaaattgtca
gctgaagctcagatggcggtagaggcattccagatggagtatagaaaatgaatgaagaccaaggacagga-
cagaaatatctggggtgcactcactaggt
gagtgtgtccagacattgaaagaggatgagcagaggaagagaacaggagaggtaagaactaaaaaggtgg-
tattaggtcctggaaggtcttaaatatcaa
gctaaagagttttactgccaagctacagaactttatcaaatgccatactgagaagactgatcgatttatt-
aaagcaaactcctaaaggatctcttcttggaaaca
attcattagtggttagtgtggaatctcagtgtggcacggaataaagtaaagtacatgggtaacggcccca-
gaaaaaccagagcacagcccagcgcattacc actcatcgcctgggtgatcttg 1457 3447472
-- NO ttttaaggagggttgcagaaagtga 1458 2331932 -- NO
tgccggtgcagttccttggtatactga 1459 2413973 USP24 YES
tacgtcgatggagttcagcacaagcacgagaatttgggaatcttcacaatacagtggcgttacttgttttgc
1460 2972147 -- NO aagtcaggagggttcagtgaccaga 1461 3568132 -- NO
ttaggtatttcgagtttgaagtgtctataagtcatctggagctgtccaggagatggttctatacatgaagatc-
aggaccagtttcttgtcatca 1462 3593984 -- NO
ccaggtggtctagcgctcctaacaaacaccttatgattatccttcattcaacagaggaggagactgcaggcat-
gcttcagtcagtggtaagaacaggaagaa
aaacccaaatcagcaacattttcttccttaatttggtataaacgtccttttcattatttcaagttactaa-
tttgctaatctcaaatgttttctgaatcaggtttgctaaatg
ctgtaaagaatagctatccttcatacaatactaggttttattttttttagtatgtcagcataataaggta-
catgcgcattcattccaccaacctgtttagataatactca
gcttgggtcatattcaaattctacacagagattctctgttttcaatacaactgcttagaaagcagaattg-
cctagtgatgactgta 1463 3878647 -- NO
gcagcccatcccgaagtgcttattacattagaacatttagtgcttttaaagatggtgtgtgtgtgtgtgtgtg-
tgtgtgtgcgtgcgtgtgtgtgtgtgtgagaga
gagagaaagcatatctaaatgttggtaccaaatcataccccattggaaagattcaattttctgaaattcc-
acctaagaatttttgtatgtatatatgaaggcaattgt
gaaattatagagaattagcaaagtttatttagaatttgaggggtttggagtgcagttttacagattttct-
gactctcttttctttaatgtccatgcagagactaacata
attgacttttagatctttatccagagagtcaatccaattcaattcaaaaatgtttattgccagtccactc-
tgaaca 1464 3271123 -- NO gtgagtccctgggtcagtgagcaca 1465 3291284
TMEM26 NO
gaaagtggcttatttgaggttgttggtgctgttggtattattgccatagttgttatttaattgcttgattaaa-
ctcagtcaaatatccttccta 1466 3859781 DMKN NO
caaggagccaccagattggatgggagcccccacactccctccttaaaacaccaccctctcatcactaatctca-
gccttgcccttgaaataaaccttagctgcc 1467 2326309 -- NO
ccttcacggatttggttggggtcagagaga 1468 3091040 BNIP3L NO
agtgcattgtgctctttccaagttcagcagcagttctatcagtggtgccactgaaactgggtatatttatgat-
ttctttcagcgttaaaaagaaacatagtgttgcc
ctttttcttaaagcatcagtgaaattatggaaaattacttaaaacgtgaatacatcatcacagtagaatt-
tattatgagagcatgtagtatgtatctgtagccctaac acatgggatgaacgttttactgctac
1469 3823592 HSH2D NO
ggggtgcttcatgtcatagcttctcagaaagcagcagtaactgaggctgtggatctgagaacgggagctgcta-
gccaagcaatgagtgaagcttttgtccgt
agtggcatgttttatctgaggccagcctttgtactcctgtgtta 1470 3551323 CCNK YES
ctacaccacaagtgccgcaagtacagcagtcacagccgtctcaaagctccgaaccatcccagccc
1471 3602745 RCN2 YES atggatttgttagtttggaagaatt 1472 2332284 -- NO
cccggcgcgtatcgtaggcagtgtaccgtggccgtgccgtcagagtgtgcgtgtgcgtgtgtgccgtgtcgag-
gctgtgtag 1473 2689891 -- NO
ctagaactatattagctgctcagtgagttgggcaattggatatttttggttttatgatttcagattttataga-
ccagtggaatacaggccttgtgcatatgaagatca ggtgacaagtttgc 1474 2952713 --
NO tgtttgttgtttggttatgatcttgctt 1475 3181289 TMOD1 NO
cggtggagtccatgcctttgaactggatgtgttctattgatgacctgtgctctgcaggggaaaccagaaggca-
aaatgctggcagcatgaaacccttttgtgg
ttcagttctttatgcactaaggttttaggttgactagtggttgtagttgaaaattttataaaataccgtt-
aatgtgaagtttttctttagtcacagaagttgaatctggtt
attatttaaaaactagaagcccccaaaccagcagatcttactgaagatgatgttccagcagcagcgactt-
agccccaggagcccagtttcaatggccttgctg
tgtggtgtttcaagtgcatttaaaatgtgtgacacagaaacggcacactcttc 1476 3412443
-- NO
acctttgacatctctagcacacggagcaattctagatggttgataaaagagcataaatcaatcgacacaaata-
tccccttaaaccttgtctttcatgtccagtatt 1477 3886313 TOX2 YES
atgagtgacggaaacccagagctcctgtcaaccagccag 1478 3976557 RBM3 NO
atgggacgtttgtagaacctgagtatttttctttttaccagttttttagtttgagctcttaggtttattggag-
ctagcaataattggttctggcaagtttggccagactg
acttcaaaaaattaatgtgtatccagggacattttaaaaacctgtacacagtgtttattgtggttaggaa-
gcaatttcccaatgtacctataagaaatgtgcatcaa
gccagcctgaccaacatggtgaaaccccatctgtactaaacataaaaaaattagcctggcatggtggtgt-
acgcctgtaatcccagtgacttgggaggctga
ggcaggagaatcgcttgaacccgggaggcggaggttgcagtgagctaagatcgcgccactgtactccagc-
ctgggcaacagcgagactccatctcaaa
aaaaaaggaaatgtgtatcaagaacatgattatccagcggtattttctaattcagatcatcaaactgatt-
atatagaagagttggctttaaaatgtttgcaaatgtc
tttttttttttaatactggaagaaaaaatattctgttgtgtctcatacagtgcttaggatgtctttc
1479 2635686 PVRL3 NO
ttccatagctgtagctggagcggtaattggagctgttcttgcccttttcatcattgctatctttgtgactgtg-
ctgctgactcctcgaaaaaaaagaccatcctatct tgacaaagt 1480 2680971 -- NO
agttggcttacaacctgtgctgtattga 1481 2715956 HTT YES
ttgagttgtacagccgctggatcctgccgtccagctcagccaggaggaccccggccatcctgatcagtgaggt-
gg 1482 2452913 -- NO ctgtgcacaggactcctcaaatattttccgtt
1483 2667796 -- NO
caagagaaggtgagcatataacaggtaaataacagaagctctgattttttttttctttttatagtttgggact-
attcatccagcaagagaaggacgcttaaaagta gatt 1484 3602153 C15orf39 NO
aagggattctgatgagccgatgggccctggaggcagcccattaaagcatctgg 1485 3752031
CRLF3 YES taccaaaaaggcctcgcacattcagttggacag 1486 3765307 APPBP2 YES
ggaaactgaacagaggctgcttcaagaagctcatgatttgcacctgtcttcactccaactagctaaaaaagct-
tttggggaatttaatgtacagactgcaaaac actatggaaaccttggaagactt 1487
3956644 -- NO gtacatgcaaacgggatgggagcag 1488 2345202 -- NO
tgatgcccgcgttgtcttttcagactctgttttttgcctttagcatgccttgtaatttttttttttttttttg-
ataagctggatgtgacataaggggtaaaaagaactgaga
taaacaggcctttagtgtggcctagaggcctatctggctaggagttaggctgtgtttactgtttgatgta-
gctttggtgtcagagattaaaatttcctctcgtgtaa
ctgcttttgtctcctttgttgtctttgggtttccctaataactccttcataagtaggttccgaggcttgt-
agttatttaagctgtaagtccctgttattacacaggagcc
ctattgatgtggtgtgtgtgtgtgtaaaagtgttctataatcttatgattagctcttagtgagcctgtgt-
ctttggactgtgaccttcatgagtgctttttagc 1489 2655521 ABCF3 YES
aaaggagagtcggttggaatcatctggcaagaacaa 1490 2920283 -- NO
gcaggacatacgctaaaaccggagcaatacagagaagattagcatggccctcacccaaagatgacacgc
1491 3102056 -- NO
agattacaaactcacatttaatgttataaatgcagaaaaaggccaaaaacacaaaaagagtggcaacgaggga-
cag 1492 3161310 -- NO
tgaagaccttcacgctttctctgtaagttttcattcaaaacatctttcaatttcttttttttctttttcttct-
tttttgccctcattttagttagtttgagtttcttgtggctctgta
gtgactgctctaatagaatatcccttacaactttgtggcagttaatttctggatgatcactgtgacttcc-
atttacatgtatttgg 1493 3289083 -- NO
acaggtaaattaggacggcactgcgggtactctgtgttccgcctgctcaagttctagacttctggtgtccata-
gcaacccagcaga 1494 3304760 -- NO cggggaggaaagacagctctaccag 1495
3895434 C20orf194 YES tctttcctgggcacttatctaacag 1496 3406522 -- NO
tggttttgtggataggggaaatctagtagatattaaatatttttatctgcaaaaagcatttggtaaggttctc-
aatgggagattaatgactaaaataaagaatgagg
cattaggagataaatttgcttatgagcaagagacagatactaacagtagaaggaaatactttttagattg-
gaaaggagtgacatatagcacaagccaggaatc agttttgggaccta 1497 2692051 -- NO
gtatcggattaagctcaaaacgggaggaggaaacaaggatgactggagtcaaggaa 1498
2835105 LOC728264 NO
ggcaggggttgggacaagtgctaagtatgcaagactcaagggaagagct 1499 3935012 --
NO cttctccaggccagatttaaccacataaacacatcaaatcccagct 1500 4038282 --
NO
tggctgggtgagttctaaaaatgcccaagacctccaagactaggtgagatctgaagtaatgaaatgcctccat-
tcactaaaggcctgaaattgtcctgactgc ctcag 1501 2856770 -- NO
atgttcaaccagatgatgggccatgattgt 1502 3579731 -- NO
cccatgtgtatgctttgagccgttccttagttgagtaggtgattgaccataccagcagcactggtgccaatta-
agcggtctgcttggttcacacagcctttcattc
ctgttctagcatggctctgtcttaaatctgcatgcatgtatttattccttaatatattacctctcttcct-
ttcttcctttttacatttcttcccattttttattgtttctctctctct
cactctctcactcattctctcttgcactttgtcttcggagctcattgccatggagtggcttggctgtacg-
catcaaaaagccacccgcaaacgtccatccttggc
cgtgcggttccacgtctcactcattacttccttcctgcattcatagcatccttccttcctgcttgctctc-
tttttattaggcatttattcctctattagtggagtcaggtg cccttatgacaagtcctagc 1503
3636549 -- NO
ctactgaaagcatgtcctgtgaatgttacttgtcagtgacaaaataggtacagaaattgaaataagagtttag-
aaatttttagagccgtttgatggagtagctttgt
gaatctaataattgaggcttacattttgtatgtctttatttttctcataatttatttttattttataaac-
atgtctgtttgcaactcattagaactttaaaaaaaaaaactagt
cattcactctaggtagagtagaagtactgactatgaaggatctttaaaggtcaatagtggtcctaatacg-
taaaataatttgctcatatggtgtatttaaactattg
gcaactatgtaaaagggggaatgggttgaccttcatgttacaaatattaatttctcctgcataaaagtac-
cctcattg 1504 3653150 -- NO
tttcatgagatctacacctgggctgggcacgcctgttggttttttactgacaacgcataatttttcgaggagt-
ggtaatcagaggcaaccgttctagtgacagtg
attcaggcgtaaacacttggctttggcccagaggttgcactgtgtgagaccacaggtgaacactagaatg-
tttacactcttccggagtctgtaggtggatgcca 1505 4011856 IL2RG NO
cagggtcctgtagccctaagtggtactaactttccttcattcaacccacctgcgtctcatactcacctcaccc-
cactgtggctgatttggaattttgtgcccccat
gtaagcaccccttcatttggcattccccacttgagaattacccttttgccccgaacatgtttttcttctc-
cctcagtctggcccttccttttcgcaggattcttcctcc
ctccctctttccctcccttcctctttccatctaccctccgattgttcctgaaccgatgagaaataaagtt
1506 2351151 -- NO aaatagctgggtctcagtgtctcttt 1507 2577491 -- NO
gttctccctagttttctctacaacagtggaaaacaaagcagtgctctctatgccaggacagtacatttggacg-
gcgacaccttgtttgcagaatcct 1508 2693258 -- NO
atctacattttcacactgacaccca 1509 3156385 -- NO
agtcacacccttggggatctcattgtgtttcatgacttaattatgctgctgactctcagattgttatcttagt-
ttttcagacttctttcttgaactccagacccgtggcc
actatgttctcgccatgtggaatctgatgtctcataagcatttcagacttaatatactcaaaaggaactg-
atattcacgccaagcctgcttctctccccttctccact
cactaaatggcactactttccttctggctgg 1510 3175668 VPS13A YES
cttggaggtattatagcagaagtgaatttggccgagcattctacagttattacatttttagattatcatgatg-
gagcagctacattcctcttaataaatcacacaaa gaatgaacttgttc 1511 2389740 --
NO
atgagtgattcattctgccctgtggacacttgggaacagaaggcgactcttgagctgggttttccaggcttat-
taggcgctcagtgggttaacagaatgagctg
gtccaggaagagatcagcctgtgaaagccgtggctgggatattattggagat 1512 3224499
-- NO
atctcttaggtcatatgtcatcgcattacctttaaaaattgtatggtctaaatgtaaaatagttatttttcaa-
catttgttttaatacccttgtaactgctttttactcaaga
cagacatttcacttacactaagtgtgtgtgtgtgtgtgtgtgtgtgtagaaacttaggatataacacgta-
tgtaaattacacacacatacctgtttaaatgtaagaa
ttcagtgataggaacagttcatctaagaagattttaatgacagggcactcttttggccaaagcagtggaa-
tttcctaagcagcaaggttggtaatagtgctggta
ggatctgtatgtgtaagctgttacacaagctgaggatcaaagtgccaatttctcaaggagaaaaacttct-
ccgagaaatgaaagtctctgatctgtgttgtatgc cctaa 1513 2807754 C7 NO
gggccagaacacactctacaaaatgactaggataacagaaagaacgtgatctcctgattagagagggtggttt-
tcctcaatggaaccaaatataaagagga
cttgaacaaaaatgacagatacaaactatttctatcctgagtagtaatctcacacttcatcctatagagt-
caaccaccacagataggaattccttattctttttttaat
ttttttaagacagagtctcactttgttgcccaggctggagcgcagtggggtgatctcatctccctgcaac-
ctccgcctcctgggttcaagcgattcttgtgcctc
agcttcccaagcagctgggattacaggtgcccgccaccacgcccagctaatttttgcatttttagtagag-
atggggtttcaccatgttggccacgctcgtctcc
aactcctgacctcaggtaatccgcctgccttggcctcccaaagtgctgggattacagacatgaaccacca-
cgcctggctggaatacttactcttgtcgggag
attgaaccactaaaatgttagagcagaattcattatgctgtggtcacaggggtgtcttgtctgagaacaa-
atacaattcagtcttctctttggggttttagtatgtgt
caaacataggactggaagtttgcccctgttcttttttcttttgaaagaacatcagttcatgcctgaggca-
tgagtgactgtgcatttgagaatagttttccctattct
gtggatacagtcccagagttttcagggagtacacaggtagattagtttgaagcattgaccttttatttat-
tccttatttctctttcatcaaaacaaaacagcagctgt
gggaggagaaatgagagggcttaaatgaaatttaaaataagctatattatacaaatactatctctgtatt-
gttctgaccctggtaa 1514 3929304 C21orf59 NO
tccacacagtgagagtccagggctcagggctgctcaagaccaaggcttcccttgatgcttcacttcgggtgat-
cagacatgggggacctgtttatctttagta
gccggcaaaggcaatcgtaaaacatttgttgtaacttcaggattgtcactctaagaacacc 1515
3947636 TSPO YES gtacggctcctacctggtctggaaa 1516 2748234 -- NO
cgaggtttatgttgtgttaggctcatgagaaggcaagaaattttattatttaaatgttttctccagtaatgta-
ttggattcaagccattgagatttggggagtgtttca
gtgacttatttgggcaaaacagaatatttgaaattggcattgtctcagaatctggc 1517
3630746 ITGA11 NO
gactgtaaatacgaacccaatctgcacactccaggcctctagttccagaaggatccaagacaaaacagatctg-
aattctgcccttttctctcacccatcccacc
cctccattggctcccaagtcacacccactcccttccccatagataggcccctggggctcccgaagaatga-
acccaagagcaagggcttgatggtgacagct
gcaagccagggatgaagaaagactctgagatgtggagactgatggccaggcaagtgggaccaggatactg-
gacgctgtcctgagatgagaggtagccg ggctctgcacccacgtgcattcacattgaccgcaactc
1518 3004500 -- NO
ctcatgcttcaaaggcatattctcaagaaacaggtgtaatttgtgcagataatcacacctgggaagggatcac-
agagaaggagaaaaagaaagaaatggct tattctgaggtgaatgtgtc 1519 3552925
DYNC1H1 YES
tgccaccttgatgacgcagtgcaaagagggggcacagaaggaaggcctgatgctggactcgcacgaggagctc-
tacaagtggttcactagccaggttat
ccgcaacctccacgtcgtgttcaccatgaacccgtcctcggagggactcaaggaccgggcagctacatca-
cc 1520 3649810 -- NO
cagcaagaggtgcaggttgagtatttggaggtggtatatttggccagactttagccgcatcgattatgctatt-
tcttgctggctgttttaaattttttttaaaaagga ggaggtgtcagatacatcatttca 1521
2782685 -- NO aaaactagggctgtccaggcttaca 1522 3166121 -- NO
caaaagcctgctgctgggtagatag 1523 2524769 -- NO
agtgtagtgcagcattgcctctggaactggcctgattcttgcctcataaaattcttgtgaccaataaatgaaa-
ttctacacatttttatgtgtctaaaatcccaagac
tagtatctgacacatggttagctctcaatatattttagctactgctattatcattattggtagtactatt-
aaacattttgaaacagaaaatcacttggggctggtcacg
gtggcacacgcctgtaatcctagcatgtggagaggccgaggcaggtggatcactggagctcaggagttca-
agaccagcctgaccaaatggtaaaatcctg
tctctaccaaaaaaatacaaaacttagatgggcgtgatggcatgcccctgtagtcccagctactcaacag-
ggtggggtaaa 1524 3101675 ADHFE1 NO
ttaactgaaagaattaccgctggccattgtagtgctgagagcaagagctgatctagctagggctttgtctttt-
catctttgcgcataacttacctgttaccagtata
ggtgggatatacatttatcttgcaggaaattccccaaagctcagagtccagttccttccataaaacaggc-
tggacaaatgaccactatgttagacccccaggc
tcgacttcaggggtcagtgttcctgtcccaaaccccacacagaatactctgcctctgtttcatgtagcaa-
atga 1525 3633418 SIN3A YES
cacctctcacttgcgtatgaagacaaacaaatactggaagatgctgctgctctgattatccaccatgtgaaga-
ggcagacaggcattcagaaggaggacaa
atataagataaaacaaatcatgcatcattttattccagatttgctctttgcccaaagaggtgatctctca-
gatgtggaggaagaggaagaagaagagatggatg
tagatgaagccacaggggcagttaagaagcacaatggtgttgggggcagtccccctaagtccaagttact-
gtttagtaacacagcagctcaaaaattaaga
ggaatggatgaagtatacaacctcttctatgtcaacaacaactggtatatttttatgcgactgcaccaga-
ttctctgcctgaggctgctacggatttgttcccaag
ccgaacggcaaattgaagaagaaaaccgagagagagaatgggaacgggaagtgctgggcataaagcgaga-
caagagtgacagccctgccattcagct acgtctcaaaga 1526 3904327 -- NO
ttccaaaggtcgctaaagatactgttactactattgagatattattggctacttcacgtttacatagtaaatg-
tttgcagcatataacattacagactcataaaccca
taattaacttataagtgttaatggacaactgtgctttgatttttgcctttagtgataagaaaacaaagta-
gtgaaatgggtcactcctcaaagcatggaacattttaa
ctttgcctagtaaggaaaaacaaaacaaaatatagcaattacatgtggaaccgtaacctgcaaaagtaac-
acaaatattgtctcaaaaggtacaaataggttgt acctggaccttaagcagcatg 1527
2652509 FNDC3B YES gcaccaattgacaacggttcaaaaatcaccaactaccttttagagtgg
1528 2441680 -- NO
aggcaagagccctttcgtgcaagtaagcaattttgctgcctcccattttttttttttttttcaatctgtttgg-
gactttgagggctggggtgggaaggtagtggaatg
gaatagataaacagccagtcaagagctgtggggaggttgacagaattggggtgcaggtacatgtaggata-
cacagaagctttgtgtctgtggaggctgtat
gagtctgtgggtgagcagcatgtctaagtgggtggaaa 1529 2694895 -- NO
atgccttggagacgagcccagaaggag 1530 3048170 C7orf44 NO
tcctatcatagctggcaccgtgttcatgcctgtggtattccctgtatccctattcctgggaagcagcccagga-
gggggattcccttggcctctccagggtcagg
tcacctttcccttcattagtgtgatgggaccttcagaagagaagcactttctgcggccaaactg
1531 3085948 -- YES
gaggccggtagtgctgaatggacatggggctggatgaaaagacttccgcctgcctctctcagccccggaatcg-
ccatgagctgctatt 1532 3300246 CPEB3 NO
ggcctttccttggtgtgacacttgaactagtcgattttttgaaggctataacctaacctcgactatttgttgt-
tatgtgca 1533 3822344 MGC3207 NO
ttggagacaccatgttagtcgtggctggtctccaactcctgacctcgggtgatccgcgccccgcggcct
1534 2345520 -- NO aagcctgtttgagagcaggactgat 1535 2549493 -- NO
gctccggccgagagaagccaccattcctttc 1536 2788417 ZNF827 YES
gaagagttactggaagcggcacatggtgattcacacaggtttaaaaagtcatcagtgtccgctctgtccattc-
cggtgtgctcgcaaggacaatctc 1537 2544515 ADCY3 YES
actatgtgaccttcatggtgggggag 1538 3329911 NDUFS3 YES
ccactgtcagaccacggaatgatgtggcccacaagcagctctcagcttttggagagtatgtggctgaaatctt-
gcccaa 1539 3467685 -- NO
cagggagctgcatgtccaactgttctcaggggagaaagtttggccttctctaggaacagacggagagaaggca-
agggatcctaagggagatggtgcaag
ggcttttggggagtttggggtttatccaaaatgtagtagagaagagggttcttgaagagttttcagcagg-
gatgggacatgtgggatttgtgtaaagcaggga
gcaaactatggctcaagggcctgctttggctcactgcctgtttttggaaacaaagttttattggatcaca-
gacacaccattagttttcttaggagctacaaaggc 1540 2535364 -- NO
atcaaggaagtcgagtaaaacacttct 1541 2979944 SYNE1 YES
gcagcaaataggtgaaagattgaatgaatgggcagtcttcagtgaaaagaacaaggaactctgtgagtggttg-
actcaaa 1542 3210881 -- NO
atggctctacagcaccggattttgcatcagaatccttcgagtttcttatcttcaccatctgtagcatttagat-
tgaaaaggcttacctgggttttctttttttgtgtttt
atgatctcaagctattgggagtagaccaattcgtgtggctcaatatgagagttaaagttacgtcagaagg-
taatgaaagctgattttgcccttttattaactatagt
attttaatcctggtatgtaaaattattactcatttgtgcctaatgcagataatgggaagcagctcactgt-
ggtaaagtaggggcattaagcacaggtgcaac 1543 3984493 -- NO
ccagggaaatatgggaactgtgagaggcagcaggcaagttatgggcagaggcagatacaatgagttcatgtgg-
gaaattt 1544 3294206 -- NO ttttttctgcactcccattgcttta 1545 2389550
-- NO atgtattggtggacagcatctaggaagaga 1546 2593736 -- NO
gctgtaacactttactatgtctatgcaaatacacatttaaacaatataggaagatttcaataaccaaactaac-
tgtacaaaaaataaacaaattaactttattacatt
gctacttcaacttcagtccttacattgatttgttttttaaaaaataccagtttgaaacacattactgaaa-
gtgagtgtacacaataaatagaaaatagggatgcata
gtgctggagacattcaaccaacttatcttcatctgttgcctactgttg 1547 3315642 ATHL1
YES gaatgcagacgggtcaggcgctgtgaacttcct 1548 2638195 -- NO
gtcaacgaggggaatccactctgcc 1549 3973655 -- NO
cagtttggcaaagagcatgccactgttcctgctgtctatcaaag 1550 2409486 -- NO
tctgaaatccgacatcccagtgtccattctggggcacagcttcccctcctttcaagtctctctcttcctccct-
ctccacaacacagaggcctttagctccccagc
ccttactgttcagtgcgtccacccctccttgtctagaccctgaagtatattacatcagctactctcttgt-
gagctcctccagtactctgccccttgtccttctattgcc ctagtctagg 1551 2635963
PHLDB2 YES
cctgcctgtccggaaggaagactttgatttgcggagccatgtagagactgctggccacaatattgacacctgt-
taccatgtatcaatcacagagaagacctgc
cgaggattcctcatcaaaatgggtgggaaaattaaaacgtggaaaaaacgttggtttgtttttgatcgga-
acaagcgaacattctc 1552 3730508 TANC2 YES
tccacaatgttgctgccttgctctgccgctcacctcagctgacagcctatcgggagcagcttctcgggaacct-
cacctgcagagcatgctgagccttcgttc ctgtgttca 1553 2512118 -- NO
ggcatatgtttggtatctctggtccttagttcctgaacaattctgggctaatgctgtagtca 1554
3181032 -- NO
tgcttctaacaaatccgccctgtcacatgcatatgctttctcaacattcactgtcaaaaatgccctaccagga-
cacaacatagtgacaataacacattcaatttaa
ggataatggttgagagggaaccagctaagaacttacaata 1555 2401404 ASAP3 NO
aggcctctggatggcagaaggaaag 1556 2496802 MAP4K4 YES
tgatctttggtcttgtggcattacagccattgagatggca 1557 3048180 -- NO
tcagatttactttcccggagtagtcacaggactgggcagtga 1558 3436406 -- NO
ctctgtgccttatcaggagagggtgactctgtgccgactttacaaggctatgggaaggacac 1559
3840203 LOC400713 YES gctgtcgtagagtggcaatcatcagtggc 1560 2633650
NIT2 YES ctggctgaaatacgccagcaaatccccgtttttagacagaagcgatcagacctctatg
1561 2835873 -- NO
tgatcaaatagtgccgtctgcctggagtacagcatgggggaagaggtttggctgtgttttgatgtagtcactg-
cccatagtgttgtagttgcttcattttgatgtgt
catacagctaaagatgctccctttaggtcatttttgttgccgctgcctctgcggcttgttactactgtt
1562 2849540 -- NO
agaagacaagaggaagccgttctgctggcatttcgtcgggatgaagacaacacagcca 1563
2986834 -- NO ctggccgtgtttcctgtgagttttgagg 1564 3222790 -- NO
tgctgttctgcttctcccattcttgcatagagtaatggagttagtgaaaatgggctttcttttacaacacaaa-
gtgttgctcttctttctcctagggagaaagtagta
agctctgtgggtgtaggaggaggaaaatagcaggagcttagccaaggagggtgctgcagcacatgtgggt-
cttcatagtccggaagggtgagtgacac 1565 3317133 -- NO
ccaaaaggactgtcgtggcagagcagccatggccaagtggactcagggttcattttcggaacccctttaagct-
tatagaaagtccccatcatcacccagctc
ggccccggggcaccgagtccgtctggtgtggggcgtcctttcgacagagcctcctccacaaacccagact-
ctggcttccaccagggccccggacacctg
cttcctcagggcagacagagaggggtgacacactgcaccctgtggctgggaaaaggggcctgggactgtg-
cccgtctgggacggagcagagccacca tcccatgcaggcactatcaccgcaggcaaa 1566
3600340 -- NO
agggccactcaaccatgcgctctgggaggagtgggctgagatggggctgcttggtcagccctgactgtgtttt-
gatctttgggcgtcacc 1567 3929187 -- NO
ctggccaccagggaacagttacgtaaattatttgatgtgtctttttaacaagatattaggaagtgctcggcat-
tgttaggattttttttggccacgtggaaaaacac
acatgatataaagcaaaggaaaataaggcagtctgcaaatggatctgcttagaactgccattacgtaa
1568 3989061 -- NO
cttgctctgtcataccttgtggaaatgtaaaagatcaatgacagctagcctttcacacaattatttatgcctc-
ggccctctaattgacacagttacccctagcact
catcgttgtgatcacctgcagccaagacgctgattttctgctcctatagcctggcaaccttgtggtacat-
gggactacgtccttta 1569 2735839 MGC48628 NO tatacatatgtctgcctctaataaa
1570 3660480 -- NO tgagaccgcaattccagcacgcattggcaggacct 1571 2655657
-- NO tgggaggaggacgtctttgggattccttctcttcatgagctgc 1572 2848543 --
NO agcataaagaaagttggcctgggttttcgtgactcggcagggtccactcagtttaaaatgc
1573 3397172 -- NO ctgccgtgggcccattgaccagagcgacctgctgtctgatgcc 1574
3790842 -- NO atgtggcgaatgggtagaagaatgt 1575 2824108 -- NO
ttttctgattcactaccactgctggtgttacagcgtgaacgtgacctgaagacaa 1576
3361136 -- NO
agaagcaggtataagccaaatgttgagagttagagaatgccagcctgcagttgtcatcacccaggcttagtac-
c 1577 3971846 -- NO atgttcactcaggctccttggtgtg 1578 3294447 ANXA7
YES gtgagttttccggatatgtagaaagtgg 1579 3850170 S1PR2 NO
gttgcactatttggggcacagaataatcaccaaaagtgagaaaaacgagtttgggtggctggggaggactttg-
ggactcttgatgcaaggcgcaacttgag
aaaattctgggtgtgatatttgcacagacaccctcctttcaaaaacagccaccccccaagctattctcag-
ctccacacctgcagccccagctaaggtaccag
gtctcctgagcaaggcagagagaagccttgagccttctctgtgtcttctttcaagaaccccgctgtgtct-
tctttcaagattttttttttgagacagtttcaagattttt
gttttgtttttgagatggagtctcactgtgtcacccaggctgaggtggcagtggttcaatctccgttcac-
tgccacctccacctcccgggttcaagcgattctcct
gcttcagcctctcgagtagctgggactacaggcacctgccaccatgtctggctaatttttgtatttttag-
tagagacagggtttcactacgttggccaggctggt
ctcaaactcctgacctcaagtgatccgcccgcctcggcctccccaattgctgggattacaggcgtgagcc-
actgtgcccggccttcttctttcaagttatatag
aatggagcatgggggtggcagtggctagggacatttcctggggacactctcccctaaccccccagaagga-
cttcacaaaaacctgtggataatggaaggg
atgttacggtacaaacgtatatttatgtgtgtgtgtgtgtatgtgtgtgcgcgcgcgcgtgtgcacatag-
gcgtgatgtctgtgaccctc 1580 3918219 -- NO
tgcggattcgtctgctccacgcagggtgctctgacgtactctgtgtggcctggagctcagaaacctgtgctgg-
actcagtg 1581 2370552 -- NO gttggggtgaactgaacctgtccattt 1582
3476124 -- NO
gagcgggatcgaggcgtttttaataattcgagttgggaagacccggatggttcatcaaaatgatggtgttgag-
cacccgggaggcagacattgggtatttgtt
cacaattttgcacctgtaagaaaatgttcctttataactttcaaggattgccgtgagcgtctttggggcc-
ttttcattcatgtacaagtttcattcattactattcaactt
ggtagacttggtgaaaaatgtaaaagcattctgtatttggatcagtcttgggaactaaatttgtcgtgaa-
ttggggcctgtcacagattgcctccagtgtgcatcc
tccacgcagaccctccttgctcagtctccctctggcgcccatggggaagccgtgctgtggttggcagtgc-
ggccatctgggctgccgcaacgtggcaggg
caccgtccagcaagactgccccttagtgcagggctaagcaaggaaaagaagaagcccaaaaaggcgggtt-
ctttttgatacttgtaattcaggcgtcctcc agagtg 1583 3929424 C21orf66 NO
ctgttgctgattttggtgacacatctctgttgatatcagtaaatatcaattgataagtaaaaaaatatgcaag-
tcttaacttggatgtatttcatcttgcatgtgctcac
ctccctcccctctcacccagtcgtttgggttgtttgcctccccttactgtcatatcttcatagtgtggaa-
ctaaaacgtagaaatgagggaagtatagtggacag
atgtttcccccaccccttcttttacctaggcaagagattaggggagtcttttttgattaaagagagtagg-
tccaaaataaagaccctgaaacactaaaatctggg
gatccccaacaaaagaactggctcagtacctagtgatccgacggagacacctctgttagacagctcctgc-
ccacacacacagcttccagtcttgctatctat
atgaacaggcagttaacgatgatcataaggaccaacctgagcagcagaaccaaagggactgaggaaacag-
acagtgctggtacaagtatgcaagttttct
gtaaacagattactttcaaacagttgggagccccagggagataatagaaggtatcctactcaacaggagt-
atatagaatgctgtagaagaggaatattgtaa
gaacaagaactatctcttgaaaactaaaaatatgataactgaaatataaatttaaataggattggaagct-
aaagctaggaaattaccctagaatgttttagagaa
atggaaaatacgaagaccaaaaaaataaaataaaactatgctgtgaaagagaaagattagcatttgagaa-
ggcggaagttggtcctgctcagatgcggtttt cagatgcc 1584 2418445 -- NO
aggtttcaacccaactggacctgcttg 1585 2977983 EPM2A YES
aattctaccaaatatctggctgggtag 1586 3074397 CNOT4 YES
ttcatccaatcacagtgcacggtccccttttgaaggggcagtaacagagtcacagtcgttattctcagacaat-
tttcgccatcccaaccctatcccaagtgggc
ttcctcctttccccagctccccacagacatccagtgactggcctacagcaccagaa 1587
3320669 USP47 NO
cggtggagcctcatgatctcttatcttttgaggctgaggcaggtcacatgcaacaaattgtgaccctgctccc-
cacaagtcatgcaaaggttttgaagagctttt
accgtggggcagatgaacttgtgtcaaccatgcacaccctgtgagaaccaagtacctgtgtttctaaggc-
gggcactcaaggtgaggggtgcattctggcc
aaagaaacaaaagctgtggtttcaggaccatgccgtgtgtagctgatctgtacgggacgtgtatgtaagg-
aagagcaatcatgatagataagaacagtgtgt
gaagcagccttcacactagagtgtttggtcatctcttataatgtaagggaaggtactttaaaattctggg-
aagatgcgatgaactcatgtcccagtcagaaaata
atccaatgaaataagcattggttgccaggccacagttaggaattgta 1588 3562057 -- NO
gagcaaaaatattgtcaggtttcttgctgtggttctggatgttcagtagcaggctcatttg 1589
3924690 DIP2A YES
gggcctcgtggagcattcgtactttgagcgtccacaggtggcttctgtgaga 1590 3029146
-- NO
agtcaactcggggagtcaaattaggaaaggcttcgaaggatgggcaggacgtaagaatccagagaggagaggg-
atgtttggagaacagaaagtggaag
gttcctgtaggaaaatgatagagctatacttggagaggcaagcggggc 1591 2480430 -- NO
tcttcactgaaggtgccagcctatgggtggactcgtgatctagacctaaagggttagtgtgagttcctagagg-
aaaagaaagccatgaggcagattgtggaa
ggctttgaaggccaggtggagggccttgaactttattccatagacaatggggagctattga 1592
2923442 -- NO ctgggaagaacttcaggctgttgttcagggcatggatatcaccactgtcca
1593 3393487 FXYD6 YES
cctctggaacctgaggcggctgcttgaacctttggatgcaaatgtcgatgcttaa 1594
3879288 -- NO
gctttcaagaatacggccatgtctgcattgttggcttacacgcagacacacgctcgggtttttcatttggcag-
ggtg 1595 2889490 AGXT2L2 NO
catctcatccaaatacacgctattgagaaggcgagcctgacctccctcttacagataaagtcagctttcagag-
gctcagggtgggggggcctgcccgaggc
cataatgctacccaccccctcctcctaaccactggtctgttggaataaccca 1596 2915334
DOPEY1 YES
agattggttgagagtctccgtttgccacaggtgccaactctccattctcaagtgttcctgtttttcagagtgt-
tacttttaagaatgtctccccaacatcttacctcac tctggcctaccatgattacagaactt
1597 3186622 -- NO
ctcatattaggatgtggacctgtccaaatcttcagggagtcctccctccccaggccaggcaatttctccagca-
ccaaggtaaccactgttttgttctctattgcta
tggattggttttgcttatttgtaaatttatttgtagacttggtccctatcactacgaattggttttgctt-
atttgtaaacttcatataattagaaatcatgaggcattttcat
aagtgtgttttcaacttctataaagagaaacacaatgtaccttcttttttgtgtcctaaaccttcttttt-
ctcagtccccttccctgtacatgcacttttcaaagtgatta
gaggtacagagaactcttcctctaatctaataaacaaaatgatacaaactcaataataggtggaaatgcc-
cctcaggttcaatgctagagagaaactgcagg gaatggtggggactatggcaaactatggaaa
1598 3720992 -- NO
catttctatggttattcgtggaatgactctttgaccacgcggagaaggcaaaacttcagccatttgtgttttt-
ttccccttggccttcccccctttcccaggaagtcc gacttgttca 1599 3916840 -- NO
tggcaatttcaacagttcgtcactgcacgctgcctcttaaagg 1600 3959370 -- NO
catgggcttctcagatccaggtgatgccca 1601 2571999 SLC35F5 YES
tggtttcactcagcgcaggcgaatggctcttgggattgttattatctgcttgttgatgtgatatgggttgctt-
cctctgaacttacttcg 1602 3757901 -- NO
tatttccttattacatgttccagacaggagtgctagccca 1603 4002896 -- NO
ctttcatggagcaccgctgctcacgacctgttacagtctagaaaaatggaaaaactgaaaatgggtatctatg-
ccacctaa 1604 4013965 -- NO aaaatctactgtggagggagtgcaaa 1605 2327098
-- NO
atacttgagagtaaatgaactgctcttgttactttactatgtcaattacaaagcttaaaattcacacaagcca-
cacgacatatttaagaatgcatgtgagggcca ggtgc 1606 2381607 -- NO
gacatcagagtggaacttgggcgatgctgccaacatga 1607 2995272 C7orf41 NO
cactcccgcttcagtggggtttctatggagttgtcttggtagcctttgccattttgaatttagagtccatttt-
gtggctgactattctcttaagtttatgttggagaatta
acattcgctgactcgaatgtagagaactctgaatgtattaaggataggttttgagtcctcacaggtgacc-
ttactgagggaaagcatggcagagaagaaatgc
agtctgcactttttatgtactttttaagtgtccgtaagtgaaaggttttgcttataaagcatgaatttta-
atatctagtcattaaactgcacaagtgcaaatacaaggg
caggaaaggataatcacttagctttggactaagagggtaagagaggcccagaagcctttaagtgttttgc-
cattactgagttacctgggtatgtagcgactgg ttc 1608 3261789 SUFU YES
gctccaacctgagtggtgtcagtgccaagtgtgcctgggatgacctgagccggccccccgaggatgacgagga-
cagccggagcatctgcatcggcaca cagcc 1609 3934119 SIK1 NO
tgtgcgcgtgcattgattactatccatttctttagtcaacgctctccacttcctgatttctgctttaaggaaa-
actgtgaactttctgcttcatgtatcagttttaaagca
gcccaggcaaagatcatctacagattctaggaattctctcccctgaaatcaaaacctggaagactttttt-
ttcttattttagttgagaagtttcataaactgctcaag
gattagttttccaggactctgcggaggaacggcaggaagaacctcagagagggcagaggtgacttcaaag-
tgctggggactccgtcctgagggtcacttg
gccctgagcccctgcgtgcccttgcggaagcccagaagcttcttcctgctgcacctcccgtttccgctgc-
tgctgacgtttatgcatttcatgatggggtccaa
caagaacacctgacttgggtgaagttgtgcaatattggaggctgactgtagggctgggcagctgggagac-
aggctcatggctcatggctcatggctcagg
gcggtgcctgccctgggccgggacccccctccccaccccccacctaggctttttgggttttgttcaagga-
aggtaaagtgagaggtttaggtcagtgttttta
agtttttgttttttttttaaagcaaatcctgtatatgtatctacatgggagacaggtagacactacttat-
ttgttacattttgtactatacgtttgtgttccaggtttcagct
tccctcgctcctgttgttaagaagcgtccctgtcagcacaggtgtgcattgaggaaggggccccagggcc-
ttcgctccctcagcactggggtggaggcgg
caggaaggggcggcccttacctggcaggtctgggcgcacctttagcaggtggactccgtggggctccacc-
agccagaagcctctggaaggcaacgaag
gcaatgctgctccctgagtccagtccccgcccccaaacccagcccaggtgccttcagctacttcggcttc-
ttaaaccctgcagtgtt 1610 2748304 -- NO
actcaaggtctgtccatgctggtgacttagagtagtgggatttaaaccagaggatgcacacttggaggcactt-
gaagatgtttcaagggacatgcaggcattg
aatatttaaaggaaattaattgccgattcttagatcttgagtgttaatcagttctaacactgaccgtcct-
gagaaaatgcctatggcccaggtgacctgctggtttt
cctttcacaccttctctttcatgattaccattctttaaagggaagacatacctttcacctaccccttatc-
agagtgccaagtagggggataattaaaatactgctgg ggctgctgggaaagtgagtgactcta
1611 2358329 TARS2 YES
ctccagcacccatgtcctgggggcagcagctgaacaattcctaggtgctgttctctgca 1612
2636804 -- NO
tcttatcacaacactgcggcgggaaaatcaggaaatgggttcacctttcagcagtcaccacagtaaacttcat-
tgagaacatacatgcccagatatctcttctg
tgcacatgtatatgttaacagctagccattcagccaacaggta 1613 2907584 KLHDC3 NO
cagggaagtcactaatgggagagtgggaggtatttgaaaagggggtttcgtgggtagtttttgtcctactttc-
atctctcttttgatcccgacag 1614 3185561 -- NO
gcgagtcgactcacctacctcttttcaagccggcctagccccttcccggaacctcggctcccccccaacgaaa-
ctactgctaagccaactggactacacttcc 1615 3752751 -- NO
atgggttcaagacctgtttatgtgcgagaacaacaggctttggtgctggtgactcaccaagatgggaaataca-
ggaaaagaagcagggatgtggtagcag agtgt 1616 2366872 -- NO
ttcccatccctgctctagcagcctg 1617 2389086 -- NO
tgagagaggtttctattgttcactttagaaaaatgtaggtcaatgtaatgggtgatatctgttcttaattatt-
ctaagaattaaatcctgtatgttatcagtcacctatta tatggcacaccctcagggg 1618
2523976 -- NO aggcaaggggtaaagtccaggatgaggc 1619 3394423 THY1 YES
gcagttcacccatccagtacgagttcagcctgacccgtgagacaaagaagcacgtgctctttggcactgtggg-
ggtgcctgagcacacataccgctcccg aaccaacttcaccagcaaataca 1620 3510096
POSTN YES
agggagaaacggtgcgattcacatattccgcgagatcatcaagccagcagagaaatccctccatgaaaagtt
1621 2974447 -- NO atggattacgggcttttatgtgggcagcaacttgtgcctcag 1622
3000375 -- NO
gtcacttttgtggcctcttggctgtaccttccctgggacaggacacggtcctttct 1623
3498077 -- NO
gcagttatgtatacacagggcaatcatcagaccataatcattactgttcgaggccagaacagagacgactagc-
tctctgtgtgcctttcccaagtctcaccgtg atggactgtcctctc 1624 3670758 -- NO
gtcttcagagctagccggctgtgtcttctccccgtttctttcactggtgaataacctttcgtttgaaccagcc-
ttgattgttctctccatgttccactgtggctcccca
tggacactgctaggtggaatctctgagaaaacaggcacttcgcagtcggcgcatctttctctgccagctt-
agggattgccgtcaaggtggaggaagggtatt ttggccatgttcggagtcgttgttttta 1625
3418194 -- NO
cagttagctgtagagatgtgatttagcaaagttggttataaagtgggtttttgtaaattgatttccttattac-
tgttctttgtagaattgaagatgtattctctcccagcaa
aatagttcacctgcagatcattgaaaagtttggctgaagaaaggggttattttggtgtgggggtaggagg-
cttctgtgggctgggcatggtggcttacatttgt
aatcccagcactttgggaggctgaggcaggaggatcacttgaggccgggagttcaagacttgcctgacca-
acataatgaatctcccatctctacaaaaaga
atcagccaggcgtggtggcgcacacctgtagtcccagccactcaggatgctgaggcgggatggtctcttg-
aacttgggagattgaggctgcagtggagca gtactcgtaccc 1626 3687863 ZNF764 YES
gaggtggcgaaatgtcagacacaaacggac 1627 2438168 -- NO
gggaatatagagaggctgctgagag 1628 3059966 KIAA1324L YES
ggctctctgtaccaacaatataacagactttacagtaaaagaaatagtggcagggtcagatgattacacaaat-
ttggtaggggcatttgtatgccagtcaacaa
ttattccttctgaaagtaagggtttccgagcagccttatcatcacaatc 1629 3281916 --
NO aaaaagtaaggtggatatgtgcagtggct 1630 2838994 -- NO
gtagaaaggggaatgtgtactgctagaggttacgggctttga 1631 2724513 UBE2K NO
gtgtaccaagactagcaagagtttgcttcaggattttgttgaataattaagataatattttgagtgtgtcagg-
gccattcaaattgttggtgttgcatcacagctac
cttaactgatttttaacatggatcctctgtgcctgtgaatttacttgcatgcttgtacttgacttcttag-
gatgggtagctgaaaagaccaccattttaagcatttgaga
attcttaaatatgaaatttattcagaattgaagatggtgacctattcagagcctttttgtccttgtcaac-
agactgggacagtgtctgattcccccttcacccccccc
acccccgccttgccacacacagctaatattctaatggtaaatttctctgtatcaggtggggaaatgtgct-
gaaggacagtatgtatcccttgcttcatttttaggtc
gtaggtttggaatgtcttgtcccagttcttcaaacactcttaaattttttcttaagtaatgtaaaaatgg-
aactgccaattttatttctcttgcaaaaatagtaaatacttg
atgttacattattcccaggtttaatgaaagaacccaacttagtttttcagtgaatttgacacctattttt-
tagtgatgaaatttttctttgagaactggcaaggatgcag tcagctgtttgcagtttttagcctga
1632 2415597 -- NO
ccctgttaatcttgtggtcaccatacactcttgggttagctgtcaaattagggtttctccaccctgcttttgt-
ataatgaagtttctaatcctaaatgcaggatgccc
cattctgagcctgtttgtatttaacagaaaatagggattttcgtcccatttttatcttaccaattcactc-
cccaactgtgccagaatgcccagaggtaatagcctttt
ggaaggagctttcccatgctacattccagcagggtaaaacaatctgaaaatgttcttgccccttttatca-
ctgagttctccatatcccaggctattttataaataga
atttttccctacagaaaatatgtaaagccattgcgaagagaaaacttttctacacatagaaaacatgata-
atttctcattagttttggaacaatacaggtctactcta
agttgtttcttattctggagtacaaaatttgcattttataatgtaaattgggacactgtatactagcttt-
ctc 1633 2818227 -- NO
cactatgtcaactgggtgtctttgctaagtttggcatcaatatggtgacctctcgggagcaggggaccactag-
gttacataaggaggggtgaactggcccag
attggaaatggagcaggtcaaaactcccatgctaaccagtagtgagatggagcct 1634
3412324 IRAK4 NO
atatacacctatctcaaccatttttttaactgatttttttcctaaatattcttctttacctttaacaaggcat-
aggctgttgcaggacagtggttattaaagcatgggttg aacttccaaaatata 1635 3598210
ANKDD1A YES gtcggggccatatggctgtgctgcagcgacttgtggacatcgggctggacct
1636 3728164 -- NO
cttgctaacgctcgccagagaaatattccgtggaggtgttaaaacaagactagtggaaagaaatggtaactta-
aaaagaaagaaaatccatggcagtgaag
aacagatttcatattagtactgtcataatattctctaatgtatcatataaataaaaatctgtttagacca-
gaattttaataagtcaccaaaggaaggttttgaatccta
cagtttatgtatccccctttgcgatgtaaatgttcacatctcaagtgaagtagagtggggagacgcttcg-
gagactagaggctgttaattagtgaggtatattttg
atcagggcaagaagactggttcattctatatcttcgtatttctctggatgattatttcattttgtaaaat-
atgtaagagttcccccccagccccttatctttttaaaaatt
aaaatggtcatgctcttctaaaaagatgacttaatttgaaggctttggagacatgaggatgatggggatc-
catcactccctgttctttgctccctttggactggag
tgttggctgtctggaagagttttgcttgagctcgtgggttattttcttctatgtggaggaaccaagagac-
tctttagcatctttcagcaagagcgaggtctgggtg
tactcaccatctgtcttaattatccttgtgtataagaaaacattcccatcttttcccaattgccatttcc-
ttccttaacttttagaggccagaacctcatctgttgatgca
gggagatctcacttctttaacctatttctagttgccttcagtcacagcggggtggccaggggcgagtcac-
ttaagcctccccaaggctcagtttcctcctttgta
aaagagggagaattatagtactcactgcctgcagttagttgtttggaggataaatgcaaaattcttcact-
gggagtctggcataaaacagcactccgcaaatgt
ctgttgatcttattattatagaattattatttttattattattatttttaagacggagcctcact
1637 2779706 -- NO
acctggtaaagtgagaagagtgatcaggagaagataatttgcatagtatatatagatttctattccatttata-
taaaacccttgaatggtaccttagtagaaacaat
ataaaataaagctaatatgggttagatgataatgtggttaagtggatttttttttcctgtctgaacaaaa-
gaactgacaatttaatcaatagacccctgtcagtctgg
agagatgcttctagtggtcagcacggcactctggtctttgtg 1638 3394582 -- NO
aacagctcaacatgtgtcgggatgtccagggaa 1639 2429120 TRIM33 YES
catattttgaaagcacggtgtgatcctgtccctgctgctaatggagcaatacgtttccattgtgatcccacct-
t 1640 3428756 -- NO
cagctaaggtaaatctgcttggtccaaacaaaacaaaacaaaacaaaacaccagactgcaacaataacaggaa-
aagatcctcttcagtgatttatgttgttct
cttactttcataactagtttgaatgcaaggctggtaaagggatacacagagaatcattattttaaataac-
aaaagccattcaaaactctctctacctgtcaaggat
gttttatgctcccattcttatttgtttggcagtaaacataccttgcccacagtcgccagcatcaaaccca-
caggacaagacattgcatgcttggtcacagaactta tcagcgagccaggaattcgcacatc 1641
3595186 -- NO
ttgtttaggcaaagcacgttatggctttttcttgcctagtttaggtctgtgcttaatgactactggaatagca-
gcaaacataacatcctgataacatttgggaggaa
aagccatatttgaaaattggtgaaatgcaataatctttaaaccaggaatcatcagtttgctaataaaagg-
tatatggctccaagttacgtattttgtcagggtcctc
tggcattttcactagtcattttgctagtgtgtacaatgattcctatcttgctgtaaaacttggtgatttt-
tttatattgttgaactaggtgacatgaatattgagtcagatc
acataatcttagagtaacacataagtgattatgtagcgttgtgggtggaaacaattctggataaaaagtg-
catgacagttcagaactactgtgcaggcagcctg
tctgaaatcaggtttaaaaattggccctgtctccagctgactcgttttgtc 1642 3959259 --
NO
ctcaagcacagtcatgattggttttgtattttcttctccaggctacataataattttttgacctggttttctt-
gatgccttataattctgaatgctggacttgtctctttatta cctgccagttagc 1643
2604457 -- NO acagcaggaatctgtcagtgtccctga 1644 2843218 PRR7 NO
ggcgcgcgcacgacttgagacctgccacgggcagcccccggccgcgggtccccgagtgacgctggcggcacct-
gagagtgtggcgcgggcccggg
gccacgcagcggagcccagtgtccagtgaagcgtctgaggacccgccgcc 1645 3039818 --
NO
gctgacctattgctgaggactatgagaaaaaagttattacagaatgagtcatatggaaaacacttgcaaac
1646 3483658 -- NO
gcagacaatccccatcagcttaaggttcccgtcaccagggtttcccttcatcgaaactttgccacagtca
1647 3605805 SCAND2 NO
tgtagtattcactactccagacctttttcaagttgaattttttttctttttccctatgtctgttcttacgtat-
tttttttaaacttttatttcagtagtgtttggggaacaagtag
tgtttggttgcatggaaaagttcttcagtggtgtttctgagttttggtgcacccatcacccaagggtagt-
cttttttatccatcaagtctgtacccaatgtgt 1648 3659197 -- NO
agagagcctagcctgaatatgccacagccgcacagagtttctcct 1649 3775146 -- NO
cagttaagtgcagctcggtgagtcccggcagttccttcccggcactggctcgtccctgggttctcaaggttcc-
atgcggccacagcgtccgtccacctgtcc
acgcgagccacatgctgaaatggaggtggataaaattcatcaggcagctgctgtaacacggaaatgtgca-
gatgccagagtagcttcgtc 1650 2534837 -- NO
tgtgcacgcatgcagcactgcgataacggggcagggggagttaggtgattgcttaaagcacaagtgtgtaggg-
aagaaacaaaggcaggaggggccat
taaggagcctgtagagtgtttgggtcgggggctcacatttgtacagagtgagctga 1651
2705269 -- NO
aaagctacaagcatggccgcctgtggtatcgaggtgttgcaaacaatatctgtgttgcgcttcctgttttaac-
ctacctcgttttgtttgtttttgtttcactgttcatc
acagcagtgttatctccaggagacatatagagagctcaaccggcaatctcaggtgcatttaacattttta-
aaacgaaacagtagttgaccaatttttcttcttaa
aaaattggaagtggggggaatccaatgacaaaaactaatgtggcttgtttctggagaaaataattactgt-
aaatggaacaacaacaacaaaaaaaactacga
tcttactgactttgcctaaatacacaagcagctgatgtactattaatgagaacgaaatacacattaggaa-
aatggagccatttcaatctagtggtttgggcaaga
tggggaagagaaggggaaacattctagtttctggattacattattatgcccctcctgaaaaggtggttgt-
catttgcatttatttaaagcaggtaatatgcaggaa
tgtaactgaggattatcttcaggcaatcagcaagatatcctcctcatggtccctttagctctcaaaagca-
atgaaatcctcctgttctcatttttactgctgtggttgt
gctgctgaacaatactatcttctcaaattccatgccacaaattcagcaataactttttggattgaattta-
acaactactgtaattggatgctgatgtggacaaaatat
attgatttcgatttcactcccgaatgtgattgccaccagctc 1652 3479382 GOLGA3 YES
tcagcaaacagcccgtgggaaaccaag 1653 2320890 -- NO
gtttcatgagacagcgatctgcctaaccattcactcctcctagaagcaaaagctaccgtgatcattgaggcac-
agccggtcttcatatatcctcaaaggaggg
ggattagcttccacatcccttctctattcctggaggtgccagtagtgggagagtcatggcagaagttacc-
agaggcaagtggggcagaggcaagtagggta
tatgtttggatcagtggatcagtgtcctttattgtgcagaaaaagctaaaattacagattcttctgaagg-
gatacatagcagccgtttcaccaatgtccctcagtc catttgtccaggtccaga 1654
2824597 -- NO
tgtaggtgctgctttaatgcttggactgatgttattgttgtgggagtggattagttattgtgagcatgggttg-
gttataaaagcaaggtcaaggctggg 1655 3916352 -- NO
taatgggcctgagtgtcaccaagag 1656 2900984 HLA-F YES
ggaatgaatggctgcgacatggggcc 1657 3003162 GBAS NO
ccctatgccgatgttgtcctggattaccttttttgtcctgtcttatcacttcgtctcctgtctcgggtttctg-
gctgtctgttcctatttctatttgatgttgtgctctcactt
cacacccagcatgtagaatcaccttgctcttccaacttccctgtctgtgccactcaccttgttttactca-
gcccgttccttagttctctgtggtgaatctgtcaccta
agctgtgcattcttcatcggacatgtattttggttctcttgtttccttctccatctctctctccaagcct-
ctcgagccccattcccaagtagcttttttttctgactaccttt
ctgggctccaagctatacctgtgtctccttcctgccctgcaatacattaccccaaagtttgtcagattga-
tctgcttgagttctgttttcttttttcatcacgttttttcttt
tctctgaaactttcagcagctccctgtttgcagaacataaagacttaactcctgcctggtttttaggggt-
cccaataatgggattctgcccaacccatccagttct
gggtacaagtactgcctgccttacaatctccattcaggtaaggccagggctcctaagagcaggtttgggg-
tccccagcaaagaggagtggctacaaatcca
tgcgtgactttgtgttggtgaaaaacctgggccccgttgccaggcccctttctggaccccacctgaatca-
tgtgtactgggcttcctcctgggcactgcctcca
atgcagggttgtctattcctgctcatgtcatgcgacgaaaaggaaatgttggacatacatttccctagca-
gaatccctctttccctgtcctcgattttcattgatcc
catgttatttctgaacattcatgagtcacgcatcagatacatttaatatcagatcctaatttaaaaagta-
aatgctactcttccaaaagtacacatgatgtggtcact
atactgggtcataaagatgtatgggttttcagttagttagacttagaccgt 1658 3743421 --
NO
ggaacaggagaagccccaattttcagaagagaggggagttgattgagaagtgtaagattgttacttgagaata-
atcttgagggtatgaaggtagggtaagg gagaatggtgataaactc 1659 2949593 DOM3Z
YES ctggcggcccagtcaccgtgtctgtacaccaagatgcaccttacgccttcctgccc 1660
3824798 MAST3 YES
acggcagaagatggtccctcgcgtctctcccatcttccggctatggaaccaacacac 1661
3933890 -- NO tctccgtaaccctataacagtccgata 1662 3340811 -- NO
catttatttatgatcaaccagagagactaaacagtggactcatgggtttggactctattgcaattcaa
1663 3888249 DDX27 YES gatgaagaactcaccaacacaagcaagaaggccct 1664
3932432 -- NO atagggaatgtgctttgagctgttt 1665 3941419 -- NO
caggaaaagagttggcctggacctgca 1666 3976987 CCDC120 NO
gttgactgcgtgtccattgttgttatagttggttgaatctgtcccattaattctccttcc 1667
2892314 -- NO acatggccagtactgtttcaggggaatattgggtggcgctgg 1668
3379157 -- NO
gggccagagaactttacaatgattatgaagatcaaagggcattagaatcaagctataaagagccactgtttga-
tgttgggatgtgaggatgctgcaggtggat
gtctgcacgttgatggtgagaacatggtcaccctggccctgctgggtctttgctaaagagactgtgctct-
gttcttggggccgttttcatcacctgatta 1669 3830022 -- NO
aggacggtcggcgtgcagagttcctggagtgctggggggcctgagatggttgtatgacgtctggaggattcag-
gagggtgtatggggtctcaaggacac 1670 3904149 CPNE1 YES
ccttggttcagctgtccatttcctgtgaccatctcattgacaaggacatcggctccaagtctgacccactctg-
cgtccattttcaggatgtggg 1671 2408020 -- NO
tgaaccatccattgcctaaaactccagcaaccctaaaaggacccaatcaaccagaagaaaaaatactaatacc-
tcatatcatacagcaacctaacatttcaaa
gtgctttcacatgtgttagttcatgcacacctgacaacagtttaactgagggagccagggc 1672
2437930 MEX3A NO
ccctgggtccagtagaatgtataaaagttgtaaggaaaagataaatagaggagggaagtggctgagtccaccc-
tgagttgcccaatcttcagataccaggg
ttggatcaggttgctagtttaagattgggagcttccagtctgctggggttgattctgagaatccttggat-
ttttaaattgtaggacaaagaaatgaggggttcattt
cccagggtcttggaaaggatgcacactgatcatctcaataagacaggggctgggttgggggcagcagagg-
aggccaagcacattcacctgcacccctag tacctgggcagcccatactccaatgtggta 1673
3264854 -- NO ctccacctctttttgtgcgagggcggcctc 1674 2701275 -- NO
acttgctggaaaaagtacatgctctcc 1675 3017578 -- NO
tatctctgatggagctagtgaacattaagccctcaatatttgtttaatcagtgctatcaaagtggtttaaatg-
gatgtagtctccaggggtctctg 1676 3625878 -- NO
ctacttcagtgagtgggactttagcctgagca 1677 2438152 -- NO
cagctccctgagatagatgtaaatcctaagcattgtgggtgttttggtttgatgggactggattgaaagattt-
acagacttaaattgtaaaggaaggtaatttaga
gagaggaaggaaataaacattatgttggtttggttataaccactggcttgtctccactgacatggcctgg-
gggtgagtggtgtatttgcaaagctcctttcaggt
ctgcattaatctctggcattagttggctgtgaccgattagcctcccagttaaagtatgtagtcagttctt-
agtgatggtaaatgggttactgaggccttcttattaca
tccaattatgaggtgactatataatttatcttgcaaactgttgagtgtgttctaaacagtatgctgtggg-
ggcgctatcactaattatgctgga 1678 2786550 -- NO
gtacccaggaggtttggcatcactcaagaccctcagaatgcttcctctgctttaaatgcttggagtggctctc-
tgtccaaactgtattaccccatccaaactaaat
cacctctcactatgtggatgaagcaaacaacagatcttttgtttcgaaatgatttcatgttaactatatt-
ccaggatattaagatcttacttaaggaaactgctttgc agtgccagggatctaagctatata
1679 3122495 ANGPT2 YES cagggacagccggcaaaataagcag 1680 3252241 --
NO
cttctccgcaccacatcgcccttactctaaaattgaccacataattggaagtaaaacactcctcagcacaagc-
aaaataata 1681 2806568 -- NO
agagcactcaattcgactatccgtccagctttcacagaatttacttctgagcccacaagactcaaattgtata-
aggatagagtctgtttcattcatcaacatatcc
agcacctgacatagttttacatggcacagagtgggtgttcaataaatatttgtcaatgattgaacagaaa-
ttttcagcaccaaatgaaagaaacacatgactttg
aacaacggcacgagaataccaactgtttgattatgcaacgacaggatcttttggc 1682
3385452 -- NO agttcctaaatgggaacactgccttatgga 1683 3968192 -- NO
gatcaacgcttaattcaaaaccaggctgtagaagaagaagaagaagagctaagaaggttcttagtgctgatgg-
ggagaagagaaggttctggagctgtgc
catccccgggtggaaagagggaatgtgttctttcttcccttgacacttctgtgcagatgaatcaggcagg-
aatcaagagcggttg 1684 2397794 -- NO
cttctgatcaccaagccacatgtgatgactcctgggcccttcttcctgggacaactgcaccagcttctaatca-
gctcgcccatctcagcctgacccctctctgc
agcctgaagtccagactctctagcctggcaccatagtcctttccttctctctgacctaatcattaaccat-
aaccc
1685 2412877 ZCCHC11 YES
cgatgtgacattggggatgcttccaggggaagtttatcttcatatg 1686 2904959 MAPK13
YES gtgggctgtatcatggcagagatgct 1687 3367083 -- NO
acagactgacagaggtgcatggtggag 1688 2762520 -- NO
tttaccatcgtttcattccatccatcc 1689 3463535 -- NO
tgcctgtagctccatacctgtataatcaacagctattaaatatctgctaagcaaactaaactaagcattttca-
aaagtaaacttgtgaaacctgatggatttcagta
gttgacatcagcatctacttttgctgaagtcagtagcctggacattatttatgacacttatttttttttc-
ccatcttgcccttatccattcattcaccaagccttgttgagt
ttatcactgagtatctcattgccatcacaccaatctaggacaccatcatctcttacataggtgattacaa-
tagcctccacactggcctccctgtctccgtttagctc
atctcccaatatattttataaaaatgatactgttactttctctgctttaatggcttaccattacctttaa-
atggagtctgaatcagtggtctccaaaggggggtgatat
ataagataatctgctagggtgcaggaggaaaatattggaacttttattcatatttacctttttatttgaa-
aaacactaaggcattaatatttaaaagctactactgtgt
aatagttatttagtcattccttctttgctctatgtgtcagatggtcatttggtactaaaggtgtcctgag-
ggaagcatgctttgttcactttctgcatgttgcacaatac
tataatttgaatgtccatctatgcggatttatgagttatctagtttaactattacaaaatatgtaagtct-
gggattagggaatttgtggagaaaatcaagtgtttaact
gcaaataagatcacattgttgttcagctggtaagatatacaaaatcaaatctgttctcatgaattaagaa-
aaattacgctgattttgaggttttaagtgaaacttttta
aaaaattctcatttttttgtaaggcatccctttctgctttgatagccattaaaaatcaaatattcaaact-
gatgttagaactagatctttgaatctctgtatcacacggt
gttaagatcttcagaaataatgaagcatattcaatatttta 1690 3533262 -- NO
tgggggagggaggatactactgagcaa 1691 3651809 -- NO
caaagatgagaggtgcgaagttgtccaagtccaacagctcaactgaactttcctaagtggaattgtta
1692 3719905 MLLT6 NO ggttttgcatctcatttacttctccattggttcaggataaag
1693 3744442 -- NO ctgagcgtgccatctcccagtggcc 1694 3994048 -- NO
gcaagcagcttgtcagacgtgcatgtggtttgga 1695 2566874 -- NO
ttccctccaaagtggaagtgagctggagagatctctgggtctgaaagtcacctgctatgttggaggagggtca-
ggctttttgaggactactctggtcaaggtc
tgcagacttgatccctcctttaacccaaatcttattattatggctacacatgtgccacacattatagctc-
cagatactcacgcaaggttc 1696 3788902 -- NO agtttcttttggcaggtggtccagaa
1697 2684832 VGLL3 NO
aacacaaccatttacgatctcagtcagcagatttactctactcaaggaaaaaaagaaacaatcttattggaag-
cagatgttgacactgtgtcagttattgaagac
ggaaggagttcacttgagccattgcagttacaaaggggtattgatggcagt 1698 2808743 --
NO
ggccaactgtcaagatgttttgaaggccaatctggaagtatatgttaaaataaagatgtgcataatttctaac-
tgagcaactctactttgtggtatttatcctagag
aaacattcacaattatgcccagagagatatatgtagggtatcccttgctacatggtttataacaaaaaaa-
tatattagccaactagggtccattagg 1699 3311746 -- NO
tttcctcagtgcattcttggtggtgagattgattggtgagcatcgtataacccactctgggagcatagcctat-
ttgtatttgtgtatgtctatactttgtgaggtttag cccacttc 1700 2398939 -- NO
atgaaatggtttggaaaggagcctt 1701 2948399 -- NO
agagggcgatcaggtctcattaggccccagggtgtctgaggggtgatctctgccagtggcggtgggcaaggca-
gaagaggcgtctgctgcagtggaag
gatcatgacagcctgagttaaattccacctcttctcagctgtgaggtcttgagtaagtgattttgctact-
ctgagtcttagttactttg 1702 2974531 -- NO
tctcattttgattctggcagtgggcccaaatgctaagtgtcttgcccaaagtagaaatttccagttgctactt-
ccatggtgtgccgcacaggcaatggctgagtt ctt 1703 3385006 CREBZF NO
tctggatgattagcacatggataaaggagatttctggaatataaaatggattgtttttgaaatttctaggttt-
ggctctatttactgtaatggttgaaaacaatttagt
atttgggtgacccttttgtttttcttctaaatgtgcctctggtaaaatacagaactagactaaagatgta-
gctttttaatatttgtcttttgatggtggcaggagttcata
cattaattgaactaacacatcatattttgacctactatttctatcatattgacttactgtttctgcactt-
ctttgaccagacttatc 1704 3777967 -- NO
gcgagtgactccgtttctttggacctgcggttgagctggcagcagaatggaggggtccgagaaacgggtgagt-
gtgaatcccttgcagaaatgctctctgg
gggtctgcccttgaatgttaggcggcatgacaagtcaaatgcagtccaccagggtc 1705
2446212 TOR1AIP2 YES atggccgacagtggacttagggaacctcaagagg 1706
2527475 -- NO ccatttgagatgttctccgaggtgg 1707 3110892 -- NO
ttggtttcaaatggacagcagcaaa 1708 3229044 BRD3 NO
gatgtttctggtaatcatggacccttctcc 1709 3518549 MYCBP2 YES
caggaccaggttctcggttgtcatctcctaagccaaagactctcccagccaataggtctagcccatcgggtgc-
tagttctccacgctcctcctcaccacatgat
aaaaatctacctcaaaaaagtactgctcctgttaagacaaagcttgatcctcctcgggaacgttctaaat-
cagactcttacacacttgatccagataccctccgc
aagaagaaaatgcccctcacagaacctttgagaggacggtcaacgtcaccaaaaccaaaatcagtaccaa-
aggattctacagattcccctggatctgaaaa
tagagctccctctccccatgtggtacaggaaaacctccacagtgaggtggtcgaagtctgcacctcaagt-
a 1710 3701324 -- NO
caaattacaattcaggttctgtttgaggtgctcctgagaagaggaaaagagtcagaaacctacacaaagatgt-
atagaagattaggtcctgagag 1711 2941831 -- NO
ttgcgtttacatgacttgagtggcctgtcagtcccgctagtaaagtctcctcatccatccactctgtttaaac-
aatcaaactctgaaacctgtgtctcctggaccat
cctataatccctaaaataggctgttatgcttttcacctctgccctactctgttagcactaccaacttatt-
gacctctttcaatcaaatcgttatctaaaggatacctgt
aactcagataggttgcctactgggcctgtttagtttta 1712 3403963 -- NO
ttttttctgcactatggcttgggccc 1713 2337265 C1orf175 YES
gaaaggcaacaacaagcagtcacagggg 1714 2774211 -- NO
catcaggagtgtggattctgccattagtacccaacagatcaatgcccagtgtttc 1715
3626362 ALDH1A2 YES
gcttcagaaaggggacgtctgttggataagcttgcagacttggtggaacgggacagggc 1716
3760869 -- NO
gagcgtctctccttcaaatacctggatttttttttttttgtacactggttcatagatcggcacttgactttga-
acctggcaccaaaaggcacaatatctgataccctgt
acaagagctattagagatgctgccatatggatgggcaaaactgagccaatcccacttaggaatggaaggc-
ttggacatggaagggaggatataaacgagg
agttggagaaaaacgcaagcccagtttttgctagagtggaaatgaaagtgggaatgagggtcttgttttt-
agtcctctaaggaccaggaagcaattttaaaact
tccttggtttttctgaaagcagcatattcaaaatgccagcaaaaactcctaacaactgcaaaaccaaaag-
aggatcaaagctcaccaacatcccttcttattgct
gaaaggctctaaaattcaggatgccctgttcccttgtaaaagggaaaataattaagtctgatttatggta-
atcataccacatcacacttctaaaaaaatattcaag tgtgtgaccaggggacgtttgacaccatt
1717 2772067 -- NO cctcaaagtgtctaggaggcggtttgatatgcagactaaagtgaga
1718 3350159 -- NO
tttacatcatggtgtgtgacaaaacaattgcttccccctcctccctgcccttccccacccctgacttctaaga-
taacta 1719 3946034 -- NO aggtctgcccatcccaaacctgggt 1720 2699092 --
NO
gcttcaaacattggcccttcacgtacaacaaactctatcattcgatgtatcagggcgagcaaattcctacaac-
aacaacacagttaaagaaaatggattcaga
cctaccactatataaaactacacttgacctaagttactataattgtgcagaaaatgattattctgctgac-
taacaccgaatttaataccaaaaaagtaacctggag
catatgttaatgccttgtgcattaagagggtgtggggcagtgggagtagggaagtgggaggggatggaaa-
ggtgagggagggtaggaaaccacaataca
gcctcatagtaatatttaattttctaaatgtcacttattttccaaaagtaaaacattaaattataaatca-
caactaattagaaagctgcaaatattgatatataaaatca
gtaacttagagcctgcatgttattacagccatcta 1721 3027187 -- NO
gttcacggcagctcccaacaggtctgaggtaagacgccgctattatcctcgtttgctgggagaagactcgggc-
ttagagcctctgattacacagctgcactct aaccatttcctaata 1722 3496668 -- NO
tctcatgtacctcgtagtatacctactatatacccagaaaaattaaaaattaaaaactaaagaaagaaataat-
tgcaaaatgtaataatgtctttgaggggaaaat
aaaaacttcagtgaaatactctaagaggggtttgatgcagagctgggggatgtgggaaagtagagatagg-
aaagttgaggagggagggatgggttacagt
ttgccaaggacagaattacttgagagggtgggagcaggacacacatgtcagggcctctggaacaggaaga-
ggttggtttatggcagaaattgaaagaatg
ctctcatacacagctcactttcctccttgctttttgtctgcatagcattattcaatatgtagcataatat-
aagttgaaatcatatatcacctttgtggtcttctcccacca
gaaatcaggcattatgaaggcagaagggcagaggtatttgtcgtgtgtgtgtgtgtgtgtgtgtgtgtgt-
gtgtgtgtgtgtgtgtttgacttttgtatttttgctgc
cgtattcctggtacctggaatagcacttggcagacaaatgtatgcaaagttattcaaatccagtgggacc-
agaccacagtg 1723 3718614 -- NO cagtggggatgtagaatgtgtccaaa 1724
3759098 -- NO
ggggcagcacaggtactctgattttggggccacgagggccaaatccgcgcctgcacgtag 1725
2721510 -- NO tattcctggactatagccgctgatctcattgatgcccttcttc 1726
2938424 -- NO
ctcaagagtgaacccggaaaggctcctaaggaggtccctgcctcagtccaggcaaggctgtggcctagacgag-
gtggcg 1727 3606484 AKAP13 NO
tgctgctgcccgcatgggatgcgcaggggaggcgtggggatccgcaggagggtggttgggatacaccggatac-
ctctgctctcattgcttgtttgcaaatg ctctatggacatttgtgtgctaaatccta 1728
3750237 -- NO
ttcacccacatacaaaatagtgcgcgttttggctacttcagcctcttcccttctctagaaataactcctcctt-
gtacttagtaaaggcacacattcacttcaagagt agg 1729 3320010 -- NO
caggaggcccgaccaaaagcagatcaaataggagtgacagagttcagagctgcctgggacaaagttttaaatt-
ttattttcactgcaacccataggaagata aacattttatatcatgacccagcacacaca 1730
3907649 -- NO
aggaatgggccgcatggactacctgggggtccccaaggccccagctcctctcctttccgcgccttctcccaac-
ctttattgcagcgtctcctccggcgagac
gaggccgggcttagaaaaagggcagcgaagacccaggggccaaactggcactgaggagctctggtctctg-
cgcggcggggcgccctctccgaatcag
ccccaacaggcgtggcctccgggcttcaggcagcggggtaaggggccaggacacgggcacagggtctgta-
tgtaaacggtgacagcggc 1731 2546923 -- NO
ggctgtgtcacgtggacagtgtcacatctgcgggtggggataacaaggcacctgagtgcgtgaaggagga
1732 2788764 -- NO
ccatgggaacagtcttgcagtgatggacggtttccatcccccatcactgacgcgggaataactgtgctgt
1733 2886332 -- NO cttttggcaaaaatgcgggccatggggtgtcaaag 1734 3307785
-- NO
aacttcaaactgtgctcatgtgggcacagaagcatcgtgcagggctgcactgtcaccagccccagcagccaca-
gggcagtttgtcaccagctccctgaga atcaactccagtgtgatggaggtgaccc 1735
2339825 -- NO
tctttaagcgagaagtagatgtggggaggggttgttgcatttttaaagattcctgtattaggccgggtgc
1736 2922550 -- NO
gtgaactttgtacttacgtgtgcttttgtggtagcaagtatcatctttctgtttccttttagcatttttggtg-
tactggtcta 1737 3319874 IPO7 YES tagcgcacagtttgacatgtcaacaag 1738
3571362 -- NO
tgggtactcgagcactgaagcattctcatcacttcccatgaagacactaatcccattaaactaggcattcctc-
tttccctgaggttcgttgatagttgtatcttttgt
catttcccatagtgggaaaactaaggtccgtggagggggatgtgaatccataatttctcttcaacaaaca-
ggcagcagagccattgtggaatttctagcctaa
gccataagatttgtggtttgtcctgatgtaagtgcattcactg 1739 2562256 -- NO
acaggcgggtatggtaatagcaatctcaggagggctcttctgttgctgtgtagaaaatgaaccaagtagcata-
gaatcgtgaccagctttccacacctggctg gagcactcctggggccttcagtagggacagttac
1740 2599272 -- NO
ggaagttactgcttcccctggtgtctgttcttctggcttcagcttcgctggggatggattc
1741 3019543 -- NO
gtggccttttaggaactgtagagtaacttaatataagagacattatttggtgggcagaattaagatcttggga-
gccattgctggtgcaatcctcacttgggaaaa
tttaacaaaatatagttagaccttttccaggtctcacccattccatt 1742 3316144 TMEM80
NO
gagggccacattcggagcctccgtccactccagttttatcagcttttgccttttgcacggagtgctaaacaaa-
ttctagctctgtgtttttttcccattcccagattt
actatcagttctccttaaaaagtatctaagctgttacagtagctttcccttcacttgattctattgtgtg-
ttttctatgtttggaataattacacccaaatatctagatattt
tctcttcaccgcattttgtaaata 1743 3808909 TCF4 YES
gtctatgctccatcagcaagcactgccgactacaatagggactcgccaggctatccttcctccaaaccagcaa-
ccagcactttccctagctcc 1744 2360953 -- NO
acattctatcagagagtacatgatatcaccatgccttatcattggtgaagttaaccttgaacttggttaaggt-
gctgtctgccaggcctcttcactgtaaagttact gcttttccctcttcatactctgttcttt
1745 2458084 WDR26 NO
cagctgttctaggatcttgtcatttttactgaaagtctcgtgcacatgtgaagtgccctctgagtttaaggtt-
tggttaatactggtatatttttataagattgaaattgt
gtccccatctttaacttaaacattttcattatcagggtcaatgtgctagaactgaattgtaacattttta-
ggcacagatggaaaaaaatgttattggctccttgaaaa
tgtgtgtgtgtggcgaggggaatagatccacaaaagcatgtatgtacttacaaaccaagctgtagagatc-
aagaaaagaacttaagtgttgatctcaagatttc
taaattgtcaagatttacatggcattgtggtggaactagttaac 1746 2775432 -- NO
tggagaccagataatggatgctggcaagatctgggaatcaaagccatggaaagggtgccattggtcag
1747 3577885 DICER1 YES tagataatatgttaatggggtcaggagcttttg 1748
2413468 TMEM48 YES
gctggaggatagttgcaagtattgtttggtcagtgctatttctacccatctgcaccacagtatttataatttt-
cagcaggattgatttgtttcatcctatacagtggct 1749 2478883 -- NO
tgaacagacctcaatgtcagacaagccaggggagcctgc 1750 2783808 -- NO
atatttttaatggtgtcagccaggcaaa 1751 2406967 -- NO
ctcctgtgactcagagccctcggctt 1752 2436718 UBE2Q1 NO
tgctgtatttggatctcacgctgcctctgtggttccctccctcatttttcctggacgtgatagctctgcctat-
tgcaggacaatgatggctattctaaacgctaagg
aaaaaaaacaaacacagaactgtttcaagtactcaagactgacttacagaccaaccaaccaccttgctgg-
aacccttgctagcaggcattcttataaaagaaa
ctttcgagcctccttatattgctggaaactcagctgtgctccagactagagcctccttacctatgctatg-
ga 1753 2663594 -- NO
ggcatcttatttcacgcaccacaggcccttgttcttcccagatgtcagcaggctttctccaataaatgcttct-
tcatttgctgttgcccttggaatcatcccagaga
ttttaaacggctgtgtgtatgtttcatggggaagtctgtggcctccttacactgtcctgcagaactggca-
cctccggctgtttt 1754 2854791 -- NO
tttagaattgactgaggagcggccgggtgcggaggctcacatctgtaatcccacacgccttgggaggctctga-
ggcgggtagatcacctgaggtcaggag
tttgagaccagcctggccaacatggcgaaaccccgtctccactaaaaatacaaaaattagccaggtgcag-
tggcacacacctgtaatcccagctactccga
aggctgaggcaggaggatcacctgagcccaggaagttgagactgcagtgagctgagattgcaccactgca-
ctccagcctcagtgacagcgagactgtct
caaaaaaagaaaaaagtgactgaggaggaagaggccaggtggcaaatggaacagaatcaccaaagggtga-
acaggactaaggcaatgtagtgtatgg
ctcagctacgtcagagtggaaaaggtgttattagagcagaaactatggtccctgcgtcacagggaagcaa-
cctacagagaagcagcagctccccaagag
aggagagataagaagccagaagcctcagagtgaacaattgtccta 1755 3350791 SIDT2 NO
tcagagtttggtgtattagaggaactgccagttgttcatactggctaggcagggccttacatttgaggggaga-
agggtgagagattgagctgggtggagga ggacatgaaggcctttgggtgccat 1756 3447872
KRAS NO
catcttcagtgccagtcttgggcaaaattgtgcaagaggtgaagtttatatttgaatatccattctcgtttta-
ggactcttcttccatattagtgtcatcttgcctccct
accttccacatgccccatgacttgatgcagttttaatacttgtaattcccctaaccataagatttactgc-
tgctgtggatatctccatgaagttttcccactgagtca catcaga 1757 3709501 -- NO
gtccagtgcctcataacatggtctcaagctcttaacaaatggagcccaggattcaaaaatctgaactctaata-
atggcttgtcattctggtttcttacccttgagg
aacctgtgaggtgttaaccaacctgtaagctgcattccagcactggcaaacctggcctctcaaatatcca-
gccaattctaagtttggtgccagga 1758 3606344 -- NO
gaaaaaattgtcagttgcagggatacatttctcactaatgaagaaacatggaaaatatctgtgtaaggggatc-
acgctgtttcttaagttcagattattggaaga
gggtggtgatgtaggtgtgtactcttcctgaggttg 1759 3884906 FAM83D YES
ttctgtctggccaagtggttgaacactttgatctggagttccgaatcctgtatgcccagtccaagcccatcag-
ccccaaactcctgtctcacttccagagcagc
aacaagtttgatcacctcaccaaccgaaaaccacagtccaaggagctcaccctgggcaacctgctgcgga-
tgcggctggctaggctgtcaagtactccc 1760 3919041 SLC5A3 NO
ttggaaacagaaacgaggcttattgctattgcagaaatcccaaactggcaaaggccagtatatatggtattcc-
ataatataaccagcttttgaaatttatgtgttt
ggattagtgccttctggttaccagtattgactctgctagtttgcacctttccgttctta 1761
2847683 -- NO
ctgggaggctttcagatgcagcatccaccaaggaatacaccgactaacacacatgacagcctgaactagcaac-
ctgcatcaacacccctgcagaaaagca
gtgcatttcaactgctcatttaataagtatttgaattcataattacaaaacatcttctgtaattaaacca-
ccatatgcatttaaaatattttggggacaaagagtagca
aagaattatattggatattgactaaaaacacttatgaatatcaataatttgctcctcctcccttttcatc-
atagactctttacaatgatactgaccttggggttg 1762 3776975 -- NO
tttgcaacccaacctgctggaagtgcaaagttcagaccagcagcaagaactcttgccccatgcttctgctgac-
at 1763 3543413 RBM25 YES
atctcgaaccagtggagcgcactcgtaacctggatcccagaaggtcgcgaaggcagtaccgtttcctcagcgg-
c 1764 3653407 -- NO
ttgagtgtggtagtgtccgtctgtagtcccagcaactcaggaggttggggcaggaggatcacttgagcccagg-
agttcaaggctgcagtgagctataattgc
accattgcactcaagctcaggcaacagagtgagaccttgtctcaaaaaaaaaaaaaaaaatttaaacaag-
cgacagtaatatttcattagaaatgtgatgaat
gctatgaaggtgtagaggatgtctttagaatatataactgggagggagaccttttgagttaaggcaggtg-
ctggtcaggaaagtcctgaggaagttacatttg gattga 1765 3670580 -- NO
gtgaaagactaaacagacgacttcaaaactctcatccaacatccaagagttctgccatttccaagattcagca-
atcctc 1766 3767260 -- NO
taccagttagtacaaagatcacagccaatatagaacctaaaagtattcacaatgaaaatgacaatgtagttgt-
cgttttgagctgcatggtacttaaatctg 1767 2456432 -- NO
cacctgctccgagggtcagggctaagtggtttgagcaagtggcaagctcacaggtccagttggctgagggcct-
gacccatgacgatccattt 1768 2750681 -- NO
tatgacactgaatacgggaaagtgatgggagtgaggctggttaaaatttttcacccacgcagtctccctgtgt-
t 1769 3071991 LOC653852 NO cacgtggtcactgacactcccatggc 1770 3436046
ATP6V0A2 YES actcggatccgcaccaacaaattcaccgagggatttca 1771 2383133 --
NO
tcagccctgtgaagatgtcattccattatcttctgtcttctattgtttctgtggagatggtagctctcagaca-
aattgttggttgctcgtttgtacatactccccactcc
catcctgccctgggtactctaacattttttcactttgtgtttagtttcagcagttttaagataacgtgcc-
taggtcgggc 1772 2434773 FAM63A NO actttccagccgcagagtagtgcag 1773
3338526 PPFIA1 YES
gtttggagcaatgatcgagtgattcgctggatcctgtcaattggccttaaagaatatgcaaacaatcttatag-
agagtggtgttcacggagcacttctggcctta
gatgaaaccttcgacttcagtgcactggcactgctgttacagatcccgacgcagaa 1774
3671856 KLHL36 YES caggcagacgcgagtgtctcggccatacaagatcagcgaatcatca
1775 3060641 -- NO
ctcccatggctggataaaccaaatctgatacatccacatttaaggttgttttccaagttggtttccataaaag-
gcctttaacaataataggcttttaacaacaaaaa
ggtatccctcccatcacaatgagagcttgatgagggctcaaaagtgacttcaaaaactgtaaataattat-
tttccttggacggctttaaaaacagctactgatag
caaatcagaaacactaaagaaaaaagacaataaggaaacagctgtttgtctagtgaatccataataaata-
ccaatttgaggctatagattacaaagccaaaat
attcttataggaaagttaatgtttatatttacaatcccatggactaaaaaaactgtctaatatcttaaag-
actg agtctacctttatttaacattgtttatacacaaaga
cccaagggatggtagaattcttgatccttctggacaaaagcatagtgagaggggactgaaattaacaaaa-
agggaaaattaacattaatctcaaaattctacc
catcgttgtcttaaaatgatcaagactcagctacatctgagaaaaaggaaaaggatcagaagtgaaagaa-
atcagaagccagtaattaaaaaaatcataacc ttgtgtgctttctactgacggcatttaaa 1776
3379623 MTL5 NO
ctgtgcctaggctgttgacaacttttgctgagttggacagaataagactgtgggccatgctgcttgcttcact-
ctctgggtgtgatggatcggtgagggtgcag
ttgctatgattgtaattggtcatctcatcatggctgttaacatttctggaccaaacaaaaatgacttcag-
ctacttccagattctgctgatacattacacaggatgat
ctaaaaggctacagttctgaagatactcatctttcttgtaatctgggggcatctggtcaatagtattgcc-
tctgtgctgtattgtgtctagaacattcaaggacattt
gatacttctcatactttaattgcgtgctctcccagttgcagcaccctctgaggcttctatgtgttgcagc-
cgatgggcatttgcacagagcagcagtcatgacag
cgttttcagggcagctatttctccttttcccccttttcctctcccccggcttcccattctcctcctcctc-
cttcctcttctcgtcccctcctcctcctctttgttctcctcc
ccctgctcttcttcctctctccttttcctccttctgtgtctatactagattattttcaatcagtcacatg-
tttttctttattttgaatgttacaaaatatttctctattgtaaacg
gtgtgccaggaaaaacatgagatgtgtatttgtattttttatgcacataattacttaatccaatgcctct-
ccacttaattgggcctgatga 1777 3547548 -- NO
ccagtgttgggtgcaaatatacctaggata 1778 2779848 -- NO
atgagaagggtattggatacgattaggttagaagctcctagctcctcagtgaagtggtacataagggctctct-
ctgc 1779 2869655 -- NO ttctttttctaccctcactgtcctct 1780 2964686 --
NO tctgagcacacctgtccagagagctc 1781 4004181 DMD YES
ccttcagaaccggaggcaacagttgaatgaaatgttaaaggattcaacacaatggctggaagctaaggaagaa-
gctgagcaggtcttaggacaggccag
agccaagcttgagtcatggaaggagggtccctatacagtagatgcaatc 1782 2432028
PDE4DIP YES atgtctaatggatatcgcactctgtcccag 1783 2443375 F5 YES
tactcaagatcaagaagataacggcaattataacacagggctgcaagtctctgtcctctgaaatgtatgtaaa-
gagctataccatccactacagtgagcaggg agtggaatggaaaccatacaggctgaaatcctc
1784 2736714 -- NO
ttccagagtttgcagggacagttagagtcaatatgaattctcagaataagcactgccagatagtccggaagcc-
ctttacaaggaaagtgacatttttgctgtgtt
ttgaatagtgaacaagaatgtgcaggaagagaatgaaaggatatcactagcagaagaaatgcctctttgt-
aaaaccatagaaaataactctgagttgccatat
aggacatatgagaatttcagtgttactgaaacaaaagcttttggaaaaggtatggtgattaaattgggta-
tacaatctgaaaggtaaattgaggacaacttgtgt gccagtttgca 1785 2969491 -- NO
ttgtagctgttagaagggatagttctacaaggtatccaaatttcctaagtatatttctttaaattttcctttt-
attgaattttctgtttactggcattagtctcatatcagttt
tggctacctttagctgcttttgttgaattctatttaataaaggcactgcaagtataaaattattaaaaat-
agacaagcacaatcctttctctgctaaacaagcttatga
aaaacctggtgatacccaaagagctacaaaggaaactctcacacttg 1786 3417650 RBMS2
NO
ctgcacttgtggaacatcacatggcaaaaacaggagttttttcgctagactttttttttctttttaaccttat-
taaaaatgagattggtcctaa 1787 2586174 -- NO
ctttgcttataatgttctgtagtgctgatggactgcctgattgtaga 1788 3777613 -- NO
aatgctgcaggcatcagtgggagag 1789 3888166 CSE1L YES
tgacatcccgtcttcctatatggccttatttcctcatctccttcagccagtgctttgggaaagaacaggaaat-
attcctgctctagtgaggcttcttcaagcattctt agaacgcggttcaaacacaatagcaagtg
1790 2332174 CTPS YES tgaattctcaagaaacgtgctgggatggcaag 1791 2684865
VGLL3 NO
agaaccaactacagtcacctctgctacctcagcatgggctggagcctttcatggaacagtagacatagtgccc-
agcgtgggattcgatacag 1792 2756426 -- NO
aggcaatggcgattttaggctctccaggtgattacaatatgcaaccatgctcccaaatgtctgctgtaaacca-
acatctttcggaggaccagttgaaaataatat
ttctcaaattaatgtgaaaagtgtttgctgttgagttgcggcctttcagtcccgcctttgttctctactc-
accactgttgagttgtggcctttcagtcccgcctgtgtt
ctctactcacctctactgcttgttttgctcctgattcaaaccagttccacacatactaagcccactgtgc-
taggtggcctgaccgtggtgaatattattgtggagg
aaggactttgctgtaagaaattgcattccccaaaactgaaaccatgatatttactcaactgaggtaaaaa-
atgaaagactaagggggactcccaagggtcag
ggcaagaataaataccttggaatattaatacccatctcatgatgcctgagtgtaaatgctcc 1793
3309131 C10orf46 NO
ggaaatgctaatttgagcttcattcataggggaacctactatatattgcatccctgctggttggaaattatct-
tcatctctggactgcattgtttagaaaaatgttaat
ggcttacaattctgagaactttattgtgtggctctg 1794 3435688 ARL6IP4 YES
ctgacggatgagcagaagtcccgaatccaggccat 1795 3544550 LOC731223 YES
tggaaagctttgaagacggcggttctggg 1796 3737293 KIAA1618 YES
tgaaggcattgtctgcatttccaagaagcacctagataaatacattccttacaagtacgtcatttataatggg-
gaatcttttgagtatgagttcatttacaagcacc agcagaagaagggcgagtacgtcaacc 1797
2769855 -- NO ttagtttgggtctgatctttgtttc 1798 2914869 -- NO
cttccttgtggaagttggcttgatg 1799 2754682 -- NO
acagagcccgagcttttgtcctgcaggctcaagcttctagattcgtcttctcgttaatgcggggacggac
1800 2353146 -- NO
ttccagcaggcaccgaaaaagccctgtgagcttctctctgagcggtggagaactgcacatgtatggatgttgc-
tgcttcc 1801 2685210 -- NO
atatttgagtgtcttattggacttggaacttccaccagtatctccagaattattgtctgtctgcag
1802 2774664 -- NO agttttggttccgacaagctgcaccattccaactgcc 1803
2517907 -- NO
tacacaaattgaacgcggtagggtgggggaggaagtagggagataaagcctatgctgctgattcctcaattat-
aggagcagtctctaaaagccctcgtcaat ctagtgatgtgt 1804 3156168 -- NO
gtgcaagctgtgtagtggatcattgagtgt 1805 3359979 NUP98 YES
ggactctttggaaccacaaataccacctctaatccttttggcagcacatctggctccctctttgggccaagta-
gttttacagctgctcctactgggactactatta 1806 3701355 -- NO
tcaataaaagttgtattgagatgtgattcacatactgtacaatttatccctttaaaatatgcaattcggtagt-
ttttagtgcattcacagagttgtgcagccattatcgt aatcagtt 1807 2329396 HMGB4
YES gtcagctagaaaccggtgcagagggaaaag 1808 3290788 CCDC6 NO
tccatgctcaagagccattgtaagagattaaggggtttctaggtttttggtgattttttgtttgtttttttct-
ttgttttttttgggtttttttttcttctttaattttttgattaaaa
catacacacagctgttagcataaagtcgtggggggcattttctggaatgctcagcagttctgattaactg-
ccaagcccaggttgcctctcatgaggcaactga aaaaatcctgtgtcttgatagcatgggtgc
1809 3449856 -- NO ctttgactccattgtctgctttggct 1810 3573894 DIO2 YES
aggggaaccagagcgcacaagggaa 1811 3670649 -- NO
ccacgttgtcaagcacagaactataaaaacaatggattcagtgggtgaaggtaggagaaggggttcaagagat-
tcagacttacagtaggaaagttatttttcc
aatctcagtaagttttttagggttatgaagattgagcactgacgacgctgaaataccacagtgcaaatgc-
ttccgtagattccctgggctctgcactcaccagat
ccatttctatgataaagcacagagctcctcaaacagaacagtcgagttgcaggctcagcagcctccttgt-
cagtgtcctgctcaactcagc 1812 3851066 -- NO
tgcagtgcctggatcataactctggatcatcactgaaacct 1813 3912092 SYCP2 YES
tccttgggagacctggcaaaatgaat 1814 2626159 RPP14 NO
tctacttttaatcaggcgtggcagc 1815 3448099 BHLHE41 NO
caccagctgtaaaagatcctatgcgaaagacactggctcttttttttaatcccccaaataaattttgccccct-
tttaggccatgttccattatctcttaaaattggaa
cctaattcgagaggaagtaagaagggtctgttctgtggctgagctaggtgaaccccggggtaggggaaag-
atgttaacacctttgacgtctttggagttgac
atggaacagcaggtagttgttatgtagagctagttctcaaagctgccctgcctgttttaggaggcgttcc-
acaaacagattgaggctcttttagaattgaatttac
tcttcagtattttctaatgttcagctttctaaaaggcatatatttttcaaagaagtgaggatgcagtttc-
tcacgttgcaacctattctgaagtggtttaaatggtatct
cttagtaacttgcactcgttaaagaaacacggagctgggccatcgtcagaactaagtcagggaaggagat-
ggatgagaaggccagaatcattcctagtaca
tttgctaacactttattgagaaattgaccatgaattaatggactcatcttaatttcttctaagtccatat-
atagatagatatctatctgtacagatttctatttatccatag
ataggtatctatacatacacatctcaagtgcatctattcccactctcattaatccatcatgttcctaaat-
ttttgtaatcttactgtaaaaaaaagtgcactgaacttca
aaacaaaacaaaaaacaacaacaacaaaaaacaagtccaaactgatatatcctatattctgttaaaattc-
aaaagtgaacgaaagcatttaactggccagtttt
gattgcaaatgctgtaaagatatagaatgaagtcctgtgaggccttcctatctccaagtctatgtatttt-
ctggagaccaaaccagataccagataatcacaaag
aaagcttttttaataaggcttaaaccaagaccttgtctagatatttttagtttgttgccaaggtag
1816 3872452 ZNF552 YES
agcacgagagactgctccctacagaagaaccttctgtgtggtgtgaatgtgggaaatcctctagcaaatatga-
cagc ttcagtaatcatcaaggagttcacac
tagagaaaaaccttatacgtgtgggatatgtgggaaattatttaacagtaagtcccacctccttgtacac-
cagagaattcacactggagagaagccatatgagt
gtgaggtttgtcagaaattttttaggcacaagtaccacctcattgcacaccagagagttcacactggaga-
aaggccatatgaatgcagtgattgtgggaagtc
atttacccacagctctacattccgtgttcataagagagttcacactggtcagaagccttatgagtgcagt-
gaatgtgggaaatcttttgccgaaagctccagtct
cactaaacacaggagagttcacactggagaaaagccttacgggtgcagtgaatgtgaaaaaaaatttagg-
caaatctcttcacttcgtcatc 1817 2489627 POLE4 NO
gtgttctgcataagtggcttcctga 1818 2934111 -- NO
tcaagattatatatggcagatgaggataa 1819 3181290 TMOD1 NO
gtaatggcccagcttagagacttcagctactgatctcatcacttattagacaaattgctgctgaccttacgcc-
tgtatattaagcctccgcaggatgccggacaa
tggtgaagaaactccagatatcaaggaattgggaaatcctggccaaaccaccccaagatgattacactga-
aatgtagtattagtactgctgccagatctcttttt
aacatcatgtgcgtctcttgggatccagcaaaagtgttaagccacaatgcccttgtgccttttaatatac-
cacagtgccagttaaactaatatttttgtttgttgcttt
tgggagttattttcattagtgatttcagcaaatctcatgataaaggacaaggtcaagaactccagagcac-
tgagcagagaggctggtgatgaaaaggtgaag gcctgcgcactgaactgtaa 1820 3487237
AKAP11 YES aatgttccctgtgccaagttcacaagtg 1821 4009127 JARID1C YES
tgagtgtccccccacagtagtggtgaaggaggagttaggtggggatgtgaaggtggagtcaacatcgcctaag-
accttcctggagagcaaggaggagct
gagtcacagcccagaaccctgcaccaagatgaccatgaggctacgga 1822 2750647 -- NO
tgagtacagcccactgattgacattcaagacccattggaaaaatcaggagacacaagagtgggaagagtgcag-
attggagcagctatccaaaaataca 1823 2916198 ZNF292 YES
gggctggacttgctacctgtatagaactgtgtgtaaaggctcttcgcttggagtctacagaaaatactgaagt-
gaaaatatctatttgcaagaccatttcatgttt
gttgcctgatgatctggaagttaaacgtgcttgtcaactgagtgaatttcttattgagcctacagtagat-
gcgtattatgctgtggaaatgttgtataatcagccag
accagaaatatgatgaagagaatcttccaataccaaattctttacgctgtgagctgttacttgtattgaa-
aactcaatggccctttgatccagaaactgggattg
gaaaaccttgaaacgacaatgtcttgcattaatgggagaagaagcatccattgtgtcttcaatagatgaa-
ctaaatgacagtgaagtatatgaaaaagtggta
gactaccaagaagagagtaaagaaacttctatgaatgggctttctggtggagttggtgctaattctggcc-
ttcttaaagacattggtgatgaaaagcagaaga
agagagagataaaacagttaagagagaggggatttatatctgctcggtttaggaattggcaagcctacat-
gcagtattgtgtgttgtgtgacaaagaattcctt
ggtcacagaatagtacgacatgctcagaaacattacaaagatggaatttatagttgccccatatgtgcaa-
agaactttaattctaaagaaacttttgtccctcatg
tcacactgcatgttaaacaatctagtaaagagagactagcagctatgaaaccattaagaagattgggaag-
gcctccaaagatcacaactaccaatgaaaatc
agaagactaatactgtggctaaacaggagcagcgacctataaaaaagaatagtctctattcaacagattt-
tatagtgtttaatgacaatgatggttcagatgatg
agaatgatgacaaagataaatcctatgagccagaagtgattccagtccagaaaccagtacctgttaatga-
atttaattgccc 1824 2984592 SFT2D1 YES
tggcttccgggcggcataaagctttttgcagtgttttataccctcggcaatcttgctgcgttagccag
1825 3123564 -- NO
cagttcattccgtttccacctggcagctgctccctctgacacccaaggactcgcagggagtggccgttggacc-
tgcagacc 1826 3165879 TEK NO
gtagcagccagtcccgtttcatttagtcatgtgaccactctgtcttgtgtttccacagcctgcaagtcagtcc-
aggatgctaacatctaaaaatagacttaaatct
cattgcttacaagcctaagaatctttagagaagtatacataagtttaggataaaataatgggattttctt-
ttcttttctctggtaatattgacttgtatattttaagaaat
aacagaaagcctgggtgacatttgggagacatgtgacatttatatattgaattaatatccctacatgtat-
tgcacattgtaaaaagttttagttttgatgagttgtga
gtttaccttgtatactgtaggcacactttgcactgatatatcatg 1827 3887555 -- NO
tccattccaggattggtgctgaagcacatgtgtcctgaagttcaggacgtcagggtaattgacacagaagaaa
1828 2356740 -- NO
tataatctagaaacattcttcagcgttttttttctttcattacatgaagagtcaagaccagtggttttgtgga-
atgcatgataatctgggttcttaaaaatcatttcttctt
gattagatttcccattgtcttgaattgactcagtcagcctttcctcaccgctactccaggttcactaatg
1829 2665536 C3orf48 YES
gagaatggataggcttttaggtcttggaagaaaagaagtgtccagggttcaatggagtggctgctct
1830 2833553 -- NO ttttggggatgacattgtggaaagtttaccctca 1831 3242698
-- NO tgtaatacctcatcatagatatttggggtgcccttca 1832 3911222 PMEPA1 NO
gaagttctagccactcgagctcatgcatgtgaaacgtgtgctttacgaaggtggcagctgacagacgtgggct-
ctgcatgccgccagcctagtagaaagttc
tcgttcattggcaacagcagaacctgcctctccgtgaagtcgtcagcctaaaatttgtttctctcttgaa-
gaggattctttgaaaaggtcctgcagagaaatcag tacaggttatcccgaaaggta 1833
2676501 -- NO attgaagaaccgctgctggagaact 1834 2839345 -- NO
gcagccttattcagcaacgctggggatgacaacatg 1835 3239038 -- NO
gaataagcagaaacggctgggcgtg 1836 3475695 ZCCHC8 YES
cctcggaatgctgctcgaataagtgaaaagagaaaagagtatatggatgcctgtggagaagcaaacaatcaga-
atttccagcagcgataccacgcagaag aagta 1837 3563672 -- NO
gttctgaggcccagcaactctgaga 1838 2333149 CDC20 YES
acctgaaccttgtggattggagttctgggaatgtactggccgtggcactggacaacagtgtgtacctgtggag-
tgcaagctctggtgacatcctgcagctttt
gcaaatggagcagcctggggaatatatatcctctgtggcctg 1839 3740914 -- NO
ctggtgaggagccgcaactgggcatctcc 1840 3949524 -- NO
ataaaacatctttgacgtgggagctgcagtactg 1841 2598329 FN1 YES
cattgtctccaccaacaaacttgcatctggag 1842 2354732 -- NO
gggtgtcatggaatcttaggagccctgcattccaattgcccaggctt 1843 2534399 -- NO
cagaatgatggagtttgcatggcacagt 1844 2677654 C3orf63 NO
cagtacctgcgcaatccttgatttaatgaaattaaattttttatttcaaaagataggcttctgtttatcaaag-
gcgttgaacaatttgatttttaaattagattttgcaaa
atggaagtataatgggaatatatttttgaggtggtcttagtagtaattaccatttgttgaacacattaat-
gctatactagacagatacagtggagatagctttcaaa
cccgtatctattcctaactactgcctctaatactaattactaacttgttactaatgctaacttttaaaaa-
tgtttttgaaaattgcaatttctacaaataaatgtcatagtg
caaataaatgtcaggatttagagaaggagcctaaactgaatttgtgttatttcagtaaaagttatggagt-
tatgggtctagacgtgttaataagttagacagaact
ttggcactttagaacaaatgcatgagtggtatttcagttcctaagttacataaaaagtgtgaaagaacac-
tgtgaggtcccagcaacgccagactatattaagg
taagtagaaagtgtttttatagggcttcaatacccaggtggtgacagagcagaagaaccggttttttttt-
ttttttttttactactaagcttttacaaaagaagtatctg
ttttattgtatagaacaagtacagcattttactacatagtatacaagtttttaatgagcatttaaaaaaa-
taagtaaatctaggctatttgaaaaatacagttgagcca
gtgagcacattttataatttggaagacacaaatcaaatgtgaaggatttgattttctacatttaaaatga-
agaaccaaaactctcttcttgattttcagctaaaggca
ggagactactttccaactccttttgcttctggagaaggccctgaaatcacattgatatatgtttgttagt-
aaaatgtgcacacctgacttgcaatgttgtgttaaact
agaattatattcacttggaaaacatatcgcttaggataaaattttgtca 1845 2495347 --
NO agaaagtcttaatgggagagtgcccatggtatat 1846 3436411 -- NO
caccatccttgaggggtcgagccaggactggaacctcagtccggccactacaacttcataaataccatcgccc-
tgagatgctgaaatcccaggggccccc caccctcagaccaggtgccggtattg 1847 3630941
-- NO
tccctggtatgtacacgcattcctgtgttttgtgaaaaaccgacaccatgctcctccctcactacatgtaaaa-
cacttttattcattaaaaagaaaactgactggct
tggacctacaaattagtttcattatttgttaatgtttgaaagccattaaaagatgaatattaaggtttct-
ttatactcaatacttgtagttttgtttgggggaatgagag
gatgcccttggtacctttgtgaggcctctccactgagggtcaatcatgacttctgttttaaaccagccca-
tcccatcttctccagctgctctccttatgtcttgcttct
ctcccctccaaccttctcagcataaggactcaatcctaggctcctaccccagacgggtgccttccaacgt-
tcctggtgc 1848 3886257 -- NO
cacttgggttggaaactctggcttctttccccccatggcctgtttggctcacaggtgccaccagcctcacctt-
gatccactgtcacttgtgcttactcggtgttag
ctgctttgcctcctttcagtccctcgaaccctgagctcttctcagagctcctagtgctcctctgtcggcc-
tgcagtgcactcccgcttgtgcctattgtgta 1849 4004292 -- NO
aggatgaattctcaccaaccatatattattttccgataacagtgtttggtagtgagggggatctattgctagg-
taaaatacgatggattcaaggagcttactgtttg
atgatagggcaagatgtgttcatggatactagattgaga 1850 2960481 -- NO
ttggagccagtcaggcttttgtttagacattttaactttttcttgctttccttgcaaactcctcagccttcag-
actggttggaaagtaaatgtacaatcttacataaattt
tcaggtaatagcatttcagctttttccccaagattttttgcttgggaggagacagattagactggattcg-
gagtcttgattttgcaaaggtaacaaaagacatgttt
ttttataagacttttcatcataagtttattttattcaacagaagcaaaatctaatataatggaaaaaata-
aagatctgtgataaatctgatctgtgtggataaacacaa
ttagaaagacttaaagattaagtattgaaacaaactaccaaaatattttaatactgatttgtaaaaattt-
cagtacatttttctcttgcttaattctactgggtcctgttt 1851 2977359 -- NO
tagtcattggtgaagcaggattccaa 1852 3199214 -- NO
tcaggcttctgttgcaagccaatgtagggaacca 1853 2743060 -- NO
ttcctgagttcaagatatagttaagtttaaataataggacttgtgtatgaattggatggtgtgggagggaaat-
caaaagttctgggccgggcgcagtggctcac
gcctgtaatcccagcactttgggagtctgaggcgggcagatcacaaggtcaggagattgagaccatcctg-
gctaacacgctgaaaccccatctctactaaa gatacaacaaaatccgggcgtgg 1854
2811122 -- NO
aggagttctccacatactctgcccaccctgatagcaactgaggtaggccagaaacactcatgcactggttacc-
tcctgagccatccacagaaagggtca 1855 3560070 -- NO
gtgtgatcaaaaaagtggtcagtgtgaa 1856 2597541 -- NO
acattgaaattcaagatgcaggcagagaaagaggacatagaccagat 1857 3747622 -- NO
gcgcgtgctcaacttggatgggacacacctagtctttcttcaagtccctggattcaaagagcttcaaccgttc-
ttgcaccgtcaggc 1858 2332216 -- NO ttgattcatcctatccgtgagcgtgg 1859
3029849 -- NO gctggcaccccagaagaagctagctcagcatgtgcgggtc 1860 3090304
ADAMDEC1 YES atacattgatctctatttggtgctgga 1861 3441298 -- NO
actatctgaaaatgggcaggtggtgca 1862 3584491 -- NO
tgcgatctccgctcaaaaagatacttttgaatccttttcaaaagtaatttgtgtttcattttttaattagtat-
gataagcacttcaagaccctttacaattctggctagat
ttggttgccatatttaatagcattttataaataatggagaaaagggaaacattatgcatgcttgattacg-
gtcatgagctgcattaacaattccgttcaacaacaga
ctgcatatgtcagagcagtcccttaagattacaaa 1863 2775809 SEC31A YES
gtaaactttgaggatgattctcgtggaaaataccttgaacttctaggataca 1864 3380586
SHANK2 YES
tttcgatacaagaagcgggtgtataaacaagccagtctcgatgagaaacagttggccaagctccacacgaag
1865 3410510 -- NO
tgtgtcccgcagctcaatcagacttctggatgccatcaaggaggtctgcatgacctaaggatcattgttcttt-
gaaaggaaaacaagttcattaatcttactggc
tgccagggttaggatgcaaagttaatcaattattagtgactaccgtctaccgaatgactacgtgcaagca-
gtcatgcatggaggaagaaaaggacaaagag
aaaggaaaataagtaaaaaacaaacgtttaatgattttgataatataggctcagttacatcaccacaaac-
a 1866 3266758 -- NO gttctggaactcttcacacctgtgacctgcat 1867 3878506
SEC23B YES gaaactggagcacccatcctaactgatgatgt 1868 3189392 -- NO
tgcaagattcttggatcctcgtccggtacattttggctgcattttatgtgacgtttgtgagggggttagaaat-
actttaaaatttcagggaacttgaataacaatga
aagatgtgcagctagtccaaacagatggacttcagtagcaattccaggggcgtttc 1869
3737624 KIAA1330 YES ctccctgcagaagcgtcccgacggccacatcgtgagtgtgag
1870 2587558 SP3 NO
tagccgctctcgaaaacctacgctgccacggccgctcattgtctctccccttccacccgggggcaaacaggaa-
gcgcgccgcctggcagaccgacggac
aggcgcctggaccaatgagcacagccgacaaagagcacggcggcgaatga 1871 2636399 BOC
YES
gccctacgtggtgtcgggctacagcggtcgcgtgtacgagaggcccgtggcaggtccttatatcaccttcacg-
gatgcggtcaatgagaccaccatcatgc tcaagtgg 1872 3383004 RSF1 YES
aactgccagtcatagtgaagctagaaaaacctttgccagaaaatgaagaaaaaaagattatcaaagaagaaag-
tgattccttcaaggaaaatgtcaaaccca
ttaaagttgaggtgaaggaatgtagagcagatcctaaagataccaaaagtagcatggagaagccagtggc-
acaggagcctgaaaggatcgaatttggtgg
caatattaaatcttctcacgaaattactgagaaatctactgaagaaactgagaaacttaaaaatgaccag-
caggccaagataccactaaaaaaacgagaaatt
aaactgagtgatgattttgacagtccagtcaagggacctttgtgtaaatcagttactccaacaaaagagt-
tttgaaagatgaaataaaacaagaggaagaga
cttgtaaaaggatctctacaatcactgctttgggtcatgaagggaaa 1873 3959450 -- NO
tgtttttatcacagggccgtcgttgaagcatgtatgactatgtgtgtgaaaatgttctgcaaaccaaaaaggg-
ctcaggtgctataatt 1874 3984482 SRPX2 YES
gatgagatgccacgcactaccattcatcactagtggcacttacacctgcacaaatggagtgcttcttgactct-
cgctgtgacta 1875 2333884 -- NO
ttgtagagtatgaacactcctttactttcagcaacgtcggcatctccaaataa 1876 3392870
-- NO atgcatgagggcacgcctcctactttc 1877 2395894 CLSTN1 NO
gccgcgcggtttcccttcgcagatgtgtat 1878 2701311 -- NO
attgagcctgcccatcatgcattgcaacaggaaggtggatttgaaaagggaaaagaattaaaacatcccatca-
cacgtgtaat 1879 2976681 -- NO
cagatacgggtgtgtacttgaatcaaggagaggcagtagagcagccttatgttttgttccccaaagagtgaga-
tgtgtacccaattcttgcacatagtgaaga
agctgttctcttttttgttgtttgtcacatctgattattcatggagaaagttgcagcttggggctagtaa-
aatttttttttaacaccgttctcatattatttgctctcttctttt
aataaaggacagataggccttgatgtggctgtaa 1880 3398768 -- NO
gcaactttcagtggaggcgctgagagcaaattgcagcagagatgcgctcagggtgcagtaacaaggaaggacc-
cgctctccgtgtcagtggcctgcagg
ggaagtgagaaccgggctcatgctgggctcctctactttgcagggtttaaggccg 1881
2376766 SRGAP2 YES actacagcatgaaggaattttccgggtgtcaggatccca 1882
2648351 -- NO ggagcagcttcaatcaaaaggcggggctt 1883 2855376 FLJ32255
NO ccttttctgggggatcctaggcagaagcgatggcaggacaa 1884 3715585 -- NO
aatcaccatgacaggcagagtgtgggca 1885 2432021 -- NO
agtttagttctcttacgtgtggctagccaat 1886 2527209 RPL37A NO
tttttataatgtgtctaggctgggt 1887 3753258 -- NO
ttgagctgcccaagccacctagagg 1888 2607727 -- NO
gctgtgcgaatggactcagctgcccgaactcacagaatatcagtaacagcaccgaaacttcaca
1889 2970557 HDAC2 YES
gctgtcaattttccaatgagagatggtatagatgatgagtcatatgggcagatatttaagcct
1890 3233715 LOC399715 NO ccttctgcaaatggggatgagtcctc 1891 2555212
PUS10 YES catgctgcatggttgctggtaaaaca 1892 2601671 DOCK10 YES
tatcctggtggagcagctatacatgtgtgtggagtttctctggaagtctgagcgatatgaactcattgctgat-
gtcaacaagcccatcattgctgtctttgag 1893 3630677 CALML4 NO
tgggcctgaaaacttggagcaattaattttttttaaaaagtgttcttttcacttgggagagatggcaaacaca-
gtggcaagacaacattacccaactatagaaga
gaggctaactagcaacaataatagatgatttcagccatggtatgagtagatcttta 1894
2677724 ARHGEF3 NO
ggcgccatcagccacttttagaagccatcagccagtgtgttgggaaaagaggtttgtcaagtgttggcctatg-
ggaaggtggtcaatgaatgttttga 1895 2898386 -- NO
tggaggcatttaatggcgatgtgcaggtgcaag 1896 3412766 ARID2 NO
catccacctcgaaagctgggcattaacgatattgaaggacagcgggtacttcagattgcagtgattttgagaa-
atctttcctttgaggagggcaatgttaagct cttggcagctaatcgtacctgtc 1897
3975856 -- NO tggaatgtacctggaatagggaagtggacagtgagggc 1898 2466297
-- NO
ccaggtcgcacatcagctgcaggcacagccagttcatgggtagacagccacatcctgccccaggaggagggca-
gccagcatgggcgatgcaagctcc
cctcgtctggaaccagcacaacctcaggcactcgagccttggcccctcacaagcaacgtcctcaatgggt-
ggcgttcgttcat 1899 3240817 -- NO
tccatcgattgactgcgaggggctagggttcacagcaagcagaacgtcctgggtttctcttcaataccacctc-
ctcctctcctgttcagatgctgagaaacatc
tggcgcagtagagatgctgcctctgacatttctatgacaaaacgcgtgcctgtgctagggtttgcacagg-
cacaagttatcacaacctcgggatggggctg 1900 3454311 LASS5 YES
catcacttggtcaccattgggcttatctccttctcctacatcaacaatatggttcgagtgggaactctgatca-
tgtgtctaca 1901 2437092 DPM3 NO
gggagtgggtctcaaatatagagggggtagcaaggtggaaggggcccttccaccttttgtgggcactcaagtt-
cggacctctgggatcggcgattccc 1902 2683293 -- NO
catctgtgcttgacgcagaggcctccggggtcgcgagcttcggaggtggaggtgccccgtcttcgggttccca-
cgccgccctggcgacctggggctcca
gccccaccgcggactccggtgggacgtgggtggcgcaagcacaccttgcccctgtgactcagcttgaggg-
ggcccaagctgtcccactgagcacgcgc
ccagcaggccgtcgcgctgcgggtcctggtcctcctgtcatttactggggtgcggaggcctccgaggagt-
ctgagggtgggacagtcccacttccggag
gagctagggcagggaacacaaagtcccgagtgccggggca 1903 3701415 -- NO
ccataaaattcgcatggtgaaatgcacgtaacataaaatttaccatcttaaccatttaaatgcacagttcagt-
ggtatcagatacattaata 1904 2590322 -- NO
ctagaattaagatatgctgatgagttgcttctgcagttcat 1905 2973489 -- NO
tttggcgtttgctacagaatggtgaatttatgtatttctcttccactttgacatggacattgcctcattcttc-
agtagtgtgcatattcaccttaatttattcaaaagctat
tttacctttttcaataacaccacatcaattaccttaacttattcacttacatcagtcttccc 1906
3020769 -- NO ggatgcaggactgagtcatgccact 1907 2807755 -- NO
gagtagatgtaactaagaggtttgagaaaggaatttcagcagagttattgaaggagaagtcaaggagaggaga-
aggagaggagcagtgaatgttgtcgtg aagaggtgttgtcttgaaatactg
1908 2918704 PRDM13 YES
ctctggagtggatagggttaatccgggcagccagaaactcccag 1909 3024096 -- NO
taacaatatgtgcaggcaggaccgaaaa 1910 3270274 -- NO
gggcgctttcccactgttctagacgtaggagagaaagcacttctcagatggtgagcttttatcttccaatctt-
gtcaaccgaggagacctggaagttccctttca
acctggaatgtgagccctgcttgctgggcacgagataaggaccaaggattgacccaggacaatttcagag-
agcacaggggtggcatatcctcatgtcagg gcgtggagctaatattcaga 1911 3356025 --
NO atggcccagaatgggttgtcagtgctccag 1912 3913713 YTHDF1 NO
ggaccgttgagctcactaccacctggagtttgagttgaagcatgaaaatggtgcccatgcctgacgctccagc-
gcctggatctgcacgtgcccttgtagagg
atccttaccgtcctagagagcagacgctactgaaaactacttgctccaaaagaccctctgagttaacgat-
cagctgtatcattagacttgtatttagagcgtgtc acttcctctgaactgtta 1913 3506761
-- NO
tgtagtgttgctgtatcttccatcgtacagtggaatggcatcttacagaaggggtttcggtcctatggttagc-
ttaatgttgaagtcagggaaagtcaaaatcacc
attggaactcccttcaactgtctataaaatacactatgcacagtaccttggtttacgtatatttgcataa-
atacatactttgtatagtcacatgttgtatgacaacttac
tgagttgttcgatgaacaactctatgtgctaataataattttgatgtattaaaatgggaaagcatttgct-
taactgagtggagaggcacaggttgctgagtcagac
gtatctcctgttgcacacgtaccttcaggatgg 1914 3888725 PTPN1 YES
gcagatcgacaagtccgggagctggg 1915 3357756 -- NO
tctgtccagagtgcaaggccgaaccagaggacacacatgatcatttctattttagaaacacgcctggggcaga-
gaggacagcaggtgaaagagactgag
agagaacagtcagaggctagtactggccaagacaggagagtgagggagcaaccgtaatgaggatggatga-
ataatttgagagagatttaggggtaacga accagactcactc 1916 2371244 -- NO
atgagctcaccttgcctgcaactgtctct 1917 2660674 -- NO
tgcccatttttctacggcttgttgatttcttgggagttccttgtaagctttatagtctctgtaattaatgagt-
tccaaacatttttcctagtttgtcttttgtcttttgtttttgg
tgtggtgtgtcaaacagaactgtttttttgttgttgttcttacatagtttaatttttaatgcttctgtat-
tctaaatcatagccaaaaatgacgttcccatgcaaaggaat
gtctcatgttttctttggatacttgctgtggtttcattacttttccgtggaaagctctgatccttgtgca-
gttgatcctgatataa 1918 3199144 -- NO tagaatgtttgtatattgctgcctggc
1919 2411720 -- NO agatccaattagagccagggtcagg 1920 2682075 -- NO
tgataatagggacgttgtcagacccttaactaagccacacactgctgggagcctccggaataactttaatgta-
gttgtagggaagggagtcgaggcaggga
tgaggatccctgcttgactgctctctttcctgacgaggaagaaaaggacagtgatcaagcacagggtctc-
aaaggaggtctta 1921 2709855 -- NO ggacagcattacggtggacagtgaa 1922
3016026 MUC3B NO
ctgcaaaacgggtacagcattcctgtatgatagctcacgccgtcgttgtgaaaaccacatagacttggtcaat-
tctcggtcctactctgccctcccgtctcagc /// cctcgtgttgccattgc MUC3A 1923
3550736 LOC730217 NO accactacttcatgcagggcagtgtgcc 1924 3059100 --
NO
ggaagctaccaaggagactattaaagaaattcaggatggtgaagacagcttaaagggaaacagttctgcaaat-
agaggcgatgggagatataggaaaga gggactatgtgtaggtcttgttgcgtcgctgaag 1925
3379723 MRPL21 YES tggttggggcagacaacttcacgctgcttggcaagccact 1926
3432355 -- NO
cgtcgtggatggatcagttttgctcgatagagggacatgtttttctgtggcaacaggagggcaaaaggagaag-
gtggccacagatgccggtagatgagctg
agagtgattgtattccctatcctctcggaagcttgaggcaaggccatcaacagacaatcagagggaataa-
gaagagatagaatatatgaagaaagggaga
aaagatgaaatcgtaattgtgtagcagggcaagaagtccagaaatttctgtgctgtgccaagttcccagt-
tgaggcggtga 1927 3511352 -- NO
ctgacggtttaagatgctgcattttaagtaatgctgagttgtatttttatttcagtcattcatttctacttat-
tttgagcacccattatatgttaggttccatgctaggcac
tgtaaagataaagatgagaaagactcagcccttacctaaaggagtatagagcctagttggggagacagga-
ggcagatagttacagcatggagagcaaatt
ctctgagggaggaatgaagtgagataagagcacagaagaaagacccggggatcagagcagacttcctgga-
ggaggcaatcattgacttg 1928 2627501 -- NO
tcctgcttgtgaacagattcctatttccgtgaggaggtgacctcgaagaagagcagcttctattctgctggga-
ggtgtactgccttctggtatcaggcttctgca tcccgggaaagctcgggataacctgaggcacc
1929 3608077 -- NO agaccacaatgagggacatggcaagttcct 1930 2393810 --
NO ttgaggaaaattgctctgtccctat 1931 2506539 -- NO
tccatttaaatgagagggtggagctgtccttgcaaaccaatgatgcagctgatgccatgcagtggatcttcct-
tccccctaaa 1932 3068053 -- NO
tttcccagagctctaccttgttgtcagcactccctgcaatag 1933 3762439 -- NO
ctaagagagttactgaccctaactcccctaaaacctaactatcaaaagcctaccactgactggaagccttaca-
ataacactaacagttgg 1934 3896232 -- NO
tcagtctgcgatgaaggtgaacccatcttataaagcagagcttacttacattctgcaggattttggtgtggat-
gcatagaaggcttacctggttagtaagcctcc
attcctccgacctacagaaggcaacccttctgcagctccaagcagggatttctagaaaagaccaggtgta-
caaaacatctaagctgtgcctcccaccacag
gtggggaagtcccctgatttggtcagacacagatgaatgtctgtgtctgactgagcccagaaacagttca-
attgatgggggctggaaccaccaagaaaaca ctcctgacctgggcaacactgtcttccagattat
1935 3916144 C21orf74 NO
tgtgtgtacctgagataagatgatgtcttgtccaatgctggtttccaccttgtgccctgagctgttgggagag-
gctcctgcgacctgtgac 1936 2389578 -- NO
ggcttacgcagcagatgcacgttcagcattgagaacccggtccgacaggaaagacacaccatttttccgccag-
aaactccagtgttcaaaatacaaactgc
caacttttcaggcaataatcatgagcttccattagaaaaagccatcagctcaccagacgacgaaatatgc-
tctcgggattaagaactttctcatcctccctgag ccctttcctttcaggggaagtgcaagtttg
1937 3290995 ANK3 YES
agcgggctaacaccactgcatgtagctgcacattacgataatcagaaagtggcccttctgcttttggaccaag-
gagcctcacctcacgcagccgcaaa 1938 3403153 EMG1 NO
tgtcacatcctttgaccctggtctgagctgactgctggaagatgatctttctgcactgagactgtggagtttg-
gggaagccaaggctgtacatttgctatttgttta
tcctatgaatactgttcttgcaaacctggttgttttggggttcctaaagtatccagtggtgtaaaactgt-
ttgttccccgggacttcagggacagataggaggtta
cagagtttgcagtttggttccatgctttgaaggcaggctttagctcccagattcccatgtgctaaaggag-
agaaccctgatgatggagaagaactgtgaaaga
gagcagtcaggaatgctagtggtgaaaaactgaacaaacagaagtgattttatctaatacagttccaagg-
tagaaaaagtggagcaggcagggccttgcac
ccctctccacccccccatggggggggtggtggtagcggcacatacacaatc 1939 3439875 --
NO
acctggctttggttattgatgagaagagtaattaatagaacattccctttgctgtgataccctacccaaaata-
gctcggttgttggttcactttcttcagatacctcc ttgtctcatggaccgcctacttact 1940
3568358 -- NO
tcatgggtttccaaatatgggatgcaatttcaagttcttaacaccaaatataaccctacttgttttagtttcc-
tggcattcatcctatcatccccagtttactgcacctc
aggttatcaaggatgtgggagggattctacaagggtatgttcccccagagctttttggtaccctgcaatc-
ccagaagttgttgatgctaggatgtctggagagc actggccatttattactga 1941 3701322
CDYL2 YES tgacgtgaatcacgctacactggcggagaacgggctc 1942 2975832 -- NO
gccatgatcgtagcactatactctagcc 1943 3072788 -- NO
gtctaattcagaacccggtgggctctccatgcattattggcagcacttttatccaggggcacagacagggaat-
agggttactggaaacagggagtgtagctc
aaggaattgttctctctctggagtggataagttgtttgacctactgactcatttcataggaattaggaaa-
acaacctagtgtggtttttattgttagtcctggaggat
tccaaaatctgtgtgcctgcaaataagatgagctggggaaagggagcaccagcatttggtgtttctactt-
gcctcttttcctgatggaatccaatcctctgcttc 1944 3380982 -- NO
gctgtttcagtccacaccttgttcacagtaagatattcaattcaattcagcaaacatttgttgagtgcttgct-
gctctgtgcctgaccagaagaaatgaagccaag
atacaaataatagaaccctgtcatgagcacagaaagacctgctgagtttctattgattgtggtaaaccag-
cctgcatccagttccaagtaacagctgcccactt
agtgaatactctctcatgtttcaacactcagttctagtgtagcctcttctataaagcctttcttttccag-
ataaaattggttaatgtgtcctgtgttaggctgattgatttt
gatgatccctattcatggtctcccctgtatccatctctttttgcctataacattgtagtcccatctcact-
ctgatgctgggaccagacatgtgacttgttttagccaat
gagatgtcgataaacatgaagcaaacagaagctttaaaggaggcctgccctcttgctctttgccagtgcc-
atgagaacatggctgatcagctggagggttat
gagatgtgtaggtgagagacatgcaaaagagccagagataccagctgaagccatcctagactagcccaca-
gtcagcctacccccagtcaagatcaggag
agtcacccaacccacagatgactgccgacacatgagtaagcc 1945 3902033 -- NO
attccacgcgtcaaattgtgggcagtga 1946 3952107 -- NO
acaggcacaggggagtcaagcttag 1947 2678585 -- NO
agcacccagtctctgttctcagagg 1948 3463862 PPFIA2 YES
tctcaggggatcacgagtggaatagaactcaacagattggagtactaagcagccacccttttgaaagtgacac-
tgaaatgtctgatattgatgatgatgacag
agaaacaatttttagctcaatggatcttctctccaagtggtcattccgatgcccagacgcta 1949
3727958 -- NO caccatcttctcggatggatggcaaag 1950 3974043 -- NO
agcaagccagtgcagtccttggtcacagtcactcacag 1951 3982214 -- NO
ccaaaaccaatgtgtctaaggtgcggcatcttg 1952 2685843 -- NO
gcggtggtccaatcatagttcactat 1953 2686522 ABI3BP NO
ccagacatgccaccaactaaatccg 1954 4014220 POF1B NO
cttcctctgtagctgccagacctgc 1955 2838069 TTC1 YES
aatggccatcaatgactgcagcaaag 1956 3701416 -- NO
cgcatctggcctataccagtgtatgttttctttaggaaaaaataaggcagaaaccagaaaactaacacttcac-
ataaatgtaggtgcagaatattggtacgatat
tggataacttaaattgctgaactgtatgaaacttaatttttctaaggcaaaaattgatatcattggaagg-
atcttggagtcagtggcaggcaaacaaaatttaaac
ttggctgcattttcttttttcgtttcaaatgaatacttaactaggtgcaatggctttatttgtggtcttc
1957 3756107 -- NO
tgaattcacagtgttgtatcccatgtagggaaaaataagactaattttccccccacactctaacacactgtaa-
ttttgcacttggaactttgctaatctactgtccaa
cctccttctcaacaaagtcaaatcaaaggagaattaacctagaagaggggacaataaaataagaggtcct-
cagggagagggagaaccaaggaaatagaa tctacttaaatctggccagatagcacctcgtggatt
1958 2382147 CAPN2 YES
atgacaggctgcccaccaaggacggggagctgctctttgtgcattcagccgaagggagcgagttct
1959 2590022 ZNF385B NO
agagaaacacatcactagattgacgagggcttttagagactgctcctataattgaggaatcagcagcataggc-
tttatctccctacttc 1960 3831701 -- NO gtattggcgactgcctgtgcatacac 1961
2792492 -- NO
ctgactgtgaattagagtttgcgctattggaaggtggaacccactgtgctcattgtata 1962
3289301 -- NO
gcatttactagtgctgtgtgcctcgttgcttttctgggtagtgtttggtgatgggcatagtgtggagtggtgg-
tagagtacacagtgtgattctgtctggtaagga
agctgtatgttgatgttcactgatgtgaataggttcatacagtcccttaggcatttggctggaggataaa-
gaacagccattgaccagcagagtactttttttgaag
tttatgcaagacagcgtgctaggtactactgccagcttga 1963 3686344 XPO6 YES
gtcctttctccagcccgacatccacctttttaaacaaaatctcttctacttggagactctcaacaccaagcag-
a 1964 2596800 -- NO
tgactaaaattttgggtctgggctgttatatcactttgtgttaagttatttgtagtagctaatgtgctaactt-
atatatgtgttctttctgattttttggattttaccttttgatttt
ggcataacttatctatatttttgtttacattattttaaaaatatcagtaactgtaataatataaaattga-
agttgtattgagttgacaatacctctagtttttaaggtcatctgt
cacataatttaagtgcaccagttcctaatgtataaag 1965 2614940 -- NO
ctgctccattggagacttcctgagggcaacagacaaactatttgatagctgaat 1966 3988991
NDUFA1 YES
tcattttgggtatcactggagtctgatggaaagagataggcgcatctctggagttgatcgttactatgtgtca-
aag 1967 3068834 -- NO
tcatataatagacagtgcggttgcaccttgtgttcatgtactgatagctgttaagggtgcagtgatgaaccaa-
cagagctc 1968 3116499 -- NO gcctctctgttctcatgggctacatg 1969 3227229
FNBP1 YES
ccaacctgaacgaaatgaatgattacgcagggcagcatgaagttatctccgagaacatggcatcacagatcat-
tgtggacttggcacgctatgttcaggaa 1970 3777767 -- NO
tgtgtttggggtgattagagcttcttgcaagcttagaagtaggaagctaatg 1971 3950135
-- NO cactggcacaggacgaccctgaagg 1972 3425446 -- NO
gcatgtcttgctactacttcatagatgtcataagacccgtttatggattagagttggtgtagaaagccattgc-
cttgagttgaaaaatgaatactgtaaaagctca atacaaatcctccaaagcacatgcactt 1973
2359042 -- NO ccaagttctcatcttcagcatcgcagtttcgttctccacc 1974 2437704
GON4L NO
ttccattctattactcttaggtttgtatctcatggaattcactttaacctctgcctcgtgttatttgctttag-
ctgtacattatgctctta 1975 2778373 -- NO
cccaaaacatagatccgaacaccagctttgccc 1976 2954503 -- NO
atttcctacactgttgatggtggcaatgacaaaatcaattgcagtg 1977 2441001 -- NO
ctggagaaatggctatgggtgactg 1978 3162378 -- NO
gaattagttcctcagcccagtgtaagactggattaaaaatcgtgcatggatgtgcaggg 1979
3199012 MPDZ YES cacccagtcagtcagagtcagagccagagaaggctccattgtgcag
1980 3449682 -- NO
aagggtgtggcacattgctggtgttttcagggaagaaagcagaacgtctgtgggcaagcagtgg
1981 3687337 -- NO
ggagatccttgtgtagcggcagaaagtttagcaacactgtctcctgcattagtgtggagggtaggaaatatac-
ctaaggaacggatggtctagctaaggagc
tttccagacagaatgttgaaggtgccacctggcttcttgctgcttatagtaaaactgaagaggagagagt-
aagttaaagaaaaaaaacacttaaatgaaaaag
agcctgaaattgttgggtttgaaaattcccagcctttccagataacaagtgatgttaaaattaacaaatg-
gcttccgtgcaaagattaaatacaaggcattaaata
cagggaaatgtggtctaaaggtcaagctgaggatgtgatgaaaaagtcctttgttaagacctcagaaata-
ccaacaagatgcctcagaggggacttccagtc
gaatgaaataataatcacgcttctgagaaggttaaaggtgttgtctttcagcgtctcagcacaagcccaa-
agtagagaagggcttaccttgcagagattttc 1982 2333554 ST3GAL3 YES
cctacccttggcagtgtggcagtga 1983 2570354 -- NO
gtgttacttccaccatggtgccacacacttaatatccattcc 1984 2873144 -- NO
ggggcttctctatgcccggaaactgcctcatcaactgaaacaaatcctgaatcatcaaagggccaaacccact-
gccacctttagacggagcaggagagtta ccctggctctgtcactgccactaagtcta 1985
3409485 -- NO
tgaataggcagctagtacatgaacctggcattaggggtttggggctggcatacttaaacatgtggctagatgt-
gatcaccttcagagtaaatgtaaatagtatc atccctccttatctgtatc 1986 3476542 --
NO gtgtgttccaggcgatggcaggaggga 1987 3620299 -- NO
atgacagtttttctctaggctaataactcaatgagcagaaaggaaagtcctcccttttaaatgtatatgaatg-
tatatgtagttcacacttacactctgacacagat
ctcattgtgtccaatgatgtgtgtgtgtgtgtgtgtgtgtgtgtctccaagactgagacacatgtactaa-
agagtgatactggccacatctactctgggcttggag ggtaacttcagcaa 1988 3626913 --
NO tgcaacctcgacctgcttggcttaagcaa 1989 2699759 -- NO
ccatcatgagctgaccaacaatttctaaattcctactcagaaacacagcaaggggaatgcagtcaagcacaaa-
gggcttaaatgaccagataaggctgggc
tggatgaataaagaggaatatcctatgaatgtgactgtgtagttttagagtatcccgattcaactgttat-
atttgacttgtggccttgtagacagtgtgtta 1990 2737582 -- NO
tagccaagtgcagagggtgtctccgggtgtgtgcgtggcccacaagagggcaagaagagagaaggcggggata-
ggagggaagagggtgggggtga
gaggcagccctgagagggcggaggaaggaagaggctgggagctcggcgcccgcggcgcagctgccgtcgc-
tgccgcagctgtccagggaggatcg
ccaaaacggcgacgaataaacaacttaccttgcggagaagagctacgactgcgatgc 1991
2964449 MDN1 YES
cccgatggaatatgcaggctctggacatgattagaaatttgatggactttgacccacaaacggaccagcctga
1992 3695220 DYNC1LI2 YES ggagctgccttgatttacacatcag 1993 2939888
LYRM4 YES taaagaatatctcctccaggtgtggt 1994 3632627 -- NO
atggagatctacactgacaccctcagtcctagaggcagagaagaggttcagatctggcctg 1995
3695228 DYNC1LI2 YES
cacgcgctgcaacgtgtggattctggatggagacttgtaccacaaaggcctgctgaaatttgcagtttctgct-
gaatccttgccagagaccctcgtcatttttgt tgcag 1996 3854016 -- NO
tagatctcgtcgctggtatgcttggttccgctcctcgtttcttagttgcttattctacccgttattcactgat-
gtta 1997 3980369 FAM155B NO
tccatcacagacagcagagccgggcagctttcttatgccattttctacactgtgcttcatgagtaggactttc-
ttgcactagttcctatgactgagtctccaaact
ggtttcctagtagtcccccatcccttcctcccttacccagctatgattcagttgtctctgccctccctct-
taccctgcctctgtgtttcggtgagagtc 1998 3799919 -- NO
tgtattacacagagactaccgcacaaaacacggacccaatgccaggcaagcacgcgcccagcctgaacctcca-
agaactgtctt 1999 3032425 -- NO cacacctgtaagctgaggtgaaggagtt 2000
2475245 PPP1CB YES
aaagaaagctaaataccagtatggtggactgaattctggacgtcctgtcactccacctcgaacagctaatccg-
ccgaagaaaa 2001 3487169 DGKH YES
tctggggataccgaaagtgggtcatgtgaagcgaattctccag 2002 3955155 -- NO
aatgacatcccttttgagctgtggatggtg 2003 2827160 PHAX YES
cacggcaactgcatgtgcaccagtatcacattatcgagctgttgaaagtgtggattcaagtgaagaaagtttt-
tctgattcagatgatgatagctgtctttggaa
acgcaaacgacagaaatgttttaaccctcctcccaaaccagagccttttcagtttggccagagcagtcag-
aaaccacctgttgctggaggaaagaagattaa
caacatatggggtgctgtgctgcaggaacagaatcaagatgcagtggccactgaacttggtatcttggga-
atggagggcactattgacagaagcagacaat ccgagacctacaatta 2004 3186892 -- NO
atagataacgtttgtgtggcactccccaagactcaggcattgtgataactaacactttccatgaataatgtca-
tagaattctcacaaacatcctgtgagatagac
actattattttcaaccccatgtacatatgagaatactgagagttggagagactgagtaacatgccctaga-
tgactcagctagcaaggaatgaaaagcacattct
aactccacccacatatatagttccaggatcccatctctctacctcacattaattagttctataccagctt-
tatgtttcctactagaatgtgcatgttttaaaggctgag ctttc 2005 3195536 -- NO
tggccttctggacagtaggtaggcatgtgatcactgttgtcactaaacctgggaaatgattcctgggtcaggg-
ttcattaattgc 2006 3238305 -- NO
gtattgaaattcctcgagccgctgcttttctcactccataattctggccagaatttggtacttaaaatatttt-
gtctaaaatattacaatagctacttaagtcatctccc
tgactccactctgttgtctttcagggcgtcgtccacactgtagccaaagtgatcttataaaaacataatt-
ctaatcatggcactcttctgcttaaaaatgttttaatg
gctttccgttaggttaaaatttaaaagtcctttgtagcctgtgaga 2007 3744218 VAMP2
NO
acttgctggaaaacggggatgcttgcccctctccaggactattgagcccagagagagctgtcctctcattggg-
tgaactgattgaggaagggtctattgtcttt
ttaaatggcacaattttaagggtttgagggtacagtcccttaacctgccacgggagggggcccccaaact-
ttcttccccccacacttctggttttctgtgtggag
ggggagcagggatatctaagctgtggtgtgaaagggtaggagagatgctggaggtgggggtgctgtgttt-
tagaccccccatattatcccagtgtcccctg
cccccctcttcccccaccccatgcccccaattctgtggcgcatccagattgtgaaaatgta 2008
3810033 -- NO
gtgaatatatctaggtccagcagggtctcagaagcagatgccaacctgaggggaatatttaccagatga
2009 3943786 -- NO
cagcagctgctatccatcgtcatcaccagtgtcatcatcgccatccccatcatcaccaccaacaccgccaccc-
ccccagcgacacactagctgtggacaca
tcctttacgcccttgaacctgagtttctacagctatgaagcaagtcccatggaatttacagaccaaacgc-
taagtgtagggctccctgggagctggtcttatgg agcacactggca 2010 2321472 -- NO
cagtccatgaggtccacttgtctaaatatgtcacttgaagtgcaaggtaccaattgctcagtggctcaaaatg-
attttctggttctgttgtcatttcaagagcttctc
ttgagggttgagagagtctgttttcctaagaatctggttctctccatcagtctctgtttccaccttatct-
tcctgggaaggtgtgctttctttgaggtgagatgtgaa
gcctgcccacgtgcagttttatgtcgaattccaagtcagatcttaacttggtactcccggagcctgttgg-
aagtctta 2011 2361272 -- NO
gtgcaacatcactttgacttgattattcttgggtctgttttatttcccgcttttattttgcttttgaaatctt-
tttccttggtggatttgtacgtgtcttcactagatgcctca
aattaagtctgaccacaatcctactctactt 2012 2447714 -- NO
tgccaacttctcttcaccacacaatctgcagaagc 2013 3175671 VPS13A YES
tatgatgatgcctatagatttgggggaaaagacaatatatttagtttcattctttgaaggtttacaacgcatt-
attttattcactgaagatccaagggtatttaaagta
acatatgaaagtgagaaagcagagttagcagagcaagaaattgcagtggcattacaagatgttggaattt-
ctcttgtcaacaattacacgaagcaagaagta gcctatata 2014 3517776 -- NO
tataaggacttcacagatagctgccgtggatgctg 2015 3626941 -- NO
taatttcacaatgggtgtgggaggttggtgagtagatggactagattcaaaagtagatacctcgctctcacct-
atagcctagcagttt 2016 2467805 TTC15 NO ctccaacacactacgtcagaaggacccgg
2017 3701421 -- NO
ttgctttgtcttgtgatcgcagctcacggcagccttggactcgtgggcacgag 2018 3717066
NF1 YES cagaaagtgctgcaattgcctgtgtca 2019 2476534 -- NO
agatggtacaaaggtcgtgatagggctg 2020 2750682 -- NO
ccaagattaggccactgccctgtaac 2021 2412205 -- NO
gggttaagctgggaaccatgtctcctggggcaaaattttaattcttctagccacttgttatgtgatctcaagc-
aaggtacatacgtctctgggtctttttttctttatct
aaaatatgaagagattaagtgttttcttaattttctttcagctctgatattatgtgattctgtgattaaa-
tgacctggatgttgataatacatgcc 2022 3019902 -- NO
ctttggagttttcgcccagatcagaattttattgccttttgccgtagactgctgcaagatttccagagcaaag-
agaaggtatagtgttccttaatgtgagttatgaa
gatcaaaatacagcaaagagaagatttcagagatttaaaagtgataatttttactgaaatttggaaatat-
gtctccatattttaactttattttataaaaaagaattact
ctgttttttgaaatggccaagcattaagtaatatatgaccgtgaatttcttgagggtgggaaatgtgact-
ggattttatatttcgattgtatcacatgcagcctc 2023 3750928 KIAA0100 YES
acactatgtggcattgtgctttggagaagtgcgtatcagaacggacctacagaaagtttctgacctgtctgcc-
ccattc 2024 2511032 -- NO atgactgagtcttatagcggtgttgggcatagca 2025
2568632 -- NO atcctttgtcccgattgggtcccagatacacaaaa 2026 3039827 --
NO gagtccttcctggatagcagcaccaaag 2027 2437284 C1orf2 YES
cagctgccaccggttggagggctgg 2028 3076362 -- NO
gcatacaagtctgcccagtcccaggaagaaagaggagagaccctgaattctgaccttttgatggtcaggcatg-
atggaaagaaactgctgctacagcttgg
gagatttgctatggaaagtctgccagtcaactttgcccttctaaccaccagatcaatttgtggctgatca-
tctgatggggcagtttcaatcaccaagcatcgttct
ctttcctgttctggaattttgttttggagctctttcccctagtgaccaccagttagtttctgagggatgg-
aacaaaaatgcagcttgccctttctatgtggtgcgtgtt
caggccttgacagattttatcaaaaggaaactattttatttaaatggaggctgagtggtgagtagatgtg-
tcttggtatggaggaaaagggcatgctgcatcttc
ttcctgacctccggggtctctggccttttgtttccttgctcactgaggggtctgtctaaccaagcaggct-
a 2029 3527927 FLJ10357 NO
tgagtcagcatccccaatttctaccacatccagcactcctaccatcttgcatgtaccttccttcctgtccccg-
gctacttgggagtcagcttcttccctctcccaac tcatctccctcttct 2030 3889598 --
NO
caggtcttagcggtcatcaggatgaaggcggtgggaagtggagcaacagagatccaaatatggaaagagcacg-
tgctgataccagaggcactggaaata
atagcaatatccgaaagtctgctcaccctgcgtcattccttcagacagtagtcgggctctattc
2031 3735624 MFSD11 NO
ttaaaatctgcaatactggccaatattcttttatcaaacaggagaccgcagctttaaagggggaaaatgcaga-
cgttggataaaaacagcaagaaatagtcat
tttcattaataggtctcaaacagtttacgaaacagccattattatc 2032 2739508 -- NO
ggcatgtgtgggtaattagttctcactatggttagactcctgaagtgagtggtccaagttgttagcgtgcttc-
tgctctgtgaggccaggccagtatcctgtctg 2033 3819517 RAB11B YES
gacatcgccaagcacctgacctatgagaacgtggagcgctggctgaaggagctgcgggaccacgcagacagca-
acatc 2034 3330082 PTPRJ NO
ggggtcagctatgcagcccatcacgtgtgtttttcatctgggatgaaaaagcctggttctcttttgaaatgct-
tgattgtacttattgagctaaacaagtcttggtg
actgttgttgatttgcctcaaaagttttaagtcctgggttttcagactactgtgta 2035
3378442 SPTBN2 NO
ggccacattctcctaatagcatgaaacagtcagctcactttctgcctcctcctcttacacttccctgctgtcc-
actgcggccaactcagcacagtgtccttgaag ctgattgagggtc 2036 2473789 -- NO
gcgcgggctttcgagcacatacaaacctgattacaaaagtcagatttctttatttcgtcttgggcacgtcatt-
ttaaccccgctcagcctctcttttgtgtatgaaa
ctgaaagtaatagcttctgctgtgcaaaatgattagaggaatttgtgaagcgcttggcaacatactagga-
ccc 2037 3115627 -- NO
ttgagatttatgtgtgtgccagacacacacacacacacatatgtacacaagcaatttttgtgtgtgtggctca-
agccaggcagagaaagacaaatactaaatg
atctcactcatatgtgaaatctaaaaaagttgatctcaaagaagtagaaaggagcctggtggttatcaga-
gtctggggagggggttggggagatattggcca
aaggatatacaatttcagttaggtaggaggaataagttcaagaagtcgattttgactatagttaataatg-
tgttgtattcatgaacaaggctaagagagtggatgt
aaagtgttcttaccacaaaaaggataactacatgaggtaatgcacatgttaattagctagatttagtaat-
tccataatgtatccactg 2038 2745189 -- NO
tccatttctttttactgcgtccgtccctgacaatacctgctgtttactcagcccttaacgttg
2039 3450260 -- NO aaagtgatacatttgtgagggaggagg 2040 2656876 -- NO
cagaccttatctcatagggtgattatgagcattagatgaaatcgtgggtgaaaggctcagtacagtgccaggt-
atacaagaagcattcagttaagtaatagct
gttattgttataactgaggttttcacaagccgcacact 2041 2952697 -- NO
gctagtttcaaagactgcgaccctgttttgaattggcttgtttatgttgcgacggtggctggaagccaggcca-
acccagggtcagctttcccaaatcagtcgcc
aaggcccacgagaacagtagtttcagaactcccagaaataggttcaaagatgcctgtcctgtaccagtcc-
tgcccagcctcgtttttccttaccaccctgactg
cagtcttaactcctgcaaactaatttgatcgctctaagtttaaccgcgcccagaatttcacttttgcttg-
cttggcctttgctgtgggtcacaacagcccttcttgc 2042 3579549 WARS YES
cctggcctctgtaagcctgtgtatgttatcaatactgtttcttcctgtgagttccattatttctatctcttat-
gggcaaagcattgtgggtaattggtgctggctaacat
tgcatggtcggatagagaagtccagctgtgagtctctccccaaagcagccccacagtggagcctttggct-
ggaagtccatgggccaccctgttcttgtccat
ggaggactccgagggttccaagtatactcttaagacccactctgtttaaaaatatatattctatgtatgc-
gtatatggaattgaaatgtcattattgtaacctagaa
agtgctttgaaatattgatgtggggaggtttattgagcacaagatgtatttcagcccatgccccctccca-
aaaagaaattgataagtaaaagcttcgttatacatt
tgactaagaaatcacccagctttaaagctgcttttaacaatgaagattgaacagagttcagcaattttga-
ttaaattaagacttgggggtgaaactttccagtttac
tgaactccagaccatgcatgtagtccactccagaaatcatgctcgcttcccttggcacaccagtgttctc-
ctgccaaatgaccctagaccctctgtcctgcaga
gtcagggtggcttttcccctgactgtgtccgatgccaaggagtcctggcctccgcagatgcttcattttg-
acccttggctgcagtggaagtcagcacagagca
gtgccctggctgtgtccctggacgggtggacttagctagggagaaagtcgaggcagcagccctcgaggcc-
ctcacagatgtctaggcaggcctca 2043 3703035 -- NO
cgatggacactgatgcccacacaggtg 2044 2444562 RC3H1 NO
tccagatggatcgttggcctaaattttcacacttctccctgttcatcctttttcctcttccctgcttcctggg-
aataaaaggaacttttttaaaaaaattaattagtcc
acaggtctcattatctttctttatgattaatctatgactttttggtacaagaacaatggaaaaagtgaat-
taaggtaatgaacaaaacctttcacccacttaaacattt
tccagttttgagattcctcttcgtgtttgtggtgtcttccccttgttaccccttctgccctttttctctg-
actatggtaatttggtctttaggctcatatcagtctccccga
gacattctgcagtcattatcacctttttgggtggattttattttgttttattttgttttttttaaaaaaa-
taactttttaacattggtgcatatttgcttgggatagagcttgtg
taatttaccaatcgtattgattgtaagtgattgtgccctgcagaggtatatttaacaagacaaaaataat-
cttggttaataaaggagcccatgagatttgagtcag
gttgtaagtgaaatcacttacacttttggatagaatttatactcctgctcttataaatcagtggtagact-
taccattttttaaagttttcttgcatttttttgtttttttattgc
cacagctccctattctttcttgcctgcctccacccccctgttcaggaaaaaaaaaaattgagccttaaag-
tgacagctgattttttaattgctgaattttgtgaaattt
tactttttccaagtgtttccaactttaaaaagagaagtgaagacaaataggttggaatggtgaagacaaa-
tggattggaatttcacaggctgtgaataattcctta
ggatctggcaaaccgtgaagtcttatttgaagaccttatctcctgagagttcttttggagtaggaaaaag-
aaccctatttgaaatagaccgtttttctcttgtttttaa
tctgtttaatatttctgatttttaagcagcttt 2045 3816284 DOT1L YES
ccaggtcgtgctccaggttgctgctgccaccaactgcaaacatcactatggcgtcgagaaagcagacatcccg-
gccaagtatgcgga 2046 3231694 -- NO atccaccaagcagtgcgtccaggtg 2047
3760111 -- NO gaatgaacgcagagagtgtcagtgctgaca 2048 3960937 -- NO
caggcacaccgccttgaggtgggcagtgccc 2049 2519659 COL3A1 NO
gaaagattcattggcatgccacaggggattctcctcc 2050 3380965 -- NO
tctaacccttgagacactgccaacatccctcctagtacaagacttttcttggtgcttgctgtttttagaggag-
ttttggcccttcagtgtttgtaaagctctcggatc
ctcagaaaaaaattctttagtgattaattttgaaattggagctgtttgattattttgattaagaagctga-
ttttcggcctggcacg 2051 3690096 DNAJA2 YES
agatgggaatgatttgcacatgacatataaaataggacttgttgaagctctatgtggatttcagttcacattt-
aagcaccttgatggacgtcagattgtggtgaaa taccc 2052 3777917 -- YES
aggatcctgccgaaaggtgctcagtggcct 2053 3811929 -- NO
atgtatcattctccatacacctgtgcctt 2054 2436400 -- NO
ccagccacgcgtccagcaggtcagggatt 2055 3868616 SHANK1 YES
tacatcattaaggagaagacagtcttgctgcagaagaaggacagtgaggggtttgg 2056
2833315 -- NO
atcttttgattgctagcccagctgctttccttgttatcactttgtggagcaggctggacattgacaatgagtt-
ctgagactgagtggaatgggagacccctccca
gctggtggtcgagctgcctagagcatggtccatctgtttgggactagggttgagctcc 2057
2886091 -- NO
tgacgaatttcgtctttcttccctacggtggagtcagtgttaaacatacaacaaggagttctggggcacaggc
2058 3146585 RNF19A YES
atgtccacgatgtgctgcttatataataaagatgaatgatgggagctgcaatcacatgacatgtgc
2059 3271059 -- NO gtgagatacttgacatggggacctttac 2060 3589673 -- NO
ttcaagaagttctggggacagaggg 2061 3971336 MBTPS2 YES
tccttggaaaaacgctgatgcagactttggcacaaatgatggctgactctccctcttcttattcttcctcctc-
ttcttcctcttcctcctcttcttcctcttcctcttcttc
atcttcttcctcttcctcgcttcacaatgaacaggtgttacaagttgtg 2062 3304025 --
NO
gtatgtgataagtatttggatttgagagtagacctttcatagtgaggcttatcaggttgaggggaggtgatga-
ctggaaatatatttatttattttaaatcccactttg
gctttagtaaaatctgaatatgtgtgcatttctagtttcttacaccaaatgtaggttccgtaagttcatg-
caagtacagtgggtc 2063 3350758 PAFAH1B2 YES
agacaaagagcctgatgtactgttcgtgggagactccatggtgcagttaatgcagcaat 2064
3921733 -- NO
cagtgtcgctacaggggatctctcaggctcacaacgggccactcctctagggaagttctggtctcatcatgat-
ccttgtttggtctcactccccatgtccttctct
gtccctcctccaactgccatttatttatttaactgaaaaagtaccaatcacccacataggcatga
2065 2361637 -- NO acaggagccaatgcccaatcatagc 2066 2625412 -- NO
accacctgggtattgaagccctataaaaacactttctacttaccttaatatagtctggcgttgctgggacctc-
acagtgttctttcacactttttatgtaacttagga
actgaaataccactcatgcatttgttctaaag 2067 2737704 -- NO
gattgctatggaagtactgagtccctgaaggagagacaaggtgcaggaagccccaatcgccaggccatcgatg-
aaattgtggagggcatcgcagagcgt tatcatccaggcaatcgtccctatt 2068 2795252
-- NO gttcggatgatttcacgggagcagc 2069 3203541 AQP7 YES
gctgtgacctttgctaactgtgcgctgggccgcg 2070 3510917 -- NO
aagaccagggtaatcatagaactgccaagcagaaagaaatgtagaatgtagcagtggtgtggagacccgtggc-
tgacaggtggtggtcttcatataggct gagggacaggctagatgcatgtcaagtggc 2071
3670551 -- NO
gagctccagggatatctcttctgcacattcttccagagcagtgcatctctcttctggttgtttgtacaccctt-
cttttactctccttattatcctctcccatgttcattca
gtacatacttagtgagtgttcaccagatgcttagcacctggggtatac 2072 3729159 DHX40
NO
gcctatggcaggattctttcttgaattaatattaatccttaaattgatttttctgggattatacaaattcctt-
tttatataaaagtatattgtttaaaacagtagctatagc
cattaaccaaaggacagatgatatatatatatatgatatatatatatatataagttcttttttagctgta-
cctacgtacttatatcagcaccatgtatgtaggtgtgata
gtactttcaaacagcgcctccacctggcctactctgttatttccacctgtttgggtagggccatttaact-
tccattatgccaaacttgggatgggattttcgaagca
gacaacactatttcatcgtgtttcaaattggaaccttgaggctagttagtatcacact 2073
2969482 CDC2L6 YES
tgtatttgccggctgccagattccataccccaaacgagaattccttaatgaagat 2074
3040116 SNX13 YES
tggcaaccttattttactacacgcattgtagatgactttggcacacacttacgagtattcagaaaggctcaac-
a 2075 3819122 LOC100129391 YES gaggtggctagaaaacggcaagaac 2076
2359763 -- NO
acctgcgtcacaccctggctagtgacccagtcagacgtgctggggaccctggctgaccacctgtaccaggggc-
aaggaaggaaggagaggggagcatt
gtgaagcagggcaggatgactcttgaaggtggagacaggccctggacagctctgggacccttaatggtgg-
cagc 2077 2969302 WASF1 YES
ggtttgatagaaaatcgccctcagtcaccagctacaggcagaacacctgtgtttgt 2078
2330410 C1orf113 NO gaagctggtcccacggaaagtggtatctcgggaatcag 2079
3265461 FAM160B1 NO
tctaggtggggaactgactgataacccttggcagcaatcaaagtgccagtggctcctcgatgtttacattttt-
ttctattttgttcagtcttttgttttaaatgattcta
aagagattaaagaaaacagagttttaaatgtcctatttacatgttaaaggatttggggaaattgggtatg-
tatgtgaatgggtgtacatgtaggaacctgtagttc
agcaaagctgcgctgggcacagcatgcttgtacttgattgacaaaatcgtgtttgccagtccactttcta-
tttttcctttaagtgatgctgatcactcaaataatgct
tttaagctattgtttgtttttatttgacatgttaagccgcagcactttcttcttcatctttccatttact-
gatatttgggggaacaggctatcaaaggttccggcttgaag ggaactgtcactac
2080 3735093 LOC643008 NO gccaccgacttcgtgcaggagatgcgc 2081 2402500
PAFAH2 YES
ggcaacattgacatgagccgtgtggctgtgatgggacattcatttggaggggccacagctatt
2082 3552152 MEG3 YES
tcttcaacccactgcttcctgactcgctctactccgtggaagcacgctcaca 2083 2736402
-- NO
attataaggtatgatatggcttcccaattgtcaaagaattaaaatgctcattaggagaggagtgactgcttct-
ccctttagtagaaaaacaattcaaactcaggtt
accaattacaatacacaaactaaaacagttatgttgagccgggaaaccgtcttcttgtaggctatcttct-
agcaccaaataatgcccacatgatttctggctgaa ggcca 2084 2751960 -- NO
gcttccttcgtgaattctaaccgtaccgttactgtgtttgaggatcactggcagccgagctctgagtggggaa-
ctgagataagaaaggtgttgtcatgataaca
cctggacagctgcatcccacagactatgggagtgccaggaaactggctacctcacagcagagtagagaaa-
atggaaataaacacaaatataagcttttcag
tgagctgtgggtcagagaaggccacaagtggtctggcagatcatggtgcagctctttgtttcatgagcta-
cgtgcagcagtagtttttatgagctctttttgtag ctttccagccctaggattcagccatggtaa
2085 3024231 -- NO
tgcccagaaacgaccattttggacaatctcatccagttttacgcttgttttattcagaaagagaatcacctat-
cctcttcacatc 2086 2928814 -- NO
taaggaaattgggttgtcaccactggctttgagtaattcgttttgtctatgcaagctgtcttcatacgaaaaa-
ggttttcatactatatccagtccc 2087 3166955 NFX1 YES
gttgaagtcgaaacatcccactggacat 2088 3829651 KIAA0355 YES
cctgactgtggtgcaagtccatttccagtttttgactcatgcgttacagaaggtccagccggtggctcactct-
tgctttgctgaggtcatcgtgcc 2089 3709186 JMJD3 YES
gtcaggcagctgtaagcggcgacagaag 2090 2947628 -- NO
ctgttgacttcagagtcgagtgtgag 2091 3820638 SLC44A2 NO
cccagtgatggccacgtcttgtttctagaatcccttcctttgcacaagccatattctgaactcttaattcctt-
cccttaacttcaatccctatgtctcctgtcctacctc
atggttttcctggccccacacctgatgctcagagcccactgtgaacccctggtgcctcttttggactcgg-
ttc 2092 3823661 AP1M1 NO
cagcctcagactttttcccactgagggtccagagagcggggccacgtgtcacccacgtctgcgcttggtcacc-
cgtcctccccaccctgtgtgtgtttatgtc atagttacattaa 2093 4038647 -- NO
aggtctccgctttcctggaaatccagaccc 2094 2543897 -- NO
agctctgggtgagacttgtcttccgggggctg 2095 2353902 -- NO
ctctgattaggtcttgtgcccattgttgaaccaaatgctgtgcttaggaggatgggacatgttctttttgttt-
tgcttagttagggcctggctctggagccaggaga
ggggaggaggaaatgttgctggatgtaagttagcactgatactaattattctaacaatgattaatagtta-
gaatggctgggtgcagtggcacatagtcccagct
ccgcaggaggttgagatgggaggatcgcctggggccaggagtccaaggctatggggcaccatgatcatga
2096 3190953 PPP2R4 YES cactttgtggatgagaaggccgtgaatgagaaccacaaggact
2097 3922999 PKNOX1 YES gcgcccggccgagaatgacatcttaa 2098 3701615 --
NO
atggacagcttcaaagggcagtttgggggtttctgtttattttcctgtatgttctggtcacctcaatcatcta-
accagaagaactggcccaaaattaggcacaag
aaaaaaggaaaaagtctagccctgccacataactcctggaactggttgcagaaactgaac 2099
2528729 -- NO gggaagacacgaagggagggcgctg 2100 3188305 -- NO
ggatagcttctattgtggacgtggaatcc 2101 3578798 -- NO
agatctactcctggatgcgggtacaggacagcatccccagactgtttgtaaagtctcatgtgatacatggagg-
gcaggcct 2102 3810041 -- NO
agcagaagcaaacgggggtgtctcaggagggggccccgtttccttcttgtaaagctgctcccacccacagcca-
cactccattcagtcaggtttatgtgctgtt
cttccttgtcccttatgaggtagaaccatcaccttgcgtgcaaagcagctta 2103 2520084
MGC13057 NO ggtgtctgtcggtctttgcttgtcagctgt 2104 2615285 -- NO
gtgtttgtgctcaatgtaagagcaaggaaggtgcgggaagatgagggggatgaggcgcaggagtacagggctg-
ttattca 2105 2676383 NEK4 YES
tggtagagtggtttgtacagatcgccatggctttgcag 2106 3337536 -- NO
aggcttcttgcacaggcagaaggggct 2107 3670582 -- NO
tacgtgcccaagaatcaatccaatccaactgataacattttctctgaagatagctgcctcttcaaatactggt-
acagagattcaagaagctgtaccacagacca tcagtt 2108 2359853 -- NO
cccatttttcattaggtccaggtgtatccaaatgttgcca 2109 3349998 -- NO
tgatgtggccccgattgcagaattgagttggaggctgaagcatgtgagctctgatccttgcc 2110
3431977 -- NO
cttccctctggaagactaacatgtactgctgaagtcttgttcagtgtccttctagccccagactttgcagcct-
accaacatggactgagacagggaaagcgtg
ggcaagtgagttccatactctaattttcctacagaagcatcctaagtggtgtgtgggttctcagatcaag-
tcacaaacacattcacagcccatgatatcgtacaa
cactactttttagttcaaattaattatgagtaacaacagactatctgccaaaatagggagctgca
2111 2482372 ACYP2 YES agctaggaaaataggagtggttggctg 2112 2619332
SS18L2 YES cattgcagatgccagtccaaccagcac 2113 3810037 -- NO
cccgtggctctaaaagtattatccgaaatcaaccagtcacccctttcaccttctctcagtttaaaaatggatc-
cagtgcatacccaatag 2114 2944959 -- NO
gtaggaatcaaacatagcgccatctatctgctttttatattatcctacactattttaaaaactgctcaacagt-
cttatacagaaatctttaaaagatagacaggataa
catgctatattaaccccaccattgaaataatccaacaccatcacgattccgattaagagaagaaaaaaat-
cttttttttttctttttttttctttttttctttttttttttccga
aaccactcgccctccactgactgcccctgtaccacatcaaacagtctcctctcctccacgcctccggggt-
ctgggaagtctcacctcactgatttc
TABLE-US-00004 TABLE 4 Differentially expressed RNA transcripts
used to plot hierarchical clustering and expression matrix (`heat
map`) in FIG. 1B. The 526 RNA transcripts represent a subset of the
differentially expressed transcripts (Table 3) between patients in
the three clinical status groups (i.e., `SYS`, `PSA` and `NED`)
disease using linear regression and a p-value cut-off of p <
0.01. Weighting factors were from the regression coeffecient
values; positive and negative values indicated transcripts
correlated to increased expression in `SYS` and `NED` disease,
respectively with intermediate expression values in the `PSA`
disease group. Weighting factors were used to derive 526-metagene
values in FIG. 2. SEQ ID No Weights 1 -6.08 2 -5.71 3 -5.68 4 -5.39
5 -5.26 6 -4.84 7 -4.7 8 -4.68 9 -4.66 10 -4.55 11 -4.53 12 -4.47
13 -4.4 14 -4.37 15 -4.32 16 -4.27 17 -4.23 18 -4.2 19 -4.18 20
-4.1 21 -4.09 22 -4.06 23 -4.03 24 -4.02 25 -4.01 26 -4 27 -3.96 28
-3.95 29 -3.95 30 -3.95 31 -3.95 32 -3.92 33 -3.91 34 -3.88 35
-3.86 36 -3.85 37 -3.8 38 -3.8 39 -3.79 40 -3.74 41 -3.73 42 -3.73
43 -3.71 44 -3.7 45 -3.7 46 -3.7 47 -3.68 48 -3.67 49 -3.66 50
-3.66 51 -3.65 52 -3.65 53 -3.64 54 -3.64 55 -3.63 56 -3.62 57 -3.6
58 -3.6 59 -3.59 60 -3.58 61 -3.58 62 -3.58 63 -3.58 64 -3.58 65
-3.57 66 -3.57 67 -3.57 68 -3.55 69 -3.52 70 -3.51 71 -3.5 72 -3.5
73 -3.49 74 -3.48 75 -3.48 76 -3.47 77 -3.47 78 -3.47 79 -3.47 80
-3.46 81 -3.45 82 -3.45 83 -3.44 84 -3.43 85 -3.43 86 -3.43 87
-3.43 88 -3.42 89 -3.41 90 -3.41 91 -3.4 92 -3.4 93 -3.39 94 -3.38
95 -3.36 96 -3.36 97 -3.36 98 -3.36 99 -3.35 100 -3.35 101 -3.35
102 -3.34 103 -3.34 104 -3.34 105 -3.33 106 -3.33 107 -3.32 108
-3.32 109 -3.31 110 -3.31 111 -3.3 112 -3.3 113 -3.3 114 -3.3 115
-3.27 116 -3.27 117 -3.26 118 -3.26 119 -3.26 120 -3.25 121 -3.25
122 -3.24 123 -3.24 124 -3.23 125 -3.23 126 -3.22 127 -3.22 128
-3.22 129 -3.22 130 -3.22 131 -3.21 132 -3.21 133 -3.21 134 -3.2
135 -3.19 136 -3.19 137 -3.19 138 -3.19 139 -3.18 140 -3.17 141
-3.17 142 -3.16 143 -3.16 144 -3.15 145 -3.14 146 -3.14 147 -3.13
148 -3.13 149 -3.12 150 -3.12 151 -3.11 152 -3.11 153 -3.11 154
-3.11 155 -3.1 156 -3.1 157 -3.09 158 -3.09 159 -3.09 160 -3.08 161
-3.08 162 -3.08 163 -3.07 164 -3.07 165 -3.07 166 -3.07 167 -3.07
168 -3.07 169 -3.06 170 -3.06 171 -3.06 172 -3.05 173 -3.05 174
-3.05 175 -3.05 176 -3.04 177 -3.03 178 -3.03 179 -3.03 180 -3.02
181 -3.02 182 -3.02 183 -3.01 184 -3.01 185 -3 186 -3 187 -2.96 188
-2.96 189 -2.96 190 -2.95 191 -2.95 192 -2.95 193 -2.94 194 -2.94
195 -2.94 196 -2.93 197 -2.92 198 -2.92 199 -2.92 200 -2.92 201
-2.91 202 -2.91 203 -2.9 204 -2.89 205 -2.89 206 -2.88 207 -2.88
208 -2.87 209 -2.87 210 -2.87 211 -2.86 212 -2.85 213 -2.85 914
5.32 915 5.27 916 4.82 917 4.64 918 4.59 919 4.54 920 4.49 921 4.45
922 4.43 923 4.38 924 4.38 925 4.36 926 4.36 927 4.33 928 4.27 929
4.27 930 4.18 931 4.17 932 4.13 933 4.12
934 4.08 935 4.08 936 4.07 937 4.07 938 4.04 939 4.03 940 4.03 941
4.02 942 4.02 943 4.01 944 3.97 945 3.95 946 3.95 947 3.95 948 3.95
949 3.92 950 3.92 951 3.9 952 3.89 953 3.88 954 3.84 955 3.84 956
3.83 957 3.8 958 3.8 959 3.8 960 3.79 961 3.77 962 3.76 963 3.75
964 3.74 965 3.72 966 3.71 967 3.71 968 3.71 969 3.7 970 3.7 971
3.69 972 3.69 973 3.68 974 3.67 975 3.66 976 3.65 977 3.64 978 3.63
979 3.62 980 3.62 981 3.61 982 3.61 983 3.6 984 3.6 985 3.59 986
3.59 987 3.58 988 3.58 989 3.57 990 3.57 991 3.56 992 3.56 993 3.55
994 3.55 995 3.55 996 3.55 997 3.54 998 3.54 999 3.54 1000 3.54
1001 3.54 1002 3.53 1003 3.53 1004 3.53 1005 3.53 1006 3.53 1007
3.53 1008 3.52 1009 3.52 1010 3.51 1011 3.51 1012 3.5 1013 3.49
1014 3.49 1015 3.48 1016 3.48 1017 3.48 1018 3.48 1019 3.47 1020
3.46 1021 3.45 1022 3.45 1023 3.44 1024 3.44 1025 3.44 1026 3.43
1027 3.43 1028 3.42 1029 3.41 1030 3.41 1031 3.41 1032 3.41 1033
3.4 1034 3.4 1035 3.4 1036 3.39 1037 3.39 1038 3.39 1039 3.39 1040
3.38 1041 3.38 1042 3.38 1043 3.38 1044 3.37 1045 3.37 1046 3.37
1047 3.36 1048 3.35 1049 3.35 1050 3.35 1051 3.34 1052 3.34 1053
3.33 1054 3.33 1055 3.33 1056 3.32 1057 3.31 1058 3.31 1059 3.31
1060 3.31 1061 3.3 1062 3.3 1063 3.3 1064 3.29 1065 3.29 1066 3.29
1067 3.28 1068 3.27 1069 3.27 1070 3.27 1071 3.27 1072 3.26 1073
3.26 1074 3.25 1075 3.24 1076 3.24 1077 3.24 1078 3.22 1079 3.22
1080 3.22 1081 3.21 1082 3.21 1083 3.2 1084 3.2 1085 3.2 1086 3.2
1087 3.2 1088 3.19 1089 3.19 1090 3.19 1091 3.19 1092 3.19 1093
3.18 1094 3.18 1095 3.18 1096 3.18 1097 3.18 1098 3.17 1099 3.17
1100 3.17 1101 3.16 1102 3.16 1103 3.16 1104 3.16 1105 3.15 1106
3.15 1107 3.15 1108 3.15 1109 3.14 1110 3.14 1111 3.14 1112 3.14
1113 3.13 1114 3.13 1115 3.12 1116 3.12 1117 3.12 1118 3.11 1119
3.11 1120 3.11 1121 3.11 1122 3.1 1123 3.1 1124 3.1 1125 3.09 1126
3.09 1127 3.09 1128 3.09 1129 3.09 1130 3.08 1131 3.08 1132 3.08
1133 3.08 1134 3.08 1135 3.07 1136 3.07 1137 3.07 1138 3.06 1139
3.06 1140 3.06 1141 3.06 1142 3.05 1143 3.05 1144 3.05 1145 3.05
1146 3.05 1147 3.04 1148 3.04 1149 3.04 1150 3.04 1151 3.04 1152
3.03 1153 3.03 1154 3.03 1155 3.03 1156 3.02 1157 3.02 1158 3.02
1159 3.01 1160 3.01 1161 3.01 1162 3.01 1163 3.01 1164 3.01 1165 3
1166 3 1167 3 1168 3 1169 3 1170 2.99 1171 2.99 1172 2.99 1173 2.99
1174 2.99 1175 2.99 1176 2.99 1177 2.98 1178 2.98 1179 2.97 1180
2.97 1181 2.97 1182 2.97 1183 2.96 1184 2.96
1185 2.96 1186 2.96 1187 2.96 1188 2.96 1189 2.95 1190 2.94 1191
2.94 1192 2.94 1193 2.94 1194 2.93 1195 2.93 1196 2.93 1197 2.93
1198 2.93 1199 2.92 1200 2.92 1201 2.91 1202 2.91 1203 2.91 1204
2.91 1205 2.9 1206 2.89 1207 2.89 1208 2.89 1209 2.89 1210 2.88
1211 2.88 1212 2.88 1213 2.87 1214 2.86 1215 2.86 1216 2.86 1217
2.86 1218 2.86 1219 2.85 1220 2.85 1221 2.85 1222 2.85 1223 2.85
1224 2.85 1225 2.85 1226 2.85
TABLE-US-00005 TABLE 5 Differentially expressed RNA transcripts
used to plot hierarchical clustering and expression matrix (`heat
map`) in FIG. 1C. The 148 RNA transcripts represent a subset of the
most differentially expressed transcripts between patients with
clinically significant `recurrent` (i.e., `SYS`) and
`non-recurrent` (i.e., `PSA` and `NED`) disease. Weighting factors
were from the test statistic values; positive and negative values
indicated transcripts correlated to increased expression in
recurrent and non-recurrent disease, respectively. Weighting
factors were used to derive 148-metagene values, which were
converted by scaling and normalizing into `POP` scores depicted in
FIG. 7. SEQ ID No Weights 1 -4.1 2 -4.21 3 -5.48 4 -3.04 6 -3.73 8
-3.88 14 -3.78 20 -3.14 32 -3.87 33 -3.75 36 -4.93 42 -3.46 45 -3.1
46 -4.14 60 -5.72 63 -4.79 65 -3.82 66 -4.02 67 -3.37 69 -3.25 79
-3.1 86 -3.57 88 -4.54 96 -3.68 100 -3.63 104 -2.93 115 -3.29 129
-3.91 130 -3.32 181 -3.27 182 -3.37 187 -3.56 189 -3.44 194 -2.09
217 -4 225 -4.01 241 -4.16 265 -3.86 280 -4.02 293 -3.36 295 -3.57
334 -3.36 355 -3.44 387 -3.73 400 -3.17 437 -4.02 445 -3.14 460
-3.36 468 -3 536 -3.65 592 -2.7 596 -2.79 684 -2.75 915 3.78 920
4.36 923 3.23 925 3.04 926 4.61 927 3.79 933 3.24 934 3.65 935 3.64
939 4.2 941 4.14 944 3.72 945 4.03 947 4.44 949 3.77 954 4.34 960
3.54 968 3.84 970 3.5 971 4.68 974 3.63 978 5.27 986 2.59 999 4.74
1004 4.5 1005 3.62 1014 4.86 1022 6.29 1023 4.08 1031 3.75 1032
3.49 1039 3.44 1045 3.41 1052 3.28 1060 4.48 1062 4.1 1080 3.97
1093 4.02 1095 3.77 1101 3.55 1108 3.39 1117 3.97 1123 4.03 1124
3.45 1126 3.25 1132 3.51 1146 3.78 1147 3.37 1153 3.71 1164 3.54
1167 3.6 1194 3.2 1208 3.35 1218 3.56 1219 2.96 1233 3.44 1234 3.86
1248 3.56 1261 3.19 1291 2.99 1299 3.74 1300 3.33 1304 3.14 1311
3.66 1314 3.95 1318 3.9 1320 3.45 1324 3.31 1330 3.02 1335 4.35
1341 3.7 1344 2.93 1346 3.51 1357 3.82 1367 3.35 1369 3.75 1372
3.07 1375 3.17 1383 3.67 1390 3.49 1395 3.19 1402 3.45 1416 3.29
1425 3.73 1443 2.97 1453 3.01 1469 3.02 1474 3.52 1489 3.66 1503
3.19 1527 3.25 1551 3.41 1598 3.26 1624 2.91 1689 2.82
TABLE-US-00006 TABLE 6 Genes identified in a literature search as
being correlated to clinical outcome or prognosis in prostate
cancer patients. Indicated are the gene name and HNGC gene symbol.
Gene Name Symbol Aminoadipate-semialdehyde dehydrogenase AASDH
ATP-binding cassette, sub-family A (ABC1), member 5 ABCA5
ATP-binding cassette, sub-family B (MDR/TAP), member 1 ABCB1
ATP-binding cassette, sub-family C (CFTR/MRP), member 2 ABCC2
ATP-binding cassette, sub-family C (CFTR/MRP), member 4 ABCC4
ATP-binding cassette, sub-family C (CFTR/MRP), member 5 ABCC5
ATP-binding cassette, sub-family G (WHITE), member 2 ABCG2 V-abl
Abelson murine leukemia viral oncogene homolog 1 ABL1
Acetyl-Coenzyme A carboxylase alpha ACACA Acyl-Coenzyme A oxidase
1, palmitoyl ACOX1 Acid phosphatase 2, lysosomal ACP2 Acid
phosphatase, prostate ACPP Actin, gamma 2, smooth muscle, enteric
ACTG2 Aspartoacylase (aminocyclase) 3 ACY3 AF4/FMR2 family, member
3 AFF3 AF4/FMR2 family, member 4 AFF4 Aryl hydrocarbon receptor AHR
Absent in melanoma 2 AIM2 V-akt murine thymoma viral oncogene
homolog 2 AKT2 Aminolevulinate, delta-, synthase 1 ALAS1 Activated
leukocyte cell adhesion molecule ALCAM Aldehyde dehydrogenase 1
family, member A2 ALDH1A2 Anaplastic lymphoma kinase (Ki-1) ALK
Arachidonate 12-lipoxygenase ALOX12 Arachidonate 15-lipoxygenase,
type B ALOX15B Alpha-methylacyl-CoA racemase AMACR Alanyl
(membrane) aminopeptidase (aminopeptidase N, ANPEP aminopeptidase
M, microsomal aminopeptidase, CD13, p150) Anthrax toxin receptor 2
ANTXR2 Annexin A2 ANXA2 APEX nuclease (multifunctional DNA repair
enzyme) 1 APEX1 Androgen receptor (dihydrotestosterone receptor;
testicular AR feminization; spinal and bulbar muscular atrophy;
Kennedy disease) V-raf murine sarcoma 3611 viral oncogene homolog
ARAF Amphiregulin (schwannoma-derived growth factor) AREG AT rich
interactive domain 4A (RBP1-like) ARID4A Armadillo repeat
containing 5 ARMC5 Aryl hydrocarbon receptor nuclear translocator
ARNT N-acylsphingosine amidohydrolase (acid ceramidase)-like ASAHL
ATPase family, AAA domain containing 2 ATAD2 Activating
transcription factor 1 ATF1 Ataxia telangiectasia mutated ATM
Atrophin 1 ATN1 ATP synthase, H+ transporting, mitochondrial F1
complex, ATP5D delta subunit ATP synthase, H+ transporting,
mitochondrial F0 complex, ATP5J subunit F6 Aurora kinase A AURKA
Aurora kinase B AURKB AXL receptor tyrosine kinase AXL
Beta-2-microglobulin B2M BCL2-antagonist of cell death BAD
BAI1-associated protein 2-like 2 BAIAP2L2 BCL2-antagonist/killer 1
BAK1 BRCA1 associated protein-1 (ubiquitin carboxy-terminal BAP1
hydrolase) BRCA1 associated RING domain 1 BARD1 B-cell CLL/lymphoma
2 BCL2 BCL2-like 1 BCL2L1 B-cell CLL/lymphoma 3 BCL3 Breakpoint
cluster region BCR BCS1-like (yeast) BCS1L Biglycan BGN Baculoviral
IAP repeat-containing 2 BIRC2 Baculoviral IAP repeat-containing 3
BIRC3 Baculoviral IAP repeat-containing 5 (survivin) BIRC5
Baculoviral IAP repeat-containing 7 (livin) BIRC7 Bloom syndrome
BLM BMI1 polycomb ring finger oncogene BMI1 Bone morphogenetic
protein 4 BMP4 BolA homolog 2 (E. coli) BOLA2 V-raf murine sarcoma
viral oncogene homolog B1 BRAF Breast cancer 1, early onset BRCA1
Breast cancer 2, early onset BRCA2 BTB (POZ) domain containing 14B
BTBD14B Bruton agammaglobulinemia tyrosine kinase BTK BUB1 budding
uninhibited by benzimidazoles 1 homolog BUB1 (yeast) Chromosome 15
open reading frame 33 C15orf33 Chromosome 17 open reading frame 56
C17orf56 Chromosome 17 open reading frame 57 C17orf57 Chromosome 1
open reading frame 115 C1orf115 Chromosome 1 open reading frame 77
C1orf77 Chromosome 2 open reading frame 33 C2orf33 Chromosome 2
open reading frame 37 C2orf37 Chromosome 3 open reading frame 14
C3orf14 Chromosome 8 open reading frame 32 C8orf32 Chromosome 8
open reading frame 53 C8orf53 Chromosome 8 open reading frame 76
C8orf76 Calcium channel, voltage-dependent, beta 4 subunit CACNB4
Calmodulin binding transcription activator 1 CAMTA1 Caspase 2,
apoptosis-related cysteine peptidase (neural CASP2 precursor cell
expressed, developmentally down-regulated 2) Caspase 3,
apoptosis-related cysteine peptidase CASP3 Caspase 8,
apoptosis-related cysteine peptidase CASP8 Caveolin 1, caveolae
protein, 22 kDa CAV1 Cas-Br-M (murine) ecotropic retroviral
transforming CBL sequence Cholecystokinin CCK Cyclin A2 CCNA2
Cyclin B1 CCNB1 Cyclin C CCNC Cyclin D1 CCND1 Cyclin E1 CCNE1
Cyclin H CCNH CD34 molecule CD34 CD38 molecule CD38 CD40 molecule,
TNF receptor superfamily member 5 CD40 CD44 molecule (Indian blood
group) CD44 CD59 molecule, complement regulatory protein CD59 CD69
molecule CD69 CD9 molecule CD9 Cell division cycle 2, G1 to S and
G2 to M CDC2 Cell division cycle 25 homolog A (S. pombe) CDC25A
Cell division cycle 25 homolog B (S. pombe) CDC25B Cell division
cycle 25 homolog C (S. pombe) CDC25C CDC42 effector protein (Rho
GTPase binding) 5 CDC42EP5 Cadherin 1, type 1, E-cadherin
(epithelial) CDH1 Cadherin 11, type 2, OB-cadherin (osteoblast)
CDH11 Cadherin 13, H-cadherin (heart) CDH13 Cyclin-dependent kinase
10 CDK10 Cyclin-dependent kinase 2 CDK2 Cyclin-dependent kinase 4
CDK4 Cyclin-dependent kinase 6 CDK6 Cyclin-dependent kinase 7 CDK7
Cyclin-dependent kinase 9 CDK9 Cyclin-dependent kinase inhibitor 1A
(p21, Cip1) CDKN1A Cyclin-dependent kinase inhibitor 1B (p27, Kip1)
CDKN1B CDKN2A interacting protein N-terminal like CDKN2AIPNL
Cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) CDKN2C
Cyclin-dependent kinase inhibitor 3 (CDK2-associated dual CDKN3
specificity phosphatase) CCAAT/enhancer binding protein (C/EBP),
alpha CEBPA Centrosomal protein 135 kDa CEP135 Centrosomal protein
70 kDa CEP70 Chromatin assembly factor 1, subunit A (p150) CHAF1A
CHK1 checkpoint homolog (S. pombe) CHEK1 Chromogranin A
(parathyroid secretory protein 1) CHGA Chromatin accessibility
complex 1 CHRAC1 Ceroid-lipofuscinosis, neuronal 5 CLN5 Clusterin
CLU Calponin 1, basic, smooth muscle CNN1 Cannabinoid receptor 1
(brain) CNR1 Collagen, type XVIII, alpha 1 COL18A1 Collagen, type
I, alpha 1 COL1A1 Collagen, type IV, alpha 3 (Goodpasture antigen)
COL4A3 COMM domain containing 5 COMMD5 Catechol-O-methyltransferase
COMT Coatomer protein complex, subunit beta 2 (beta prime) COPB2
COP9 constitutive photomorphogenic homolog subunit 5 COPS5
(Arabidopsis) Cytoplasmic polyadenylation element binding protein 3
CPEB3 Cysteine-rich secretory protein 3 CRISP3 V-crk sarcoma virus
CT10 oncogene homolog (avian) CRK V-crk sarcoma virus CT10 oncogene
homolog (avian)-like CRKL Colony stimulating factor 1 receptor,
formerly McDonough CSF1R feline sarcoma viral (v-fms) oncogene
homolog Colony stimulating factor 2 (granulocyte-macrophage) CSF2
Colony stimulating factor 3 receptor (granulocyte) CSF3R C-src
tyrosine kinase CSK Cystatin B (stefin B) CSTB Connective tissue
growth factor CTGF Collagen triple helix repeat containing 1 CTHRC1
Catenin (cadherin-associated protein), alpha 1, 102 kDa CTNNA1
Catenin (cadherin-associated protein), beta 1, 88 kDa CTNNB1
Cathepsin B CTSB Cathepsin L1 CTSL1 Cortactin CTTN Cullin 2 CUL2
Chemokine (C--X--C motif) ligand 14 CXCL14 Chemokine (C--X--C
motif) ligand 9 CXCL9 Chromosome X open reading frame 41 CXorf41
Cytochrome b5 type A (microsomal) CYB5A Cytoplasmic FMR1
interacting protein 1 CYFIP1 Cytochrome P450, family 27, subfamily
A, polypeptide 1 CYP27A1 Cytochrome P450, family 2, subfamily C,
polypeptide 9 CYP2C9 Cytochrome P450, family 3, subfamily A,
polypeptide 5 CYP3A5 Disabled homolog 2, mitogen-responsive
phosphoprotein DAB2 (Drosophila) Death associated protein 3 DAP3
Death-associated protein kinase 1 DAPK1 Deleted in colorectal
carcinoma DCC Dodecenoyl-Coenzyme A delta isomerase (3,2
trans-enoyl- DCI Coenzyme A isomerase) Decorin DCN Dynactin 2 (p50)
DCTN2 Damage-specific DNA binding protein 2, 48 kDa DDB2 Dopa
decarboxylase (aromatic L-amino acid decarboxylase) DDC Development
and differentiation enhancing factor 1 DDEF1 DNA-damage-inducible
transcript 3 DDIT3 DEAD (Asp-Glu-Ala-Asp) box polypeptide 6 DDX6
2,4-dienoyl CoA reductase 2, peroxisomal DECR2 DEK oncogene (DNA
binding) DEK DENN/MADD domain containing 3 DENND3 DEP domain
containing 1B DEPDC1B DEP domain containing 6 DEPDC6 Diacylglycerol
kinase, alpha 80 kDa DGKA DEAH (Asp-Glu-Ala-His) box polypeptide 9
DHX9 Deiodinase, iodothyronine, type II DIO2 DIRAS family,
GTP-binding RAS-like 3 DIRAS3 Dyskeratosis congenita 1, dyskerin
DKC1 DKEZP564O0823 protein DKEZP564O0823 Discs, large homolog 3
(neuroendocrine-dlg, Drosophila) DLG3 Discs, large (Drosophila)
homolog-associated protein 1 DLGAP1 Deleted in malignant brain
tumors 1 DMBT1 Dedicator of cytokinesis 5 DOCK5 Desmoplakin DSP E2F
transcription factor 1 E2F1 E2F transcription factor 2 E2F2 E2F
transcription factor 3 E2F3 E2F transcription factor 4,
p107/p130-binding E2F4 Endothelial differentiation,
lysophosphatidic acid G-protein- EDG7 coupled receptor, 7
Endothelin receptor type B EDNRB Eukaryotic translation elongation
factor 1 alpha 1 EEF1A1 Embryonal Fyn-associated substrate EFS
Epidermal growth factor (beta-urogastrone) EGF Epidermal growth
factor receptor (erythroblastic leukemia EGFR viral (v-erb-b)
oncogene homolog, avian) Early growth response 2 (Krox-20 homolog,
Drosophila) EGR2 Early growth response 3 EGR3 Euchromatic
histone-lysine N-methyltransferase 1 EHMT1 Euchromatic
histone-lysine N-methyltransferase 2 EHMT2 Eukaryotic translation
initiation factor 2-alpha kinase 2 EIF2AK2 Eukaryotic translation
initiation factor 3, subunit H EIF3H ELK1, member of ETS oncogene
family ELK1 ELK3, ETS-domain protein (SRF accessory protein 2) ELK3
Elongation factor RNA polymerase II ELL Elongation factor RNA
polymerase II-like 3 ELL3 Epithelial membrane protein 2 EMP2
Ectonucleotide pyrophosphatase/phosphodiesterase 2 ENPP2
(autotaxin) Enhancer of yellow 2 homolog (Drosophila) ENY2 EPH
receptor A1 EPHA1 EPH receptor B4 EPHB4 Epsin 1 EPN1 Erythropoietin
EPO Epidermal growth factor receptor pathway substrate 15 EPS15
Epidermal growth factor receptor pathway substrate 8 EPS8 V-erb-b2
erythroblastic leukemia viral oncogene homolog 2, ERBB2
neuro/glioblastoma derived oncogene homolog (avian) V-erb-b2
erythroblastic leukemia viral oncogene homolog 3 ERBB3 (avian)
V-erb-a erythroblastic leukemia viral oncogene homolog 4 ERBB4
(avian) Excision repair cross-complementing rodent repair ERCC1
deficiency, complementation group 1 (includes overlapping antisense
sequence) Excision repair cross-complementing rodent repair ERCC2
deficiency, complementation group 2 (xeroderma pigmentosum D)
Excision repair cross-complementing rodent repair ERCC3 deficiency,
complementation group 3 (xeroderma pigmentosum group B
complementing) Excision repair cross-complementing rodent repair
ERCC4 deficiency, complementation group 4 Excision repair
cross-complementing rodent repair ERCC5 deficiency, complementation
group 5 (xeroderma pigmentosum, complementation group G (Cockayne
syndrome)) Excision repair cross-complementing rodent repair ERCC6
deficiency, complementation group 6 V-ets erythroblastosis virus
E26 oncogene homolog (avian) ERG Endoplasmic reticulum to nucleus
signaling 2 ERN2 Estrogen receptor 1 ESR1 Estrogen receptor 2 (ER
beta) ESR2 V-ets erythroblastosis virus E26 oncogene homolog 1 ETS1
(avian) V-ets erythroblastosis virus E26 oncogene homolog 2 ETS2
(avian) Ets variant gene 1 ETV1 Ets variant gene 4 (E1A enhancer
binding protein, E1AF) ETV4 Ets variant gene 6 (TEL oncogene) ETV6
Even-skipped homeobox 1 EVX1 Exocyst complex component 2 EXOC2
Exostoses (multiple) 1 EXT1 Exostoses (multiple) 2 EXT2 Enhancer of
zeste homolog 2 (Drosophila) EZH2 Ezrin EZR Coagulation factor II
(thrombin) receptor F2R Coagulation factor V (proaccelerin, labile
factor) F5 Family with sequence similarity 114, member A1 FAM114A1
Family with sequence similarity 13, member C1 FAM13C1 Family with
sequence similarity 49, member B FAM49B Family with sequence
similarity 84, member B FAM84B Family with sequence similarity 8,
member A1 FAM8A1 Fanconi anemia, complementation group A FANCA
Fanconi anemia, complementation group G FANCG Fas (TNF receptor
superfamily, member 6) FAS Fas ligand (TNF superfamily, member 6)
FASLG Fatty acid synthase FASN Fibulin 1 FBLN1 F-box protein 32
FBXO32 F-box and WD repeat domain containing 11 FBXW11 Farnesyl
diphosphate synthase (farnesyl pyrophosphate FDPS synthetase,
dimethylallyltranstransferase, geranyltranstransferase) Fer
(fps/fes related) tyrosine kinase (phosphoprotein FER NCP94) Feline
sarcoma oncogene FES FEV (ETS oncogene family) FEV Fibroblast
growth factor 12 FGF12 Fibroblast growth factor 3 (murine mammary
tumor virus FGF3 integration site (v-int-2) oncogene homolog)
Fibroblast growth factor 5 FGF5 Fibroblast growth factor 8
(androgen-induced) FGF8 Fibroblast growth factor 9 (glia-activating
factor) FGF9 Fibroblast growth factor receptor 1 (fms-related
tyrosine FGFR1 kinase 2, Pfeiffer syndrome) Fibroblast growth
factor receptor 2 (bacteria-expressed FGFR2 kinase, keratinocyte
growth factor receptor, craniofacial dysostosis 1, Crouzon
syndrome, Pfeiffer syndrome, Jackson-Weiss syndrome) Fibroblast
growth factor receptor 4 FGFR4 Fragile histidine triad gene FHIT
Folliculin FLCN Friend leukemia virus integration 1 FLI1
Hypothetical protein FLJ90709 FLJ90709 Fms-related tyrosine kinase
1 (vascular endothelial growth FLT1 factor/vascular permeability
factor receptor) Fms-related tyrosine kinase 4 FLT4 Flavin
containing monooxygenase 5 FMO5 Fibromodulin FMOD Folate hydrolase
(prostate-specific membrane antigen) 1 FOLH1 Folate receptor 1
(adult) FOLR1 V-fos FBJ murine osteosarcoma viral oncogene homolog
FOS FK506 binding protein 12-rapamycin associated protein 1 FRAP1
Frizzled-related protein FRZB FYN oncogene related to SRC, FGR, YES
FYN Frizzled homolog 7 (Drosophila) FZD7 Gamma-aminobutyric acid
(GABA) A receptor, gamma 2 GABRG2 Growth arrest and
DNA-damage-inducible, alpha GADD45A G protein beta subunit-like GBL
Gastrulation brain homeobox 2 GBX2 Ganglioside-induced
differentiation-associated protein 1 GDAP1 Growth differentiation
factor 15 GDF15 Glioma-associated oncogene homolog 1 (zinc finger
protein) GLI1 Glutaredoxin 2 GLRX2 GPI anchored molecule like
protein GML Geminin, DNA replication inhibitor GMNN Guanine
nucleotide binding protein (G protein), alpha 15 GNA15 GNAS complex
locus GNAS Guanine nucleotide binding protein (G protein), beta
GNB1 polypeptide 1 Glucosamine (UDP-N-acetyl)-2-epimerase/N- GNE
acetylmannosamine kinase N-acetylglucosamine-1-phosphate
transferase, alpha and GNPTAB beta subunits Golgi membrane protein
1 GOLM1 Golgi-localized protein GOLSYN G protein-coupled receptor
137B GPR137B Growth factor receptor-bound protein 2 GRB2 Growth
factor receptor-bound protein 7 GRB7 Gremlin 2, cysteine knot
superfamily, homolog (Xenopus GREM2 laevis) Gastrin-releasing
peptide receptor GRPR Glycogen synthase kinase 3 alpha GSK3A
Glutathione S-transferase pi GSTP1 Glucuronidase, beta GUSB H1
histone family, member X H1FX Heparin-binding EGF-like growth
factor HBEGF HCCA2 protein HCCA2 Host cell factor C1
(VP16-accessory protein) HCFC1 Hemopoietic cell kinase HCK Histone
deacetylase 1 HDAC1 Histone deacetylase 7A HDAC7A Hepatoma-derived
growth factor (high-mobility group HDGF protein 1-like) HECT, C2
and WW domain containing E3 ubiquitin protein HECW2 ligase 2
Hypoxia-inducible factor 1, alpha subunit (basic helix-loop- HIF1A
helix transcription factor) Hydroxymethylbilane synthase HMBS
3-hydroxy-3-methylglutaryl-Coenzyme A reductase HMGCR
Hyaluronan-mediated motility receptor (RHAMM) HMMR Hook homolog 1
(Drosophila) HOOK1 Homeobox A9 HOXA9 Homeobox C4 HOXC4 Hepsin
(transmembrane protease, serine 1) HPN Hypoxanthine
phosphoribosyltransferase 1 (Lesch-Nyhan HPRT1 syndrome) V-Ha-ras
Harvey rat sarcoma viral oncogene homolog HRAS Hydroxysteroid
(17-beta) dehydrogenase 4 HSD17B4 Hydroxysteroid (17-beta)
dehydrogenase 6 homolog HSD17B6 (mouse) Heat shock transcription
factor 4 HSF4 Heat shock 27 kDa protein 1 HSPB1 Intercellular
adhesion molecule 1 (CD54), human rhinovirus ICAM1 receptor
Immediate early response 3 IER3 Interferon, gamma IFNG Interferon
gamma receptor 1 IFNGR1 Insulin-like growth factor 1 (somatomedin
C) IGF1 Insulin-like growth factor 1 receptor IGF1R Insulin-like
growth factor 2 receptor IGF2R Insulin-like growth factor binding
protein 1 IGFBP1 Insulin-like growth factor binding protein 2, 36
kDa IGFBP2 Insulin-like growth factor binding protein 3 IGFBP3
Insulin-like growth factor binding protein 6 IGFBP6 IKAROS family
zinc finger 1 (Ikaros) IKZF1 Interleukin 11 IL11 Interleukin 12A
(natural killer cell stimulatory factor 1, IL12A cytotoxic
lymphocyte maturation factor 1, p35) Interleukin 12B (natural
killer cell stimulatory factor 2, IL12B cytotoxic lymphocyte
maturation factor 2, p40) Interleukin 13 IL13 Interleukin 1, beta
IL1B Interleukin 2 IL2 Interleukin 3 (colony-stimulating factor,
multiple) IL3 Interleukin 4 IL4 Interleukin 6 (interferon, beta 2)
IL6 Interleukin 6 receptor IL6R Interleukin 8 IL8 Integrin-linked
kinase ILK Inner membrane protein, mitochondrial (mitofilin) IMMT
Inhibin, alpha INHA Inhibin, beta A INHBA Interferon regulatory
factor 1 IRF1 Insulin receptor substrate 2 IRS2 ISL LIM homeobox 1
ISL1 Integrin, alpha V (vitronectin receptor, alpha polypeptide,
ITGAV antigen CD51) Integrin, beta 1 (fibronectin receptor, beta
polypeptide, ITGB1 antigen CD29 includes MDF2, MSK12) Integrin,
beta 3 (platelet glycoprotein IIIa, antigen CD61) ITGB3 Integrin,
beta 4 ITGB4 Inositol 1,4,5-trisphosphate 3-kinase A ITPKA Inositol
1,4,5-triphosphate receptor, type 1 ITPR1 Isovaleryl Coenzyme A
dehydrogenase IVD Janus kinase 2 (a protein tyrosine kinase) JAK2
Jumonji, AT rich interactive domain 1A JARID1A Jumonji domain
containing 2B JMJD2B Jun oncogene JUN Jun B proto-oncogene JUNB Jun
D proto-oncogene JUND Potassium channel regulator KCNRG Kinase
insert domain receptor (a type III receptor tyrosine KDR kinase) KH
domain containing, RNA binding, signal transduction KHDRBS3
associated 3 KIAA0196 KIAA0196 KIAA0922 KIAA0922 KIAA1324 KIAA1324
Kinesin family member C2 KIFC2 V-kit Hardy-Zuckerman 4 feline
sarcoma viral oncogene KIT homolog Kruppel-like factor 6 KLF6 Ketch
domain containing 4 KLHDC4 Kallikrein-related peptidase 2 KLK2
Kallikrein-related peptidase 3 KLK3 Kallikrein-related peptidase 4
KLK4 Karyopherin (importin) beta 1 KPNB1 Keratin 15 KRT15 Keratin 5
(epidermolysis bullosa simplex, Dowling- KRT5
Meara/Kobner/Weber-Cockayne types) L1 cell adhesion molecule L1CAM
Lymphocyte-specific protein tyrosine kinase LCK Lipocalin 2 LCN2
Leprecan-like 1 LEPREL1 Leucine-rich repeat-containing G
protein-coupled receptor 4 LGR4 Ligase I, DNA, ATP-dependent LIG1
Ligase III, DNA, ATP-dependent LIG3 LIM domain only 1 (rhombotin 1)
LMO1 LIM domain only 2 (rhombotin-like 1) LMO2 Poly (ADP-ribose)
polymerase family, member 1 LOC649459 Lactotransferrin LOC728320
Hypothetical protein BC008326 LOC89944 Lysyl oxidase LOX Leucine
rich repeat containing 2 LRRC2 Limbic system-associated membrane
protein LSAMP Latent transforming growth factor beta binding
protein 2 LTBP2 Mal, T-cell differentiation protein-like MALL
Mucosa associated lymphoid tissue lymphoma translocation MALT1 gene
1 Monoamine oxidase B MAOB Mitogen-activated protein kinase kinase
6 MAP2K6 Mitogen-activated protein kinase kinase kinase 8 MAP3K8
Mitogen-activated protein kinase 1 MAPK1 Mitogen-activated protein
kinase 10 MAPK10 Mitogen-activated protein kinase 14 MAPK14
MARCKS-like 1 MARCKSL1 MARVEL domain containing 3 MARVELD3 MAS1
oncogene MAS1 Megakaryocyte-associated tyrosine kinase MATK
Methyl-CpG binding domain protein 2 MBD2 Melanoma cell adhesion
molecule MCAM Mutated in colorectal cancers MCC MCF.2 cell line
derived transforming sequence MCF2 Myeloid cell leukemia sequence 1
(BCL2-related) MCL1 Minichromosome maintenance complex component 7
MCM7 Microcephalin 1 MCPH1
Mdm4, transformed 3T3 cell double minute 4, p53 binding MDM4
protein (mouse) Mediator complex subunit 30 MED30 Myocyte enhancer
factor 2C MEF2C Meis homeobox 2 MEIS2 Multiple endocrine neoplasia
I MEN1 Met proto-oncogene (hepatocyte growth factor receptor) MET
Methyltransferase 10 domain containing METT10D Hypothetical protein
MGC15523 MGC15523 Antigen identified by monoclonal antibody Ki-67
MKI67 Myeloid leukemia factor 1 MLF1 Myeloid leukemia factor 2 MLF2
MutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) MLH1
Myeloid/lymphoid or mixed-lineage leukemia (trithorax MLLT3
homolog, Drosophila); translocated to, 3 Myeloid/lymphoid or
mixed-lineage leukemia (trithorax MLLT4 homolog, Drosophila);
translocated to, 4 Myeloid/lymphoid or mixed-lineage leukemia
(trithorax MLLT6 homolog, Drosophila); translocated to, 6 Matrix
metallopeptidase 1 (interstitial collagenase) MMP1 Matrix
metallopeptidase 10 (stromelysin 2) MMP10 Matrix metallopeptidase
14 (membrane-inserted) MMP14 Matrix metallopeptidase 2 (gelatinase
A, 72 kDa gelatinase, MMP2 72 kDa type IV collagenase) Matrix
metallopeptidase 3 (stromelysin 1, progelatinase) MMP3 Matrix
metallopeptidase 7 (matrilysin, uterine) MMP7 Matrix
metallopeptidase 9 (gelatinase B, 92 kDa gelatinase, MMP9 92 kDa
type IV collagenase) V-mos Moloney murine sarcoma viral oncogene
homolog MOS Membrane protein, palmitoylated 7 (MAGUK p55 MPP7
subfamily member 7) Mitochondrial ribosomal protein L13 MRPL13 MutS
homolog 2, colon cancer, nonpolyposis type 1 (E. coli) MSH2 MutS
homolog 3 (E. coli) MSH3 MutS homolog 6 (E. coli) MSH6
Microseminoprotein, beta- MSMB Macrophage scavenger receptor 1 MSR1
Macrophage stimulating 1 receptor (c-met-related tyrosine MST1R
kinase) Metastasis associated 1 MTA1 5,10-methylenetetrahydrofolate
reductase (NADPH) MTHFR Myotrophin MTPN
5-methyltetrahydrofolate-homocysteine methyltransferase MTR
Metastasis suppressor 1 MTSS1 Mucin 1, cell surface associated MUC1
MAX dimerization protein 1 MXD1 MAX interactor 1 MXI1 V-myb
myeloblastosis viral oncogene homolog (avian) MYB V-myb
myeloblastosis viral oncogene homolog (avian)-like 2 MYBL2 Myosin
binding protein C, slow type MYBPC1 V-myc myelocytomatosis viral
oncogene homolog (avian) MYC V-myc myelocytomatosis viral related
oncogene, MYCN neuroblastoma derived (avian) Myosin, heavy chain
11, smooth muscle MYH11 Myosin, light chain 9, regulatory MYL9
Myosin, light chain kinase MYLK N-acetyltransferase 2 (arylamine
N-acetyltransferase) NAT2 Neuroblastoma, suppression of
tumorigenicity 1 NBL1 Nibrin NBN Non-SMC condensin II complex,
subunit D3 NCAPD3 N-myc downstream regulated gene 1 NDRG1 NADH
dehydrogenase (ubiquinone) 1 beta subcomplex, 9, NDUFB9 22 kDa
Neurofilament, heavy polypeptide 200 kDa NEFH Neogenin homolog 1
(chicken) NEO1 Neuropilin (NRP) and tolloid (TLL)-like 2 NETO2
Neurofibromin 1 (neurofibromatosis, von Recklinghausen NF1 disease,
Watson disease) Nuclear factor of kappa light polypeptide gene
enhancer in NFKB1 B-cells 1 (p105) Nuclear factor of kappa light
polypeptide gene enhancer in NFKB2 B-cells 2 (p49/p100) Nuclear
factor of kappa light polypeptide gene enhancer in NFKBIA B-cells
inhibitor, alpha Nitric oxide synthase 3 (endothelial cell) NOS3
Notch homolog 1, translocation-associated (Drosophila) NOTCH1 Notch
homolog 2 (Drosophila) NOTCH2 Notch homolog 4 (Drosophila) NOTCH4
Nephroblastoma overexpressed gene NOV NADPH oxidase 4 NOX4
Aminopeptidase-like 1 NPEPL1 NAD(P)H dehydrogenase, quinone 1 NQO1
Nuclear receptor subfamily 4, group A, member 1 NR4A1 Neuroblastoma
RAS viral (v-ras) oncogene homolog NRAS Neuropilin 1 NRP1
Neurotrophic tyrosine kinase, receptor, type 1 NTRK1 Neurotrophic
tyrosine kinase, receptor, type 2 NTRK2 Neurotrophic tyrosine
kinase, receptor, type 3 NTRK3 Nuclear mitotic apparatus protein 1
NUMA1 Nucleoporin 98 kDa NUP98 Ornithine decarboxylase antizyme 2
OAZ2 Oxysterol binding protein-like 9 OSBPL9 P antigen family,
member 4 (prostate associated) PAGE4 PAP associated domain
containing 1 PAPD1 Par-3 partitioning defective 3 homolog (C.
elegans) PARD3 PAS domain containing serine/threonine kinase PASK
Pre-B-cell leukemia homeobox 1 PBX1 Proliferating cell nuclear
antigen PCNA PCTAIRE protein kinase 1 PCTK1 Platelet-derived growth
factor alpha polypeptide PDGFA Platelet-derived growth factor
receptor, alpha polypeptide PDGFRA Platelet-derived growth factor
receptor, beta polypeptide PDGFRB Protein disulfide isomerase
family A, member 5 PDIA5 PDZ and LIM domain 5 PDLIM5
Phosphatidylethanolamine-binding protein 4 PEBP4
Phosphatidylethanolamine N-methyltransferase PEMT Placental growth
factor, vascular endothelial growth factor- PGF related protein
Phosphoglycerate kinase 1 PGK1 Progesterone receptor PGR
Phosphatase and actin regulator 2 PHACTR2 PHD finger protein
20-like 1 PHF20L1 PHD finger protein 8 PHF8 Phytanoyl-CoA
2-hydroxylase interacting protein-like PHYHIPL Protein inhibitor of
activated STAT, 2 PIAS2 Phosphoinositide-3-kinase, catalytic, alpha
polypeptide PIK3CA Phosphoinositide-3-kinase, catalytic, delta
polypeptide PIK3CD Polycystic kidney and hepatic disease 1
(autosomal PKHD1L1 recessive)-like 1 Phospholipase A2, group IIA
(platelets, synovial fluid) PLA2G2A Phospholipase A2, group VII
(platelet-activating factor PLA2G7 acetylhydrolase, plasma)
Pleiomorphic adenoma gene 1 PLAG1 Plasminogen activator, tissue
PLAT Plasminogen activator, urokinase receptor PLAUR Plasminogen
PLG Plexin domain containing 1 PLXDC1 Promyelocytic leukemia PML
PMS1 postmeiotic segregation increased 1 (S. cerevisiae) PMS1
Polymerase (RNA) I polypeptide C, 30 kDa POLR1C Periostin,
osteoblast specific factor POSTN POU class 2 homeobox 1 POU2F1
Peroxisome proliferator-activated receptor delta PPARD Peroxisome
proliferator-activated receptor gamma PPARG Protein phosphatase 2
(formerly 2A), regulatory subunit A, PPP2R1B beta isoform Papillary
renal cell carcinoma (translocation-associated) PRCC Peroxisomal
proliferator-activated receptor A interacting PRIC285 complex 285
Protein kinase, cAMP-dependent, regulatory, type I, alpha PRKAR1A
(tissue specific extinguisher 1) Protease, serine, 8 PRSS8 Prostate
stem cell antigen PSCA Proteasome (prosome, macropain) 26S subunit,
non- PSMD1 ATPase, 1 Patched homolog 1 (Drosophila) PTCH1 Patched
homolog 2 (Drosophila) PTCH2 Prostaglandin E receptor 3 (subtype
EP3) PTGER3 Prostaglandin-endoperoxide synthase 1 (prostaglandin
G/H PTGS1 synthase and cyclooxygenase) Prostaglandin-endoperoxide
synthase 2 (prostaglandin G/H PTGS2 synthase and cyclooxygenase)
Parathyroid hormone-like hormone PTHLH PTK2 protein tyrosine kinase
2 PTK2 PTK7 protein tyrosine kinase 7 PTK7 Pleiotrophin (heparin
binding growth factor 8, neurite PTN growth-promoting factor 1)
Protein tyrosine phosphatase type IVA, member 3 PTP4A3 Protein
tyrosine phosphatase-like (proline instead of PTPLB catalytic
arginine), member b Protein tyrosine phosphatase, receptor type, F
PTPRF Protein tyrosine phosphatase, receptor type, G PTPRG Protein
tyrosine phosphatase, receptor type, H PTPRH Protein tyrosine
phosphatase, receptor type, N polypeptide 2 PTPRN2 Poly-U binding
splicing factor 60 KDa PUF60 Purine-rich element binding protein A
PURA Paxillin PXN Pyrroline-5-carboxylate reductase 1 PYCR1
Pyrroline-5-carboxylate reductase-like PYCRL Glutaminyl-tRNA
synthetase QARS RAB32, member RAS oncogene family RAB32 RAB8A,
member RAS oncogene family RAB8A Rabaptin, RAB GTPase binding
effector protein 2 RABEP2 RAD21 homolog (S. pombe) RAD21 RAD23
homolog A (S. cerevisiae) RAD23A RAD50 homolog (S. cerevisiae)
RAD50 RAD54 homolog B (S. cerevisiae) RAD54B V-raf-1 murine
leukemia viral oncogene homolog 1 RAF1 V-ral simian leukemia viral
oncogene homolog B (ras RALB related; GTP binding protein) RAP1,
GTP-GDP dissociation stimulator 1 RAP1GDS1 RAP2A, member of RAS
oncogene family RAP2A Retinoic acid receptor, alpha RARA RAS p21
protein activator (GTPase activating protein) 1 RASA1
Retinoblastoma 1 (including osteosarcoma) RB1 Retinoblastoma
binding protein 6 RBBP6 Retinoblastoma-like 2 (p130) RBL2 Retinol
dehydrogenase 11 (all-trans/9-cis/11-cis) RDH11 RecQ protein-like
(DNA helicase Q1-like) RECQL RecQ protein-like 4 RECQL4 V-rel
reticuloendotheliosis viral oncogene homolog (avian) REL V-rel
reticuloendotheliosis viral oncogene homolog A, RELA nuclear factor
of kappa light polypeptide gene enhancer in B-cells 3, p65 (avian)
Ret proto-oncogene RET Ras homolog gene family, member A RHOA Ras
homolog gene family, member H RHOH Receptor (TNFRSF)-interacting
serine-threonine kinase 1 RIPK1 Relaxin 1 RLN1 Ring finger protein
139 RNF139 Ring finger protein 185 RNF185 V-ros UR2 sarcoma virus
oncogene homolog 1 (avian) ROS1 Replication protein A1, 70 kDa RPA1
Ras-related GTP binding C RRAGC Related RAS viral (r-ras) oncogene
homolog RRAS Rhabdoid tumor deletion region gene 1 RTDR1 S100
calcium binding protein A4 S100A4 Sterile alpha motif domain
containing 12 SAMD12 Stearoyl-CoA desaturase 5 SCD5 Sodium channel
and clathrin linker 1 SCLT1 Sodium channel, nonvoltage-gated 1
alpha SCNN1A Scribbled homolog (Drosophila) SCRIB Syndecan 2 SDC2
Succinate dehydrogenase complex, subunit B, iron sulfur SDHB (Ip)
Succinate dehydrogenase complex, subunit C, integral SDHC membrane
protein, 15 kDa SEC14-like 1 (S. cerevisiae) SEC14L1 Sema domain,
immunoglobulin domain (Ig), short basic SEMA3F domain, secreted,
(semaphorin) 3F Serpin peptidase inhibitor, clade B (ovalbumin),
member 5 SERPINB5 Serpin peptidase inhibitor, clade I
(neuroserpin), member 1 SERPINI1 Splicing factor 1 SF1 Secreted
frizzled-related protein 4 SFRP4 SH3-domain binding protein 2
SH3BP2 SH3 domain containing ring finger 2 SH3RF2 Sonic hedgehog
homolog (Drosophila) SHH Seven in absentia homolog 1 (Drosophila)
SIAH1 V-ski sarcoma viral oncogene homolog (avian) SKI SKI-like
oncogene SKIL Solute carrier family 14 (urea transporter), member 1
(Kidd SLC14A1 blood group) Solute carrier family 20 (phosphate
transporter), member 1 SLC20A1 Solute carrier family 22
(extraneuronal monoamine SLC22A3 transporter), member 3 Solute
carrier family 25, member 42 SLC25A42 Solute carrier family 44,
member 1 SLC44A1 Solute carrier family 45, member 3 SLC45A3 SMAD
family member 4 SMAD4 SWI/SNF related, matrix associated, actin
dependent SMARCB1 regulator of chromatin, subfamily b, member 1
SWI/SNF related, matrix associated, actin dependent SMARCC1
regulator of chromatin, subfamily c, member 1 Sphingomyelin
phosphodiesterase, acid-like 3B SMPDL3B Small nuclear
ribonucleoprotein polypeptide E SNRPE Syntrophin, beta 1
(dystrophin-associated protein A1, SNTB1 59 kDa, basic component 1)
Syntrophin, beta 2 (dystrophin-associated protein A1, SNTB2 59 kDa,
basic component 2) Syntrophin, gamma 1 SNTG1 Suppressor of cytokine
signaling 7 SOCS7
Superoxide dismutase 1, soluble (amyotrophic lateral SOD1 sclerosis
1 (adult)) Secreted protein, acidic, cysteine-rich (osteonectin)
SPARC SAM pointed domain containing ets transcription factor SPDEF
Spleen focus forming virus (SFFV) proviral integration SPI1
oncogene spi1 Secreted phosphoprotein 1 (osteopontin, bone
sialoprotein I, SPP1 early T-lymphocyte activation 1) Squalene
epoxidase SQLE Sulfide quinone reductase-like (yeast) SQRDL V-src
sarcoma (Schmidt-Ruppin A-2) viral oncogene SRC homolog (avian)
Steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 SRD5A2
alpha-steroid delta 4-dehydrogenase alpha 2) ST3 beta-galactoside
alpha-2,3-sialyltransferase 1 ST3GAL1 ST3 beta-galactoside
alpha-2,3-sialyltransferase 5 ST3GAL5 ST6 beta-galactosamide
alpha-2,6-sialyltranferase 1 ST6GAL1 Suppression of tumorigenicity
7 ST7 Signal transducer and activator of transcription 1, 91 kDa
STAT1 Signal transducer and activator of transcription 3 (acute-
STAT3 phase response factor) Signal transducer and activator of
transcription 5B STAT5B Six transmembrane epithelial antigen of the
prostate 2 STEAP2 Stress-induced-phosphoprotein 1
(Hsp70/Hsp90-organizing STIP1 protein) Serine/threonine kinase 11
STK11 Spleen tyrosine kinase SYK Synapsin I SYN1 Synapsin III SYN3
Tumor-associated calcium signal transducer 1 TACSTD1 TATA box
binding protein (TBP)-associated factor, RNA TAF1C polymerase I, C,
110 kDa TAF2 RNA polymerase II, TATA box binding protein TAF2
(TBP)-associated factor, 150 kDa T-cell acute lymphocytic leukemia
1 TAL1 Tax1 (human T-cell leukemia virus type I) binding protein 1
TAX1BP1 TATA box binding protein TBP Transcription factor 7-like 2
(T-cell specific, HMG-box) TCF7L2 TEK tyrosine kinase, endothelial
(venous malformations, TEK multiple cutaneous and mucosal)
Telomerase reverse transcriptase TERT Transcription factor AP-2
gamma (activating enhancer TFAP2C binding protein 2 gamma)
Transcription factor Dp-1 TFDP1 Transcription factor binding to
IGHM enhancer 3 TFE3 Trefoil factor 1 TFF1 TRK-fused gene TFG
Transferrin receptor (p90, CD71) TFRC Transforming growth factor,
alpha TGFA Transforming growth factor, beta 1 TGFB1 Transforming
growth factor, beta 2 TGFB2 Transforming growth factor, beta 3
TGFB3 Transforming growth factor, beta-induced, 68 kDa TGFBI
Transforming growth factor, beta receptor I (activin A TGFBR1
receptor type II-like kinase, 53 kDa) Transforming growth factor,
beta receptor II (70/80 kDa) TGFBR2 Transforming growth factor,
beta receptor III TGFBR3 Transglutaminase 2 (C polypeptide,
protein-glutamine- TGM2 gamma-glutamyltransferase) Thrombospondin 1
THBS1 Thrombospondin 2 THBS2 Thrombopoietin (myeloproliferative
leukemia virus THPO oncogene ligand, megakaryocyte growth and
development factor) T-cell lymphoma invasion and metastasis 1 TIAM1
TIMP metallopeptidase inhibitor 2 TIMP2 Thymidine kinase 1, soluble
TK1 Transmembrane protein with EGF-like and two follistatin- TMEFF2
like domains 2 Transmembrane protein 134 TMEM134 Transmembrane
protein 45B TMEM45B Transmembrane protein 65 TMEM65 Transmembrane
protein 71 TMEM71 Transmembrane protease, serine 2 TMPRSS2 Tumor
necrosis factor receptor superfamily, member 10a TNFRSF10A Tumor
necrosis factor receptor superfamily, member 10b TNFRSF10B Tumor
necrosis factor receptor superfamily, member 11a, TNFRSF11A NFKB
activator Tumor necrosis factor receptor superfamily, member 11b
TNFRSF11B (osteoprotegerin) Tumor necrosis factor receptor
superfamily, member 1A TNFRSF1A Tumor necrosis factor (ligand)
superfamily, member 10 TNFSF10 Tumor necrosis factor (ligand)
superfamily, member 8 TNFSF8 Topoisomerase (DNA) I TOP1
Topoisomerase (DNA) II alpha 170 kDa TOP2A Tumor protein p53
(Li-Fraumeni syndrome) TP53 Tumor protein p53 inducible protein 11
TP53I11 Tumor protein p73 TP73 Translocated promoter region (to
activated MET oncogene) TPR TPX2, microtubule-associated, homolog
(Xenopus laevis) TPX2 Tripartite motif-containing 38 TRIM38 TRNA
methyltransferase 12 homolog (S. cerevisiae) TRMT12 Transient
receptor potential cation channel, subfamily M, TRPM8 member 8
Trichorhinophalangeal syndrome I TRPS1 Tuberous sclerosis 1 TSC1
Tuberous sclerosis 2 TSC2 Tetraspanin 13 TSPAN13 Tetraspanin 14
TSPAN14 Tissue specific transplantation antigen P35B TSTA3
Tetratricopeptide repeat domain 29 TTC29 Thymidylate synthetase
TYMS TYRO3 protein tyrosine kinase TYRO3 Ubiquitin-conjugating
enzyme E2, J2 (UBC6 homolog, UBE2J2 yeast) UBX domain containing 3
UBXD3 Vesicle-associated membrane protein 2 (synaptobrevin 2) VAMP2
Vav 1 guanine nucleotide exchange factor VAV1 Vav 2 guanine
nucleotide exchange factor VAV2 Versican VCAN Vascular endothelial
growth factor A VEGFA Vestigial like 3 (Drosophila) VGLL3
Wiskott-Aldrich syndrome (eczema-thrombocytopenia) WAS WD repeat
domain 67 WDR67 WEE1 homolog (S. pombe) WEE1 WNT1 inducible
signaling pathway protein 1 WISP1 Wingless-type MMTV integration
site family, member 10B WNT10B Wingless-type MMTV integration site
family member 2 WNT2 Wingless-type MMTV integration site family,
member 2B WNT2B Wingless-type MMTV integration site family, member
5A WNT5A Wingless-type MMTV integration site family, member 8B
WNT8B Werner syndrome WRN Wilms tumor 1 WT1 Xanthine dehydrogenase
XDH Xeroderma pigmentosum, complementation group A XPA Xeroderma
pigmentosum, complementation group C XPC X-ray repair complementing
defective repair in Chinese XRCC1 hamster cells 1 X-ray repair
complementing defective repair in Chinese XRCC4 hamster cells 4
X-ray repair complementing defective repair in Chinese XRCC5
hamster cells 5 (double-strand-break rejoining; Ku autoantigen, 80
kDa) X-ray repair complementing defective repair in Chinese XRCC6
hamster cells 6 (Ku autoantigen, 70 kDa) V-yes-1 Yamaguchi sarcoma
viral oncogene homolog 1 YES1 Yip1 domain family, member 1 YIPF1
Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase YWHAB
activation protein, beta polypeptide Zinc finger protein 36, C3H
type, homolog (mouse) ZFP36 Zinc finger protein 313 ZNF313 Zinc
finger protein 34 ZNF34 Zinc finger protein 511 ZNF511 Zinc finger
protein 7 ZNF7
TABLE-US-00007 TABLE 7 RNA transcripts used to derive metagene
values for 18-RNA metagene depicted in FIG. 3. The 6-RNA metagene
is a subset of the sequences listed in Table 7, also depicted in
FIG. 3. 18-RNA metagene scores were scaled and normalized to
generate `POP` scores depicted in FIG. 4. Weighting factors were
from the linear regression coefficient values; positive and
negative values indicated transcripts correlated to increased
expression in `SYS` and `NED` disease, respectively with
intermediate expression values in the `PSA` disease group. SEQ ID
No Weights 1 -6.08 2 -5.71 3 -5.68 4 -5.39 5 -5.26 6 -4.84 7 -4.7 8
-4.68 9 -4.66 10 -4.55 11 -4.53 914 5.32 915 5.27 916 4.82 917 4.64
918 4.59 919 4.54 920 4.49
TABLE-US-00008 TABLE 8 RNA transcripts used to derive metagene
values for 20-RNA metagene depicted in FIG. 3. Weighting factors
were from the linear regression coefficient values; positive and
negative values indicated transcripts correlated to increased
expression in `SYS` and `NED` disease, respectively with
intermediate expression values in the `PSA` disease group. SEQ ID
No Weights 1 -6.08 4 -5.39 6 -4.84 9 -4.66 14 -4.37 15 -4.32 16
-4.27 18 -4.2 19 -4.18 20 -4.1 21 -4.09 915 5.27 916 4.82 917 4.64
920 4.49 922 4.43 928 4.27 929 4.27 931 4.17 935 4.08 936 4.07
TABLE-US-00009 TABLE 9 RNA transcripts used to derive 10-RNA
metagene values, which were converted by scaling and normalizing
into `POP` scores depicted in FIG. 5. RNA transcripts were
identified using Nearest Shrunken Centroids algorithm with
leave-1-out cross-validation to distinguish `recurren` (i.e.,
`SYS`) and `non-recurrent` (i.e., `PSA` and `NED`) disease from
Table 3 RNA transcripts. Weighting factors were from the test
statistic values; positive and negative values indicated
transcripts correlated to increased expression in `recurrent` and
`non-recurrent` disease, respectively. Seq ID Weights 3 -5.48 36
-4.93 60 -5.72 63 -4.79 926 4.61 971 4.68 978 5.27 999 4.74 1014
4.86 1022 6.29
TABLE-US-00010 TABLE 10 RNA transcripts used to derive 41-RNA
metagene values, which were converted by scaling and normalizing
into `POP` scores depicted in FIG. 6. RNA transcripts were
identified using Nearest Shrunken Centroids algorithm with
leave-1-out cross-validation to distinguish `recurrent` (i.e.,
`SYS`) and `non-recurrent` (i.e., `PSA` and `NED`) disease from
Table 3 RNA transcripts. Weighting factors were from the test
statistic values; positive and negative values indicated
transcripts correlated to increased expression in `recurrent` and
`non-recurrent` disease, respectively. Seq ID Weights 1 -4.1 2
-4.21 3 -5.48 32 -3.87 33 -3.75 36 -4.93 46 -4.14 60 -5.72 63 -4.79
66 -4.02 69 -3.25 88 -4.54 100 -3.63 241 -4.16 265 -3.86 334 -3.36
437 -4.02 920 4.36 925 3.04 934 3.65 945 4.03 947 4.44 954 4.34 971
4.68 978 5.27 999 4.74 1004 4.5 1014 4.86 1022 6.29 1023 4.08 1032
3.49 1080 3.97 1093 4.02 1101 3.55 1164 3.54 1248 3.56 1304 3.14
1311 3.66 1330 3.02 1402 3.45 1425 3.73
[0226] Although the invention has been described with reference to
certain specific embodiments, various modifications thereof will be
apparent to those skilled in the art without departing from the
spirit and scope of the invention. All such modifications as would
be apparent to one skilled in the art are intended to be included
within the scope of the following claims.
Sequence CWU 0 SQTB SEQUENCE LISTING The patent application
contains a lengthy "Sequence Listing" section. A copy of the
"Sequence Listing" is available in electronic form from the USPTO
web site
(http://seqdata.uspto.gov/?pageRequest=docDetail&DocID=US20110136683A1).
An electronic copy of the "Sequence Listing" will also be available
from the USPTO upon request and payment of the fee set forth in 37
CFR 1.19(b)(3).
0 SQTB SEQUENCE LISTING The patent application contains a lengthy
"Sequence Listing" section. A copy of the "Sequence Listing" is
available in electronic form from the USPTO web site
(http://seqdata.uspto.gov/?pageRequest=docDetail&DocID=US20110136683A1).
An electronic copy of the "Sequence Listing" will also be available
from the USPTO upon request and payment of the fee set forth in 37
CFR 1.19(b)(3).
* * * * *
References